{"sentText": "Agents that have only begun to undergo clinical evaluation include CI1033 an irreversible pan erbB tyrosine kinase inhibitor and PKI166 and GW572016 both examples of dual kinase inhibitors inhibiting epidermal growth factor receptor and Her2", "relationMentions": [{"em1Text": "CI1033", "em2Text": "erbB", "label": "CPR:4"}, {"em1Text": "CI1033", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "PKI166", "label": "CPR:4"}, {"em1Text": "PKI166", "em2Text": "epidermal growth factor receptor", "label": "CPR:4"}, {"em1Text": "PKI166", "em2Text": "Her2", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "epidermal growth factor receptor", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "Her2", "label": "CPR:4"}]}
{"sentText": "Epidermal growth factor receptor inhibitors currently under investigation include the small molecules gefitinib Iressa ZD1839 and erlotinib Tarceva OSI774 as well as monoclonal antibodies such as cetuximab IMC225 Erbitux", "relationMentions": [{"em1Text": "Epidermal growth factor receptor", "em2Text": "gefitinib", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "Iressa", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "ZD1839", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "erlotinib", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "Tarceva", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "OSI774", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "cetuximab", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "IMC225", "label": "CPR:4"}, {"em1Text": "Epidermal growth factor receptor", "em2Text": "Erbitux", "label": "CPR:4"}]}
{"sentText": "Alprenolol and BAAM at 107 3 x 107 and 106 M inhibited the cardiac stimulation response slightly which is indicative of membranestabilizing activity independent of betaadrenoceptor blockade", "relationMentions": [{"em1Text": "Alprenolol", "em2Text": "betaadrenoceptor", "label": "CPR:4"}, {"em1Text": "BAAM", "em2Text": "betaadrenoceptor", "label": "CPR:4"}]}
{"sentText": "Alprenolol and BAAM also caused surmountable antagonism of isoprenaline responses and this beta 1adrenoceptor antagonism was slowly reversible", "relationMentions": [{"em1Text": "isoprenaline", "em2Text": "beta 1adrenoceptor", "label": "CPR:5"}, {"em1Text": "Alprenolol", "em2Text": "beta 1adrenoceptor", "label": "CPR:6"}, {"em1Text": "BAAM", "em2Text": "beta 1adrenoceptor", "label": "CPR:6"}]}
{"sentText": "We conclude that alprenolol and BAAM are competitive slowly reversible beta 1adrenoceptor antagonists on rat left atria", "relationMentions": [{"em1Text": "alprenolol", "em2Text": "beta 1adrenoceptor", "label": "CPR:6"}, {"em1Text": "BAAM", "em2Text": "beta 1adrenoceptor", "label": "CPR:6"}]}
{"sentText": "Alprenolol and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the beta 1adrenoceptors of rat left atria", "relationMentions": [{"em1Text": "Alprenolol", "em2Text": "beta 1adrenoceptors", "label": "CPR:6"}, {"em1Text": "bromoacetylalprenololmenthane", "em2Text": "beta 1adrenoceptors", "label": "CPR:6"}]}
{"sentText": "Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase2 a structural basis for the reduction of albumin binding", "relationMentions": [{"em1Text": "anthranilic acid sulfonamides", "em2Text": "albumin", "label": "CPR:4"}]}
{"sentText": "Adenine phosphoribosyltransferase plays a role in purine salvage by catalyzing the direct conversion of adenine to adenosine monophosphate", "relationMentions": [{"em1Text": "Adenine phosphoribosyltransferase", "em2Text": "adenine", "label": "CPR:9"}, {"em1Text": "Adenine phosphoribosyltransferase", "em2Text": "adenosine monophosphate", "label": "CPR:9"}]}
{"sentText": "BACKGROUND Since the introduction of the first cholinesterase inhibitor ChEI in 1997 most clinicians and probably most patients would consider the cholinergic drugs donepezil galantamine and rivastigmine to be the first line pharmacotherapy for mild to moderate Alzheimers diseaseThe drugs have slightly different pharmacological properties but they all work by inhibiting the breakdown of acetylcholine an important neurotransmitter associated with memory by blocking the enzyme acetylcholinesterase", "relationMentions": [{"em1Text": "cholinesterase", "em2Text": "donepezil", "label": "CPR:4"}, {"em1Text": "donepezil", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "cholinesterase", "em2Text": "galantamine", "label": "CPR:4"}, {"em1Text": "galantamine", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "cholinesterase", "em2Text": "rivastigmine", "label": "CPR:4"}, {"em1Text": "rivastigmine", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "acetylcholine", "em2Text": "acetylcholinesterase", "label": "CPR:9"}]}
{"sentText": "Mitiglinide KAD1229 a new antidiabetic drug is thought to stimulate insulin secretion by closing the ATPsensitive K KATP channels in pancreatic betacells", "relationMentions": [{"em1Text": "KAD1229", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "Mitiglinide", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "KAD1229", "em2Text": "ATPsensitive K KATP channels", "label": "CPR:4"}, {"em1Text": "Mitiglinide", "em2Text": "ATPsensitive K KATP channels", "label": "CPR:4"}]}
{"sentText": "Patchclamp analysis using insideout recording configuration showed that mitiglinide inhibits the Kir62 SUR1 channel currents in a dosedependent manner IC50 value 100 nM but does not significantly inhibit either Kir62SUR2A or Kir62SUR2B channel currents even at high doses more than 10 microM", "relationMentions": [{"em1Text": "mitiglinide", "em2Text": "Kir62", "label": "CPR:4"}, {"em1Text": "mitiglinide", "em2Text": "SUR1", "label": "CPR:4"}]}
{"sentText": "Nateglinide inhibits Kir62 SUR1 and Kir62 SUR2B channels at 100 nM and inhibits Kir62 SUR2A channels at high concentrations 1 microM", "relationMentions": [{"em1Text": "Nateglinide", "em2Text": "Kir62", "label": "CPR:4"}, {"em1Text": "Nateglinide", "em2Text": "SUR1", "label": "CPR:4"}, {"em1Text": "Nateglinide", "em2Text": "Kir62", "label": "CPR:4"}, {"em1Text": "Nateglinide", "em2Text": "SUR2B", "label": "CPR:4"}, {"em1Text": "Nateglinide", "em2Text": "Kir62", "label": "CPR:4"}, {"em1Text": "Nateglinide", "em2Text": "SUR2A", "label": "CPR:4"}]}
{"sentText": "These results indicate that similar to the sulfonylureas mitiglinide is highly specific to the Kir62SUR1 complex ie the pancreatic betacell KATP channel and suggest that mitiglinide may be a clinically useful antidiabetic drug", "relationMentions": [{"em1Text": "mitiglinide", "em2Text": "KATP channel", "label": "CPR:5"}]}
{"sentText": "Although generally highly specific for angiotensin II type 1 receptors some ARBs particularly telmisartan are partial agonists at peroxisome proliferatoractivated receptor\u03b3", "relationMentions": [{"em1Text": "telmisartan", "em2Text": "peroxisome proliferatoractivated receptor\u03b3", "label": "CPR:5"}, {"em1Text": "angiotensin II type 1 receptors", "em2Text": "telmisartan", "label": "CPR:6"}]}
{"sentText": "In further studies the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats displayed a relatively rapid onset to action and were dosedependently antagonized by 30 minutes pretreatment with rimonabant but not by the vanilloid receptor type I antagonist capsazepine nor were the effects of WIN 55212 antagonized by the CB2 antagonist AM630 6iodo2methyl124morpholinylethyl1Hindol3yl4methoxyphenyl methanone", "relationMentions": [{"em1Text": "CB1", "em2Text": "AM4054", "label": "CPR:5"}, {"em1Text": "WIN 55212", "em2Text": "CB2", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "rimonabant", "label": "CPR:6"}, {"em1Text": "vanilloid receptor type I", "em2Text": "capsazepine", "label": "CPR:6"}, {"em1Text": "CB2", "em2Text": "AM630", "label": "CPR:6"}, {"em1Text": "CB2", "em2Text": "6iodo2methyl124morpholinylethyl1Hindol3yl4methoxyphenyl methanone", "label": "CPR:6"}]}
{"sentText": "Directacting CB1 agonists including \u03949tetrahydrocannabinol WIN 55212 R123dihydro5methyl3morpholinylmethylpyrrolo123de14benzoxazinyl1naphthalenylmethanone mesylate AM2389 9\u03b2hydroxy31hexylcyclobut1ylhexahydrocannabinol and AM4054 9\u03b2hydroxymethyl31adamantylhexahydrocannabinol produced dosedependent increases in diuresis and decreases in colonic temperature with slightly lower ED50 values for diuresis than for hypothermia", "relationMentions": [{"em1Text": "CB1", "em2Text": "\u03949tetrahydrocannabinol", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "WIN 55212", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "R123dihydro5methyl3morpholinylmethylpyrrolo123de14benzoxazinyl1naphthalenylmethanone mesylate", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "AM2389", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "9\u03b2hydroxy31hexylcyclobut1ylhexahydrocannabinol", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "AM4054", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "9\u03b2hydroxymethyl31adamantylhexahydrocannabinol", "label": "CPR:5"}]}
{"sentText": "Methanandamide 100 mgkg had lesser effect than other CB agonists and the CB2 agonist AM1241 1methylpiperidin2ylmethyl32iodo5nitrobenzoylindole the anandamide transport inhibitor AM404 and the CB antagonist rimonabant did not have diuretic effects", "relationMentions": [{"em1Text": "CB2", "em2Text": "AM1241", "label": "CPR:5"}, {"em1Text": "CB2", "em2Text": "1methylpiperidin2ylmethyl32iodo5nitrobenzoylindole", "label": "CPR:5"}, {"em1Text": "CB2", "em2Text": "AM404", "label": "CPR:5"}]}
{"sentText": "N2cyclohexyloxyl4nitrophenylmethanesulfonamide NS398 a selective cyclooxygenase2 inhibitor also inhibited cell proliferation whereas it did not cause apoptosis", "relationMentions": [{"em1Text": "N2cyclohexyloxyl4nitrophenylmethanesulfonamide", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "NS398", "em2Text": "cyclooxygenase2", "label": "CPR:4"}]}
{"sentText": "Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta14galactosyltransferase I Beta14galactosyltransferase I beta4GalT1 normally transfers Gal from UDPGal to GlcNAc in the presence of Mn2 ion GalT activity and also transfers Glc from UDPGlc to GlcNAc GlcT activity albeit at only 03 efficiency", "relationMentions": [{"em1Text": "lysine", "em2Text": "glucosyltransferase", "label": "CPR:3"}, {"em1Text": "UDPGlc", "em2Text": "GlcT", "label": "CPR:9"}, {"em1Text": "GalT", "em2Text": "UDPGal", "label": "CPR:9"}, {"em1Text": "beta4GalT1", "em2Text": "UDPGal", "label": "CPR:9"}]}
{"sentText": "In this study a novel series of 2hydroxydiarylamide derivatives were synthesized and evaluated for inhibiting TMPRSS4 serine protease activity and suppressing cancer cell invasion", "relationMentions": [{"em1Text": "2hydroxydiarylamide", "em2Text": "TMPRSS4", "label": "CPR:4"}, {"em1Text": "2hydroxydiarylamide", "em2Text": "serine protease", "label": "CPR:4"}]}
{"sentText": "Discovery of novel 2hydroxydiarylamide derivatives as TMPRSS4 inhibitors", "relationMentions": [{"em1Text": "2hydroxydiarylamide", "em2Text": "TMPRSS4", "label": "CPR:4"}]}
{"sentText": "In contrast the selective beta2AR antagonists ICI118551 and butoxamine inhibited isoproterenol mediated enhancement with apparent low affinities Kb of 222 61 and 9268 512 nM respectively", "relationMentions": [{"em1Text": "beta2AR", "em2Text": "isoproterenol", "label": "CPR:5"}, {"em1Text": "beta2AR", "em2Text": "butoxamine", "label": "CPR:6"}, {"em1Text": "beta2AR", "em2Text": "ICI118551", "label": "CPR:6"}]}
{"sentText": "Together this pharmacological profile of subtypeselective betaAR antagonists indicates that in this model beta1AR activation is responsible for the enhanced hippocampal CA3 network activity initiated by isoproterenol", "relationMentions": [{"em1Text": "beta1AR", "em2Text": "isoproterenol", "label": "CPR:5"}]}
{"sentText": "The selective betaAR agonist isoproterenol caused an enhancement of hippocampal CA3 network activity as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region", "relationMentions": [{"em1Text": "betaAR", "em2Text": "isoproterenol", "label": "CPR:5"}]}
{"sentText": "The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol induced enhancement with apparent Kb values of 85 36 and 39 17 nM respectively", "relationMentions": [{"em1Text": "beta1AR", "em2Text": "isoproterenol", "label": "CPR:5"}, {"em1Text": "beta1AR", "em2Text": "atenolol", "label": "CPR:6"}, {"em1Text": "beta1AR", "em2Text": "metoprolol", "label": "CPR:6"}]}
{"sentText": "P2Y2 receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice", "relationMentions": [{"em1Text": "P2Y2 receptor", "em2Text": "INS37217", "label": "CPR:5"}]}
{"sentText": "Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate", "relationMentions": [{"em1Text": "GluR5", "em2Text": "topiramate", "label": "CPR:4"}, {"em1Text": "kainate receptors", "em2Text": "topiramate", "label": "CPR:4"}]}
{"sentText": "In wholecell voltageclamp recordings from principal neurons of the rat basolateral amygdala topiramate at low concentrations IC50 approximately 05 microm selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit", "relationMentions": [{"em1Text": "topiramate", "em2Text": "kainate receptors", "label": "CPR:4"}, {"em1Text": "topiramate", "em2Text": "GluR5", "label": "CPR:4"}]}
{"sentText": "Topiramate also partially depressed predominantly AMPAreceptor mediated EPSCs but with lower efficacy", "relationMentions": [{"em1Text": "Topiramate", "em2Text": "AMPAreceptor", "label": "CPR:4"}]}
{"sentText": "Selective antagonism of GluR5 kainatereceptor mediated synaptic currents by topiramate in rat basolateral amygdala neurons", "relationMentions": [{"em1Text": "GluR5", "em2Text": "topiramate", "label": "CPR:6"}, {"em1Text": "kainatereceptor", "em2Text": "topiramate", "label": "CPR:6"}]}
{"sentText": "Density functional theory calculations using the hybrid functional B3LYP have been performed to study the methyl transfer step in glycine Nmethyltransferase GNMT", "relationMentions": [{"em1Text": "methyl", "em2Text": "glycine Nmethyltransferase", "label": "CPR:9"}, {"em1Text": "methyl", "em2Text": "GNMT", "label": "CPR:9"}]}
{"sentText": "The starting point for the calculations is the recent Xray crystal structure of GNMT complexed with SAM and acetate", "relationMentions": [{"em1Text": "GNMT", "em2Text": "SAM", "label": "CPR:9"}]}
{"sentText": "In this study we demonstrate significant inhibitory activity of dasatinib against both wildtype KIT and the KIT D816V mutation in the nanomolar range in in vitro and cellbased kinase assays", "relationMentions": [{"em1Text": "dasatinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "dasatinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "dasatinib", "em2Text": "D816V", "label": "CPR:4"}]}
{"sentText": "Additionally dasatinib leads to growth inhibition of a KIT D816V harboring human mastocytosis cell line", "relationMentions": [{"em1Text": "dasatinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "dasatinib", "em2Text": "D816V", "label": "CPR:4"}]}
{"sentText": "Dasatinib BMS354825 inhibits KIT D816V an imatinibresistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis", "relationMentions": [{"em1Text": "Dasatinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "D816V", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "D816V", "label": "CPR:4"}]}
{"sentText": "Dasatinib BMS354825 is a novel orally bioavailable SRC ABL inhibitor that has activity against multiple imatinibresistant BCRABL isoforms in vitro that is presently showing considerable promise in earlyphase clinical trials of chronic myeloid leukemia CML", "relationMentions": [{"em1Text": "Dasatinib", "em2Text": "SRC", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "SRC", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "ABL", "label": "CPR:4"}]}
{"sentText": "The results reinforce previous assumptions that dopamine may interact with eicosanoid metabolism by means of D2 receptor activation and implicate an involvement of cPLA2 and COX2 in this effect", "relationMentions": [{"em1Text": "dopamine", "em2Text": "D2 receptor", "label": "CPR:3"}]}
{"sentText": "It was also antagonized by the nonspecific cyclooxygenase COX inhibitor indomethacin and by the selective COX2 inhibitor NS398 but not by the specific COX1 inhibitor valeryl salicylate", "relationMentions": [{"em1Text": "cyclooxygenase", "em2Text": "indomethacin", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "indomethacin", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "NS398", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "valeryl salicylate", "label": "CPR:4"}]}
{"sentText": "Both the nonspecific phospholipase A2 inhibitor quinacrine and an inhibitor of cPLA2 and iPLA2 AACOF3 counteracted the effect in contrast a selective iPLA2 inhibitor BEL and a selective sPLA2 inhibitor TAPC were ineffective", "relationMentions": [{"em1Text": "phospholipase A2", "em2Text": "quinacrine", "label": "CPR:4"}]}
{"sentText": "The effect was counteracted by the D2 antagonist eticlopride pertussis toxin the inhibitor of intracellular Ca2 release TMB8 incubation in Ca2free experimental medium and PKC desensitization obtained by chronic pretreatment with the phorbol ester TPA", "relationMentions": [{"em1Text": "D2", "em2Text": "eticlopride", "label": "CPR:6"}]}
{"sentText": "Dopamine D2 receptorinduced COX2 mediated production of prostaglandin E2 in D2transfected Chinese hamster ovary cells without simultaneous administration of a Ca2mobilizing agent", "relationMentions": [{"em1Text": "COX2", "em2Text": "prostaglandin E2", "label": "CPR:9"}]}
{"sentText": "At a substrate concentration of 20 \u00b5M the most active HFC glucuronidation catalysts were UGT1A10 followed by UGT1A6 UGT1A7 UGT2A1 whereas at 300 \u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant UGTs", "relationMentions": [{"em1Text": "HFC", "em2Text": "UGT1A10", "label": "CPR:9"}, {"em1Text": "HFC", "em2Text": "UGT1A6", "label": "CPR:9"}, {"em1Text": "HFC", "em2Text": "UGT1A7", "label": "CPR:9"}, {"em1Text": "HFC", "em2Text": "UGT2A1", "label": "CPR:9"}, {"em1Text": "HFC", "em2Text": "UGT1A6", "label": "CPR:9"}, {"em1Text": "HFC", "em2Text": "UGTs", "label": "CPR:9"}]}
{"sentText": "A high throughput assay for the glucuronidation of 7hydroxy4trifluoromethylcoumarin by recombinant human UDPglucuronosyltransferases and liver microsomes", "relationMentions": [{"em1Text": "7hydroxy4trifluoromethylcoumarin", "em2Text": "human UDPglucuronosyltransferases", "label": "CPR:9"}]}
{"sentText": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP glucuronic acid than the other UGTs", "relationMentions": [{"em1Text": "HFC", "em2Text": "UGTs", "label": "CPR:9"}, {"em1Text": "UGT1A6", "em2Text": "HFC", "label": "CPR:9"}, {"em1Text": "UDP", "em2Text": "UGTs", "label": "CPR:9"}, {"em1Text": "UGT1A6", "em2Text": "UDP", "label": "CPR:9"}, {"em1Text": "glucuronic acid", "em2Text": "UGTs", "label": "CPR:9"}, {"em1Text": "UGT1A6", "em2Text": "glucuronic acid", "label": "CPR:9"}]}
{"sentText": "We have developed a convenient quantitative multiwell plate assay to measure the glucuronidation rate of 7hydroxy4trifluoromethylcoumarin HFC for several UGTs", "relationMentions": [{"em1Text": "7hydroxy4trifluoromethylcoumarin", "em2Text": "UGTs", "label": "CPR:9"}, {"em1Text": "HFC", "em2Text": "UGTs", "label": "CPR:9"}]}
{"sentText": "We have used this method to screen 11 recombinant human UGTs for HFC glucuronidation activity and studied the reaction kinetics with the most active enzymes", "relationMentions": [{"em1Text": "human UGTs", "em2Text": "HFC", "label": "CPR:9"}]}
{"sentText": "This inhibition was blocked when mice were pretreated with the selective H3R agonist Ralphamethylhistamine 10 mgkg", "relationMentions": [{"em1Text": "H3R", "em2Text": "Ralphamethylhistamine", "label": "CPR:5"}]}
{"sentText": "These results suggest that clomipramine induces hyperglycemia in mice by blocking the 5HT2B andor 5HT2C receptors which results in facilitation of adrenaline release", "relationMentions": [{"em1Text": "clomipramine", "em2Text": "5HT2B", "label": "CPR:4"}, {"em1Text": "clomipramine", "em2Text": "5HT2C", "label": "CPR:4"}]}
{"sentText": "The 5HT1257receptor antagonist methysergide and the 5HT2A2B2Creceptor antagonist LY 53857 enhanced clomipramineinduced hyperglycemia while the 5HT1A1Breceptor antagonist propranolol and the 5HT34receptor antagonist tropisetron did not affect it", "relationMentions": [{"em1Text": "5HT1A1Breceptor", "em2Text": "propranolol", "label": "CPR:6"}, {"em1Text": "5HT34receptor", "em2Text": "tropisetron", "label": "CPR:6"}, {"em1Text": "5HT2A2B2Creceptor", "em2Text": "LY 53857", "label": "CPR:6"}]}
{"sentText": "The 5HT2B2Creceptor antagonist SB 206553 facilitated hyperglycemia induced by clomipramine although the 5HT2A receptor antagonist ketanserin was without effect", "relationMentions": [{"em1Text": "5HT2B2Creceptor", "em2Text": "SB 206553", "label": "CPR:6"}, {"em1Text": "5HT2A", "em2Text": "ketanserin", "label": "CPR:6"}]}
{"sentText": "Phosphatidylserine PtdSer is made in mammalian cells by two PtdSer synthases PSS1 and PSS2", "relationMentions": [{"em1Text": "Phosphatidylserine", "em2Text": "PtdSer synthases", "label": "CPR:9"}, {"em1Text": "Phosphatidylserine", "em2Text": "PSS1", "label": "CPR:9"}, {"em1Text": "Phosphatidylserine", "em2Text": "PSS2", "label": "CPR:9"}]}
{"sentText": "Moreover a normal level of expression of PSS1 andor PSS2 is not required for generating the pool of PtdSer externalized during apoptosis", "relationMentions": [{"em1Text": "PSS1", "em2Text": "PtdSer", "label": "CPR:9"}, {"em1Text": "PSS2", "em2Text": "PtdSer", "label": "CPR:9"}]}
{"sentText": "I3A induced a higher level of secretion of the inflammatory cytokine interleukin 6 compared with PMA in the WEHI231 cells and displayed a marked biphasic doseresponse curve for the induction", "relationMentions": [{"em1Text": "I3A", "em2Text": "interleukin 6", "label": "CPR:3"}, {"em1Text": "I3A", "em2Text": "cytokine", "label": "CPR:3"}, {"em1Text": "interleukin 6", "em2Text": "PMA", "label": "CPR:3"}, {"em1Text": "cytokine", "em2Text": "PMA", "label": "CPR:3"}]}
{"sentText": "The in vitro kinase activity of PKCalpha induced by I3A was lower than that induced by PMA", "relationMentions": [{"em1Text": "PKCalpha", "em2Text": "I3A", "label": "CPR:3"}, {"em1Text": "PKCalpha", "em2Text": "PMA", "label": "CPR:3"}]}
{"sentText": "PKC isoforms did show different sensitivity and selectivity for downregulation by I3A and phorbol 12myristate 13acetate PMA in WEHI231 HOP92 and Colo205 cells", "relationMentions": [{"em1Text": "PKC", "em2Text": "I3A", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "phorbol 12myristate 13acetate", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "PMA", "label": "CPR:4"}]}
{"sentText": "Type I deiodinase liver fattyacid binding protein and cytochrome P450 CYP 3A37 mRNA levels were significantly induced by TCPP while TDCPP induced CYP3A37 and CYP2H1", "relationMentions": [{"em1Text": "Type I deiodinase", "em2Text": "TCPP", "label": "CPR:3"}, {"em1Text": "liver fattyacid binding protein", "em2Text": "TCPP", "label": "CPR:3"}, {"em1Text": "cytochrome P450 CYP 3A37", "em2Text": "TCPP", "label": "CPR:3"}, {"em1Text": "TDCPP", "em2Text": "CYP3A37", "label": "CPR:3"}, {"em1Text": "TDCPP", "em2Text": "CYP2H1", "label": "CPR:3"}]}
{"sentText": "The results suggested that both the EtOAc extract and berberine were able to activate PPAR\u03b1\u03b2\u03b3 and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine", "relationMentions": [{"em1Text": "EtOAc", "em2Text": "PPAR\u03b1\u03b2\u03b3", "label": "CPR:5"}, {"em1Text": "berberine", "em2Text": "PPAR\u03b1\u03b2\u03b3", "label": "CPR:5"}, {"em1Text": "berberine", "em2Text": "PPAR\u03b1\u03b2\u03b3", "label": "CPR:5"}, {"em1Text": "berberine", "em2Text": "PPARs", "label": "CPR:5"}]}
{"sentText": "This hypothesis was tested by investigating whether in subjects with essential hypertension the natriuretic response to specific renin angiotensin aldosterone system RAAS blockade by renininhibitor remikiren could be predicted from pretreatment renal vascular tone", "relationMentions": [{"em1Text": "renin", "em2Text": "remikiren", "label": "CPR:4"}, {"em1Text": "angiotensin", "em2Text": "remikiren", "label": "CPR:4"}, {"em1Text": "renin", "em2Text": "remikiren", "label": "CPR:4"}]}
{"sentText": "TREK1 currents are insensitive to pharmacological agents that block TWIK1 activity such as quinine and quinidine", "relationMentions": [{"em1Text": "TWIK1", "em2Text": "quinine", "label": "CPR:4"}, {"em1Text": "TWIK1", "em2Text": "quinidine", "label": "CPR:4"}]}
{"sentText": "3HCGP 12177A saturation binding in the presence of propranolol increased approximately 5fold following overexpression of beta1adrenoceptors", "relationMentions": [{"em1Text": "propranolol", "em2Text": "beta1adrenoceptors", "label": "CPR:3"}, {"em1Text": "3HCGP 12177A", "em2Text": "beta1adrenoceptors", "label": "CPR:3"}]}
{"sentText": "CGP 12177A mediates cardiostimulation by activation of the putative beta4adrenoceptor however it has recently been reported that disruption of the beta1adrenoceptor gene abolishes this effect", "relationMentions": [{"em1Text": "CGP 12177A", "em2Text": "beta1adrenoceptor", "label": "CPR:3"}, {"em1Text": "CGP 12177A", "em2Text": "beta4adrenoceptor", "label": "CPR:3"}]}
{"sentText": "CGP 12177A but not isoprenaline initiated arrhythmias at lower concentrations following beta1adrenoceptor overexpression", "relationMentions": [{"em1Text": "CGP 12177A", "em2Text": "beta1adrenoceptor", "label": "CPR:3"}]}
{"sentText": "125ICyanopindolol saturation binding in Advbeta1 myocytes demonstrated approximately 18fold increase in beta1adrenoceptors", "relationMentions": [{"em1Text": "125ICyanopindolol", "em2Text": "beta1adrenoceptors", "label": "CPR:3"}]}
{"sentText": "In contrast in the presence of Ca UFH accelerated the inhibition of factor Xa by antithrombin 10fold more efficiently than comparable concentrations of the high affinity fractions of enoxaparin and fragmin", "relationMentions": [{"em1Text": "Ca", "em2Text": "factor Xa", "label": "CPR:4"}, {"em1Text": "Ca", "em2Text": "antithrombin", "label": "CPR:4"}]}
{"sentText": "CONCLUSION Oral quinidine is effective in suppressing the gain of function in IKr responsible for some cases of short QT syndrome with a mutation in HERG and thus restoring normal rate dependence of the QT interval and rendering ventricular tachycardiaventricular fibrillation noninducible", "relationMentions": [{"em1Text": "quinidine", "em2Text": "IKr", "label": "CPR:4"}]}
{"sentText": "INTRODUCTION The principal aim of this study was to assess the efficacy of quinidine in suppressing IKr in vitro and in modulating the rate dependence of the QT interval in the SQT1 form of the short QT syndrome", "relationMentions": [{"em1Text": "quinidine", "em2Text": "IKr", "label": "CPR:4"}]}
{"sentText": "Our results indicate that Salix extract 1520L inhibits COX2 mediated PGE2 release through compounds other than salicin or salicylate", "relationMentions": [{"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "The IC50values obtained for the inhibition of lipopolysaccharide LPSinduced release of prostaglandin E2 PGE2 reflecting cyclooxygenase COX2 mediated PGE2 release were 47 microgml and 06 microgml for the Salix extract 1520L and rofecoxiblike research compound L745337 respectively", "relationMentions": [{"em1Text": "PGE2", "em2Text": "cyclooxygenase COX2", "label": "CPR:9"}]}
{"sentText": "Folliclestimulating hormone FSH a dimeric glycoprotein synthesized in the anterior pituitary gland is important for the production of sex steroids and gametes", "relationMentions": [{"em1Text": "Folliclestimulating hormone", "em2Text": "steroids", "label": "CPR:9"}, {"em1Text": "FSH", "em2Text": "steroids", "label": "CPR:9"}]}
{"sentText": "Humans with FSH beta gene mutations tend to have a more severe phenotype than those with FSHR gene mutations although infertility and varying degrees of impaired sex steroid production occur in both types of mutations", "relationMentions": [{"em1Text": "FSH beta", "em2Text": "steroid", "label": "CPR:9"}]}
{"sentText": "OBJECTIVES The aim of the current study was to assess the activity of rolipram a nonsubtypeselective PDE4 inhibitor in several animal models predictive of antipsychoticlike efficacy and sideeffect liability and to use PDE4B wildtype and knockout mice to begin to understand the subtypes involved in the activity of rolipram", "relationMentions": [{"em1Text": "rolipram", "em2Text": "PDE4", "label": "CPR:4"}]}
{"sentText": "These results suggest that PDE4B mediates the antipsychotic effects of rolipram in CAR and that the PDE4B regulated cyclic adenosine monophosphate signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis", "relationMentions": [{"em1Text": "PDE4B", "em2Text": "cyclic adenosine monophosphate", "label": "CPR:9"}]}
{"sentText": "Cat1 the transporter for the essential amino acids arginine and lysine is one of the upregulated genes", "relationMentions": [{"em1Text": "Cat1", "em2Text": "amino acids", "label": "CPR:9"}, {"em1Text": "Cat1", "em2Text": "arginine", "label": "CPR:9"}, {"em1Text": "Cat1", "em2Text": "lysine", "label": "CPR:9"}]}
{"sentText": "RESULTS Fractionated bulb extracts and the two isolated steroidal glycoalkaloids 1 and 2 induced NO production and TGF\u03b2 receptor I mRNA expression in fibroblast cell culture", "relationMentions": [{"em1Text": "steroidal glycoalkaloids", "em2Text": "TGF\u03b2 receptor I", "label": "CPR:3"}]}
{"sentText": "A prerequisite for this hypothesis was the unproved assumption that rabbit and human alpha2Aadrenoceptors are equally activated by rilmenidine", "relationMentions": [{"em1Text": "alpha2Aadrenoceptors", "em2Text": "rilmenidine", "label": "CPR:3"}]}
{"sentText": "On the basis of data obtained in rabbits the imidazoline receptor ligand rilmenidine has been suggested to decrease blood pressure in humans by activating central alpha2Aadrenoceptors", "relationMentions": [{"em1Text": "rilmenidine", "em2Text": "alpha2Aadrenoceptors", "label": "CPR:3"}]}
{"sentText": "Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of alpha2adrenoceptor agonists in inhibiting the electrically 2 Hz evoked 3Hnorepinephrine release and of antagonists in counteracting the alpha2adrenoceptor mediated inhibition induced by moxonidine", "relationMentions": [{"em1Text": "alpha2adrenoceptor", "em2Text": "moxonidine", "label": "CPR:4"}]}
{"sentText": "The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with alpha2Aautoreceptors at which however both rilmenidine and oxymetazoline exhibit different properties antagonism and agonism respectively", "relationMentions": [{"em1Text": "alpha2Aautoreceptors", "em2Text": "oxymetazoline", "label": "CPR:5"}, {"em1Text": "alpha2Aautoreceptors", "em2Text": "rilmenidine", "label": "CPR:6"}]}
{"sentText": "In the rabbit pulmonary artery rilmenidine and oxymetazoline are potent full agonists whereas in the human atrial appendages they are antagonists at the alpha2autoreceptors sharing this property with rauwolscine phentolamine and idazoxan", "relationMentions": [{"em1Text": "rilmenidine", "em2Text": "alpha2autoreceptors", "label": "CPR:6"}, {"em1Text": "oxymetazoline", "em2Text": "alpha2autoreceptors", "label": "CPR:6"}, {"em1Text": "alpha2autoreceptors", "em2Text": "rauwolscine", "label": "CPR:6"}, {"em1Text": "alpha2autoreceptors", "em2Text": "phentolamine", "label": "CPR:6"}, {"em1Text": "alpha2autoreceptors", "em2Text": "idazoxan", "label": "CPR:6"}]}
{"sentText": "The antagonistic property of rilmenidine at human alpha2Aadrenoceptors indicates that in contrast to the suggestion based on rabbit data the hypotensive property of the drug in humans is not due to activation of alpha2Aadrenoceptors but other presumably I1imidazoline receptors are probably involved", "relationMentions": [{"em1Text": "rilmenidine", "em2Text": "human alpha2Aadrenoceptors", "label": "CPR:6"}]}
{"sentText": "Cetrorelix completely blocked the rise of levels of the two most abundant species 50 kb and 45 kb of the GnRHR mRNA during both the infantile and the juvenile periods", "relationMentions": [{"em1Text": "Cetrorelix", "em2Text": "GnRHR", "label": "CPR:4"}]}
{"sentText": "Cetrorelix also abolished the developmental rise of the gonadotropin beta subunit mRNAs during the two periods of the study", "relationMentions": [{"em1Text": "Cetrorelix", "em2Text": "gonadotropin beta", "label": "CPR:4"}]}
{"sentText": "The chemistry pharmacology pharmacokinetics clinical efficacy adverse effects and dosages of the nonsedating histamine H1receptor antagonists terfenadine astemizole loratadine and acrivastine are reviewed", "relationMentions": [{"em1Text": "histamine H1receptor", "em2Text": "terfenadine", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "astemizole", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "loratadine", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "acrivastine", "label": "CPR:6"}]}
{"sentText": "Terfenadine and astemizole are chemically unrelated to histamine H1receptor antagonists such as diphenhydramine and chlorpheniramine", "relationMentions": [{"em1Text": "Terfenadine", "em2Text": "histamine H1receptor", "label": "CPR:6"}, {"em1Text": "astemizole", "em2Text": "histamine H1receptor", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "diphenhydramine", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "chlorpheniramine", "label": "CPR:6"}]}
{"sentText": "Promoter assay revealed that prunetin inhibits LPSinduced nitric oxide and prostaglandin E2 production through the suppression of iNOS and COX2 at the transcriptional level", "relationMentions": [{"em1Text": "prunetin", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "prunetin", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Antiinflammatory effect of prunetin via the suppression of NF\u03baB pathway", "relationMentions": [{"em1Text": "prunetin", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "In addition prunetin inhibits NF\u03baB dependent inflammatory responses by modulating I\u03baB kinase IKKinhibitor \u03baB\u03b1 I\u03baB\u03b1NF\u03baB signaling", "relationMentions": [{"em1Text": "prunetin", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "Consistent with these results prunetin significantly reduced serum levels of inflammatory cytokines and mortality in mice challenged with lipopolysaccharide", "relationMentions": [{"em1Text": "prunetin", "em2Text": "cytokines", "label": "CPR:4"}]}
{"sentText": "G6PC2 A Negative Regulator of Basal Glucose Stimulated Insulin Secretion", "relationMentions": [{"em1Text": "Glucose", "em2Text": "Insulin", "label": "CPR:3"}]}
{"sentText": "G6pc2 deletion resulted in a leftward shift in the doseresponse curve for glucose stimulated insulin secretion GSIS", "relationMentions": [{"em1Text": "glucose", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "These data suggest that G6pc2 represents a novel negative regulator of basal GSIS that acts by hydrolyzing glucose6phosphate thereby reducing glycolytic flux", "relationMentions": [{"em1Text": "G6pc2", "em2Text": "glucose6phosphate", "label": "CPR:9"}]}
{"sentText": "PP242 induced reversal of deptor suppression by TGF\u03b2 was associated with a significant inhibition of TGF\u03b2stimulated protein synthesis and hypertrophy", "relationMentions": [{"em1Text": "PP242", "em2Text": "deptor", "label": "CPR:3"}]}
{"sentText": "Using the mTOR inhibitor PP242 we found that TGF\u03b2induced both early and sustained activation of TORC1 and TORC2 was necessary for deptor suppression", "relationMentions": [{"em1Text": "mTOR", "em2Text": "PP242", "label": "CPR:4"}]}
{"sentText": "METHODS Modafinil and its R and Senantiomers were synthesized and tested for inhibition of 3H dopamine DA uptake and 3HWIN 35428 binding in human dopamine transporter DAT wildtype and mutants with altered conformational equilibria", "relationMentions": [{"em1Text": "3H dopamine", "em2Text": "human dopamine transporter", "label": "CPR:9"}, {"em1Text": "3H dopamine", "em2Text": "DAT", "label": "CPR:9"}, {"em1Text": "DA", "em2Text": "human dopamine transporter", "label": "CPR:9"}, {"em1Text": "DA", "em2Text": "DAT", "label": "CPR:9"}]}
{"sentText": "RESULTS R and Smodafinil bind to the DAT and inhibit DA uptake less potently than cocaine with Rmodafinil having approximately threefold higher affinity than its Senantiomer", "relationMentions": [{"em1Text": "DA", "em2Text": "DAT", "label": "CPR:9"}]}
{"sentText": "Furthermore the upregulation of IL12 and TNF\u03b1 was found in the procyanidin trimerstreated cells in the presence of OVA", "relationMentions": [{"em1Text": "IL12", "em2Text": "procyanidin", "label": "CPR:3"}, {"em1Text": "TNF\u03b1", "em2Text": "procyanidin", "label": "CPR:3"}]}
{"sentText": "A significant decrease in HLADR expression was observed in the AP and fractionated procyanidin treated cells in the presence of ovalbumin OVA but no effect on CD86 expression was observed", "relationMentions": [{"em1Text": "HLADR", "em2Text": "procyanidin", "label": "CPR:4"}]}
{"sentText": "Apple polyphenols suppress antigen presentation of ovalbumin by THP1derived dendritic cells", "relationMentions": [{"em1Text": "polyphenols", "em2Text": "ovalbumin", "label": "CPR:4"}]}
{"sentText": "In phosphotriesterase and physostigminetreated mice a 4 and 2fold higher sarin dose respectively was needed to cause a 50 inhibition of brain AChE activity", "relationMentions": [{"em1Text": "sarin", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "The acute toxicity of organophosphorus OP compounds in mammals is due to their irreversible inhibition of acetylcholinesterase AChE in the nervous system which leads to increased synaptic acetylcholine levels", "relationMentions": [{"em1Text": "organophosphorus", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "organophosphorus", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "acetylcholine", "em2Text": "acetylcholinesterase", "label": "CPR:9"}, {"em1Text": "acetylcholine", "em2Text": "AChE", "label": "CPR:9"}]}
{"sentText": "The CYP3A4 activity could be induced 2fold by rifampicin whereas CYP2C9 activity remained equally high", "relationMentions": [{"em1Text": "CYP3A4", "em2Text": "rifampicin", "label": "CPR:3"}, {"em1Text": "rifampicin", "em2Text": "CYP2C9", "label": "CPR:3"}]}
{"sentText": "The modification of the inhibitor scaffold of 1 and 2 from a dihydroquinolinone core to a tetrahydropyrazolopyridinone core led to discovery of a new series of potent KAT II inhibitors with excellent physicochemical properties", "relationMentions": [{"em1Text": "dihydroquinolinone", "em2Text": "KAT II", "label": "CPR:4"}, {"em1Text": "tetrahydropyrazolopyridinone", "em2Text": "KAT II", "label": "CPR:4"}]}
{"sentText": "The structurebased design synthesis and biological evaluation of a new pyrazole series of irreversible KAT II inhibitors are described herein", "relationMentions": [{"em1Text": "pyrazole", "em2Text": "KAT II", "label": "CPR:4"}]}
{"sentText": "PF04859989 as a template for structurebased drug design identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency", "relationMentions": [{"em1Text": "PF04859989", "em2Text": "KAT II", "label": "CPR:4"}, {"em1Text": "pyrazole", "em2Text": "KAT II", "label": "CPR:4"}]}
{"sentText": "Moreover the rank order for potency in inhibiting acetylcholinesterase ambenonium neostigmine = physostigmine = tacrine pyridostigmine = edrophonium = galanthamine desoxypeganine parathion gramine indicated that the most effective inhibitors of acetylcholinesterase also displaced 3HoxotremorineM to the greatest extent", "relationMentions": [{"em1Text": "acetylcholinesterase", "em2Text": "pyridostigmine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "pyridostigmine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "edrophonium", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "edrophonium", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "galanthamine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "galanthamine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "desoxypeganine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "desoxypeganine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "parathion", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "parathion", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "gramine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "gramine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "ambenonium", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "ambenonium", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "neostigmine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "neostigmine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "physostigmine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "physostigmine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "tacrine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "tacrine", "label": "CPR:4"}]}
{"sentText": "The capacity of acetylcholinesterase inhibitors with the exception of tacrine and ambenonium to displace bound 3HoxotremorineM in preference to 3Hquinuclinidyl benzilate predicts that the former compounds could act as potential agonists at muscarinic receptors", "relationMentions": [{"em1Text": "acetylcholinesterase", "em2Text": "tacrine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "ambenonium", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS Total vitamin B6 is abnormally high in autism consistent with previous reports of an impaired pyridoxal kinase for the conversion of pyridoxine and pyridoxal to PLP", "relationMentions": [{"em1Text": "pyridoxal kinase", "em2Text": "pyridoxine", "label": "CPR:9"}, {"em1Text": "pyridoxal", "em2Text": "pyridoxal kinase", "label": "CPR:9"}, {"em1Text": "pyridoxal kinase", "em2Text": "PLP", "label": "CPR:9"}]}
{"sentText": "\u03b2Amyloid aggregation results showed that all compounds exhibited remarkable A\u03b2 fibril aggregation inhibition activity with a nearly similar potential as the reference compound rifampicin which makes them promising antiAlzheimer drug candidates", "relationMentions": [{"em1Text": "A\u03b2", "em2Text": "rifampicin", "label": "CPR:4"}]}
{"sentText": "To develop new drugs for treatment of Alzheimers disease a group of N24Benzylpiperidinpiperazin1ylacylhydrazones was designed synthesized and tested for their ability to inhibit acetylcholinesterase butyrylcholinesterase and aggregation of amyloid beta peptides 140 142 and 140142", "relationMentions": [{"em1Text": "N24Benzylpiperidinpiperazin1ylacylhydrazones", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "N24Benzylpiperidinpiperazin1ylacylhydrazones", "em2Text": "butyrylcholinesterase", "label": "CPR:4"}]}
{"sentText": "Synthesis molecular modeling and evaluation of novel N24benzylpiperidinpiperazin1ylacylhydrazone derivatives as dual inhibitors for cholinesterases and A\u03b2 aggregation", "relationMentions": [{"em1Text": "N24benzylpiperidinpiperazin1ylacylhydrazone", "em2Text": "cholinesterases", "label": "CPR:4"}, {"em1Text": "N24benzylpiperidinpiperazin1ylacylhydrazone", "em2Text": "A\u03b2", "label": "CPR:4"}]}
{"sentText": "Here translocation studies using the human androgen receptor hAR and the human glucocorticoid receptor hGR were performed to aid in identifying the mechanism by which anabolicandrogenic steroids AAS were activating hAR and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR", "relationMentions": [{"em1Text": "hAR", "em2Text": "steroids", "label": "CPR:3"}]}
{"sentText": "We examined the antiinflammatory effect of licofelone on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of COX2 rofecoxib", "relationMentions": [{"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}]}
{"sentText": "Licofelone reduced intimamedia ratio in injured arteries the macrophages infiltration in the neointimal area monocyte chemoattractant protein1 MCP1 gene expression and the activation of nuclear factorkappaB in rabbit atheroma", "relationMentions": [{"em1Text": "Licofelone", "em2Text": "monocyte chemoattractant protein1", "label": "CPR:4"}, {"em1Text": "Licofelone", "em2Text": "MCP1", "label": "CPR:4"}, {"em1Text": "Licofelone", "em2Text": "nuclear factorkappaB", "label": "CPR:4"}]}
{"sentText": "Licofelone a balanced inhibitor of cyclooxygenase and 5lipoxygenase reduces inflammation in a rabbit model of atherosclerosis", "relationMentions": [{"em1Text": "Licofelone", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "Licofelone", "em2Text": "5lipoxygenase", "label": "CPR:4"}]}
{"sentText": "Licofelone a dual antiinflammatory drug that inhibits 5lipoxygenase LOX and cyclooxygenase COX enzymes may have a better cardiovascular profile that cycloxygenase2 inhibitors due to cycloxygenase1 blockademediated antithrombotic effect and a better gastrointestinal tolerability", "relationMentions": [{"em1Text": "Licofelone", "em2Text": "cycloxygenase1", "label": "CPR:4"}, {"em1Text": "Licofelone", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "Licofelone", "em2Text": "LOX", "label": "CPR:4"}, {"em1Text": "Licofelone", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "Licofelone", "em2Text": "COX", "label": "CPR:4"}]}
{"sentText": "Moreover licofelone inhibited COX2 and 5LOX protein expression in vascular lesions", "relationMentions": [{"em1Text": "licofelone", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "licofelone", "em2Text": "5LOX", "label": "CPR:4"}]}
{"sentText": "Rofecoxib only diminished COX2 protein expression and MCP1 gene expression in vascular atheroma", "relationMentions": [{"em1Text": "Rofecoxib", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "Rofecoxib", "em2Text": "MCP1", "label": "CPR:4"}]}
{"sentText": "Licofelone almost abolished 5LOX activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood", "relationMentions": [{"em1Text": "Licofelone", "em2Text": "5LOX", "label": "CPR:4"}, {"em1Text": "5LOX", "em2Text": "leukotriene B4", "label": "CPR:9"}, {"em1Text": "5LOX", "em2Text": "thromboxane B2", "label": "CPR:9"}]}
{"sentText": "No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib an oral COX2 selective inhibitor", "relationMentions": [{"em1Text": "lumiracoxib", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics PK of the novel cyclooxygenase2 COX2 selective inhibitor lumiracoxib Prexige so that dose recommendations for clinical use can be provided", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "lumiracoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "lumiracoxib", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "Prexige", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "Prexige", "label": "CPR:4"}]}
{"sentText": "In addition ethanol induced degradation of DNA methyltransferases DNMT 1 DNMT 3a and DNMT 3b as well as the methyl CpGbinding proteins MeCP2 MBD2 and MBD3 in MEF cells by the proteasomal pathway", "relationMentions": [{"em1Text": "ethanol", "em2Text": "DNA methyltransferases", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "DNMT", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "methyl CpGbinding proteins", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "MeCP2", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "MBD2", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "MBD3", "label": "CPR:4"}]}
{"sentText": "Before the next drug intake MAOA inhibition as judged by the decrease of plasma DHPG concentration was significantly different from placebo with moclobemide but not with toloxatone", "relationMentions": [{"em1Text": "MAOA", "em2Text": "moclobemide", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "toloxatone", "label": "CPR:4"}]}
{"sentText": "The effects of two reversible predominantly monoamine oxidaseA MAOA inhibitors moclobemide 150 mg three times daily and toloxatone 400200400 mg day1 on monoamine metabolites and psychometric performance were compared in a doubleblind placebo controlled crossover study in 12 healthy subjects", "relationMentions": [{"em1Text": "monoamine oxidaseA", "em2Text": "moclobemide", "label": "CPR:4"}, {"em1Text": "monoamine oxidaseA", "em2Text": "toloxatone", "label": "CPR:4"}]}
{"sentText": "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidaseA inhibitors moclobemide and toloxatone and assessment of their effect on psychometric performance in healthy subjects", "relationMentions": [{"em1Text": "monoamine oxidase", "em2Text": "moclobemide", "label": "CPR:4"}, {"em1Text": "monoamine oxidaseA", "em2Text": "moclobemide", "label": "CPR:4"}, {"em1Text": "monoamine oxidase", "em2Text": "toloxatone", "label": "CPR:4"}, {"em1Text": "monoamine oxidaseA", "em2Text": "toloxatone", "label": "CPR:4"}]}
{"sentText": "Previously we have found that BRN103 a nicotinamide derivative inhibits vascular endothelial growth factor VEGF mediated angiogenesis signaling in human endothelial cells", "relationMentions": [{"em1Text": "BRN103", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "BRN103", "em2Text": "vascular endothelial growth factor", "label": "CPR:4"}, {"em1Text": "nicotinamide", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "nicotinamide", "em2Text": "vascular endothelial growth factor", "label": "CPR:4"}]}
{"sentText": "Furthermore BRN250 inhibited the VEGFinduced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 VEGFR2 and the activation of its downstream AKT pathway", "relationMentions": [{"em1Text": "BRN250", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "BRN250", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "BRN250", "em2Text": "VEGF receptor 2", "label": "CPR:4"}, {"em1Text": "BRN250", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "BRN250", "em2Text": "AKT", "label": "CPR:4"}]}
{"sentText": "Both BB94 and captopril also prevented substrate degradation by gelatinase A and B released in conditioned medium by cultured cells", "relationMentions": [{"em1Text": "BB94", "em2Text": "gelatinase A and B", "label": "CPR:4"}]}
{"sentText": "We have examined the effects of the synthetic matrix metalloproteinase inhibitor batimastat BB94 and the angiotensinconverting enzyme inhibitor captopril on metalloproteinase activity of murine Lewislungcarcinoma cells 3LL in vitro and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL6 mice", "relationMentions": [{"em1Text": "matrix metalloproteinase", "em2Text": "batimastat", "label": "CPR:4"}, {"em1Text": "matrix metalloproteinase", "em2Text": "BB94", "label": "CPR:4"}, {"em1Text": "angiotensinconverting enzyme", "em2Text": "captopril", "label": "CPR:4"}]}
{"sentText": "Inhibition of gelatinase A MMP2 by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma", "relationMentions": [{"em1Text": "gelatinase A", "em2Text": "batimastat", "label": "CPR:4"}, {"em1Text": "MMP2", "em2Text": "batimastat", "label": "CPR:4"}, {"em1Text": "gelatinase A", "em2Text": "captopril", "label": "CPR:4"}, {"em1Text": "MMP2", "em2Text": "captopril", "label": "CPR:4"}]}
{"sentText": "Here we report that captopril treatment resulted in decreased transcription and protein levels of gelatinase A by 3LL cells", "relationMentions": [{"em1Text": "captopril", "em2Text": "gelatinase A", "label": "CPR:4"}]}
{"sentText": "Methionine synthase reductase MTRR is an enzyme involved in the conversion of Hcy to methionine", "relationMentions": [{"em1Text": "MTRR", "em2Text": "Hcy", "label": "CPR:9"}, {"em1Text": "Methionine synthase reductase", "em2Text": "Hcy", "label": "CPR:9"}, {"em1Text": "MTRR", "em2Text": "methionine", "label": "CPR:9"}, {"em1Text": "Methionine synthase reductase", "em2Text": "methionine", "label": "CPR:9"}]}
{"sentText": "GPxs reduce hydroperoxides to the corresponding alcohols by means of glutathione GSH", "relationMentions": [{"em1Text": "GPxs", "em2Text": "alcohols", "label": "CPR:9"}]}
{"sentText": "TCDD decreased the expression of the glucose transporter SLC2A1 and most of the glycolytic transcripts followed by decreases in glycolytic intermediates including pyruvate", "relationMentions": [{"em1Text": "TCDD", "em2Text": "glucose transporter", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "SLC2A1", "label": "CPR:4"}]}
{"sentText": "Mitochondrial glutathione GSH reductase activity and the GSHglutathione disulfide ratio were decreased by TCDD ultimately leading to mitochondrial dysfunction characterized by decreased inner mitochondrial membrane potential and ATP production and increased production of the reactive oxygen species ROS hydrogen peroxide", "relationMentions": [{"em1Text": "glutathione GSH reductase", "em2Text": "TCDD", "label": "CPR:4"}]}
{"sentText": "Second probucol an antiatherogenic compound reported to be an inactivator of ABCA1 reduced hepatic alphatocopherol secretion", "relationMentions": [{"em1Text": "probucol", "em2Text": "ABCA1", "label": "CPR:4"}]}
{"sentText": "alphaTocopherol transfer protein alphaTTP the product of the gene responsible for familial isolated vitamin E deficiency plays an important role in maintaining the plasma alphatocopherol level by mediating the secretion of alphatocopherol by the liver", "relationMentions": [{"em1Text": "alphaTTP", "em2Text": "alphatocopherol", "label": "CPR:9"}, {"em1Text": "alphaTocopherol transfer protein", "em2Text": "alphatocopherol", "label": "CPR:9"}, {"em1Text": "alphaTTP", "em2Text": "alphatocopherol", "label": "CPR:9"}, {"em1Text": "alphaTocopherol transfer protein", "em2Text": "alphatocopherol", "label": "CPR:9"}]}
{"sentText": "First addition of apolipoprotein AI apoAI a direct acceptor of the ATPbinding cassette transporter A1 ABCA1 secreted lipids increased alphatocopherol secretion in a dosedependent manner", "relationMentions": [{"em1Text": "apolipoprotein AI", "em2Text": "alphatocopherol", "label": "CPR:9"}, {"em1Text": "apoAI", "em2Text": "alphatocopherol", "label": "CPR:9"}, {"em1Text": "ATPbinding cassette transporter A1", "em2Text": "alphatocopherol", "label": "CPR:9"}, {"em1Text": "ABCA1", "em2Text": "alphatocopherol", "label": "CPR:9"}]}
{"sentText": "ATPbinding cassette transporter A1 is involved in hepatic alphatocopherol secretion", "relationMentions": [{"em1Text": "ATPbinding cassette transporter A1", "em2Text": "alphatocopherol", "label": "CPR:9"}]}
{"sentText": "Third ABCA1 RNAi suppressed hepatic alphatocopherol secretion", "relationMentions": [{"em1Text": "ABCA1", "em2Text": "alphatocopherol", "label": "CPR:9"}]}
{"sentText": "These results strongly suggest that ABCA1 is substantially involved in hepatic alphatocopherol secretion", "relationMentions": [{"em1Text": "ABCA1", "em2Text": "alphatocopherol", "label": "CPR:9"}]}
{"sentText": "2Amino33hydroxy52thiazolyl4isoxazolylpropionic acid 1 is a potent AMPA receptor agonist with moderate affinity for native kainic acid KA receptors whereas SE422dimethylpropylideneglutamic acid 3 show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors", "relationMentions": [{"em1Text": "2Amino33hydroxy52thiazolyl4isoxazolylpropionic acid", "em2Text": "AMPA receptor", "label": "CPR:5"}]}
{"sentText": "Pranlukast a leukotriene receptor antagonist inhibits interleukin5 production via a mechanism distinct from leukotriene receptor antagonism", "relationMentions": [{"em1Text": "Pranlukast", "em2Text": "interleukin5", "label": "CPR:4"}, {"em1Text": "Pranlukast", "em2Text": "leukotriene receptor", "label": "CPR:6"}, {"em1Text": "Pranlukast", "em2Text": "leukotriene receptor", "label": "CPR:6"}]}
{"sentText": "Pranlukast induced inhibition of IL5 mRNA expression was noted in various cells irrespective of their CysLTR1 mRNA expression status", "relationMentions": [{"em1Text": "Pranlukast", "em2Text": "IL5", "label": "CPR:4"}]}
{"sentText": "CONCLUSION Our results indicate that pranlukast inhibits IL5 synthesis via a mechanism distinct from CysLTR1 antagonism", "relationMentions": [{"em1Text": "pranlukast", "em2Text": "IL5", "label": "CPR:4"}, {"em1Text": "pranlukast", "em2Text": "CysLTR1", "label": "CPR:6"}]}
{"sentText": "The aim of this study was to determine the mechanism of pranlukast induced interleukin5 IL5 inhibition in allergic inflammation", "relationMentions": [{"em1Text": "pranlukast", "em2Text": "interleukin5", "label": "CPR:4"}, {"em1Text": "pranlukast", "em2Text": "IL5", "label": "CPR:4"}]}
{"sentText": "RESULTS Pretreatment of lung tissues with pranlukast alone significantly decreased the amount of IL5 protein in the culture medium by 40", "relationMentions": [{"em1Text": "pranlukast", "em2Text": "IL5", "label": "CPR:4"}]}
{"sentText": "BACKGROUND Pranlukast a cysteinyl leukotriene receptor 1 CysLTR1 antagonist inhibits not only airway smooth muscle contraction but also allergic inflammation", "relationMentions": [{"em1Text": "Pranlukast", "em2Text": "cysteinyl leukotriene receptor 1", "label": "CPR:6"}, {"em1Text": "Pranlukast", "em2Text": "CysLTR1", "label": "CPR:6"}]}
{"sentText": "Thiazolidinediones are a new class of antidiabetic agents which increase insulin sensitivity by binding to the peroxisome proliferatoractivated receptor gamma PPARgamma and stimulating the expression of insulin responsive genes involved in glucose and lipid metabolism", "relationMentions": [{"em1Text": "Thiazolidinediones", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "Thiazolidinediones", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "The difference in structure of troglitazone did not account for its inhibitory effect on ENT1 because Vitamin E did not inhibit 3Hadenosine uptake by HASMCs", "relationMentions": [{"em1Text": "troglitazone", "em2Text": "ENT1", "label": "CPR:4"}]}
{"sentText": "Using the nucleoside transporter deficient PK15NTD cells stably expressing ENT1 and ENT2 it was found that troglitazone inhibited ENT1 but had no effect on ENT2", "relationMentions": [{"em1Text": "ENT1", "em2Text": "troglitazone", "label": "CPR:4"}]}
{"sentText": "From these results it is suggested that troglitazone may enhance the vasodilatory effect of adenosine by inhibiting ENT1", "relationMentions": [{"em1Text": "troglitazone", "em2Text": "ENT1", "label": "CPR:4"}]}
{"sentText": "Pharmacologically troglitazone is a novel inhibitor of ENT1", "relationMentions": [{"em1Text": "troglitazone", "em2Text": "ENT1", "label": "CPR:4"}]}
{"sentText": "The effect of troglitazone on ENT1 was PPARgammaindependent and kinetic studies revealed that troglitazone was a competitive inhibitor of ENT1", "relationMentions": [{"em1Text": "troglitazone", "em2Text": "ENT1", "label": "CPR:4"}]}
{"sentText": "Phenytoin is principally metabolized by CYP2C9 and both are probable substrates of the drug transporter Pglycoprotein", "relationMentions": [{"em1Text": "Phenytoin", "em2Text": "CYP2C9", "label": "CPR:9"}, {"em1Text": "Phenytoin", "em2Text": "drug transporter", "label": "CPR:9"}, {"em1Text": "Phenytoin", "em2Text": "Pglycoprotein", "label": "CPR:9"}]}
{"sentText": "We also observed that fisetin efficiently suppressed the phosphorylation of Akt S6K1 and mTORC1 in adipose tissue", "relationMentions": [{"em1Text": "fisetin", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "fisetin", "em2Text": "S6K1", "label": "CPR:4"}, {"em1Text": "fisetin", "em2Text": "mTORC1", "label": "CPR:4"}]}
{"sentText": "Collectively these results suggest that inhibition of mTORC1 signaling by fisetin prevents adipocyte differentiation of 3T3L1 preadipocytes and obesity in HFDfed mice", "relationMentions": [{"em1Text": "mTORC1", "em2Text": "fisetin", "label": "CPR:4"}]}
{"sentText": "Fisetin treatment of preadipocytes reduced the phosphorylation of S6K1 and mTORC1 in a time and concentrationdependent manner", "relationMentions": [{"em1Text": "Fisetin", "em2Text": "S6K1", "label": "CPR:4"}, {"em1Text": "Fisetin", "em2Text": "mTORC1", "label": "CPR:4"}]}
{"sentText": "To further our understanding of how fisetin negatively regulates mTORC1 signaling we analyzed the phosphorylation of S6K1 mTOR and Akt in fisetintreated TSC2knockdown cells", "relationMentions": [{"em1Text": "fisetin", "em2Text": "mTORC1", "label": "CPR:4"}]}
{"sentText": "The results suggested that fisetin treatment inhibits mTORC1 activity in an Akt dependent manner", "relationMentions": [{"em1Text": "fisetin", "em2Text": "mTORC1", "label": "CPR:4"}, {"em1Text": "fisetin", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Fisetin treatment inhibited adipocyte differentiation consistent with the negative effect of fisetin on mTOR", "relationMentions": [{"em1Text": "fisetin", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Tomudex treatment resulted in the decrease in p27kip1 expression with an increase in cyclin E and cdk2 protein expression and kinase activities 24 h after a 2h exposure", "relationMentions": [{"em1Text": "Tomudex", "em2Text": "cyclin E", "label": "CPR:3"}, {"em1Text": "Tomudex", "em2Text": "cdk2", "label": "CPR:3"}, {"em1Text": "Tomudex", "em2Text": "kinase", "label": "CPR:3"}, {"em1Text": "Tomudex", "em2Text": "p27kip1", "label": "CPR:4"}]}
{"sentText": "The studies with dThyd rescue from cyclin E cdk2 protein overexpression and growth inhibition by Tomudex indicate that increased cyclin Ecdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance", "relationMentions": [{"em1Text": "cyclin E", "em2Text": "Tomudex", "label": "CPR:3"}, {"em1Text": "cdk2", "em2Text": "Tomudex", "label": "CPR:3"}, {"em1Text": "cyclin E", "em2Text": "Tomudex", "label": "CPR:3"}, {"em1Text": "cdk2", "em2Text": "Tomudex", "label": "CPR:3"}, {"em1Text": "cyclin E", "em2Text": "Tomudex", "label": "CPR:4"}, {"em1Text": "cdk2", "em2Text": "Tomudex", "label": "CPR:4"}, {"em1Text": "Tomudex", "em2Text": "thymidylate synthase", "label": "CPR:4"}]}
{"sentText": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by Tomudex and kilobase DNA fragmentation may correlate with the reduction of p27kip1 expression and the increase in cyclin E and cdk2 kinase activities", "relationMentions": [{"em1Text": "Tomudex", "em2Text": "cyclin E", "label": "CPR:3"}, {"em1Text": "Tomudex", "em2Text": "cdk2", "label": "CPR:3"}, {"em1Text": "Tomudex", "em2Text": "kinase", "label": "CPR:3"}, {"em1Text": "thymidylate synthase", "em2Text": "Tomudex", "label": "CPR:4"}, {"em1Text": "Tomudex", "em2Text": "p27kip1", "label": "CPR:4"}]}
{"sentText": "Studies were carried out in vitro to evaluate downstream molecular alterations induced as a consequence of the potent and sustained inhibition of thymidylate synthase by Tomudex", "relationMentions": [{"em1Text": "thymidylate synthase", "em2Text": "Tomudex", "label": "CPR:4"}]}
{"sentText": "Cyclin Ecdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex", "relationMentions": [{"em1Text": "thymidylate synthase", "em2Text": "Tomudex", "label": "CPR:4"}]}
{"sentText": "Tomudex ZD1694 is a specific antifolatebased thymidylate synthase inhibitor active in a variety of solid tumor malignancies", "relationMentions": [{"em1Text": "Tomudex", "em2Text": "thymidylate synthase", "label": "CPR:4"}]}
{"sentText": "Saturated palmitic and stearic acids increased ceramides upregulated PTP1B and had AKt and PTP1B phosphorylation at Ser 50 impaired", "relationMentions": [{"em1Text": "palmitic and stearic acids", "em2Text": "PTP1B", "label": "CPR:3"}, {"em1Text": "palmitic and stearic acids", "em2Text": "AKt", "label": "CPR:3"}, {"em1Text": "palmitic and stearic acids", "em2Text": "PTP1B", "label": "CPR:3"}]}
{"sentText": "Cells were also evaluated in the presence of wortmannin an inhibitor of phosphatidylinositol 3kinases and thus AKt 0100 nM", "relationMentions": [{"em1Text": "wortmannin", "em2Text": "phosphatidylinositol 3kinases", "label": "CPR:4"}, {"em1Text": "wortmannin", "em2Text": "AKt", "label": "CPR:4"}]}
{"sentText": "Only FFAs that increased ceramides caused impairment of AKt and PTP1B phosphorylation at Ser 50", "relationMentions": [{"em1Text": "ceramides", "em2Text": "AKt", "label": "CPR:4"}, {"em1Text": "ceramides", "em2Text": "PTP1B", "label": "CPR:4"}]}
{"sentText": "Indoleamine 23dioxygenase IDO a tryptophan catabolizing enzyme has been implicated in the pathogenesis of various neurological disorders", "relationMentions": [{"em1Text": "IDO", "em2Text": "tryptophan", "label": "CPR:9"}, {"em1Text": "Indoleamine 23dioxygenase", "em2Text": "tryptophan", "label": "CPR:9"}]}
{"sentText": "Peroxisome proliferatoractivated receptor\u03b1 PPAR\u03b1 activation mimicked the effects of resveratrol while PPAR\u03b1 inhibition prevented the effects of this SIRT1 activator", "relationMentions": [{"em1Text": "resveratrol", "em2Text": "SIRT1", "label": "CPR:3"}]}
{"sentText": "SIRT1 coprecipitated with PPAR\u03b1 and nicotinamide increased the acetylation of the PPAR\u03b1 coactivator PGC1\u03b1 which was suppressed by resveratrol", "relationMentions": [{"em1Text": "nicotinamide", "em2Text": "PGC1\u03b1", "label": "CPR:3"}, {"em1Text": "PGC1\u03b1", "em2Text": "resveratrol", "label": "CPR:4"}]}
{"sentText": "To determine whether dysregulation of SIRT1 promotes NADPH oxidase dependent production of reactive oxygen species ROS and impairs endothelial function we assessed the effects of three structurally different inhibitors of SIRT1 nicotinamide sirtinol EX527 in aorta segments isolated from young Wistar rats", "relationMentions": [{"em1Text": "SIRT1", "em2Text": "nicotinamide", "label": "CPR:4"}, {"em1Text": "SIRT1", "em2Text": "sirtinol", "label": "CPR:4"}, {"em1Text": "SIRT1", "em2Text": "EX527", "label": "CPR:4"}, {"em1Text": "NADPH oxidase", "em2Text": "oxygen", "label": "CPR:9"}]}
{"sentText": "Endothelial dysfunction induced by SIRT1 inhibition was prevented by treatment of the vessels with the NADPH oxidase inhibitor apocynin or superoxide dismutase", "relationMentions": [{"em1Text": "NADPH oxidase", "em2Text": "apocynin", "label": "CPR:4"}]}
{"sentText": "Inhibition of SIRT1 significantly increased vascular superoxide production enhanced NADPH oxidase activity and mRNA expression of its subunits p22phox and NOX4 which were prevented by resveratrol", "relationMentions": [{"em1Text": "NADPH oxidase", "em2Text": "resveratrol", "label": "CPR:4"}, {"em1Text": "p22phox", "em2Text": "resveratrol", "label": "CPR:4"}, {"em1Text": "NOX4", "em2Text": "resveratrol", "label": "CPR:4"}, {"em1Text": "SIRT1", "em2Text": "superoxide", "label": "CPR:9"}]}
{"sentText": "EROD activity induction in peripheral blood lymphocytes liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons", "relationMentions": [{"em1Text": "EROD", "em2Text": "polycyclic aromatic hydrocarbons", "label": "CPR:3"}]}
{"sentText": "Little is known in terms of multimatrix cytochrome P450 activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons PHH PAH", "relationMentions": [{"em1Text": "cytochrome P450", "em2Text": "halogenated and polycyclic aromatic hydrocarbons", "label": "CPR:3"}, {"em1Text": "cytochrome P450", "em2Text": "PAH", "label": "CPR:3"}]}
{"sentText": "Repression of farnesyltransferase FNTA by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoAI secretion from hepatocytes and from transgenic mice expressing hApoAI and cholesterol ester transfer protein transgenes", "relationMentions": [{"em1Text": "manumycin A", "em2Text": "ApoAI", "label": "CPR:3"}, {"em1Text": "manumycin A", "em2Text": "hApoAI", "label": "CPR:3"}, {"em1Text": "farnesyltransferase", "em2Text": "manumycin A", "label": "CPR:4"}, {"em1Text": "FNTA", "em2Text": "manumycin A", "label": "CPR:4"}]}
{"sentText": "The potent and selective thirdgeneration aromatase inhibitors anastrozole letrozole and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies", "relationMentions": [{"em1Text": "aromatase", "em2Text": "letrozole", "label": "CPR:4"}, {"em1Text": "aromatase", "em2Text": "anastrozole", "label": "CPR:4"}]}
{"sentText": "Anastrozole and letrozole are both nonsteroidal aromatase inhibitors that compete with the substrate for binding to the enzyme active site", "relationMentions": [{"em1Text": "Anastrozole", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "letrozole", "em2Text": "aromatase", "label": "CPR:4"}]}
{"sentText": "Estrogens are biosynthesised from androgens by the CYP450 enzyme complex called aromatase", "relationMentions": [{"em1Text": "Estrogens", "em2Text": "CYP450", "label": "CPR:9"}, {"em1Text": "Estrogens", "em2Text": "aromatase", "label": "CPR:9"}, {"em1Text": "androgens", "em2Text": "aromatase", "label": "CPR:9"}]}
{"sentText": "In breast cancer intratumoural aromatase is the source for local estrogen production in the tissue", "relationMentions": [{"em1Text": "aromatase", "em2Text": "estrogen", "label": "CPR:9"}]}
{"sentText": "In this study we employed virtual screening and chemical synthesis to identify a series of Nthiophen2yl benzamide derivatives as potent BRAF V600E inhibitors", "relationMentions": [{"em1Text": "Nthiophen2yl benzamide", "em2Text": "BRAF", "label": "CPR:4"}, {"em1Text": "Nthiophen2yl benzamide", "em2Text": "V600E", "label": "CPR:4"}]}
{"sentText": "Identification and synthesis of Nthiophen2yl benzamide derivatives as BRAF V600E inhibitors", "relationMentions": [{"em1Text": "Nthiophen2yl benzamide", "em2Text": "BRAF", "label": "CPR:4"}, {"em1Text": "Nthiophen2yl benzamide", "em2Text": "V600E", "label": "CPR:4"}]}
{"sentText": "Exposure of cells to 4mM NaF for 24h induced caspase3 activation ultrastructural alterations and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial intermembrane space into the cytosol indicating that fluoridemediated apoptosis is mitochondriadependent", "relationMentions": [{"em1Text": "NaF", "em2Text": "caspase3", "label": "CPR:3"}]}
{"sentText": "Fluoride treatment also increased phosphorylation of JNK and ERK but not p38 and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors respectively", "relationMentions": [{"em1Text": "Fluoride", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "Fluoride", "em2Text": "ERK", "label": "CPR:3"}]}
{"sentText": "Furthermore the Panx1 channel blockers carbenoxolone and Probenecid were less effective in inhibiting Panx1 currents when Kvbeta3 was coexpressed", "relationMentions": [{"em1Text": "Panx1", "em2Text": "carbenoxolone", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "Probenecid", "label": "CPR:4"}]}
{"sentText": "67Methoxy2trifluoromethylpyrazolo15apyridin4yl5methyl45dihydropyridazin32Hone KCA1490 exhibits moderate dual PDE34 inhibitory activity and promises as a combined bronchodilatoryantiinflammatory agent", "relationMentions": [{"em1Text": "67Methoxy2trifluoromethylpyrazolo15apyridin4yl5methyl45dihydropyridazin32Hone", "em2Text": "PDE34", "label": "CPR:4"}, {"em1Text": "KCA1490", "em2Text": "PDE34", "label": "CPR:4"}]}
{"sentText": "N alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses PDE3 inhibition", "relationMentions": [{"em1Text": "N", "em2Text": "PDE4", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "PDE3", "label": "CPR:4"}, {"em1Text": "pyridazinone", "em2Text": "PDE4", "label": "CPR:4"}, {"em1Text": "pyridazinone", "em2Text": "PDE3", "label": "CPR:4"}]}
{"sentText": "Addition of a 6aryl45dihydropyridazin32Hone extension to the N alkyl group facilitates both enhancement of PDE4 inhibitory activity and restoration of potent PDE3 inhibition", "relationMentions": [{"em1Text": "6aryl45dihydropyridazin32Hone", "em2Text": "PDE4", "label": "CPR:4"}, {"em1Text": "6aryl45dihydropyridazin32Hone", "em2Text": "PDE3", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "PDE4", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "PDE3", "label": "CPR:4"}]}
{"sentText": "Given that FRD present in all H pylori strains is immunogenic in H pylori infected patients and H pylori growth in vitro can be inhibited by three anthelmintics morantel oxantel and thiabendazole this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H pylori prevention and eradication", "relationMentions": [{"em1Text": "FRD", "em2Text": "morantel", "label": "CPR:4"}, {"em1Text": "FRD", "em2Text": "oxantel", "label": "CPR:4"}, {"em1Text": "FRD", "em2Text": "thiabendazole", "label": "CPR:4"}]}
{"sentText": "Fumarate reductase FRD is the key enzyme in fumarate respiration induced by anaerobic growth of bacteria", "relationMentions": [{"em1Text": "FRD", "em2Text": "fumarate", "label": "CPR:9"}, {"em1Text": "Fumarate reductase", "em2Text": "fumarate", "label": "CPR:9"}]}
{"sentText": "The frdA gene coding for subunit A of FRD and two control genes copA and copP associated with the export of copper out of H pylori were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes", "relationMentions": [{"em1Text": "copA", "em2Text": "copper", "label": "CPR:9"}, {"em1Text": "copP", "em2Text": "copper", "label": "CPR:9"}]}
{"sentText": "To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase TPH the ratelimiting enzyme in 5HT biosynthesis we quantitated its mRNA levels by competitive reverse transcriptionpolymerase chain reaction RTPCR", "relationMentions": [{"em1Text": "tryptophan hydroxylase", "em2Text": "5HT", "label": "CPR:9"}, {"em1Text": "TPH", "em2Text": "5HT", "label": "CPR:9"}]}
{"sentText": "In contrast there was little change in mRNA levels for GTP cyclohydrolase I GTPCH the rate limiting enzyme in synthesis of the tetrahydrobiopterin BH4 the obligate cofactor for TPH", "relationMentions": [{"em1Text": "GTP cyclohydrolase I", "em2Text": "tetrahydrobiopterin", "label": "CPR:9"}, {"em1Text": "GTPCH", "em2Text": "tetrahydrobiopterin", "label": "CPR:9"}, {"em1Text": "GTP cyclohydrolase I", "em2Text": "BH4", "label": "CPR:9"}, {"em1Text": "GTPCH", "em2Text": "BH4", "label": "CPR:9"}]}
{"sentText": "In relation to zinc bioavailability \u03b1CPPs \u03b2CPPs \u03b1s1CN 64744P and \u03b2CN 1254P increased zinc uptake", "relationMentions": [{"em1Text": "zinc", "em2Text": "\u03b1CPPs", "label": "CPR:9"}, {"em1Text": "zinc", "em2Text": "\u03b2CPPs", "label": "CPR:9"}, {"em1Text": "zinc", "em2Text": "\u03b1s1CN", "label": "CPR:9"}, {"em1Text": "zinc", "em2Text": "\u03b2CN", "label": "CPR:9"}]}
{"sentText": "In contrast to parenteral delivery of rBChE which currently requires posttranslational modification for good plasma stability an unmodified aerrBChE pretreatment given 140h prior to 1 LD50 of aer paraoxon Px was able to prevent inhibition of circulating cholinesterase in a dosedependent manner", "relationMentions": [{"em1Text": "paraoxon", "em2Text": "cholinesterase", "label": "CPR:3"}]}
{"sentText": "Next to Glut4 the predominant protein influencing glucose metabolism is PPAR\u03b1 and \u03b3 whose expressions were also positively modulated", "relationMentions": [{"em1Text": "Glut4", "em2Text": "glucose", "label": "CPR:9"}]}
{"sentText": "Both the 5 alphareductase inhibitor finasteride and alpha 1adrenoceptor antagonists eg", "relationMentions": [{"em1Text": "5 alphareductase", "em2Text": "finasteride", "label": "CPR:4"}]}
{"sentText": "Central 5HT3 receptor stimulation by mCPBG increases blood glucose in rats", "relationMentions": [{"em1Text": "5HT3", "em2Text": "mCPBG", "label": "CPR:3"}]}
{"sentText": "Injections of mCPBG a selective 5HT3 receptor agonist induced a significant increase in blood glucose in nonstressed rats in both fasted and in fed states", "relationMentions": [{"em1Text": "mCPBG", "em2Text": "5HT3", "label": "CPR:5"}]}
{"sentText": "The hyperglycemic effect of mCPBG central administration was blocked by pretreatment with ondansetron a specific 5HT3 receptor antagonist indicating that the effects here obtained with mCPBG were a result of its interaction with 5HT3 receptors", "relationMentions": [{"em1Text": "mCPBG", "em2Text": "5HT3", "label": "CPR:5"}]}
{"sentText": "Guided by the acetylcholinesterase inhibiting activity the bisindole alkaloid 3RShydroxyvoacamine was isolated from a stem extract of Tabernaemontana divaricata a plant used in Thailand in traditional rejuvenation remedies for improving the memory", "relationMentions": [{"em1Text": "acetylcholinesterase", "em2Text": "bisindole alkaloid", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "3RShydroxyvoacamine", "label": "CPR:4"}]}
{"sentText": "3RSHydroxyvoacamine a potent acetylcholinesterase inhibitor from Tabernaemontana divaricata", "relationMentions": [{"em1Text": "3RSHydroxyvoacamine", "em2Text": "acetylcholinesterase", "label": "CPR:4"}]}
{"sentText": "\u03b1Amino\u03b1\u00b4Halomethylketones Synthetic Methodologies and Pharmaceutical Applications as Serine and Cysteine Protease Inhibitors", "relationMentions": [{"em1Text": "\u03b1Amino\u03b1\u00b4Halomethylketones", "em2Text": "Serine and Cysteine Protease", "label": "CPR:4"}]}
{"sentText": "Introduction 5Lipoxygenase 5LO is a crucial enzyme of the arachidonic acid AA cascade and catalyzes the formation of bioactive leukotrienes LTs with the help of FLAP the 5LOactivating protein", "relationMentions": [{"em1Text": "5LO", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "5Lipoxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "Using a transient heterologous cell expression system we find that the transport activities of the short OATP2B1 variant towards substrates estrone sulfate and rosuvastatin are similar to the wellcharacterized full length variant", "relationMentions": [{"em1Text": "short OATP2B1", "em2Text": "estrone sulfate", "label": "CPR:9"}, {"em1Text": "short OATP2B1", "em2Text": "rosuvastatin", "label": "CPR:9"}]}
{"sentText": "Blockade of NMDA receptor s by memantine could theoretically confer diseasemodifying activity in AD by inhibiting the weak NMDA receptor dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia", "relationMentions": [{"em1Text": "NMDA receptor", "em2Text": "memantine", "label": "CPR:4"}]}
{"sentText": "Moreover recent in vitro studies suggest that memantine abrogates betaamyloid Abeta toxicity and possibly inhibits Abeta production", "relationMentions": [{"em1Text": "memantine", "em2Text": "betaamyloid", "label": "CPR:4"}, {"em1Text": "memantine", "em2Text": "Abeta", "label": "CPR:4"}, {"em1Text": "memantine", "em2Text": "Abeta", "label": "CPR:4"}]}
{"sentText": "Memantine is an uncompetitive channel blocking NMDA receptor antagonist", "relationMentions": [{"em1Text": "Memantine", "em2Text": "NMDA receptor", "label": "CPR:6"}]}
{"sentText": "Like other NMDA receptor antagonists memantine at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory", "relationMentions": [{"em1Text": "NMDA receptor", "em2Text": "memantine", "label": "CPR:6"}]}
{"sentText": "Considerable attention has focused on the investigation of theories to explain the better tolerability of memantine over other NMDA receptor antagonists particularly those that act by a similar channel blocking mechanism such as dissociative anestheticlike agents phencyclidine ketamine MK801", "relationMentions": [{"em1Text": "memantine", "em2Text": "NMDA receptor", "label": "CPR:6"}]}
{"sentText": "In general rifampicin can act on a pattern rifampicin activates the nuclear pregnane X receptor that in turn affects cytochromes P450 glucuronosyltransferases and pglycoprotein activities", "relationMentions": [{"em1Text": "rifampicin", "em2Text": "nuclear pregnane X receptor", "label": "CPR:3"}, {"em1Text": "rifampicin", "em2Text": "nuclear pregnane X receptor", "label": "CPR:5"}]}
{"sentText": "The concomitantly administered effects of rifampicin on other drugs can result in their altered metabolism or transportation that are metabolised by cytochromes P450 or transported by pglycoprotein in the gastrointestinal tract and liver", "relationMentions": [{"em1Text": "rifampicin", "em2Text": "pglycoprotein", "label": "CPR:9"}, {"em1Text": "rifampicin", "em2Text": "cytochromes P450", "label": "CPR:9"}]}
{"sentText": "We describe here the isolation and biochemical characterization of the marine natural sesquiterpene palinurin as a GSK3\u03b2 inhibitor", "relationMentions": [{"em1Text": "sesquiterpene", "em2Text": "GSK3\u03b2", "label": "CPR:4"}, {"em1Text": "palinurin", "em2Text": "GSK3\u03b2", "label": "CPR:4"}]}
{"sentText": "Experimental studies performed for characterizing the inhibitory mechanism indicate that GSK3\u03b2 inhibition by palinurin cannot be competed out by ATP nor peptide substrate", "relationMentions": [{"em1Text": "GSK3\u03b2", "em2Text": "palinurin", "label": "CPR:4"}]}
{"sentText": "Moreover molecular dynamics simulations have identified an allosteric mechanism by which binding of palinurin leads to GSK3\u03b2 inhibition", "relationMentions": [{"em1Text": "palinurin", "em2Text": "GSK3\u03b2", "label": "CPR:4"}]}
{"sentText": "Plateletinduced COX2 dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21 WAF1 CIP1 and upregulation of cyclinB1 since these effects were prevented by rofecoxib a selective COX2 inhibitor and rescued by exogenous PGE2", "relationMentions": [{"em1Text": "p21", "em2Text": "rofecoxib", "label": "CPR:3"}, {"em1Text": "WAF1", "em2Text": "rofecoxib", "label": "CPR:3"}, {"em1Text": "CIP1", "em2Text": "rofecoxib", "label": "CPR:3"}, {"em1Text": "cyclinB1", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "CyclooxygenaseCOX2 derived prostanoids can influence several processes that are linked to carcinogenesis", "relationMentions": [{"em1Text": "CyclooxygenaseCOX2", "em2Text": "prostanoids", "label": "CPR:9"}]}
{"sentText": "The antihyperthermic effect of Lu AF21934 5 mgkg in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil 10 mgkg and was not serotonindependent as it persisted in serotonindeficient mice and upon blockade of either 5HT1A receptors by WAY100635 or 5HT2A2C receptors by ritanserin", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "WAY100635", "label": "CPR:4"}, {"em1Text": "5HT2A2C", "em2Text": "ritanserin", "label": "CPR:4"}, {"em1Text": "benzodiazepine receptor", "em2Text": "flumazenil", "label": "CPR:6"}]}
{"sentText": "Previous studies demonstrated that the Group III mGlu receptor selective orthosteric agonist LSP12111 produced anxiolytic but not antidepressantlike effects upon peripheral administration", "relationMentions": [{"em1Text": "Group III mGlu receptor", "em2Text": "LSP12111", "label": "CPR:5"}]}
{"sentText": "Catalyticsite affinities for cGMP vardenafil sildenafil tadalafil or 3isobutyl1methylxanthine IBMX were respectively weakened 14 123 30 51 and 43fold for Y612A 63 511 43 95 and 61fold for Q817A and 59 448 71 137 and 93fold for F820A", "relationMentions": [{"em1Text": "tadalafil", "em2Text": "Q817A", "label": "CPR:9"}]}
{"sentText": "Allicin treatment showed reduced production of proinflammatory cytokines and NO and increased HO1 activity", "relationMentions": [{"em1Text": "Allicin", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "Allicin", "em2Text": "cytokines", "label": "CPR:4"}]}
{"sentText": "Recently it has been shown that the activation of particular T2R bitter taste receptors is partially involved with the bitter aftertaste sensation of saccharin and acesulfameK To more fully understand the biology behind these phenomena we have addressed the question of whether AS could stimulate transient receptor potential vanilloid1 TRPV1 receptors as these receptors are activated by a large range of structurally different chemicals", "relationMentions": [{"em1Text": "T2R", "em2Text": "saccharin", "label": "CPR:3"}, {"em1Text": "T2R", "em2Text": "acesulfameK", "label": "CPR:3"}]}
{"sentText": "We also found that TRPV1 receptors are activated by CuSO4 ZnSO4 and FeSO4 three salts known to produce a metallic taste sensation", "relationMentions": [{"em1Text": "TRPV1", "em2Text": "CuSO4", "label": "CPR:3"}, {"em1Text": "TRPV1", "em2Text": "ZnSO4", "label": "CPR:3"}, {"em1Text": "TRPV1", "em2Text": "FeSO4", "label": "CPR:3"}]}
{"sentText": "RKetoprofen 1 was previously reported to be a potent and specific noncompetitive inhibitor of CXCL8 induced human PMNs chemotaxis", "relationMentions": [{"em1Text": "RKetoprofen", "em2Text": "CXCL8", "label": "CPR:4"}]}
{"sentText": "2Arylpropionic CXC chemokine receptor 1 CXCR1 ligands as novel noncompetitive CXCL8 inhibitors", "relationMentions": [{"em1Text": "2Arylpropionic", "em2Text": "CXCL8", "label": "CPR:4"}]}
{"sentText": "Inhibition by phenformin of oxygen consumption via complex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria whereas inhibitory effect of phenformin on complex I respiration was similar in insideout structured submitochondrial particles prepared from rat livers and hearts", "relationMentions": [{"em1Text": "phenformin", "em2Text": "complex I", "label": "CPR:4"}, {"em1Text": "phenformin", "em2Text": "complex I", "label": "CPR:4"}]}
{"sentText": "Role of organic cationcarnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria", "relationMentions": [{"em1Text": "phenformin", "em2Text": "complex I", "label": "CPR:4"}, {"em1Text": "organic cationcarnitine transporter 1", "em2Text": "phenformin", "label": "CPR:9"}]}
{"sentText": "Phenformin causes lactic acidosis in clinical situations due to inhibition of mitochondrial respiratory chain complex I", "relationMentions": [{"em1Text": "Phenformin", "em2Text": "mitochondrial respiratory chain complex I", "label": "CPR:4"}]}
{"sentText": "These observations suggest that uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of complex I respiration", "relationMentions": [{"em1Text": "phenformin", "em2Text": "complex I", "label": "CPR:4"}, {"em1Text": "phenformin", "em2Text": "OCTN1", "label": "CPR:9"}]}
{"sentText": "In this study uptake of phenformin and 14Ctetraethylammonium TEA and complex I inhibition by phenformin were examined in isolated liver and heart mitochondria", "relationMentions": [{"em1Text": "phenformin", "em2Text": "complex I", "label": "CPR:4"}]}
{"sentText": "A series of xanthine derivatives in which a methylene was inserted at position 8 of xanthine scaffold was synthesized and evaluated as inhibitors of dipeptidyl peptidase 4 DPP4 for the treatment of type 2 diabetes", "relationMentions": [{"em1Text": "xanthine", "em2Text": "dipeptidyl peptidase 4", "label": "CPR:4"}, {"em1Text": "xanthine", "em2Text": "DPP4", "label": "CPR:4"}, {"em1Text": "xanthine", "em2Text": "dipeptidyl peptidase 4", "label": "CPR:4"}, {"em1Text": "xanthine", "em2Text": "DPP4", "label": "CPR:4"}]}
{"sentText": "In an earlier report DRD2 E8 AA genotype was associated with reduced responsiveness to the dopamine D2 agonist apomorphine however it is not clear whether both findings share the same biological basis", "relationMentions": [{"em1Text": "dopamine D2", "em2Text": "apomorphine", "label": "CPR:5"}]}
{"sentText": "Functional and biochemical studies indicated that TES signaling involved activity of the phosphoinositide 3 PI3 kinaseprotein kinase B Akt cascade initiated by activation of the androgen receptor and culminated in enhanced production of cGMP and microvascular vasodilation", "relationMentions": [{"em1Text": "TES", "em2Text": "androgen receptor", "label": "CPR:3"}]}
{"sentText": "These findings derived from a variety of analytical and functional approaches provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature TESstimulated vasodilation mediated primarily by peroxynitrite formed from xanthine oxidase generated superoxide and NO", "relationMentions": [{"em1Text": "peroxynitrite", "em2Text": "xanthine oxidase", "label": "CPR:9"}, {"em1Text": "xanthine oxidase", "em2Text": "superoxide", "label": "CPR:9"}, {"em1Text": "xanthine oxidase", "em2Text": "NO", "label": "CPR:9"}]}
{"sentText": "As predicted TES enhanced the production of both peroxynitrite precursors ie superoxide and nitic oxide and xanthine oxidase was identified as the likely source of TESstimulated superoxide production", "relationMentions": [{"em1Text": "TES", "em2Text": "xanthine oxidase", "label": "CPR:9"}, {"em1Text": "superoxide", "em2Text": "xanthine oxidase", "label": "CPR:9"}]}
{"sentText": "DSerine was previously identified in mammalian brain and was shown to be a coagonist at the glycine site of the NmethylDaspartate NMDAtype receptors", "relationMentions": [{"em1Text": "DSerine", "em2Text": "NmethylDaspartate NMDAtype receptors", "label": "CPR:5"}]}
{"sentText": "Mouse brain serine racemase catalyzes specific elimination of Lserine to pyruvate", "relationMentions": [{"em1Text": "Mouse brain serine racemase", "em2Text": "Lserine", "label": "CPR:9"}, {"em1Text": "Mouse brain serine racemase", "em2Text": "pyruvate", "label": "CPR:9"}]}
{"sentText": "Racemization of serine is catalyzed by serine racemase a pyridoxal 5phosphatedependent enzyme expressed mainly in brain and liver", "relationMentions": [{"em1Text": "serine", "em2Text": "serine racemase", "label": "CPR:9"}]}
{"sentText": "Pharmacogenetic analysis of two genes the warfarin metabolic enzyme CYP2C9 and warfarin target enzyme vitamin K epoxide reductase complex 1 VKORC1 confirmed their influence on warfarin maintenance dose", "relationMentions": [{"em1Text": "warfarin", "em2Text": "CYP2C9", "label": "CPR:9"}]}
{"sentText": "Possession of CYP2C92 or CYP2C9 3 variant alleles which result in decreased enzyme activity is associated with a significant decrease in the mean warfarin dose", "relationMentions": [{"em1Text": "CYP2C9", "em2Text": "warfarin", "label": "CPR:9"}, {"em1Text": "CYP2C9", "em2Text": "warfarin", "label": "CPR:9"}]}
{"sentText": "In addition PSE inhibited the transcriptional activity of NFAT without interfering with the calcium induced NFAT dephosphorylation event which represents the major signaling pathway for its activation", "relationMentions": [{"em1Text": "NFAT", "em2Text": "calcium", "label": "CPR:3"}, {"em1Text": "PSE", "em2Text": "NFAT", "label": "CPR:4"}]}
{"sentText": "We found that PSE inhibits interleukin2 IL2 and tumor necrosis factor TNF alpha gene transcription in stimulated Jurkat cells a human Tcell leukemia cell line", "relationMentions": [{"em1Text": "PSE", "em2Text": "tumor necrosis factor TNF alpha", "label": "CPR:3"}, {"em1Text": "PSE", "em2Text": "interleukin2", "label": "CPR:4"}, {"em1Text": "PSE", "em2Text": "IL2", "label": "CPR:4"}]}
{"sentText": "To further characterize the inhibitory mechanisms of PSE at the transcriptional level we examined the transcriptional activities of nuclear factor kappa B NFkappaB nuclear factor of activated T cells NFAT and activator protein1 AP1 transcription factors and found that PSE inhibited NFkappaB dependent transcriptional activity without affecting either the phosphorylation the degradation of the cytoplasmic NFkappaB inhibitory protein IkappaBalpha or the DNAbinding activity", "relationMentions": [{"em1Text": "PSE", "em2Text": "NFkappaB", "label": "CPR:4"}]}
{"sentText": "Pseudoephedrine inhibits Tcell activation by targeting NFkappaB NFAT and AP1 signaling pathways", "relationMentions": [{"em1Text": "Pseudoephedrine", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "Pseudoephedrine", "em2Text": "NFAT", "label": "CPR:4"}, {"em1Text": "Pseudoephedrine", "em2Text": "AP1", "label": "CPR:4"}]}
{"sentText": "However phosphorylation of the p65 RelA subunit was clearly inhibited by PSE in stimulated cells", "relationMentions": [{"em1Text": "p65", "em2Text": "PSE", "label": "CPR:4"}, {"em1Text": "RelA", "em2Text": "PSE", "label": "CPR:4"}]}
{"sentText": "NFAT cooperates with cJun a compound of the AP1 complex to activate target genes and we also found that PSE inhibited both JNK activation and AP1 transcriptional activity", "relationMentions": [{"em1Text": "PSE", "em2Text": "JNK", "label": "CPR:4"}, {"em1Text": "AP1", "em2Text": "PSE", "label": "CPR:4"}]}
{"sentText": "Furthermore experiments showed that treatment with DEC results in a reduction in the amount of COX1 protein in peritoneal exudate cells", "relationMentions": [{"em1Text": "DEC", "em2Text": "COX1", "label": "CPR:4"}]}
{"sentText": "Micromolar Ntp dosedependently increased the mean open channel probability in ligandfree solution POmax and attenuated the ATP inhibition of KIR62 SUR1 but had no effect on homomeric KIR62 channels", "relationMentions": [{"em1Text": "ATP", "em2Text": "KIR62", "label": "CPR:4"}, {"em1Text": "ATP", "em2Text": "SUR1", "label": "CPR:4"}]}
{"sentText": "These effects resemble those seen with Nterminal deletions DeltaN of KIR60 and application of Ntp to DeltaNKATP channels decreased their POmax and apparent IC50 for ATP in the absence of Mg2", "relationMentions": [{"em1Text": "DeltaNKATP channels", "em2Text": "ATP", "label": "CPR:4"}]}
{"sentText": "Monocarboxylate transporters MCTs are protonlinked membrane carriers involved in the transport of monocarboxylates such as lactate pyruvate as well as ketone bodies", "relationMentions": [{"em1Text": "Monocarboxylate transporters", "em2Text": "monocarboxylates", "label": "CPR:9"}, {"em1Text": "MCTs", "em2Text": "monocarboxylates", "label": "CPR:9"}, {"em1Text": "Monocarboxylate transporters", "em2Text": "lactate", "label": "CPR:9"}, {"em1Text": "MCTs", "em2Text": "lactate", "label": "CPR:9"}, {"em1Text": "Monocarboxylate transporters", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "MCTs", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "Monocarboxylate transporters", "em2Text": "ketone", "label": "CPR:9"}, {"em1Text": "MCTs", "em2Text": "ketone", "label": "CPR:9"}]}
{"sentText": "Interestingly part of MCT2 immunoreactivity is located at postsynaptic sites suggesting a particular role of monocarboxylates and their transporters in synaptic transmission", "relationMentions": [{"em1Text": "MCT2", "em2Text": "monocarboxylates", "label": "CPR:9"}]}
{"sentText": "Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850 an mGlu2 agonist mGlu3 antagonist", "relationMentions": [{"em1Text": "mGlu2", "em2Text": "LY541850", "label": "CPR:5"}, {"em1Text": "mGlu3", "em2Text": "LY541850", "label": "CPR:6"}]}
{"sentText": "These results confirm the selective mGlu2 agonist and mGlu3 antagonist actions of LY541850", "relationMentions": [{"em1Text": "mGlu2", "em2Text": "LY541850", "label": "CPR:5"}, {"em1Text": "mGlu3", "em2Text": "LY541850", "label": "CPR:6"}]}
{"sentText": "LY541850 was claimed from human mGlu receptors expressed in nonneuronal cells to be a selective orthosteric mGlu2 agonist and mGlu3 antagonist", "relationMentions": [{"em1Text": "LY541850", "em2Text": "mGlu2", "label": "CPR:5"}, {"em1Text": "LY541850", "em2Text": "mGlu3", "label": "CPR:6"}]}
{"sentText": "Selective precipitation of cytosol receptors with 36 NH42SO4 reduced CBG concentrations to negligible levels", "relationMentions": [{"em1Text": "NH42SO4", "em2Text": "CBG", "label": "CPR:4"}]}
{"sentText": "The activity of the human nasal mucosa microsomes was inhibited by 8methoxypsoralen a known CYP2A inhibitor", "relationMentions": [{"em1Text": "8methoxypsoralen", "em2Text": "CYP2A", "label": "CPR:4"}]}
{"sentText": "Acetylcholinesterase AChE inhibited by the organophosphate soman 122trimethylpropylmethylphosphonofluoridate rapidly becomes resistant to reactivation by oximes due to dealkylation of the somanenzyme complex", "relationMentions": [{"em1Text": "Acetylcholinesterase", "em2Text": "oximes", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "oximes", "label": "CPR:3"}, {"em1Text": "Acetylcholinesterase", "em2Text": "organophosphate", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "organophosphate", "label": "CPR:4"}, {"em1Text": "Acetylcholinesterase", "em2Text": "soman", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "soman", "label": "CPR:4"}, {"em1Text": "Acetylcholinesterase", "em2Text": "122trimethylpropylmethylphosphonofluoridate", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "122trimethylpropylmethylphosphonofluoridate", "label": "CPR:4"}]}
{"sentText": "The effect of the four mono and bisquaternary ammonium compounds tetramethylammonium TMA hexamethonium decamethonium and suxamethonium on the reactivatability of soman inhibited solubilized AChE from human erythrocytes was investigated in vitro", "relationMentions": [{"em1Text": "soman", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "Effects of some mono and bisquaternary ammonium compounds on the reactivatability of soman inhibited human acetylcholinesterase in vitro", "relationMentions": [{"em1Text": "soman", "em2Text": "human acetylcholinesterase", "label": "CPR:4"}]}
{"sentText": "If the effectors were added after 5 min of aging they increased the activity of soman inhibited AChE but to a considerably smaller extent than HI 6", "relationMentions": [{"em1Text": "soman", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "In addition ADP was shown to strongly antagonize TOP2 mediated DNA cleavage induced by ATP sensitive but not ATPinsensitive TOP2 poisons", "relationMentions": [{"em1Text": "TOP2", "em2Text": "ATP", "label": "CPR:3"}]}
{"sentText": "Second C427A mutant human TOP2alpha which exhibits reduced ATPase activity was shown to exhibit crossresistance to all ATPsensitive but not ATP insensitive TOP2 poisons", "relationMentions": [{"em1Text": "ATP", "em2Text": "ATPase", "label": "CPR:4"}]}
{"sentText": "Activation of ALDH2 with ethanol attenuates diabetes induced myocardial injury in rats", "relationMentions": [{"em1Text": "ALDH2", "em2Text": "ethanol", "label": "CPR:3"}]}
{"sentText": "This study assessed changes in myocardial ALDH2 expression in the diabetic rat in particular the diabetic rat pretreated with ALDH2 activator ethanol EtOH", "relationMentions": [{"em1Text": "ALDH2", "em2Text": "ethanol", "label": "CPR:3"}, {"em1Text": "ALDH2", "em2Text": "EtOH", "label": "CPR:3"}]}
{"sentText": "Compared with DM8W group SOD and ALDH2 in EtOH DM8W group was increased MDA was decreased", "relationMentions": [{"em1Text": "SOD", "em2Text": "EtOH", "label": "CPR:3"}, {"em1Text": "ALDH2", "em2Text": "EtOH", "label": "CPR:3"}]}
{"sentText": "HbA1c level in DM12W group was higher than in DM4W group HbA1c level in EtOH DM8W group was lower than in DM8W group", "relationMentions": [{"em1Text": "HbA1c", "em2Text": "EtOH", "label": "CPR:4"}]}
{"sentText": "To investigate the mechanism and consequences of inhibition of QR2 by the quinolines further we have used steadystate and transientstate kinetics to define the mechanism of QR2", "relationMentions": [{"em1Text": "QR2", "em2Text": "quinolines", "label": "CPR:4"}, {"em1Text": "QR2", "em2Text": "quinolines", "label": "CPR:4"}]}
{"sentText": "Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines", "relationMentions": [{"em1Text": "quinone oxidoreductase 2", "em2Text": "quinolines", "label": "CPR:4"}]}
{"sentText": "Our studies shed light on the possible in vivo potency of the quinolines and provide a foundation for future studies aimed at creating more potent QR2 inhibitors and at understanding the physiological significance of QR2", "relationMentions": [{"em1Text": "quinolines", "em2Text": "QR2", "label": "CPR:4"}]}
{"sentText": "QR2 catalyzes the twoelectron reduction of menadione via the oxidation of Nalkylated or Nribosylated nicotinamides", "relationMentions": [{"em1Text": "QR2", "em2Text": "Nribosylated nicotinamides", "label": "CPR:9"}, {"em1Text": "QR2", "em2Text": "menadione", "label": "CPR:9"}, {"em1Text": "QR2", "em2Text": "Nalkylated", "label": "CPR:9"}]}
{"sentText": "Results Our results demonstrate that treatment with LBH589 leads to NIS RNA expression as shown by RTPCR and luciferase assay and to protein expression as determined by immunofluorescence in vitro and by immunohistochemistry in xenograft tumors", "relationMentions": [{"em1Text": "LBH589", "em2Text": "NIS", "label": "CPR:3"}]}
{"sentText": "Methods Stabilized anaplastic thyroid cancer cell lines BHT101 and CAL62 and primary cultures from patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the histone deacetylase inhibitor LBH589", "relationMentions": [{"em1Text": "histone deacetylase", "em2Text": "LBH589", "label": "CPR:4"}]}
{"sentText": "Given these findings a unified PK model including the inhibition of MAOA and CYP2D6 catalyzed 5MeODMT metabolism by harmaline was developed to describe blood harmaline 5MeODMT and bufotenine PK profiles in both wildtype and Tg CYP2D6 mouse models", "relationMentions": [{"em1Text": "MAOA", "em2Text": "harmaline", "label": "CPR:4"}, {"em1Text": "CYP2D6", "em2Text": "harmaline", "label": "CPR:4"}, {"em1Text": "CYP2D6", "em2Text": "harmaline", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "harmaline", "label": "CPR:4"}, {"em1Text": "CYP2D6", "em2Text": "harmaline", "label": "CPR:4"}, {"em1Text": "CYP2D6", "em2Text": "harmaline", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "5MeODMT", "label": "CPR:9"}, {"em1Text": "CYP2D6", "em2Text": "5MeODMT", "label": "CPR:9"}, {"em1Text": "CYP2D6", "em2Text": "5MeODMT", "label": "CPR:9"}, {"em1Text": "MAOA", "em2Text": "5MeODMT", "label": "CPR:9"}, {"em1Text": "CYP2D6", "em2Text": "5MeODMT", "label": "CPR:9"}, {"em1Text": "CYP2D6", "em2Text": "5MeODMT", "label": "CPR:9"}]}
{"sentText": "Our recent study has demonstrated that coadministration of monoamine oxidase A MAOA inhibitor harmaline 5 mgkg increases systemic exposure to 5MeODMT 2 mgkg and active metabolite bufotenine", "relationMentions": [{"em1Text": "monoamine oxidase A", "em2Text": "harmaline", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "harmaline", "label": "CPR:4"}]}
{"sentText": "Our data revealed that inhibition of MAOA mediated metabolic elimination by harmaline 2 5 and 15 mgkg led to a sharp increase in systemic and cerebral exposure to 5MeODMT 2 and 10 mgkg at all dose combinations", "relationMentions": [{"em1Text": "MAOA", "em2Text": "harmaline", "label": "CPR:4"}]}
{"sentText": "Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5MethoxyNNDimethyltryptamine and the Impact of CYP2D6 Status", "relationMentions": [{"em1Text": "Monoamine Oxidase A", "em2Text": "Harmaline", "label": "CPR:4"}]}
{"sentText": "The in vivo inhibitory effect of harmaline on CYP2D6 catalyzed bufotenine formation was confirmed by in vitro study using purified CYP2D6", "relationMentions": [{"em1Text": "harmaline", "em2Text": "CYP2D6", "label": "CPR:4"}, {"em1Text": "harmaline", "em2Text": "CYP2D6", "label": "CPR:4"}, {"em1Text": "CYP2D6", "em2Text": "bufotenine", "label": "CPR:9"}, {"em1Text": "CYP2D6", "em2Text": "bufotenine", "label": "CPR:9"}]}
{"sentText": "The potent histamine H1receptor antagonist cetirizine Zyrtec is a racemic mixture of levocetirizine now available under the trademark Xyzal and dextrocetirizine", "relationMentions": [{"em1Text": "histamine H1receptor", "em2Text": "cetirizine", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "Zyrtec", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "levocetirizine", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "Xyzal", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "dextrocetirizine", "label": "CPR:6"}]}
{"sentText": "Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine two histamine H1receptor antagonists", "relationMentions": [{"em1Text": "cetirizine", "em2Text": "histamine H1receptor", "label": "CPR:6"}, {"em1Text": "levocetirizine", "em2Text": "histamine H1receptor", "label": "CPR:6"}]}
{"sentText": "A new inhibitor of VEGF receptor tyrosine kinases vegfrecine 1 was isolated from the culture broth of Streptomyces sp", "relationMentions": [{"em1Text": "VEGF receptor tyrosine kinases", "em2Text": "vegfrecine", "label": "CPR:4"}]}
{"sentText": "Vegfrecine an Inhibitor of VEGF Receptor Tyrosine Kinases Isolated from the Culture Broth of Streptomyces sp", "relationMentions": [{"em1Text": "Vegfrecine", "em2Text": "VEGF Receptor Tyrosine Kinases", "label": "CPR:4"}]}
{"sentText": "As opposed to the rat and flounder orthologs hNaDC3 was hardly inhibited by lithium concentrations up to 5 mM", "relationMentions": [{"em1Text": "hNaDC3", "em2Text": "lithium", "label": "CPR:4"}]}
{"sentText": "When amiloride was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment uPA activity in both cornea and tear fluid was strongly inhibited", "relationMentions": [{"em1Text": "amiloride", "em2Text": "uPA", "label": "CPR:4"}]}
{"sentText": "In conclusion early application of amiloride inhibited uPA activity in UVBirradiated corneas as well as in tear fluid and diminished the development of corneal pathology", "relationMentions": [{"em1Text": "amiloride", "em2Text": "uPA", "label": "CPR:4"}]}
{"sentText": "The purpose of the present study was to test our hypothesis that amiloride a specific uPA inhibitor effectively decreases uPA activity in cornea as well as in tear fluid and favourably affects corneal healing", "relationMentions": [{"em1Text": "amiloride", "em2Text": "uPA", "label": "CPR:4"}, {"em1Text": "amiloride", "em2Text": "uPA", "label": "CPR:4"}]}
{"sentText": "Effects of inhibition of urokinasetype plasminogen activator uPA by amiloride in the cornea and tear fluid of eyes irradiated with UVB", "relationMentions": [{"em1Text": "urokinasetype plasminogen activator", "em2Text": "amiloride", "label": "CPR:4"}, {"em1Text": "uPA", "em2Text": "amiloride", "label": "CPR:4"}]}
{"sentText": "Therefore comparative histochemical and biochemical studies of uPA and the effects of amiloride were performed on rabbit corneas and tear fluid using the sensitive fluorogenic substrate ZGlyGlyArg7amino4trifluoromethylcoumarin", "relationMentions": [{"em1Text": "uPA", "em2Text": "ZGlyGlyArg7amino4trifluoromethylcoumarin", "label": "CPR:9"}]}
{"sentText": "Prednisolone also inhibited ACTH and cortisol secretion in response to exogenous CRH stimulation inferring rapid feedback inhibition at the anterior pituitary", "relationMentions": [{"em1Text": "Prednisolone", "em2Text": "CRH", "label": "CPR:4"}, {"em1Text": "cortisol", "em2Text": "CRH", "label": "CPR:9"}]}
{"sentText": "Pharmacophore identification of cMyc inhibitor 10074G5", "relationMentions": [{"em1Text": "cMyc", "em2Text": "10074G5", "label": "CPR:4"}]}
{"sentText": "Importantly the carboxylic acid of JY3094 improves the physicochemical properties of the lead compound which will facilitate the incorporation of additional hydrophobicity that might enhance Myc inhibitory activity further still", "relationMentions": [{"em1Text": "JY3094", "em2Text": "Myc", "label": "CPR:4"}]}
{"sentText": "A structureactivity relationship SAR study of the cMyc Myc inhibitor 10074G5 N11biphenyl2yl7nitrobenzoc125oxadiazol4amine 1 which targets a hydrophobic domain of the Myc oncoprotein that is flanked by arginine residues was executed in order to determine its pharmacophore", "relationMentions": [{"em1Text": "cMyc", "em2Text": "10074G5", "label": "CPR:4"}, {"em1Text": "Myc", "em2Text": "10074G5", "label": "CPR:4"}, {"em1Text": "cMyc", "em2Text": "N11biphenyl2yl7nitrobenzoc125oxadiazol4amine", "label": "CPR:4"}, {"em1Text": "Myc", "em2Text": "N11biphenyl2yl7nitrobenzoc125oxadiazol4amine", "label": "CPR:4"}]}
{"sentText": "Miglustat a small iminosugar molecule approved for the treatment of Gaucher disease reversibly inhibits glucosylceramide synthase which catalyses the first committed step in glycosphingolipid synthesis", "relationMentions": [{"em1Text": "Miglustat", "em2Text": "glucosylceramide synthase", "label": "CPR:4"}]}
{"sentText": "Furthermore compared with control groups the plaque endothelium level of p75NTR was 3fold increased and the liver level of p75NTR was 174fold increased by SFO HD", "relationMentions": [{"em1Text": "p75NTR", "em2Text": "SFO", "label": "CPR:3"}, {"em1Text": "p75NTR", "em2Text": "SFO", "label": "CPR:3"}]}
{"sentText": "Meanwhile the serum level of KC a functional homolog of IL8 and the main proinflammatory alpha chemokine in mice in apoE mice was up to 357pgml in SFO HD treated group", "relationMentions": [{"em1Text": "IL8", "em2Text": "SFO", "label": "CPR:3"}, {"em1Text": "alpha chemokine", "em2Text": "SFO", "label": "CPR:3"}]}
{"sentText": "Thus SFO contributes to the instability of atherosclerotic plaque in apoE mice through activating p75NTR and IL8 and cell apoptosis in plaque", "relationMentions": [{"em1Text": "SFO", "em2Text": "p75NTR", "label": "CPR:3"}, {"em1Text": "SFO", "em2Text": "IL8", "label": "CPR:3"}]}
{"sentText": "Because gastric AADC and COMT degrade levodopa the drug is given with inhibitors of AADC carbidopa or benserazide and inhibitors of COMT will also enter clinical use", "relationMentions": [{"em1Text": "AADC", "em2Text": "benserazide", "label": "CPR:4"}, {"em1Text": "AADC", "em2Text": "carbidopa", "label": "CPR:4"}, {"em1Text": "AADC", "em2Text": "levodopa", "label": "CPR:9"}, {"em1Text": "COMT", "em2Text": "levodopa", "label": "CPR:9"}]}
{"sentText": "Levodopa is absorbed in the small bowel and is rapidly catabolized by aromaticLaminoacid decarboxylase AADC and catecholOmethyltransferase COMT", "relationMentions": [{"em1Text": "Levodopa", "em2Text": "aromaticLaminoacid decarboxylase", "label": "CPR:9"}, {"em1Text": "Levodopa", "em2Text": "AADC", "label": "CPR:9"}, {"em1Text": "Levodopa", "em2Text": "catecholOmethyltransferase", "label": "CPR:9"}, {"em1Text": "Levodopa", "em2Text": "COMT", "label": "CPR:9"}]}
{"sentText": "Rats were fed experimental diets containing SPI or casein as a nitrogen source", "relationMentions": [{"em1Text": "casein", "em2Text": "nitrogen", "label": "CPR:9"}]}
{"sentText": "The inhibition of aminopeptidase activity in the presence of bestatin and puromycin inhibitors was also investigated", "relationMentions": [{"em1Text": "aminopeptidase", "em2Text": "bestatin", "label": "CPR:4"}, {"em1Text": "aminopeptidase", "em2Text": "puromycin", "label": "CPR:4"}]}
{"sentText": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity 4methoxy2naphthylamide of Lalanine for aminopeptidase N 4methoxy2naphthylamide of Lleucine for leucine aminopeptidase 4methoxy2naphthylamide of Lglutamic acid for aminopeptidase A and 4methoxy2naphthylamide of Larginine for aminopeptidase B", "relationMentions": [{"em1Text": "Larginine", "em2Text": "aminopeptidase B", "label": "CPR:9"}, {"em1Text": "4methoxy2naphthylamide", "em2Text": "aminopeptidase N", "label": "CPR:9"}, {"em1Text": "Lalanine", "em2Text": "aminopeptidase N", "label": "CPR:9"}, {"em1Text": "4methoxy2naphthylamide", "em2Text": "leucine aminopeptidase", "label": "CPR:9"}, {"em1Text": "Lleucine", "em2Text": "leucine aminopeptidase", "label": "CPR:9"}, {"em1Text": "4methoxy2naphthylamide", "em2Text": "aminopeptidase A", "label": "CPR:9"}, {"em1Text": "Lglutamic acid", "em2Text": "aminopeptidase A", "label": "CPR:9"}, {"em1Text": "4methoxy2naphthylamide", "em2Text": "aminopeptidase B", "label": "CPR:9"}]}
{"sentText": "Here we demonstrate that peptidylprolyl cistransisomerase A1 Pin1 an enzyme that catalyzes the conversion of the peptide bond of pSer pThr Pro moieties in signaling proteins from cis to trans is highly susceptible to HNE modification", "relationMentions": [{"em1Text": "peptidylprolyl cistransisomerase A1", "em2Text": "pSer", "label": "CPR:9"}, {"em1Text": "Pin1", "em2Text": "pSer", "label": "CPR:9"}, {"em1Text": "peptidylprolyl cistransisomerase A1", "em2Text": "pThr", "label": "CPR:9"}, {"em1Text": "Pin1", "em2Text": "pThr", "label": "CPR:9"}, {"em1Text": "peptidylprolyl cistransisomerase A1", "em2Text": "Pro", "label": "CPR:9"}, {"em1Text": "Pin1", "em2Text": "Pro", "label": "CPR:9"}]}
{"sentText": "Withdrawal from freechoice ethanol consumption results in increased packing density of glutamine synthetase immunoreactive astrocytes in the prelimbic cortex of alcoholpreferring rats", "relationMentions": [{"em1Text": "ethanol", "em2Text": "glutamine synthetase", "label": "CPR:3"}]}
{"sentText": "Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released glutamate and its conversion to glutamine through the enzyme glutamine synthetase GS", "relationMentions": [{"em1Text": "glutamate", "em2Text": "glutamine synthetase", "label": "CPR:9"}, {"em1Text": "glutamate", "em2Text": "GS", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "glutamine synthetase", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "GS", "label": "CPR:9"}]}
{"sentText": "Alltrans retinoic acid protects hepatocellular carcinoma cells against serumstarvationinduced cell death by upregulating collagen 8A2", "relationMentions": [{"em1Text": "Alltrans retinoic acid", "em2Text": "collagen 8A2", "label": "CPR:3"}]}
{"sentText": "The protein exhibited modest H2O2 dependent peroxidase activities with guaiacol potassium iodide and 22azinobis3ethylbenzothiazoline6sulfonic acid ABTS", "relationMentions": [{"em1Text": "H2O2", "em2Text": "peroxidase", "label": "CPR:3"}, {"em1Text": "peroxidase", "em2Text": "guaiacol", "label": "CPR:9"}, {"em1Text": "peroxidase", "em2Text": "potassium iodide", "label": "CPR:9"}, {"em1Text": "peroxidase", "em2Text": "22azinobis3ethylbenzothiazoline6sulfonic acid", "label": "CPR:9"}, {"em1Text": "peroxidase", "em2Text": "ABTS", "label": "CPR:9"}]}
{"sentText": "Luciferase reporter assays showed that transcription of FDX1 was synergistically activated by the NR5A family and 8BrcAMP treatment through two SF1 binding sites and a CRElike sequence in a human ovarian granulosa cell line KGN", "relationMentions": [{"em1Text": "FDX1", "em2Text": "8BrcAMP", "label": "CPR:3"}]}
{"sentText": "These results indicate transcription of FDX1 is regulated by the NR5A family and cAMP signaling and participates in steroid hormone production in ovarian granulosa cells", "relationMentions": [{"em1Text": "FDX1", "em2Text": "cAMP", "label": "CPR:3"}, {"em1Text": "FDX1", "em2Text": "steroid", "label": "CPR:9"}]}
{"sentText": "Ferredoxin 1 FDX1 adrenodoxin is an ironsulfur protein that is involved in various metabolic processes including steroid hormone synthesis in mammalian tissues", "relationMentions": [{"em1Text": "FDX1", "em2Text": "steroid", "label": "CPR:9"}, {"em1Text": "adrenodoxin", "em2Text": "steroid", "label": "CPR:9"}, {"em1Text": "Ferredoxin 1", "em2Text": "steroid", "label": "CPR:9"}, {"em1Text": "FDX1", "em2Text": "steroid hormone", "label": "CPR:9"}, {"em1Text": "adrenodoxin", "em2Text": "steroid hormone", "label": "CPR:9"}, {"em1Text": "Ferredoxin 1", "em2Text": "steroid hormone", "label": "CPR:9"}]}
{"sentText": "In the liver of rats given flutamide as initiating agent at the dose of 500 mgkgweek for 6 successive weeks gammaglutamyltraspeptidase positive foci were detected only in 3 of 10 rats", "relationMentions": [{"em1Text": "flutamide", "em2Text": "gammaglutamyltraspeptidase", "label": "CPR:3"}]}
{"sentText": "Flutamide an effective competitive inhibitor of the androgen receptor used orally for palliative treatment of prostatic carcinoma and regulation of prostatic hyperplasia was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes", "relationMentions": [{"em1Text": "Flutamide", "em2Text": "androgen receptor", "label": "CPR:4"}]}
{"sentText": "Cycloxygenase2 COX2 derived prostaglandin E2 PGE2 has been shown to be important in esophageal tumorigenesis", "relationMentions": [{"em1Text": "Cycloxygenase2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "Cycloxygenase2", "em2Text": "PGE2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "We conclude that mPGES1 mediates acidinduced increase in PGE2 production and cell proliferation", "relationMentions": [{"em1Text": "mPGES1", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "We have shown that COX2 mediates acidinduced PGE2 production", "relationMentions": [{"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "Butein also increased heme oxygenase1 HO1 protein expression and HO activity", "relationMentions": [{"em1Text": "Butein", "em2Text": "heme oxygenase1", "label": "CPR:3"}, {"em1Text": "Butein", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "Butein", "em2Text": "HO", "label": "CPR:3"}]}
{"sentText": "Furthermore butein treatment caused nuclear accumulation of nuclear factorE2related factor 2 Nrf2 and increased the promoter activity of antioxidant response elements AREs", "relationMentions": [{"em1Text": "butein", "em2Text": "antioxidant response elements", "label": "CPR:3"}, {"em1Text": "butein", "em2Text": "AREs", "label": "CPR:3"}, {"em1Text": "butein", "em2Text": "nuclear factorE2related factor 2", "label": "CPR:3"}, {"em1Text": "butein", "em2Text": "Nrf2", "label": "CPR:3"}]}
{"sentText": "Treatment of HDP cells with a cJun NH2terminal kinase JNK inhibitor also reduced buteininduced HO1 expression and butein treatment led to increased JNK phosphorylation", "relationMentions": [{"em1Text": "butein", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "JNK", "em2Text": "butein", "label": "CPR:3"}]}
{"sentText": "The refolding kinetics of guanidinedenatured disulfideintact bovine pancreatic ribonuclease A RNase A and its proline42toalanine mutant Pro42Ala have been studied by monitoring tyrosine burial and 2cytidine monophosphate 2CMP inhibitor binding", "relationMentions": [{"em1Text": "proline42toalanine", "em2Text": "2cytidine monophosphate", "label": "CPR:4"}, {"em1Text": "Pro42Ala", "em2Text": "2cytidine monophosphate", "label": "CPR:4"}, {"em1Text": "bovine pancreatic ribonuclease A", "em2Text": "2cytidine monophosphate", "label": "CPR:4"}, {"em1Text": "RNase A", "em2Text": "2cytidine monophosphate", "label": "CPR:4"}, {"em1Text": "proline42toalanine", "em2Text": "2CMP", "label": "CPR:4"}, {"em1Text": "Pro42Ala", "em2Text": "2CMP", "label": "CPR:4"}, {"em1Text": "bovine pancreatic ribonuclease A", "em2Text": "2CMP", "label": "CPR:4"}, {"em1Text": "RNase A", "em2Text": "2CMP", "label": "CPR:4"}]}
{"sentText": "The folding rate for wildtype RNase A is faster in the presence of the inhibitor 2CMP than in its absence indicating that the transitionstate structure in the ratedetermining step is stabilized by 2CMP", "relationMentions": [{"em1Text": "RNase A", "em2Text": "2CMP", "label": "CPR:4"}]}
{"sentText": "Cortisol and IFNT stimulated endometrial HSD11B1 expression and activity increased endometrial PTGS2 activity and the amount of PG in the uterine lumen and upregulated many conceptus elongationrelated genes in the endometrium", "relationMentions": [{"em1Text": "Cortisol", "em2Text": "HSD11B1", "label": "CPR:3"}, {"em1Text": "Cortisol", "em2Text": "PTGS2", "label": "CPR:3"}]}
{"sentText": "In study 1 cyclic ewes received vehicle cortisol PF 915275 PF a selective inhibitor of HSD11B1 cortisol and PF meloxicam a selective inhibitor of PTGS2 cortisol and meloxicam recombinant ovine IFNT or IFNT and PF into the uterus from day 10 to day14 after estrus", "relationMentions": [{"em1Text": "PF 915275", "em2Text": "HSD11B1", "label": "CPR:4"}, {"em1Text": "meloxicam", "em2Text": "PTGS2", "label": "CPR:4"}]}
{"sentText": "The primary aim of these studies was to test the hypothesis that HSD11B1 derived cortisol has a biological role in endometrial function and conceptus development during early pregnancy in sheep", "relationMentions": [{"em1Text": "HSD11B1", "em2Text": "cortisol", "label": "CPR:9"}]}
{"sentText": "During early pregnancy in sheep the elongating conceptus secretes interferon\u03c4 IFNT and the conceptus as well as endometrial epithelia produce prostaglandins PG via PG synthase 2 PTGS2 and cortisol via hydroxysteroid 11\u03b2 dehydrogenase 1 HSD11B1", "relationMentions": [{"em1Text": "prostaglandins", "em2Text": "PG synthase 2", "label": "CPR:9"}, {"em1Text": "prostaglandins", "em2Text": "PTGS2", "label": "CPR:9"}, {"em1Text": "cortisol", "em2Text": "hydroxysteroid 11\u03b2 dehydrogenase 1", "label": "CPR:9"}, {"em1Text": "cortisol", "em2Text": "HSD11B1", "label": "CPR:9"}]}
{"sentText": "These results suggest that HSD11B1 derived cortisol mediates in part actions of ovarian progesterone and the conceptus on endometrial function and support the hypothesis that IFNT PG and cortisol coordinately regulate endometrial functions important for conceptus elongation and implantation during early pregnancy in sheep", "relationMentions": [{"em1Text": "HSD11B1", "em2Text": "cortisol", "label": "CPR:9"}]}
{"sentText": "It is concluded that D1997 contracts the canine basilar artery by stimulating 5HT1like receptors unrelated to either the 5HT1A or 5HT1B receptor subtypes", "relationMentions": [{"em1Text": "D1997", "em2Text": "5HT1like receptors", "label": "CPR:3"}, {"em1Text": "D1997", "em2Text": "5HT1A", "label": "CPR:3"}, {"em1Text": "D1997", "em2Text": "5HT1B", "label": "CPR:3"}]}
{"sentText": "The effects of D1997 in the basilar artery were not modified by incubation with either the 5HT2 receptor antagonist ketanserin 0011 microM the 5HT3 and 5HT4 receptor antagonist ICS205930 tropisetron 0110 microM the 5HT1A receptor antagonist spiroxatrine 0011 microM the betaadrenoceptor blocker with high affinity for 5HT1A and 5HT1B binding sites pindolol 0011 microM or the alpha 1adrenoceptor antagonist prazosin 0011 microM", "relationMentions": [{"em1Text": "betaadrenoceptor", "em2Text": "pindolol", "label": "CPR:4"}, {"em1Text": "5HT2 receptor", "em2Text": "ketanserin", "label": "CPR:6"}, {"em1Text": "5HT3", "em2Text": "tropisetron", "label": "CPR:6"}, {"em1Text": "5HT4", "em2Text": "tropisetron", "label": "CPR:6"}, {"em1Text": "5HT1A", "em2Text": "spiroxatrine", "label": "CPR:6"}, {"em1Text": "alpha 1adrenoceptor", "em2Text": "prazosin", "label": "CPR:6"}]}
{"sentText": "22Aminoethylquinoline D1997 a novel agonist at 5hydroxytryptamine1like receptors in the canine basilar artery", "relationMentions": [{"em1Text": "22Aminoethylquinoline", "em2Text": "5hydroxytryptamine1like receptors", "label": "CPR:5"}, {"em1Text": "D1997", "em2Text": "5hydroxytryptamine1like receptors", "label": "CPR:5"}]}
{"sentText": "In contrast the D1997 induced responses were potently and concentrationdependently antagonized by the mixed 5HT1like and 5HT2 receptor antagonist methiothepin 0011 microM", "relationMentions": [{"em1Text": "D1997", "em2Text": "5HT1like", "label": "CPR:5"}, {"em1Text": "D1997", "em2Text": "5HT2 receptor", "label": "CPR:5"}, {"em1Text": "5HT1like", "em2Text": "methiothepin", "label": "CPR:6"}, {"em1Text": "5HT2 receptor", "em2Text": "methiothepin", "label": "CPR:6"}]}
{"sentText": "Although Bak and Bcl2associated X protein Bax another member of the Bcl2 family are generally thought to be functionally redundant only Bak is necessary and sufficient for VK2 induced cytochrome c cyt c release and cell death", "relationMentions": [{"em1Text": "VK2", "em2Text": "cytochrome c", "label": "CPR:3"}, {"em1Text": "VK2", "em2Text": "cyt c", "label": "CPR:3"}]}
{"sentText": "In muscle and liver TCDD 10 ngkgday induced increases in methylation and decreases in mRNA expression of Igf2r", "relationMentions": [{"em1Text": "TCDD", "em2Text": "Igf2r", "label": "CPR:4"}]}
{"sentText": "Rasagiline is a propargylamine and irreversible monoamine oxidase MAO B inhibitor used for the treatment of Parkinsons disease PD", "relationMentions": [{"em1Text": "Rasagiline", "em2Text": "monoamine oxidase MAO B", "label": "CPR:4"}, {"em1Text": "propargylamine", "em2Text": "monoamine oxidase MAO B", "label": "CPR:4"}]}
{"sentText": "Prolonged use of tolvaptan leads to increased endogenous levels of AVP and perhaps overstimulation of V1A receptors", "relationMentions": [{"em1Text": "tolvaptan", "em2Text": "AVP", "label": "CPR:3"}, {"em1Text": "tolvaptan", "em2Text": "V1A receptors", "label": "CPR:3"}]}
{"sentText": "Tolvaptan is a selective arginine vasopressin AVP V2 receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia", "relationMentions": [{"em1Text": "Tolvaptan", "em2Text": "arginine vasopressin AVP V2 receptor", "label": "CPR:4"}]}
{"sentText": "In addition tolvaptan is metabolized by the CYP3A4 system thus physicians should be aware of the potential for increased interactions with other medications", "relationMentions": [{"em1Text": "tolvaptan", "em2Text": "CYP3A4", "label": "CPR:9"}]}
{"sentText": "Fisetin treatment showed a significant decline in the levels of blood glucose glycosylated hemoglobin HbA1c NFkB p65 unit in pancreas and IL1\u03b2 plasma serum nitric oxide NO with an elevation in plasma insulin", "relationMentions": [{"em1Text": "Fisetin", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "Fisetin", "em2Text": "glycosylated hemoglobin", "label": "CPR:4"}, {"em1Text": "Fisetin", "em2Text": "HbA1c", "label": "CPR:4"}, {"em1Text": "Fisetin", "em2Text": "NFkB", "label": "CPR:4"}, {"em1Text": "Fisetin", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "Fisetin", "em2Text": "IL1\u03b2", "label": "CPR:4"}]}
{"sentText": "In conclusion IL8 production and neutrophil infiltration are increased in high glucose environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin", "relationMentions": [{"em1Text": "IL8", "em2Text": "glucose", "label": "CPR:3"}]}
{"sentText": "Using cultured human keratinocytes and diabetic rat model the current study showed that high glucose environment enhanced IL8 production via epidermal growth factor receptor EGFR extracelluar signalregulated kinase ERK pathway in a reactive oxygen species ROSdependent manner in keratinocytes", "relationMentions": [{"em1Text": "glucose", "em2Text": "IL8", "label": "CPR:3"}]}
{"sentText": "High glucose environment enhanced oxidative stress and increased interleukin8 secretion from keratinocytes New insights on impaired diabetic wound healing", "relationMentions": [{"em1Text": "glucose", "em2Text": "interleukin8", "label": "CPR:3"}]}
{"sentText": "With the elevated doses of PhIP malondialdehyde MDA contents protein carbonyl PCO contents and DNAprotein crosslinks DPC coefficients were significantly raised in a dosedependent manner 3 PhIP at the doses of 10mgkg andor 15mgkg significantly inhibited p16 mRNA and protein expression whereas enhanced cfos and cjun expression relative to control", "relationMentions": [{"em1Text": "PhIP", "em2Text": "cjun", "label": "CPR:3"}, {"em1Text": "PhIP", "em2Text": "cfos", "label": "CPR:3"}, {"em1Text": "PhIP", "em2Text": "p16", "label": "CPR:4"}]}
{"sentText": "The data indicated that PhIP could cause stomach injury oxidative stress in rat stomachs as well as the activation of cfos and cjun and inactivation of p16 which may play a role in the pathogenesis of PhIPassociated stomach cancer", "relationMentions": [{"em1Text": "PhIP", "em2Text": "cfos", "label": "CPR:3"}, {"em1Text": "PhIP", "em2Text": "cjun", "label": "CPR:3"}, {"em1Text": "PhIP", "em2Text": "p16", "label": "CPR:4"}]}
{"sentText": "The results showed that 1 15mgkg body weight PhIP induced obvious histopathological changes in gastric mucosa 2 PhIP 10 andor 15mgkg significantly decreased superoxide dismutase SOD and glutathioneperoxidase GPx activities while increased catalase CAT activity compared with the control", "relationMentions": [{"em1Text": "PhIP", "em2Text": "catalase", "label": "CPR:3"}, {"em1Text": "PhIP", "em2Text": "CAT", "label": "CPR:3"}, {"em1Text": "PhIP", "em2Text": "superoxide dismutase", "label": "CPR:4"}, {"em1Text": "PhIP", "em2Text": "SOD", "label": "CPR:4"}, {"em1Text": "PhIP", "em2Text": "glutathioneperoxidase", "label": "CPR:4"}, {"em1Text": "PhIP", "em2Text": "GPx", "label": "CPR:4"}]}
{"sentText": "We also shortly discuss the ongoing debate on whether NO is the actual reaction product of NOS catalysis as well as the phenomenon of NOmediated autoinhibition", "relationMentions": [{"em1Text": "NO", "em2Text": "NOS", "label": "CPR:9"}]}
{"sentText": "These results suggest that prostacyclin may play a role in downregulating tissue factor expression in monocytes at least in part via elevation of intracellular levels of cyclic AMP", "relationMentions": [{"em1Text": "prostacyclin", "em2Text": "tissue factor", "label": "CPR:4"}, {"em1Text": "tissue factor", "em2Text": "cyclic AMP", "label": "CPR:4"}]}
{"sentText": "The present studies were undertaken to determine whether stable analogues of prostacyclin a potent endotheliumderived platelet inhibitor and vasodilator could inhibit tissue factor expression by human monocytic cells", "relationMentions": [{"em1Text": "prostacyclin", "em2Text": "tissue factor", "label": "CPR:4"}]}
{"sentText": "Preincubation for 30 minutes with iloprost ciprostene and carbacyclin led to a dosedependent inhibition of tissue factor expression induced by all three challenging agents", "relationMentions": [{"em1Text": "iloprost", "em2Text": "tissue factor", "label": "CPR:4"}, {"em1Text": "ciprostene", "em2Text": "tissue factor", "label": "CPR:4"}, {"em1Text": "carbacyclin", "em2Text": "tissue factor", "label": "CPR:4"}]}
{"sentText": "Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP1 via a cyclic AMPdependent mechanism", "relationMentions": [{"em1Text": "Prostacyclin", "em2Text": "tissue factor", "label": "CPR:4"}]}
{"sentText": "This effect was potentiated by isobutylmethylxanthine an inhibitor of phosphodiesterase", "relationMentions": [{"em1Text": "isobutylmethylxanthine", "em2Text": "phosphodiesterase", "label": "CPR:4"}]}
{"sentText": "The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and d ibutyryl cyclic AMP but not dibutyryl cyclic GMP", "relationMentions": [{"em1Text": "tissue factor", "em2Text": "isobutylmethylxanthine", "label": "CPR:4"}, {"em1Text": "tissue factor", "em2Text": "forskolin", "label": "CPR:4"}, {"em1Text": "tissue factor", "em2Text": "ibutyryl cyclic AMP", "label": "CPR:4"}]}
{"sentText": "5FU interferes with DNA synthesis by blocking thymidylate synthase TS but is inactivated by dihydropyrimidine dehydrogenase DPD", "relationMentions": [{"em1Text": "5FU", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "5FU", "em2Text": "TS", "label": "CPR:4"}]}
{"sentText": "PURPOSE The fluoropyrimidine carbamate capecitabine is converted to 5fluorouracil 5FU by thymidine phosphorylase TP inside target tissues", "relationMentions": [{"em1Text": "5fluorouracil", "em2Text": "TP", "label": "CPR:9"}, {"em1Text": "5fluorouracil", "em2Text": "thymidine phosphorylase", "label": "CPR:9"}, {"em1Text": "5FU", "em2Text": "TP", "label": "CPR:9"}, {"em1Text": "5FU", "em2Text": "thymidine phosphorylase", "label": "CPR:9"}, {"em1Text": "fluoropyrimidine carbamate", "em2Text": "TP", "label": "CPR:9"}, {"em1Text": "fluoropyrimidine carbamate", "em2Text": "thymidine phosphorylase", "label": "CPR:9"}, {"em1Text": "capecitabine", "em2Text": "TP", "label": "CPR:9"}, {"em1Text": "capecitabine", "em2Text": "thymidine phosphorylase", "label": "CPR:9"}]}
{"sentText": "Favorable enzyme profiles high TP and low DPD generate high intratumor levels of 5FU that are effective against many tumors especially those with low TS", "relationMentions": [{"em1Text": "TP", "em2Text": "5FU", "label": "CPR:9"}, {"em1Text": "DPD", "em2Text": "5FU", "label": "CPR:9"}]}
{"sentText": "Histamine and Ca added to NSAIDs amplified the activating effect of the latter on CA II", "relationMentions": [{"em1Text": "Ca", "em2Text": "CA II", "label": "CPR:3"}]}
{"sentText": "Indomethacin abolished the inhibitory effect of acetazolamide on CA I and CA II", "relationMentions": [{"em1Text": "Indomethacin", "em2Text": "CA I", "label": "CPR:3"}, {"em1Text": "Indomethacin", "em2Text": "CA II", "label": "CPR:3"}, {"em1Text": "acetazolamide", "em2Text": "CA I", "label": "CPR:4"}, {"em1Text": "acetazolamide", "em2Text": "CA II", "label": "CPR:4"}]}
{"sentText": "Association of PGE2 or acetazolamide to NSAIDs reduced NSAIDinduced activation of CA I and CA II", "relationMentions": [{"em1Text": "acetazolamide", "em2Text": "CA I", "label": "CPR:4"}, {"em1Text": "acetazolamide", "em2Text": "CA II", "label": "CPR:4"}]}
{"sentText": "Previous studies by this research team proved that vasodilating prostaglandins PGs E1 E2 and I2 inhibit carbonic anhydrase CA in vitro and in vivo which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs", "relationMentions": [{"em1Text": "prostaglandins", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "prostaglandins", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "PGs", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "PGs", "em2Text": "CA", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS In the maximum registered dosage nabumetone inhibits thromboxane production much more than meloxicam signifying less COX2 selectivity of the former", "relationMentions": [{"em1Text": "nabumetone", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "COX1 inhibition was measured as percentage inhibition of serum TXB2 generation in clotting whole blood and as closure time with use of the platelet function analyser PFA100", "relationMentions": [{"em1Text": "COX1", "em2Text": "TXB2", "label": "CPR:9"}]}
{"sentText": "Treatment with diclofenac resulted in nuclear condensation a morphological change due to apoptosis of NSCs 24hr after the treatment and activated caspase3 after 6 hr indicating that diclofenac may cause apoptosis of neuronal cells via activation of the caspase cascade", "relationMentions": [{"em1Text": "diclofenac", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "diclofenac", "em2Text": "caspase", "label": "CPR:3"}]}
{"sentText": "Correlation between activation of PPAR\u03b3 and resistin downregulation in a mouse adipocyte cell line by a series of thiazolidinediones", "relationMentions": [{"em1Text": "PPAR\u03b3", "em2Text": "thiazolidinediones", "label": "CPR:3"}, {"em1Text": "resistin", "em2Text": "thiazolidinediones", "label": "CPR:4"}]}
{"sentText": "Firstly in the normal human renal epithelial HK2 cells the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers sulforaphane tertbutylhydroquinone cinnamic aldehyde and hydrogen peroxide showed that the aldoketo reductase AKR 1C1 is highly inducible by all treatments", "relationMentions": [{"em1Text": "NRF2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "NRF2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "sulforaphane", "em2Text": "aldoketo reductase AKR 1C1", "label": "CPR:3"}, {"em1Text": "NRF2", "em2Text": "tertbutylhydroquinone", "label": "CPR:3"}, {"em1Text": "NRF2", "em2Text": "tertbutylhydroquinone", "label": "CPR:3"}, {"em1Text": "tertbutylhydroquinone", "em2Text": "aldoketo reductase AKR 1C1", "label": "CPR:3"}, {"em1Text": "NRF2", "em2Text": "cinnamic aldehyde", "label": "CPR:3"}, {"em1Text": "NRF2", "em2Text": "cinnamic aldehyde", "label": "CPR:3"}, {"em1Text": "cinnamic aldehyde", "em2Text": "aldoketo reductase AKR 1C1", "label": "CPR:3"}, {"em1Text": "NRF2", "em2Text": "hydrogen peroxide", "label": "CPR:3"}, {"em1Text": "NRF2", "em2Text": "hydrogen peroxide", "label": "CPR:3"}, {"em1Text": "hydrogen peroxide", "em2Text": "aldoketo reductase AKR 1C1", "label": "CPR:3"}]}
{"sentText": "The treatment of U937 cells with NRF2 inducers including sulforaphane effectively elevated the expression of AKR1B1 1B10 1C1 1C2 and 1C3", "relationMentions": [{"em1Text": "NRF2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "sulforaphane", "em2Text": "AKR1B1 1B10 1C1 1C2 and 1C3", "label": "CPR:3"}]}
{"sentText": "Whereas the levels of both the basal and sulforaphane inducible expression of AKR1C1 were significantly reduced in NRF2silenced stable U937 cells compared to the control cells", "relationMentions": [{"em1Text": "sulforaphane", "em2Text": "AKR1C1", "label": "CPR:3"}]}
{"sentText": "Endothelial NO synthase expression was increased by cilazapril but not by losartan", "relationMentions": [{"em1Text": "Endothelial NO synthase", "em2Text": "cilazapril", "label": "CPR:3"}]}
{"sentText": "Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments whereas no changes in the expression of rat ACE and AT1A receptor genes were observed", "relationMentions": [{"em1Text": "Human and rat renin", "em2Text": "losartan", "label": "CPR:3"}, {"em1Text": "angiotensinogen", "em2Text": "losartan", "label": "CPR:3"}, {"em1Text": "Human and rat renin", "em2Text": "cilazapril", "label": "CPR:3"}, {"em1Text": "angiotensinogen", "em2Text": "cilazapril", "label": "CPR:3"}]}
{"sentText": "In addition to this pronounced loss of function M1766L also showed a 10fold increase in the persistent late sodium current", "relationMentions": [{"em1Text": "M1766L", "em2Text": "sodium", "label": "CPR:3"}]}
{"sentText": "OMT showed partial protection in the cortical neurons via downregulation of NR2B containing NMDA receptors and upregulation of Bcl2 family", "relationMentions": [{"em1Text": "OMT", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "OMT", "em2Text": "NR2B", "label": "CPR:4"}, {"em1Text": "OMT", "em2Text": "NMDA receptors", "label": "CPR:4"}]}
{"sentText": "Western blot analysis revealed that OMT decreased the expression of Bax and repaired the balance of pro and antiapoptotic proteins", "relationMentions": [{"em1Text": "OMT", "em2Text": "Bax", "label": "CPR:4"}]}
{"sentText": "Furthermore OMT significantly reversed the upregulation of NR2B and inhibited the calcium overload in the cultured neurons after challenging the NMDA", "relationMentions": [{"em1Text": "OMT", "em2Text": "NR2B", "label": "CPR:4"}]}
{"sentText": "Emodin6O\u03b2Dglucoside inhibits HMGB1 induced inflammatory responses in vitro and in vivo", "relationMentions": [{"em1Text": "Emodin6O\u03b2Dglucoside", "em2Text": "HMGB1", "label": "CPR:4"}]}
{"sentText": "Ramelteon Rozerem Takeda Pharmaceutical Company Limited Osaka Japan is an orally active highly selective melatonin MT1 MT2 receptor agonist", "relationMentions": [{"em1Text": "Ramelteon", "em2Text": "MT1", "label": "CPR:5"}, {"em1Text": "Ramelteon", "em2Text": "MT2", "label": "CPR:5"}]}
{"sentText": "Unlike the sedative hypnotics that target GABAA receptor complexes ramelteon is a chronohypnotic that acts on the melatonin MT1 and MT2 receptors which are primarily located in the suprachiasmatic nucleus the bodys master clock", "relationMentions": [{"em1Text": "ramelteon", "em2Text": "MT1", "label": "CPR:5"}, {"em1Text": "ramelteon", "em2Text": "MT2", "label": "CPR:5"}]}
{"sentText": "Pharmacology of ramelteon a selective MT1 MT2 receptor agonist a novel therapeutic drug for sleep disorders", "relationMentions": [{"em1Text": "ramelteon", "em2Text": "MT1", "label": "CPR:5"}, {"em1Text": "ramelteon", "em2Text": "MT2", "label": "CPR:5"}]}
{"sentText": "Am80 inhibited VEGF induced phosphorylation of VEGF receptor", "relationMentions": [{"em1Text": "Am80", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "Am80", "em2Text": "VEGF", "label": "CPR:4"}]}
{"sentText": "In addition VEGF induced formation of tubelike structures in vitro and neovascularization in mouse corneas were significantly inhibited by Am80", "relationMentions": [{"em1Text": "VEGF", "em2Text": "Am80", "label": "CPR:4"}]}
{"sentText": "Am80 slightly inhibited the growth of both myeloma cells and HUVECs and remarkably inhibited the growth of HUVECs stimulated by VEGF", "relationMentions": [{"em1Text": "Am80", "em2Text": "VEGF", "label": "CPR:4"}]}
{"sentText": "We have examined the effect of dihydropyridine Ca2channel blockers felodipine and nicardipine on CaMPDE", "relationMentions": [{"em1Text": "Ca2channel", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "Ca2channel", "em2Text": "nicardipine", "label": "CPR:4"}, {"em1Text": "dihydropyridine", "em2Text": "Ca2channel", "label": "CPR:4"}]}
{"sentText": "The results suggest that the 63kDa PDE 1B1 and 60kDa PDE 1A2 CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2 antagonists appear to counteract each other", "relationMentions": [{"em1Text": "PDE 1B1", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "PDE 1A2", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "CaMPDE", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "PDE 1B1", "em2Text": "nicardipine", "label": "CPR:4"}, {"em1Text": "PDE 1A2", "em2Text": "nicardipine", "label": "CPR:4"}, {"em1Text": "CaMPDE", "em2Text": "nicardipine", "label": "CPR:4"}]}
{"sentText": "Felodipine and nicardipine have similar affinities for 60kDa CaMPDE isozymes but bring about different levels of enzyme inhibition suggesting the possibility of designing specific drugs that can protect the enzyme from inhibition by dihydropyridine Ca2channel blockers", "relationMentions": [{"em1Text": "CaMPDE", "em2Text": "dihydropyridine", "label": "CPR:4"}, {"em1Text": "dihydropyridine", "em2Text": "Ca2channel", "label": "CPR:4"}]}
{"sentText": "Several inhibitors of LpPLA2 have been described including darapladib which is currently in phase 3 clinical development for the treatment of atherosclerosis", "relationMentions": [{"em1Text": "LpPLA2", "em2Text": "darapladib", "label": "CPR:4"}]}
{"sentText": "We show that both darapladib and a novel class of structurally distinct carbamate inhibitors inactivate LpPLA2 in mouse tissues and human cell lines with high selectivity", "relationMentions": [{"em1Text": "darapladib", "em2Text": "LpPLA2", "label": "CPR:4"}, {"em1Text": "carbamate", "em2Text": "LpPLA2", "label": "CPR:4"}]}
{"sentText": "Sepracor in the US is developing arformoterol RRformoterol a single isomer form of the beta2adrenoceptor agonist formoterol eformoterol", "relationMentions": [{"em1Text": "formoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "beta2adrenoceptor", "em2Text": "eformoterol", "label": "CPR:5"}]}
{"sentText": "Nitric oxide products of VP16 displayed significantly diminished topoisomerase II dependent cleavage of DNA and cytotoxicity to human HL60 leukemia cells", "relationMentions": [{"em1Text": "VP16", "em2Text": "topoisomerase II", "label": "CPR:4"}]}
{"sentText": "Refeeding normal chow or a high sucrose diet for 24 h after a 48h fast increased both ACS1 and ACS4 protein expression 1520fold consistent with inhibition studies", "relationMentions": [{"em1Text": "sucrose", "em2Text": "ACS1", "label": "CPR:3"}, {"em1Text": "sucrose", "em2Text": "ACS4", "label": "CPR:3"}]}
{"sentText": "Consistent with these locations Nethylmaleimide an inhibitor of ACS4 inhibited ACS activity 47 in MAM and 28 in endoplasmic reticulum", "relationMentions": [{"em1Text": "Nethylmaleimide", "em2Text": "ACS4", "label": "CPR:4"}, {"em1Text": "Nethylmaleimide", "em2Text": "ACS", "label": "CPR:4"}]}
{"sentText": "Troglitazone a second ACS4 inhibitor inhibited ACS activity 10 in microsomes and mitochondria and 45 in MAM", "relationMentions": [{"em1Text": "Troglitazone", "em2Text": "ACS4", "label": "CPR:4"}, {"em1Text": "Troglitazone", "em2Text": "ACS", "label": "CPR:4"}]}
{"sentText": "Triacsin C a competitive inhibitor of both ACS1 and ACS4 inhibited ACS activity similarly in endoplasmic reticulum MAM and mitochondria suggesting that a hitherto unidentified triacsinsensitive ACS is present in mitochondria", "relationMentions": [{"em1Text": "Triacsin C", "em2Text": "ACS1", "label": "CPR:4"}, {"em1Text": "Triacsin C", "em2Text": "ACS4", "label": "CPR:4"}, {"em1Text": "Triacsin C", "em2Text": "ACS", "label": "CPR:4"}]}
{"sentText": "These results suggest that ACS1 and ACS4 may be linked to triacylglycerol synthesis", "relationMentions": [{"em1Text": "ACS1", "em2Text": "triacylglycerol", "label": "CPR:9"}, {"em1Text": "ACS4", "em2Text": "triacylglycerol", "label": "CPR:9"}]}
{"sentText": "ZD1839 Iressa a quinazoline t tyrosine kinase inhibitor selective for the EGFR has shown good activity in preclinical studies and in the early phase of clinical trials", "relationMentions": [{"em1Text": "ZD1839", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "ZD1839", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "Iressa", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "Iressa", "em2Text": "EGFR", "label": "CPR:4"}]}
{"sentText": "The tyrosine kinase inhibitor ZD1839 Iressa inhibits HER2 driven signaling and suppresses the growth of HER2 overexpressing tumor cells", "relationMentions": [{"em1Text": "tyrosine kinase", "em2Text": "ZD1839", "label": "CPR:4"}, {"em1Text": "ZD1839", "em2Text": "HER2", "label": "CPR:4"}, {"em1Text": "Iressa", "em2Text": "HER2", "label": "CPR:4"}, {"em1Text": "tyrosine kinase", "em2Text": "Iressa", "label": "CPR:4"}, {"em1Text": "Iressa", "em2Text": "HER2", "label": "CPR:4"}, {"em1Text": "tyrosine", "em2Text": "kinase", "label": "CPR:9"}]}
{"sentText": "These studies suggest that HER2overexpressing tumors are particularly susceptible to the inhibition of HER family tyrosine kinase signaling and suggest novel strategies to treat these particularly aggressive tumors", "relationMentions": [{"em1Text": "tyrosine", "em2Text": "kinase", "label": "CPR:9"}]}
{"sentText": "Growth inhibition of these tumor cell lines was associated with the dephosphorylation of EGFR HER2 and HER3 accompanied by the loss of association of HER3 with phosphatidylinositol 3kinase and downregulation of Akt activity", "relationMentions": [{"em1Text": "phosphatidylinositol", "em2Text": "3kinase", "label": "CPR:9"}]}
{"sentText": "Pharmacological effects of a muopioid receptor antagonist naltrexone on alcohol dependence", "relationMentions": [{"em1Text": "muopioid receptor", "em2Text": "naltrexone", "label": "CPR:6"}]}
{"sentText": "In many countries a muopioid receptor antagonist naltrexone has been used in the treatment of alcohol dependence", "relationMentions": [{"em1Text": "muopioid receptor", "em2Text": "naltrexone", "label": "CPR:6"}]}
{"sentText": "Lisuride dose dependently decreased body temperature in rats with a potency similar to that of the selective 5HT1A agonist LY 293284", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "LY 293284", "label": "CPR:5"}]}
{"sentText": "RESULTS In drug discrimination studies lisuride fully mimicked the 5HT1A agonist LY 293284 only partially substituted for LSD and DOI and failed to substitute for amphetamine", "relationMentions": [{"em1Text": "lisuride", "em2Text": "5HT1A", "label": "CPR:5"}, {"em1Text": "5HT1A", "em2Text": "LY 293284", "label": "CPR:5"}]}
{"sentText": "Only pMPPI 4iodoN24methoxyphenyl1piperazinylethylN2pyridynylbenzamide hydrochloride a selective 5HT1A antagonist was effective in inhibiting all 5HT syndrome behaviors produced by lisuride whereas pMPPI was without effect on any behavior induced by LSD", "relationMentions": [{"em1Text": "4iodoN24methoxyphenyl1piperazinylethylN2pyridynylbenzamide hydrochloride", "em2Text": "5HT1A", "label": "CPR:6"}]}
{"sentText": "Thus bupropion acts as an antagonist at alpha3beta2 and alpha3beta4 nAChRs in rat striatum and hippocampus respectively across the same concentration range that inhibits DAT and NET function", "relationMentions": [{"em1Text": "bupropion", "em2Text": "DAT", "label": "CPR:4"}, {"em1Text": "bupropion", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "The combination of nAChR and transporter inhibition produced by bupropion may contribute to its clinical efficacy as a smoking cessation agent", "relationMentions": [{"em1Text": "nAChR", "em2Text": "bupropion", "label": "CPR:4"}]}
{"sentText": "Bupropion an efficacious antidepressant and smoking cessation agent inhibits dopamine and norepinephrine transporters DAT and NET respectively", "relationMentions": [{"em1Text": "Bupropion", "em2Text": "DAT", "label": "CPR:4"}, {"em1Text": "Bupropion", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "To eliminate the interaction of bupropion with DAT or NET nomifensine or desipramine respectively was included in the superfusion buffer", "relationMentions": [{"em1Text": "bupropion", "em2Text": "DAT", "label": "CPR:4"}, {"em1Text": "bupropion", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "Furthermore N BPs decreased the levels of phosphorylated extracellular signalregulated kinase ERK and mTOR via suppression of Ras prenylation and enhanced Bim expression", "relationMentions": [{"em1Text": "N", "em2Text": "Bim", "label": "CPR:3"}, {"em1Text": "BPs", "em2Text": "Bim", "label": "CPR:3"}, {"em1Text": "N", "em2Text": "phosphorylated extracellular signalregulated kinase", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "Ras", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "phosphorylated extracellular signalregulated kinase", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "Ras", "label": "CPR:4"}]}
{"sentText": "The present results indicated that N BPs induce apoptosis by decreasing the mitochondrial transmembrane potential increasing the activation of caspase9 and caspase3 and enhancing Bim expression through inhibition of the Ras MEK ERK and Ras mTOR pathways", "relationMentions": [{"em1Text": "N", "em2Text": "caspase9", "label": "CPR:3"}, {"em1Text": "N", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "N", "em2Text": "Bim", "label": "CPR:3"}, {"em1Text": "BPs", "em2Text": "caspase9", "label": "CPR:3"}, {"em1Text": "BPs", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "BPs", "em2Text": "Bim", "label": "CPR:3"}, {"em1Text": "N", "em2Text": "Ras", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "MEK", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "Ras", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "Ras", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "MEK", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "Ras", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Nitrogen containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim mediated activation of the intrinsic apoptotic pathway", "relationMentions": [{"em1Text": "Nitrogen", "em2Text": "Bim", "label": "CPR:3"}, {"em1Text": "bisphosphonates", "em2Text": "Bim", "label": "CPR:3"}, {"em1Text": "Nitrogen", "em2Text": "Ras", "label": "CPR:4"}, {"em1Text": "bisphosphonates", "em2Text": "Ras", "label": "CPR:4"}]}
{"sentText": "Nitrogen containing bisphosphonates N BPs induce apoptosis in tumor cells by inhibiting the prenylation of small Gproteins", "relationMentions": [{"em1Text": "Nitrogen", "em2Text": "Gproteins", "label": "CPR:4"}, {"em1Text": "bisphosphonates", "em2Text": "Gproteins", "label": "CPR:4"}, {"em1Text": "N", "em2Text": "Gproteins", "label": "CPR:4"}, {"em1Text": "BPs", "em2Text": "Gproteins", "label": "CPR:4"}]}
{"sentText": "The reduction of P2X3 expression levels was reversed by the proteasomal inhibitor MG132", "relationMentions": [{"em1Text": "P2X3", "em2Text": "MG132", "label": "CPR:3"}]}
{"sentText": "We investigated the involvement of the farnesoid X receptor FXR a nuclear receptor for bile acids in the chenodeoxycholic acid CDCA induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells RGM1 cells", "relationMentions": [{"em1Text": "chenodeoxycholic acid", "em2Text": "Cdx2", "label": "CPR:3"}, {"em1Text": "chenodeoxycholic acid", "em2Text": "MUC2", "label": "CPR:3"}, {"em1Text": "CDCA", "em2Text": "Cdx2", "label": "CPR:3"}, {"em1Text": "CDCA", "em2Text": "MUC2", "label": "CPR:3"}]}
{"sentText": "CDCA induced dosedependent expression of Cdx2 and MUC2 at both the mRNA and protein levels", "relationMentions": [{"em1Text": "CDCA", "em2Text": "Cdx2", "label": "CPR:3"}, {"em1Text": "CDCA", "em2Text": "MUC2", "label": "CPR:3"}]}
{"sentText": "The maximum stimulation of Cdx2 and MUC2 mRNA induced by CDCA was observed at 3 h and by 6 h respectively", "relationMentions": [{"em1Text": "Cdx2", "em2Text": "CDCA", "label": "CPR:3"}, {"em1Text": "MUC2", "em2Text": "CDCA", "label": "CPR:3"}]}
{"sentText": "The effects of CDCA and GW4064 on expression of Cdx2 and MUC2 were abolished by guggulsterone", "relationMentions": [{"em1Text": "Cdx2", "em2Text": "guggulsterone", "label": "CPR:4"}, {"em1Text": "MUC2", "em2Text": "guggulsterone", "label": "CPR:4"}]}
{"sentText": "RGM1 cells were treated with CDCA or GW4064 an FXR agonist in the presence or absence of guggulsterone an FXR antagonist", "relationMentions": [{"em1Text": "CDCA", "em2Text": "FXR", "label": "CPR:5"}, {"em1Text": "GW4064", "em2Text": "FXR", "label": "CPR:5"}, {"em1Text": "FXR", "em2Text": "guggulsterone", "label": "CPR:6"}]}
{"sentText": "Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter", "relationMentions": [{"em1Text": "Mazindol", "em2Text": "cocaine binding site", "label": "CPR:4"}, {"em1Text": "Mazindol", "em2Text": "dopamine transporter", "label": "CPR:4"}, {"em1Text": "dopamine", "em2Text": "transporter", "label": "CPR:9"}]}
{"sentText": "Several active analogues were also evaluated for their ability to block uptake of DA 5HT and NE and inhibit binding of 125I RTI55 at HEK hDAT HEK hSERT and HEK hNET cells", "relationMentions": [{"em1Text": "5HT", "em2Text": "hSERT", "label": "CPR:9"}, {"em1Text": "NE", "em2Text": "hNET", "label": "CPR:9"}, {"em1Text": "DA", "em2Text": "hDAT", "label": "CPR:9"}]}
{"sentText": "Glyphosate affects aromatic amino acid biosynthesis by inhibiting 5enolpyruvylshikimate3phosphate synthase EPSPS", "relationMentions": [{"em1Text": "Glyphosate", "em2Text": "5enolpyruvylshikimate3phosphate synthase", "label": "CPR:4"}, {"em1Text": "Glyphosate", "em2Text": "EPSPS", "label": "CPR:4"}]}
{"sentText": "Glufosinate inhibits glutamine synthetase and blocks biosynthesis of glutamine", "relationMentions": [{"em1Text": "Glufosinate", "em2Text": "glutamine synthetase", "label": "CPR:4"}, {"em1Text": "glutamine", "em2Text": "glutamine synthetase", "label": "CPR:9"}]}
{"sentText": "Mechanisms of Glucose Lowering of Dipeptidyl Peptidase4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes A doubletracer study", "relationMentions": [{"em1Text": "Dipeptidyl Peptidase4", "em2Text": "Sitagliptin", "label": "CPR:4"}]}
{"sentText": "Upon coexposure to V5 and TCDD V5 significantly potentiated the TCDDmediated induction of the Cyp1a1 Cyp1a2 and Cyp1b1 mRNA protein and catalytic activity levels at 24 h In vitro V5 decreased the TCDDmediated induction of Cyp1a1 mRNA protein and catalytic activity levels", "relationMentions": [{"em1Text": "V5", "em2Text": "Cyp1a1", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "Cyp1a2", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "Cyp1b1", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "Cyp1a1", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "Cyp1a2", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "Cyp1b1", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "Cyp1a1", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "Cyp1a2", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "Cyp1b1", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "Cyp1a1", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "Cyp1a2", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "Cyp1b1", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "Cyp1a1", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "Cyp1a1", "label": "CPR:4"}]}
{"sentText": "V5 also increased serum hemoglobin Hb levels in animals treated for 24 h Upon treatment of isolated hepatocytes with Hb alone or in the presence of TCDD there was an increase in the AhR dependent luciferase activity", "relationMentions": [{"em1Text": "V5", "em2Text": "serum hemoglobin", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "Hb", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "AhR", "label": "CPR:3"}]}
{"sentText": "Furthermore V5 significantly inhibited the TCDD induced AhR dependent luciferase activity", "relationMentions": [{"em1Text": "TCDD", "em2Text": "AhR", "label": "CPR:3"}, {"em1Text": "V5", "em2Text": "AhR", "label": "CPR:4"}]}
{"sentText": "DEX enhanced the ratio IFNgamma IL4 mean SEM control 287 176 with 107 M DEX 550 275 P0005", "relationMentions": [{"em1Text": "DEX", "em2Text": "IFNgamma", "label": "CPR:3"}, {"em1Text": "DEX", "em2Text": "IL4", "label": "CPR:3"}]}
{"sentText": "Interestingly two categories of clones were distinguished based on the effects of GCS on IL2 production and IL2R alpha expression and proliferation 1 In low IL2 producers DEX blocked IL2 production and decreased IL2R alpha expression and proliferation 2 In high IL2 producers DEX inhibited IL2 production partially and enhanced IL2R alpha expression and proliferation", "relationMentions": [{"em1Text": "IL2R alpha", "em2Text": "DEX", "label": "CPR:3"}, {"em1Text": "IL2", "em2Text": "DEX", "label": "CPR:4"}, {"em1Text": "IL2R alpha", "em2Text": "DEX", "label": "CPR:4"}, {"em1Text": "IL2", "em2Text": "DEX", "label": "CPR:4"}]}
{"sentText": "Dexamethasone DEX inhibited the anti CD3 induced production of IL4 IL5 and IFNgamma in all 20 clones tested", "relationMentions": [{"em1Text": "DEX", "em2Text": "CD3", "label": "CPR:4"}, {"em1Text": "DEX", "em2Text": "IL4", "label": "CPR:4"}, {"em1Text": "DEX", "em2Text": "IL5", "label": "CPR:4"}, {"em1Text": "DEX", "em2Text": "IFNgamma", "label": "CPR:4"}, {"em1Text": "Dexamethasone", "em2Text": "CD3", "label": "CPR:4"}, {"em1Text": "Dexamethasone", "em2Text": "IL4", "label": "CPR:4"}, {"em1Text": "Dexamethasone", "em2Text": "IL5", "label": "CPR:4"}, {"em1Text": "Dexamethasone", "em2Text": "IFNgamma", "label": "CPR:4"}]}
{"sentText": "GCS therapy results in reduced mRNA expression of interleukin4 IL4 and IL5 in cells from bronchoalveolar lavage BAL but not of IFNgamma", "relationMentions": [{"em1Text": "GCS", "em2Text": "interleukin4", "label": "CPR:4"}, {"em1Text": "GCS", "em2Text": "IL4", "label": "CPR:4"}, {"em1Text": "GCS", "em2Text": "IL5", "label": "CPR:4"}]}
{"sentText": "In conclusion the production of IL4 and IL5 by Tcell clones derived either from BAL or blood was more sensitive to inhibition by DEX than that of IFNgamma which may account for the therapeutic effects of glucocorticosteroids in patients with asthma", "relationMentions": [{"em1Text": "IL4", "em2Text": "DEX", "label": "CPR:4"}, {"em1Text": "IL5", "em2Text": "DEX", "label": "CPR:4"}, {"em1Text": "DEX", "em2Text": "IFNgamma", "label": "CPR:4"}]}
{"sentText": "In vitro studies with bloodderived T cells however show inhibition of all three cytokines by GCS", "relationMentions": [{"em1Text": "cytokines", "em2Text": "GCS", "label": "CPR:4"}]}
{"sentText": "Amprenavir mediated PXR activation stimulated the expression of several key intestinal genes involved in lipid homeostasis", "relationMentions": [{"em1Text": "Amprenavir", "em2Text": "PXR", "label": "CPR:3"}]}
{"sentText": "Amprenavir efficiently activated PXR and induced PXR target gene expression in vitro and in vivo", "relationMentions": [{"em1Text": "Amprenavir", "em2Text": "PXR", "label": "CPR:3"}, {"em1Text": "Amprenavir", "em2Text": "PXR", "label": "CPR:3"}]}
{"sentText": "Pregnane X Receptor Mediates Dyslipidemia Induced by the HIV Protease Inhibitor Amprenavir in Mice", "relationMentions": [{"em1Text": "HIV Protease", "em2Text": "Amprenavir", "label": "CPR:4"}]}
{"sentText": "In the present study we identified amprenavir a widely used HIV PI as a potent PXR selective agonist", "relationMentions": [{"em1Text": "amprenavir", "em2Text": "PXR", "label": "CPR:5"}]}
{"sentText": "Antidiabetic Activity of Swertiamarin is due to an Active Metabolite Gentianine that Upregulates PPAR\u03b3 Gene Expression in 3T3L1 cells", "relationMentions": [{"em1Text": "Gentianine", "em2Text": "PPAR\u03b3", "label": "CPR:3"}]}
{"sentText": "Swertiamarin treatment had no significant effect on adipogenesis or the mRNA expression of PPAR\u03b3 and GLUT4 however there was a significant increase in the mRNA expression of adiponectin", "relationMentions": [{"em1Text": "Swertiamarin", "em2Text": "adiponectin", "label": "CPR:3"}]}
{"sentText": "On the other hand treatment with gentianine significantly increased adipogenesis which was associated with a significant increase in the mRNA expression of PPAR\u03b3 GLUT4 and adiponectin", "relationMentions": [{"em1Text": "gentianine", "em2Text": "PPAR\u03b3", "label": "CPR:3"}, {"em1Text": "gentianine", "em2Text": "GLUT4", "label": "CPR:3"}, {"em1Text": "gentianine", "em2Text": "adiponectin", "label": "CPR:3"}]}
{"sentText": "Jaspamide also inhibited other channels including Cav12 Cav32 and HCN2 however the Kv111 hERG channel was minimally affected", "relationMentions": [{"em1Text": "Jaspamide", "em2Text": "Cav12", "label": "CPR:4"}, {"em1Text": "Jaspamide", "em2Text": "Cav32", "label": "CPR:4"}, {"em1Text": "Jaspamide", "em2Text": "HCN2", "label": "CPR:4"}]}
{"sentText": "Treatment with carvedilol reversed both protein and mRNA of HIF1alpha VEGF BNP and NGFbeta to the baseline values", "relationMentions": [{"em1Text": "carvedilol", "em2Text": "NGFbeta", "label": "CPR:3"}, {"em1Text": "carvedilol", "em2Text": "HIF1alpha", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "BNP", "label": "CPR:4"}]}
{"sentText": "Increased immunohistochemical labeling of HIF1alpha VEGF and BNP in the ventricular myocardium was observed in the shunt group and carvedilol again normalized the labeling", "relationMentions": [{"em1Text": "HIF1alpha", "em2Text": "carvedilol", "label": "CPR:4"}, {"em1Text": "VEGF", "em2Text": "carvedilol", "label": "CPR:4"}, {"em1Text": "BNP", "em2Text": "carvedilol", "label": "CPR:4"}]}
{"sentText": "Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF1alpha and VEGF in the failing ventricular myocardium", "relationMentions": [{"em1Text": "carvedilol", "em2Text": "HIF1alpha", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "VEGF", "label": "CPR:4"}]}
{"sentText": "These effects were fully counteracted by dietary phenolics which inhibited ROS overproduction and GSH consumption rendered the reactive transcription of glutathioneassociated enzymes unnecessary and blocked the intracellular signals leading to the overexpression and rearrangement of p66Shc signalling molecule", "relationMentions": [{"em1Text": "phenolics", "em2Text": "p66Shc", "label": "CPR:4"}]}
{"sentText": "The enzyme requires PLP and divalent cations such as Ca2 Mg2 or Mn2 but not ATP whereas mammalian serine racemase activity is increased by ATP", "relationMentions": [{"em1Text": "ATP", "em2Text": "serine racemase", "label": "CPR:3"}]}
{"sentText": "These data support the conclusion that renal ecto phosphodiesterase activity is not mediated by PDE1 PDE2 PDE3 PDE4 PDE5 PDE6 PDE7 PDE9 PDE10 or PDE11 and is inhibited by high concentrations of dipyridamole", "relationMentions": [{"em1Text": "phosphodiesterase", "em2Text": "dipyridamole", "label": "CPR:4"}]}
{"sentText": "A broadspectrum phosphodiesterase PDE inhibitor 13isobutyl1methylxanthine 300 microM n=6 and an ectophosphodiesterase inhibitor 13dipropyl8psulfophenylxanthine 1 mM n=6 significantly attenuated cAMPinduced AMP secretion by 60 and 74 respectively", "relationMentions": [{"em1Text": "phosphodiesterase", "em2Text": "13isobutyl1methylxanthine", "label": "CPR:4"}, {"em1Text": "PDE", "em2Text": "13isobutyl1methylxanthine", "label": "CPR:4"}]}
{"sentText": "Blockade of PDE1 8methoxymethyl3isobutyl1methylxanthine 100 microM PDE2 erythro92hydroxy3nonyladenine 30 microM PDE3 milrinone 10 microM cGMP 10 microM PDE4 Ro 201724 43butoxy4methoxybenzylimidazolidin2one 100 microM PDE5 and PDE6 zaprinast 30 microM and PDE7 BRL50481 5nitro2NNtrimethylbenzenesulfonamide 10 microM did not alter renal ectophosphodiesterase activity", "relationMentions": [{"em1Text": "PDE3", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "PDE1", "em2Text": "8methoxymethyl3isobutyl1methylxanthine", "label": "CPR:4"}, {"em1Text": "PDE2", "em2Text": "erythro92hydroxy3nonyladenine", "label": "CPR:4"}, {"em1Text": "PDE4", "em2Text": "43butoxy4methoxybenzylimidazolidin2one", "label": "CPR:4"}, {"em1Text": "PDE5", "em2Text": "zaprinast", "label": "CPR:4"}, {"em1Text": "PDE6", "em2Text": "zaprinast", "label": "CPR:4"}, {"em1Text": "PDE7", "em2Text": "BRL50481", "label": "CPR:4"}, {"em1Text": "PDE7", "em2Text": "5nitro2NNtrimethylbenzenesulfonamide", "label": "CPR:4"}]}
{"sentText": "Administration of a concentration 100 microM of dipyridamole that blocks PDE8 inhibited ecto phosphodiesterase activity by 44", "relationMentions": [{"em1Text": "dipyridamole", "em2Text": "PDE8", "label": "CPR:4"}, {"em1Text": "dipyridamole", "em2Text": "phosphodiesterase", "label": "CPR:4"}]}
{"sentText": "However a lower concentration of dipyridamole 3 microM that blocks PDE9 PDE10 and PDE11 but not PDE8 did not inhibit ectophosphodiesterase activity", "relationMentions": [{"em1Text": "dipyridamole", "em2Text": "PDE9", "label": "CPR:4"}, {"em1Text": "dipyridamole", "em2Text": "PDE10", "label": "CPR:4"}, {"em1Text": "dipyridamole", "em2Text": "PDE11", "label": "CPR:4"}]}
{"sentText": "In kidneys stimulation of adenylyl cyclase causes egress of cAMP conversion of cAMP to AMP by ecto phosphodiesterase and metabolism of AMP to adenosine by ecto5nucleotidase", "relationMentions": [{"em1Text": "cAMP", "em2Text": "phosphodiesterase", "label": "CPR:9"}, {"em1Text": "AMP", "em2Text": "phosphodiesterase", "label": "CPR:9"}, {"em1Text": "AMP", "em2Text": "ecto5nucleotidase", "label": "CPR:9"}, {"em1Text": "adenosine", "em2Text": "ecto5nucleotidase", "label": "CPR:9"}]}
{"sentText": "In summary ketoconazole had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan therefore no changes in ambrisentan dose should be necessary when the drug is administered concomitantly with known CYP3A4 inhibitors", "relationMentions": [{"em1Text": "ketoconazole", "em2Text": "CYP3A4", "label": "CPR:4"}]}
{"sentText": "The potential for ketoconazole the archetypal strong inhibitor of CYP3A4 to alter the pharmacokinetic profile of ambrisentan and its oxidative metabolite 4hydroxymethyl ambrisentan was assessed in an openlabel nonrandomized 2period singlesequence study in 16 healthy men", "relationMentions": [{"em1Text": "ketoconazole", "em2Text": "CYP3A4", "label": "CPR:4"}]}
{"sentText": "Ambrisentan is an endothelin type A ETAselective receptor antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4", "relationMentions": [{"em1Text": "Ambrisentan", "em2Text": "endothelin type A ETAselective receptor", "label": "CPR:6"}, {"em1Text": "Ambrisentan", "em2Text": "CYP3A4", "label": "CPR:9"}]}
{"sentText": "Although thioredoxin reductase TRR inhibitors aurothioglucose and SbIII inhibited cytosolic DMAsV reduction recombinant rat TRR plus NADPH alone or when added to the cytosol failed to support DMAsV reduction", "relationMentions": [{"em1Text": "thioredoxin reductase", "em2Text": "aurothioglucose", "label": "CPR:4"}, {"em1Text": "TRR", "em2Text": "aurothioglucose", "label": "CPR:4"}, {"em1Text": "thioredoxin reductase", "em2Text": "SbIII", "label": "CPR:4"}, {"em1Text": "TRR", "em2Text": "SbIII", "label": "CPR:4"}]}
{"sentText": "Pretreatment of rats with glutathione GSH depletors phorone or BSO delayed the elimination of DMAsV and the accumulation of RBCbound DMAs whereas the indirect methyltransferase inhibitor periodateoxidized adenosine was without effect", "relationMentions": [{"em1Text": "methyltransferase", "em2Text": "adenosine", "label": "CPR:4"}]}
{"sentText": "Although glutathione Stransferase omega 1 GSTO1 and arsenic methyltransferase have been shown or thought to catalyze DMAsV reduction their role in DMAsV reduction in vivo or in cell extracts is uncertain", "relationMentions": [{"em1Text": "glutathione Stransferase omega 1", "em2Text": "DMAsV", "label": "CPR:9"}, {"em1Text": "arsenic methyltransferase", "em2Text": "DMAsV", "label": "CPR:9"}]}
{"sentText": "The kinase activity of EGFR was little inhibited by TTB in a cellfree system", "relationMentions": [{"em1Text": "kinase", "em2Text": "TTB", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "TTB", "label": "CPR:4"}]}
{"sentText": "Sorafenib BAY 439006 Nexavar a dualaction inhibitor that targets RAF MEK ERK pathway in tumor cells and tyrosine kinases VEGFR PDGFR in tumor vasculature", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "tyrosine kinases", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "VEGFR", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "PDGFR", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "RAF", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "MEK", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "tyrosine kinases", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "VEGFR", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "PDGFR", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "RAF", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "MEK", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "tyrosine kinases", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "VEGFR", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "PDGFR", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "RAF", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "MEK", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "ERK", "label": "CPR:4"}]}
{"sentText": "Further characterization of sorafenib revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family VEGFR2 and VEGFR3 and plateletderived growth factor receptor family PDGFRbeta and Kit which play key roles in tumor progression and angiogenesis", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "vascular endothelial growth factor receptor", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "VEGFR3", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "plateletderived growth factor receptor", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "Kit", "label": "CPR:4"}]}
{"sentText": "Thus sorafenib may inhibit tumor growth by a dual mechanism acting either directly on the tumor through inhibition of Raf and Kit signaling andor on tumor angiogenesis through inhibition of VEGFR and PDGFR signaling", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "Raf", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "Kit", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "VEGFR", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "PDGFR", "label": "CPR:4"}]}
{"sentText": "A novel class of biaryl urea that inhibits CRAF kinase was discovered using a combination of medicinal and combinatorial chemistry approaches", "relationMentions": [{"em1Text": "biaryl urea", "em2Text": "CRAF", "label": "CPR:4"}, {"em1Text": "biaryl urea", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Sorafenib inhibited the kinase activity of both CRAF and BRAF wild type and V600E mutant", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "CRAF", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "BRAF", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "V600E", "label": "CPR:4"}]}
{"sentText": "Rapamycin inhibits proteinase and selected peptidase activities of the catalytic core proteasome at low micromolar concentrations", "relationMentions": [{"em1Text": "Rapamycin", "em2Text": "proteinase", "label": "CPR:4"}, {"em1Text": "Rapamycin", "em2Text": "peptidase", "label": "CPR:4"}, {"em1Text": "Rapamycin", "em2Text": "proteasome", "label": "CPR:4"}]}
{"sentText": "Ten IUmL urokinase was also incubated with pooled plasma of stroke patients that was previously oxidized with the singlet oxygen 1O2 donor chloramine T CT to destroy plasmatic PAI1 and alpha2anti plasmin", "relationMentions": [{"em1Text": "chloramine T", "em2Text": "plasmatic PAI1", "label": "CPR:4"}, {"em1Text": "chloramine T", "em2Text": "plasmin", "label": "CPR:4"}, {"em1Text": "CT", "em2Text": "plasmatic PAI1", "label": "CPR:4"}, {"em1Text": "CT", "em2Text": "plasmin", "label": "CPR:4"}, {"em1Text": "singlet oxygen", "em2Text": "plasmatic PAI1", "label": "CPR:4"}, {"em1Text": "1O2", "em2Text": "plasmatic PAI1", "label": "CPR:4"}]}
{"sentText": "After 0 to 80 minutes 37 degrees C 50microL samples were withdrawn and added to 100 microL 15 M arginine pH 87 and oxidized with 50 microL of 20 mM CT For determination of plasmin activity 10 microL thereof was incubated with 150 microL 15 M arginine pH 87 and 100 microL 20 mM CT preoxidized 15 minutes 37 degrees C pooled normal citrate buffered EDTAplasma for 30 minutes 37 degrees C", "relationMentions": [{"em1Text": "arginine", "em2Text": "plasmin", "label": "CPR:9"}]}
{"sentText": "For determination of PA Pli activity arginine was added after this incubation", "relationMentions": [{"em1Text": "PA", "em2Text": "arginine", "label": "CPR:9"}, {"em1Text": "Pli", "em2Text": "arginine", "label": "CPR:9"}]}
{"sentText": "KCNK1 a member of the family of twopore K ion channels is specifically induced in the livers of male mice after phenobarbital treatment", "relationMentions": [{"em1Text": "KCNK1", "em2Text": "phenobarbital", "label": "CPR:3"}, {"em1Text": "K ion channels", "em2Text": "phenobarbital", "label": "CPR:3"}]}
{"sentText": "Here we have determined the molecular mechanism of this malespecific activation of the Kcnk1 gene and characterized KCNK1 as a phenobarbital inducible antihyperplasia factor", "relationMentions": [{"em1Text": "Kcnk1", "em2Text": "phenobarbital", "label": "CPR:3"}, {"em1Text": "KCNK1", "em2Text": "phenobarbital", "label": "CPR:3"}]}
{"sentText": "Upon activation by phenobarbital nuclear receptor CAR binds the 97bp response element 24412345 within the Kcnk1 promoter", "relationMentions": [{"em1Text": "phenobarbital", "em2Text": "nuclear receptor", "label": "CPR:3"}, {"em1Text": "phenobarbital", "em2Text": "CAR", "label": "CPR:3"}]}
{"sentText": "These results indicate that phenobarbital treatment induces KCNK1 to elicit a malespecific and growthsuppressing signal", "relationMentions": [{"em1Text": "phenobarbital", "em2Text": "KCNK1", "label": "CPR:3"}]}
{"sentText": "In both OFC and mPFC no strain differences in Vmax or Km for dopamine uptake into synaptosomes were found between vehicletreated SHR WKY and WIS Methylphenidate increased DAT Vmax in SHR mPFC and decreased DAT Vmax in WKY OFC", "relationMentions": [{"em1Text": "Methylphenidate", "em2Text": "DAT", "label": "CPR:3"}, {"em1Text": "Methylphenidate", "em2Text": "DAT", "label": "CPR:4"}]}
{"sentText": "Thus the increase in mPFC DAT function was an SHRspecific long term consequence of methylphenidate treatment during adolescence which may be responsible for the treatmentinduced alterations in behavior including the observed increases in cocaine selfadministration", "relationMentions": [{"em1Text": "DAT", "em2Text": "methylphenidate", "label": "CPR:3"}]}
{"sentText": "Methylphenidate an inhibitor of dopamine and norepinephrine transporters DAT and NET respectively is a standard treatment for ADHD", "relationMentions": [{"em1Text": "Methylphenidate", "em2Text": "dopamine and norepinephrine transporters", "label": "CPR:4"}, {"em1Text": "Methylphenidate", "em2Text": "DAT", "label": "CPR:4"}, {"em1Text": "Methylphenidate", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "Also methylphenidate decreased DAT Km in WIS OFC", "relationMentions": [{"em1Text": "methylphenidate", "em2Text": "DAT", "label": "CPR:4"}]}
{"sentText": "Thus our data suggest that the COX2 preference of meloxicam observed in vitro may not result in clinical advantages when the higher dose of 15 mg is needed", "relationMentions": [{"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "The effects of meloxicam were compared with those of diclofenac a nonselective COX inhibitor", "relationMentions": [{"em1Text": "meloxicam", "em2Text": "COX", "label": "CPR:4"}, {"em1Text": "diclofenac", "em2Text": "COX", "label": "CPR:4"}]}
{"sentText": "METHODS COX1 inhibition was determined by measuring thromboxane B2 TXB2generation from clotting whole blood ex vivo after single oral doses of 75 and 15 mg meloxicam and 75 mg diclofenac and at steady state 15 mg meloxicam daily and 150 mg diclofenac daily", "relationMentions": [{"em1Text": "COX1", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "diclofenac", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "diclofenac", "label": "CPR:4"}]}
{"sentText": "OBJECTIVE To evaluate the extent of human cyclooxygenase1 COX1 inhibition by meloxicam which has been reported to preferentially inhibit cyclooxygenase2 COX2", "relationMentions": [{"em1Text": "meloxicam", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "meloxicam", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "human cyclooxygenase1", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "Gelatin zymography showed that DMBT inhibited secretion and activity of MMP9", "relationMentions": [{"em1Text": "DMBT", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "Western blotting demonstrated that DMBT effectively suppressed the expression of VEGF pVEGFR2 pEGFR and pAkt", "relationMentions": [{"em1Text": "DMBT", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "DMBT", "em2Text": "pVEGFR2", "label": "CPR:4"}, {"em1Text": "DMBT", "em2Text": "pEGFR", "label": "CPR:4"}, {"em1Text": "DMBT", "em2Text": "pAkt", "label": "CPR:4"}]}
{"sentText": "Inhibition of angiogenesis and invasion by DMBT is mediated by downregulation of VEGF and MMP9 through Akt pathway in MDAMB231 breast cancer cells", "relationMentions": [{"em1Text": "DMBT", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "DMBT", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "DMBT", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "These results suggested that DMBT could inhibit invasion and angiogenesis by downregulation of VEGF and MMP9 resulting from the inhibition of Akt pathway", "relationMentions": [{"em1Text": "DMBT", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "DMBT", "em2Text": "MMP9", "label": "CPR:4"}, {"em1Text": "DMBT", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Expression of Ltype pyruvate kinase LPK is upregulated in the liver by dietary carbohydrate", "relationMentions": [{"em1Text": "LPK", "em2Text": "carbohydrate", "label": "CPR:3"}, {"em1Text": "Ltype pyruvate kinase", "em2Text": "carbohydrate", "label": "CPR:3"}]}
{"sentText": "To investigate the possibility that felbamates favorable toxicity profile could be related to NMDA receptor subtype selectivity we examined the specificity of felbamate block of recombinant NMDA receptors composed of the NR1a subunit and various NR2 subunits", "relationMentions": [{"em1Text": "felbamate", "em2Text": "NMDA receptors", "label": "CPR:4"}, {"em1Text": "felbamate", "em2Text": "NR1a", "label": "CPR:4"}, {"em1Text": "felbamate", "em2Text": "NR2", "label": "CPR:4"}]}
{"sentText": "Felbamate produced a rapid concentrationdependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit and either the NR2A NR2B or NR2C subunits the IC50 values for block were 26 052 and 24 mM respectively holding potential 60 mV", "relationMentions": [{"em1Text": "Felbamate", "em2Text": "rat NR1a", "label": "CPR:4"}, {"em1Text": "Felbamate", "em2Text": "NR2A", "label": "CPR:4"}, {"em1Text": "Felbamate", "em2Text": "NR2B", "label": "CPR:4"}, {"em1Text": "Felbamate", "em2Text": "NR2C", "label": "CPR:4"}]}
{"sentText": "Felbamate block of recombinant NmethylDaspartate receptors selectivity for the NR2B subunit", "relationMentions": [{"em1Text": "Felbamate", "em2Text": "NmethylDaspartate receptors", "label": "CPR:4"}, {"em1Text": "Felbamate", "em2Text": "NR2B", "label": "CPR:4"}]}
{"sentText": "The higher affinity of felbamate block of NMDA receptors containing the NR2B subunit could be accounted for by more rapid association and slower dissociation from these sites", "relationMentions": [{"em1Text": "felbamate", "em2Text": "NMDA receptors", "label": "CPR:4"}, {"em1Text": "felbamate", "em2Text": "NR2B", "label": "CPR:4"}]}
{"sentText": "We conclude that felbamate exhibits modest selectivity for NMDA receptors composed of NR1a NR2B subunits", "relationMentions": [{"em1Text": "felbamate", "em2Text": "NMDA receptors", "label": "CPR:4"}, {"em1Text": "felbamate", "em2Text": "NR1a", "label": "CPR:4"}, {"em1Text": "felbamate", "em2Text": "NR2B", "label": "CPR:4"}]}
{"sentText": "The anticonvulsant felbamate blocks NmethylDasparate NMDA receptors but fails to exhibit the neurobehavioral toxicity characteristic of other NMDA receptor antagonists", "relationMentions": [{"em1Text": "felbamate", "em2Text": "NmethylDasparate NMDA receptors", "label": "CPR:4"}, {"em1Text": "felbamate", "em2Text": "NMDA receptor", "label": "CPR:6"}]}
{"sentText": "This selectivity could in part account for the more favorable clinical profile of felbamate in comparison with NMDA receptor antagonists that do not show subunit selectivity", "relationMentions": [{"em1Text": "felbamate", "em2Text": "NMDA receptor", "label": "CPR:6"}]}
{"sentText": "In four 10 patients the peak ACTH stimulated cortisol values were lower than 18 \u03bcgdL", "relationMentions": [{"em1Text": "ACTH", "em2Text": "cortisol", "label": "CPR:9"}]}
{"sentText": "ACTH stimulated peak cortisol delta cortisol and delta DHEA S levels are decreased during hyperthyroidism probably due to increased turnover", "relationMentions": [{"em1Text": "ACTH", "em2Text": "cortisol", "label": "CPR:9"}, {"em1Text": "ACTH", "em2Text": "delta cortisol", "label": "CPR:9"}, {"em1Text": "ACTH", "em2Text": "delta DHEA", "label": "CPR:9"}]}
{"sentText": "U50 488H caused a significant downregulation of the hkor although etorphine did not", "relationMentions": [{"em1Text": "U50 488H", "em2Text": "hkor", "label": "CPR:4"}]}
{"sentText": "Expression of the dominant negative mutants arrestin2319418 or dynamin IK44A significantly reduced U50488H induced downregulation of the hkor", "relationMentions": [{"em1Text": "U50488H", "em2Text": "hkor", "label": "CPR:4"}]}
{"sentText": "Coexpression of GRK2 or GRK2 and arrestin2 permitted etorphine to induce downregulation of the hkor although expression of arrestin2 or dynamin I alone did not", "relationMentions": [{"em1Text": "etorphine", "em2Text": "hkor", "label": "CPR:4"}]}
{"sentText": "Expression of the dominant negative mutants rab5A N133I or rab7 N125I blunted U50488H induced downregulation", "relationMentions": [{"em1Text": "rab5A", "em2Text": "U50488H", "label": "CPR:4"}, {"em1Text": "N133I", "em2Text": "U50488H", "label": "CPR:4"}, {"em1Text": "rab7", "em2Text": "U50488H", "label": "CPR:4"}, {"em1Text": "N125I", "em2Text": "U50488H", "label": "CPR:4"}]}
{"sentText": "Pretreatment with lysosomal enzyme inhibitors 2S 3StransepoxysuccinylLleucylamido3methylbutane ethyl ester or chloroquine or proteasome inhibitors proteasome inhibitor I MG132 or lactacystin decreased the extent of U50488Hinduced downregulation", "relationMentions": [{"em1Text": "proteasome", "em2Text": "MG132", "label": "CPR:4"}, {"em1Text": "proteasome", "em2Text": "lactacystin", "label": "CPR:4"}]}
{"sentText": "These results indicate that U50488H induced downregulation of the hkor involves GRK arrestin2 dynamin rab5 and rab7dependent mechanisms and receptors seem to be trafficked to lysosomes and proteasomes for degradation", "relationMentions": [{"em1Text": "U50488H", "em2Text": "hkor", "label": "CPR:4"}]}
{"sentText": "Thus U50488H induced internalization and downregulation of the hkor share initial common mechanisms", "relationMentions": [{"em1Text": "U50488H", "em2Text": "hkor", "label": "CPR:4"}]}
{"sentText": "Previously we showed that the human kappaopioid receptor hkor stably expressed in Chinese hamster ovary CHO cells underwent downregulation after prolonged U50488H treatment", "relationMentions": [{"em1Text": "human kappaopioid receptor", "em2Text": "U50488H", "label": "CPR:4"}, {"em1Text": "hkor", "em2Text": "U50488H", "label": "CPR:4"}]}
{"sentText": "In Alexander cells only when they were transfected with FXRRXR GW4064 caused upregulation of SHP and OST\u03b2 and a downregulation of CYP27A1", "relationMentions": [{"em1Text": "GW4064", "em2Text": "SHP", "label": "CPR:3"}, {"em1Text": "GW4064", "em2Text": "OST\u03b2", "label": "CPR:3"}, {"em1Text": "GW4064", "em2Text": "CYP27A1", "label": "CPR:4"}]}
{"sentText": "Moreover GCs have a synergistic effect on GW4064 induced FXR activation whereas chenodeoxycholate and GW4064 have an additive effect", "relationMentions": [{"em1Text": "GW4064", "em2Text": "FXR", "label": "CPR:3"}]}
{"sentText": "Stereochemical studies established that PAM inactivation by 4oxo5acetamido62thienylhex2enoic acid is stereospecific with respect to the moiety at the P2 position which is consistent with previous results with substrates and reversible inhibitors", "relationMentions": [{"em1Text": "PAM", "em2Text": "4oxo5acetamido62thienylhex2enoic acid", "label": "CPR:4"}]}
{"sentText": "In contrast 2 4dioxo5acetamido6phenylhexanoic acid which is a competitive inhibitor with respect to ascorbate exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopaminebetahydroxylase", "relationMentions": [{"em1Text": "2 4dioxo5acetamido6phenylhexanoic acid", "em2Text": "PAM", "label": "CPR:4"}, {"em1Text": "2 4dioxo5acetamido6phenylhexanoic acid", "em2Text": "dopaminebetahydroxylase", "label": "CPR:4"}]}
{"sentText": "Kinetic parameters for PAM inactivation by 4oxo5acetamido6phenylhex2enoic acid and 4oxo5acetamido62thienylhex2enoic acid were obtained by using both the conventional dilution assay method and the more complex progress curve method", "relationMentions": [{"em1Text": "PAM", "em2Text": "4oxo5acetamido6phenylhex2enoic acid and 4oxo5acetamido62thienylhex2enoic acid", "label": "CPR:4"}]}
{"sentText": "Sixteen of 34 CGPs inhibited MRP1 mediated E217\u03b2G uptake by 50 IC50s 0776 \u03bcM", "relationMentions": [{"em1Text": "CGPs", "em2Text": "MRP1", "label": "CPR:4"}, {"em1Text": "MRP1", "em2Text": "E217\u03b2G", "label": "CPR:9"}]}
{"sentText": "Of 9 CGPs with IC50s \u22642 \u03bcM two belonged to Class I two to Class III and five to Class V When tested in the intact cells only 4 of 16 CGPs at 10 \u03bcM inhibited MRP1 mediated calcein efflux by 50 III1 V3 4 6 while a fifth I5 inhibited efflux by just 23", "relationMentions": [{"em1Text": "CGPs", "em2Text": "MRP1", "label": "CPR:4"}, {"em1Text": "MRP1", "em2Text": "calcein", "label": "CPR:9"}]}
{"sentText": "These five CGPs also inhibited 3HE217\u03b2G uptake by MRP4", "relationMentions": [{"em1Text": "CGPs", "em2Text": "MRP4", "label": "CPR:4"}, {"em1Text": "3HE217\u03b2G", "em2Text": "MRP4", "label": "CPR:9"}]}
{"sentText": "Five classes of chalcogenopyrylium dyes CGPs were examined for their ability to modulate transport of 3Hestradiol glucuronide E217\u03b2G a prototypical MRP substrate into MRPenriched insideout membrane vesicles", "relationMentions": [{"em1Text": "3Hestradiol glucuronide", "em2Text": "MRP", "label": "CPR:9"}, {"em1Text": "E217\u03b2G", "em2Text": "MRP", "label": "CPR:9"}]}
{"sentText": "Since gemfibrozil is known to activate peroxisome proliferatoractivated receptoralpha PPARalpha we investigated the role of PPARalpha in gemfibrozil mediated inhibition of iNOS", "relationMentions": [{"em1Text": "gemfibrozil", "em2Text": "peroxisome proliferatoractivated receptoralpha", "label": "CPR:3"}, {"em1Text": "gemfibrozil", "em2Text": "PPARalpha", "label": "CPR:3"}, {"em1Text": "gemfibrozil", "em2Text": "PPARalpha", "label": "CPR:3"}, {"em1Text": "gemfibrozil", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "Gemfibrozil induced peroxisome proliferatorresponsive element PPRE dependent luciferase activity which was inhibited by the expression of DeltahPPARalpha the dominantnegative mutant of human PPARalpha", "relationMentions": [{"em1Text": "Gemfibrozil", "em2Text": "peroxisome proliferatorresponsive element", "label": "CPR:3"}, {"em1Text": "Gemfibrozil", "em2Text": "PPRE", "label": "CPR:3"}]}
{"sentText": "Inhibition of human iNOS promoter driven luciferase activity by gemfibrozil in cytokinestimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS", "relationMentions": [{"em1Text": "human iNOS promoter", "em2Text": "gemfibrozil", "label": "CPR:4"}, {"em1Text": "iNOS", "em2Text": "gemfibrozil", "label": "CPR:4"}]}
{"sentText": "However DeltahPPARalpha was unable to abrogate gemfibrozilmediated inhibition of iNOS suggesting that gemfibrozil inhibits iNOS independent of PPARalpha", "relationMentions": [{"em1Text": "gemfibrozil", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "gemfibrozil", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "Gemfibrozil a lipidlowering drug inhibits the induction of nitricoxide synthase in human astrocytes", "relationMentions": [{"em1Text": "Gemfibrozil", "em2Text": "nitricoxide synthase", "label": "CPR:4"}, {"em1Text": "nitricoxide", "em2Text": "synthase", "label": "CPR:9"}]}
{"sentText": "Gemfibrozil a lipidlowering drug inhibited cytokine induced production of NO and the expression of inducible nitricoxide synthase iNOS in human U373MG astroglial cells and primary astrocytes", "relationMentions": [{"em1Text": "Gemfibrozil", "em2Text": "inducible nitricoxide synthase", "label": "CPR:4"}, {"em1Text": "Gemfibrozil", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "Gemfibrozil", "em2Text": "cytokine", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "inducible nitricoxide synthase", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "iNOS", "label": "CPR:9"}, {"em1Text": "nitricoxide", "em2Text": "iNOS", "label": "CPR:9"}]}
{"sentText": "Interestingly gemfibrozil strongly inhibited the activation of NFkappaB AP1 and CEBPbeta but not that of GAS in cytokinestimulated astroglial cells", "relationMentions": [{"em1Text": "gemfibrozil", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "gemfibrozil", "em2Text": "AP1", "label": "CPR:4"}, {"em1Text": "gemfibrozil", "em2Text": "CEBPbeta", "label": "CPR:4"}]}
{"sentText": "These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting the activation of NFkappaB AP1 and CEBPbeta and that gemfibrozil a prescribed drug for humans may further find its therapeutic use in neuroinflammatory diseases", "relationMentions": [{"em1Text": "gemfibrozil", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "gemfibrozil", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "gemfibrozil", "em2Text": "AP1", "label": "CPR:4"}, {"em1Text": "gemfibrozil", "em2Text": "CEBPbeta", "label": "CPR:4"}]}
{"sentText": "Similar to gemfibrozil clofibrate another fibrate drug also inhibited the expression of iNOS", "relationMentions": [{"em1Text": "gemfibrozil", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "clofibrate", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "fibrate", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "OBJECTIVES The aim of this study was to determine whether cocaines sympathomimetic actions can be reversed by a potent centrally acting alpha2 adrenergic receptor AR agonist dexmedetomidine", "relationMentions": [{"em1Text": "alpha2 adrenergic receptor", "em2Text": "dexmedetomidine", "label": "CPR:5"}, {"em1Text": "AR", "em2Text": "dexmedetomidine", "label": "CPR:5"}]}
{"sentText": "We demonstrate that among the three nitrates only SNP inhibits HIF1 activation in response to hypoxia", "relationMentions": [{"em1Text": "SNP", "em2Text": "HIF1", "label": "CPR:4"}]}
{"sentText": "SNP inhibits the accumulation of HIF1alpha the regulatory subunit of HIF1 and the transcriptional activation of HIF1alpha via a mechanism that is not dependent on either NO or soluble guanylate cyclase", "relationMentions": [{"em1Text": "SNP", "em2Text": "HIF1alpha", "label": "CPR:4"}, {"em1Text": "SNP", "em2Text": "HIF1", "label": "CPR:4"}, {"em1Text": "SNP", "em2Text": "HIF1alpha", "label": "CPR:4"}]}
{"sentText": "The inhibitory effect of sodium nitroprusside on HIF1 activation is not dependent on nitric oxidesoluble guanylyl cyclase pathway", "relationMentions": [{"em1Text": "sodium nitroprusside", "em2Text": "HIF1", "label": "CPR:4"}]}
{"sentText": "Indomethacin completely antagonizes CA activity ie", "relationMentions": [{"em1Text": "Indomethacin", "em2Text": "CA", "label": "CPR:3"}]}
{"sentText": "Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide by a direct mechanism of action", "relationMentions": [{"em1Text": "Indomethacin", "em2Text": "carbonic anhydrase", "label": "CPR:3"}, {"em1Text": "Indomethacin", "em2Text": "carbonic anhydrase", "label": "CPR:3"}, {"em1Text": "carbonic anhydrase", "em2Text": "acetazolamide", "label": "CPR:4"}, {"em1Text": "carbonic anhydrase", "em2Text": "acetazolamide", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS Our results show that indomethacin a known cyclooxygenase COX inhibitor is also an activator of CA", "relationMentions": [{"em1Text": "indomethacin", "em2Text": "CA", "label": "CPR:3"}, {"em1Text": "indomethacin", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "indomethacin", "em2Text": "COX", "label": "CPR:4"}]}
{"sentText": "Our data also prove that indomethacin is not only an activator of CA but also antagonizes the effect of acetazolamide a specific inhibitor of this enzyme", "relationMentions": [{"em1Text": "indomethacin", "em2Text": "CA", "label": "CPR:3"}, {"em1Text": "CA", "em2Text": "acetazolamide", "label": "CPR:4"}]}
{"sentText": "In view of the role of CA in acidbase balance as well as the fact that an increase or decrease in its activity is accompanied by an increase or decrease in intra and extracellular pH our results suggest that firstly CA activation induced by indomethacin might cause changes in COX activity secondly PGs are synthetized as a consequence of the changes in COX activity a hypothesis that requires further study", "relationMentions": [{"em1Text": "CA", "em2Text": "indomethacin", "label": "CPR:3"}]}
{"sentText": "Acetazolamide a specific inhibitor of CA reduces the activity of CA I and CA II from red cells", "relationMentions": [{"em1Text": "Acetazolamide", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "Acetazolamide", "em2Text": "CA I", "label": "CPR:4"}, {"em1Text": "Acetazolamide", "em2Text": "CA II", "label": "CPR:4"}]}
{"sentText": "abolishes the inhibitory effect of acetazolamide on CA", "relationMentions": [{"em1Text": "acetazolamide", "em2Text": "CA", "label": "CPR:4"}]}
{"sentText": "These compounds are competitive and in a few cases noncompetitive inhibitors for AChE the most potent being compound 14 though threefold less active than tacrine", "relationMentions": [{"em1Text": "AChE", "em2Text": "tacrine", "label": "CPR:4"}]}
{"sentText": "The acetylcholinesterase AChE and butyrylcholinesterase BuChE inhibitory activities of a series of pyrano23bquinolines 2 3 18naphthyridines 5 6 4amino23diaryl5678tetrahydrofuro23bquinolines 1113 4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine 14 4amino5678tetrahydro23diphenylthieno23bquinoline 15 4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine 16 are described", "relationMentions": [{"em1Text": "AChE", "em2Text": "pyrano23bquinolines", "label": "CPR:4"}, {"em1Text": "butyrylcholinesterase", "em2Text": "pyrano23bquinolines", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "pyrano23bquinolines", "label": "CPR:4"}, {"em1Text": "BuChE", "em2Text": "pyrano23bquinolines", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "18naphthyridines", "label": "CPR:4"}, {"em1Text": "butyrylcholinesterase", "em2Text": "18naphthyridines", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "18naphthyridines", "label": "CPR:4"}, {"em1Text": "BuChE", "em2Text": "18naphthyridines", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "4amino23diaryl5678tetrahydrofuro23bquinolines", "label": "CPR:4"}, {"em1Text": "butyrylcholinesterase", "em2Text": "4amino23diaryl5678tetrahydrofuro23bquinolines", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "4amino23diaryl5678tetrahydrofuro23bquinolines", "label": "CPR:4"}, {"em1Text": "BuChE", "em2Text": "4amino23diaryl5678tetrahydrofuro23bquinolines", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine", "label": "CPR:4"}, {"em1Text": "butyrylcholinesterase", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine", "label": "CPR:4"}, {"em1Text": "BuChE", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "4amino5678tetrahydro23diphenylthieno23bquinoline", "label": "CPR:4"}, {"em1Text": "butyrylcholinesterase", "em2Text": "4amino5678tetrahydro23diphenylthieno23bquinoline", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "4amino5678tetrahydro23diphenylthieno23bquinoline", "label": "CPR:4"}, {"em1Text": "BuChE", "em2Text": "4amino5678tetrahydro23diphenylthieno23bquinoline", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine", "label": "CPR:4"}, {"em1Text": "butyrylcholinesterase", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine", "label": "CPR:4"}, {"em1Text": "BuChE", "em2Text": "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine", "label": "CPR:4"}]}
{"sentText": "The BuChE inhibitory activity is only significant in compounds 11 and 14 tenfold less active than tacrine", "relationMentions": [{"em1Text": "BuChE", "em2Text": "tacrine", "label": "CPR:4"}]}
{"sentText": "Juglone isolated from Juglans mandshurica Maxim induces apoptosis via downregulation of AR expression in human prostate cancer LNCaP cells", "relationMentions": [{"em1Text": "Juglone", "em2Text": "AR", "label": "CPR:4"}]}
{"sentText": "Moreover we found that juglone significantly inhibited the expression levels of androgen receptor AR and prostatespecific antigen PSA in a dosedependent manner as well as abrogated upregulation of AR and PSA genes with andor without dihydrotestosterone DHT", "relationMentions": [{"em1Text": "juglone", "em2Text": "androgen receptor", "label": "CPR:4"}, {"em1Text": "juglone", "em2Text": "AR", "label": "CPR:4"}, {"em1Text": "juglone", "em2Text": "prostatespecific antigen", "label": "CPR:4"}, {"em1Text": "juglone", "em2Text": "PSA", "label": "CPR:4"}, {"em1Text": "juglone", "em2Text": "AR", "label": "CPR:4"}, {"em1Text": "juglone", "em2Text": "PSA", "label": "CPR:4"}]}
{"sentText": "Take together our results demonstrated that juglone might induce the apoptosis in LNCaP cell via downregulation of AR expression", "relationMentions": [{"em1Text": "juglone", "em2Text": "AR", "label": "CPR:4"}]}
{"sentText": "The efficacy of astemizole a new long acting oral histamine H1receptor antagonist was compared to placebo for the treatment of allergic rhinitis and conjunctivitis during the grass pollen season of 1982", "relationMentions": [{"em1Text": "astemizole", "em2Text": "histamine H1receptor", "label": "CPR:6"}]}
{"sentText": "Astemizole a potent histamine H1receptor antagonist effect in allergic rhinoconjunctivitis on antigen and histamine induced skin weal responses and relationship to serum levels", "relationMentions": [{"em1Text": "Astemizole", "em2Text": "histamine H1receptor", "label": "CPR:6"}]}
{"sentText": "Tacrine the first of the cholinesterase inhibitors to undergo extensive trials for this purpose was associated with significant adverse effects including hepatotoxicity", "relationMentions": [{"em1Text": "Tacrine", "em2Text": "cholinesterase", "label": "CPR:4"}]}
{"sentText": "Other cholinesterase inhibitors including rivastigmine with superior properties in terms of specificity of action and low risk of adverse effects have now been introduced", "relationMentions": [{"em1Text": "cholinesterase", "em2Text": "rivastigmine", "label": "CPR:4"}]}
{"sentText": "Nevertheless 3 mM DMA a higher concentration that inhibits NHE1 NHE2 and NHE3 significantly increased DBS", "relationMentions": [{"em1Text": "DMA", "em2Text": "NHE1", "label": "CPR:4"}, {"em1Text": "DMA", "em2Text": "NHE2", "label": "CPR:4"}, {"em1Text": "DMA", "em2Text": "NHE3", "label": "CPR:4"}]}
{"sentText": "Moreover S1611 and S3226 both specific inhibitors of NHE3 only or perfusion with Nafree solutions dose dependently increased DBS as measured by pHstat and CO2sensitive electrode without affecting intracellular pH", "relationMentions": [{"em1Text": "S1611", "em2Text": "NHE3", "label": "CPR:4"}, {"em1Text": "S3226", "em2Text": "NHE3", "label": "CPR:4"}]}
{"sentText": "Nevertheless coperfusion with 01 and 03 mM 5nitro23phenylpropylamino benzoic acid which inhibits the cystic fibrosis transmembrane conductor regulator CFTR dose dependently inhibited S3226induced DBS", "relationMentions": [{"em1Text": "5nitro23phenylpropylamino benzoic acid", "em2Text": "cystic fibrosis transmembrane conductor regulator", "label": "CPR:4"}, {"em1Text": "5nitro23phenylpropylamino benzoic acid", "em2Text": "CFTR", "label": "CPR:4"}]}
{"sentText": "5NNdimethylamiloride 50 microM DMA a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2 but not NHE3 did not affect DBS", "relationMentions": [{"em1Text": "5NNdimethylamiloride", "em2Text": "NHE", "label": "CPR:4"}, {"em1Text": "5NNdimethylamiloride", "em2Text": "NHE1", "label": "CPR:4"}, {"em1Text": "5NNdimethylamiloride", "em2Text": "NHE2", "label": "CPR:4"}, {"em1Text": "5NNdimethylamiloride", "em2Text": "NHE3", "label": "CPR:4"}, {"em1Text": "DMA", "em2Text": "NHE", "label": "CPR:4"}, {"em1Text": "DMA", "em2Text": "NHE1", "label": "CPR:4"}, {"em1Text": "DMA", "em2Text": "NHE2", "label": "CPR:4"}, {"em1Text": "DMA", "em2Text": "NHE3", "label": "CPR:4"}]}
{"sentText": "In conclusion only specific apical NHE3 inhibition increased DBS whereas prostaglandin synthesis NaHCO3 cotransporter activation or intracellular HCO3 formation by carbonic anhydrase was not involved", "relationMentions": [{"em1Text": "HCO3", "em2Text": "carbonic anhydrase", "label": "CPR:9"}]}
{"sentText": "Mechanisms limiting distribution of the threonineprotein kinase BRaF V600E inhibitor dabrafenib to the brain implications for the treatment of melanoma brain metastases", "relationMentions": [{"em1Text": "threonineprotein kinase BRaF", "em2Text": "dabrafenib", "label": "CPR:4"}, {"em1Text": "V600E", "em2Text": "dabrafenib", "label": "CPR:4"}]}
{"sentText": "Further compared with vemurafenib another BRAF V600E inhibitor dabrafenib showed greater brain penetration with a similar dose", "relationMentions": [{"em1Text": "vemurafenib", "em2Text": "BRAF", "label": "CPR:4"}, {"em1Text": "vemurafenib", "em2Text": "V600E", "label": "CPR:4"}]}
{"sentText": "In vitro accumulation studies conducted in MadinDarby canine kidney II cells indicate that dabrafenib is an avid substrate for both Pgp and BCRP", "relationMentions": [{"em1Text": "dabrafenib", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "dabrafenib", "em2Text": "BCRP", "label": "CPR:9"}]}
{"sentText": "Since the original discovery of azoles analogs as PXR antagonists we have preliminarily defined an important PXR antagonist pharmacophore and developed lesstoxic PXR antagonists", "relationMentions": [{"em1Text": "azoles", "em2Text": "PXR", "label": "CPR:6"}, {"em1Text": "azoles", "em2Text": "PXR", "label": "CPR:6"}, {"em1Text": "azoles", "em2Text": "PXR", "label": "CPR:6"}]}
{"sentText": "Activation of endogenous somatostatin receptor subtype 2 sst2 by somatostatin14 or activation of transiently transfected rat D2 dopamine receptors rD2 long by quinpirole had no effect", "relationMentions": [{"em1Text": "somatostatin receptor subtype 2", "em2Text": "somatostatin14", "label": "CPR:3"}, {"em1Text": "sst2", "em2Text": "somatostatin14", "label": "CPR:3"}, {"em1Text": "rat D2 dopamine receptors", "em2Text": "quinpirole", "label": "CPR:3"}, {"em1Text": "rD2", "em2Text": "quinpirole", "label": "CPR:3"}]}
{"sentText": "In contrast in the same system N type currents formed from transiently transfected alpha1Balpha2delta1beta3 showed strong Gprotein mediated inhibition", "relationMentions": [{"em1Text": "N", "em2Text": "Gprotein", "label": "CPR:4"}]}
{"sentText": "Cotreatment of astrocytes with antofine and the intracellular Ca2 chelator BAPTAAM prevented downregulation of Cx43 and inhibition of GJIC", "relationMentions": [{"em1Text": "BAPTAAM", "em2Text": "Cx43", "label": "CPR:3"}, {"em1Text": "antofine", "em2Text": "Cx43", "label": "CPR:4"}]}
{"sentText": "Taken together these findings indicate that antofine induces Cx43 gap junction disassembly by the PKC\u03b2 signaling pathway", "relationMentions": [{"em1Text": "antofine", "em2Text": "PKC\u03b2", "label": "CPR:3"}]}
{"sentText": "Levels of Cx43 protein were also decreased in a dose and timedependent manner following antofine treatment", "relationMentions": [{"em1Text": "Cx43", "em2Text": "antofine", "label": "CPR:4"}]}
{"sentText": "Moreover cotreatment with antofine and a specific PKC\u03b2 inhibitor prevented endocytosis of gap junctions downregulation of Cx43 and inhibition of GJIC", "relationMentions": [{"em1Text": "antofine", "em2Text": "Cx43", "label": "CPR:4"}]}
{"sentText": "Torasemide inhibits angiotensin II induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats", "relationMentions": [{"em1Text": "Torasemide", "em2Text": "angiotensin II", "label": "CPR:4"}]}
{"sentText": "Isometric contraction induced by a submaximal concentration of Ang II 107 molL was reduced in a dosedependent way by torasemide IC50=05004 micromolL", "relationMentions": [{"em1Text": "Ang II", "em2Text": "torasemide", "label": "CPR:4"}]}
{"sentText": "The stimulatory effect of Ca2i induced by a submaximal concentration of Ang II 107 molL was blocked by torasemide IC50=0503 nmolL", "relationMentions": [{"em1Text": "Ang II", "em2Text": "torasemide", "label": "CPR:4"}]}
{"sentText": "Our findings suggest that torasemide blocks the vasoconstrictor action of Ang II in vitro", "relationMentions": [{"em1Text": "torasemide", "em2Text": "Ang II", "label": "CPR:4"}]}
{"sentText": "This action can be related to the ability of torasemide to block the increase of Ca2i induced by Ang II in VSMCs", "relationMentions": [{"em1Text": "torasemide", "em2Text": "Ang II", "label": "CPR:4"}]}
{"sentText": "Among the isolated compounds transdihydromorin 8 oxyresveratrol 9 and steppogenin 12 were found to exhibit significant tyrosinase inhibition activities", "relationMentions": [{"em1Text": "transdihydromorin", "em2Text": "tyrosinase", "label": "CPR:4"}, {"em1Text": "oxyresveratrol", "em2Text": "tyrosinase", "label": "CPR:4"}, {"em1Text": "steppogenin", "em2Text": "tyrosinase", "label": "CPR:4"}]}
{"sentText": "It was concluded that PGE1 selectively reduces both N and Rtype Ca2 currents by activating a Gprotein probably through the EP3 receptor in paratracheal ganglion cells", "relationMentions": [{"em1Text": "PGE1", "em2Text": "Gprotein", "label": "CPR:3"}]}
{"sentText": "Prostaglandin E1 E2 STA2 a stable analogue of thromboxane A2 17phenyltrinor PGE2 an EP1 selective agonist and sulprostone an EP3 selective agonist inhibited the HVA Ca2 current HVA ICa dosedependently and the rank order of potency to inhibit HVA Ca2 channels was sulprostone PGE2 PGE1 STA217phenyltrinor PGE2", "relationMentions": [{"em1Text": "STA2", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "thromboxane A2", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "sulprostone", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "sulprostone", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "PGE2", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "HVA Ca2 channels", "em2Text": "PGE1", "label": "CPR:4"}, {"em1Text": "STA2", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "sulprostone", "em2Text": "EP3", "label": "CPR:5"}]}
{"sentText": "SC51089 105 M a selective EP1receptor antagonist showed no effect on the PGE1 or PGE2 induced inhibition of the HVA ICa thereby indicating that PGE1 and PGE2 induced inhibition of the HVA Ca2 channels is possibly mediated by the EP3 receptor", "relationMentions": [{"em1Text": "PGE1", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "PGE2", "em2Text": "HVA Ca2 channels", "label": "CPR:4"}, {"em1Text": "SC51089", "em2Text": "EP1receptor", "label": "CPR:6"}]}
{"sentText": "The inhibitory effect of PGE1 or sulprostone was prevented by pretreatment with pertussis toxin islet activating protein IAP or phorbol12myristate13acetate PMA and the protein kinase C PKC inhibitor chelerythrine blocked the action of PMA", "relationMentions": [{"em1Text": "protein kinase C", "em2Text": "chelerythrine", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "chelerythrine", "label": "CPR:4"}]}
{"sentText": "In addition we found that MCP1 transcription and translation was completely inhibited by mimosine while MIP2 transcription and translation was partially inhibited at 30 and 40 days yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T spiralis", "relationMentions": [{"em1Text": "MCP1", "em2Text": "mimosine", "label": "CPR:4"}, {"em1Text": "mimosine", "em2Text": "MIP2", "label": "CPR:4"}]}
{"sentText": "Inhibition of MCP1 and MIP2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis", "relationMentions": [{"em1Text": "MCP1", "em2Text": "mimosine", "label": "CPR:4"}, {"em1Text": "MIP2", "em2Text": "mimosine", "label": "CPR:4"}]}
{"sentText": "This is described in a case study of the expedited review and approval of peramivir a novel neuraminidase inhibitor in Japan in the context of the emergence of new strain of influenza in 2009", "relationMentions": [{"em1Text": "peramivir", "em2Text": "neuraminidase", "label": "CPR:4"}]}
{"sentText": "These results suggest that CYP2B6 genotype is the most important patient variable for predicting the level of CYP2B6 activity in women when measured by the metabolism of bupropion", "relationMentions": [{"em1Text": "CYP2B6", "em2Text": "bupropion", "label": "CPR:9"}, {"em1Text": "CYP2B6", "em2Text": "bupropion", "label": "CPR:9"}]}
{"sentText": "The bupropion metabolic ratio appears to detect known differences in CYP2B6 activity associated with genetic polymorphism across different ethnic groups", "relationMentions": [{"em1Text": "bupropion", "em2Text": "CYP2B6", "label": "CPR:9"}]}
{"sentText": "To identify important covariates associated with interindividual variation in CYP2B6 activity in vivo we evaluated these effects in healthy volunteers using bupropion Wellbutrin SR GlaxoSmithKline Research Triangle Park NC as a CYP2B6 probe substrate", "relationMentions": [{"em1Text": "CYP2B6", "em2Text": "bupropion", "label": "CPR:9"}, {"em1Text": "CYP2B6", "em2Text": "Wellbutrin SR", "label": "CPR:9"}]}
{"sentText": "The influence of sex ethnicity and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans", "relationMentions": [{"em1Text": "CYP2B6", "em2Text": "bupropion", "label": "CPR:9"}]}
{"sentText": "The identification of the succinate receptor SUCNR1 in platelets is of particular interest because physiologically relevant concentrations of succinate were shown to potentiate the effect of low doses of a variety of platelet agonists", "relationMentions": [{"em1Text": "succinate", "em2Text": "succinate receptor", "label": "CPR:5"}, {"em1Text": "succinate", "em2Text": "SUCNR1", "label": "CPR:5"}]}
{"sentText": "The results demonstrated that \u03b2iononeinduced apoptosis in a dosedependent manner in SGC7901 cells treated with \u03b2ionone 25 50 100 and 200 \u03bcmolL for 24 h \u03b2ionone was also shown to induce the expression of cleaved caspase3 and inhibit bcl2 expression in SGC7901 cells in a dosedependent manner", "relationMentions": [{"em1Text": "\u03b2ionone", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "\u03b2ionone", "em2Text": "bcl2", "label": "CPR:4"}]}
{"sentText": "The significantly decreased levels of pPI3K and pAKT expression were observed in SGC7901 cells after \u03b2ionone treatments in a time and dosedependent manner P 001", "relationMentions": [{"em1Text": "pPI3K", "em2Text": "\u03b2ionone", "label": "CPR:4"}, {"em1Text": "pAKT", "em2Text": "\u03b2ionone", "label": "CPR:4"}]}
{"sentText": "However AII receptor blockers differ from ACE inhibitors with respect to side effects and induce less cough a side effect which may be related to bradykinin or other mediators such as substance P Within the class of AII blockers eprosartan differs from other currently available agents in terms of chemical structure as it is a nonbiphenyl nontetrazole nonpeptide antagonist with a dual pharmacological mode of action", "relationMentions": [{"em1Text": "AII", "em2Text": "eprosartan", "label": "CPR:4"}]}
{"sentText": "In clinical trials eprosartan has been demonstrated to be at least as effective in reducing blood pressure as the ACE inhibitor enalapril and has significantly lower side effects", "relationMentions": [{"em1Text": "ACE", "em2Text": "enalapril", "label": "CPR:4"}]}
{"sentText": "On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs we hypothesized that the reductive detoxification of arylhydroxylamine carcinogens was catalyzed by NADH cytochrome b5 reductase b5R and cytochrome b5 cyt b5", "relationMentions": [{"em1Text": "arylhydroxylamine", "em2Text": "NADH cytochrome b5 reductase", "label": "CPR:9"}, {"em1Text": "arylhydroxylamine", "em2Text": "b5R", "label": "CPR:9"}, {"em1Text": "arylhydroxylamine", "em2Text": "cytochrome b5", "label": "CPR:9"}, {"em1Text": "arylhydroxylamine", "em2Text": "cyt b5", "label": "CPR:9"}]}
{"sentText": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4aminobiphenyl 4ABP found in cigarette smoke and the heterocyclic amine 2amino1methyl6phenylimidazo 45b pyridine PhIP found in grilled meats was indeed catalyzed by a purified system containing only human b5R and cyt b5", "relationMentions": [{"em1Text": "hydroxylamines", "em2Text": "human b5R", "label": "CPR:9"}, {"em1Text": "hydroxylamines", "em2Text": "cyt b5", "label": "CPR:9"}, {"em1Text": "aromatic amine", "em2Text": "human b5R", "label": "CPR:9"}, {"em1Text": "aromatic amine", "em2Text": "cyt b5", "label": "CPR:9"}, {"em1Text": "4aminobiphenyl", "em2Text": "human b5R", "label": "CPR:9"}, {"em1Text": "4aminobiphenyl", "em2Text": "cyt b5", "label": "CPR:9"}, {"em1Text": "4ABP", "em2Text": "human b5R", "label": "CPR:9"}, {"em1Text": "4ABP", "em2Text": "cyt b5", "label": "CPR:9"}, {"em1Text": "heterocyclic amine", "em2Text": "human b5R", "label": "CPR:9"}, {"em1Text": "heterocyclic amine", "em2Text": "cyt b5", "label": "CPR:9"}, {"em1Text": "2amino1methyl6phenylimidazo 45b pyridine", "em2Text": "human b5R", "label": "CPR:9"}, {"em1Text": "2amino1methyl6phenylimidazo 45b pyridine", "em2Text": "cyt b5", "label": "CPR:9"}, {"em1Text": "PhIP", "em2Text": "human b5R", "label": "CPR:9"}, {"em1Text": "PhIP", "em2Text": "cyt b5", "label": "CPR:9"}]}
{"sentText": "Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5", "relationMentions": [{"em1Text": "arylhydroxylamine", "em2Text": "cytochrome b5", "label": "CPR:9"}, {"em1Text": "arylhydroxylamine", "em2Text": "human NADH cytochrome b5 reductase", "label": "CPR:9"}]}
{"sentText": "Polyclonal antisera to either b5R or cyt b5 significantly inhibited Nhydroxy4aminobiphenyl NHOH4ABP reduction by 95 and 89 respectively and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH4ABP and NhydroxyPhIP NHOHPhIP", "relationMentions": [{"em1Text": "b5R", "em2Text": "Nhydroxy4aminobiphenyl", "label": "CPR:9"}, {"em1Text": "cyt b5", "em2Text": "Nhydroxy4aminobiphenyl", "label": "CPR:9"}, {"em1Text": "b5R", "em2Text": "NHOH4ABP", "label": "CPR:9"}, {"em1Text": "cyt b5", "em2Text": "NHOH4ABP", "label": "CPR:9"}]}
{"sentText": "Pranlukast is a new orally active selective inhibitor of CysLt1 leukotriene receptor", "relationMentions": [{"em1Text": "Pranlukast", "em2Text": "CysLt1", "label": "CPR:4"}, {"em1Text": "Pranlukast", "em2Text": "leukotriene receptor", "label": "CPR:4"}]}
{"sentText": "Clinical effects of pranlukast an oral leukotriene receptor antagonist in mildtomoderate asthma a 4 week randomized multicentre controlled trial", "relationMentions": [{"em1Text": "pranlukast", "em2Text": "leukotriene receptor", "label": "CPR:6"}]}
{"sentText": "We used mutagenesis of these residues combined with an investigation of hERG block by close analogs of clofilium and ibutilide to assess how specific alterations in drug structure affected potency and binding interactions", "relationMentions": [{"em1Text": "hERG", "em2Text": "clofilium", "label": "CPR:4"}, {"em1Text": "hERG", "em2Text": "ibutilide", "label": "CPR:4"}]}
{"sentText": "There was also an increase in ckit Trio RhoA Rac3 EGFR Notch4 Dvl2 Ezrin beta catenin and mutant p53 protein expression in the parathion treated cells", "relationMentions": [{"em1Text": "ckit", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "Trio", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "RhoA", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "Rac3", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "Notch4", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "Dvl2", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "Ezrin", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "beta catenin", "em2Text": "parathion", "label": "CPR:3"}, {"em1Text": "p53", "em2Text": "parathion", "label": "CPR:3"}]}
{"sentText": "Parathion is a cholinesterase inhibitor that induces the hydrolysis of body choline esters including acetylcholine at cholinergic synapses", "relationMentions": [{"em1Text": "Parathion", "em2Text": "cholinesterase", "label": "CPR:4"}]}
{"sentText": "The purified phosphodiester alphaGlcNAcase has a specific activity of 498 micromol of 3HGlcNAcalphaphosphomannosealphamethyl cleaved per h per mg of protein using 05 mM 3HGlcNAcalphaphosphomannosealphamethyl as substrate", "relationMentions": [{"em1Text": "phosphodiester alphaGlcNAcase", "em2Text": "3HGlcNAcalphaphosphomannosealphamethyl", "label": "CPR:9"}, {"em1Text": "phosphodiester alphaGlcNAcase", "em2Text": "3HGlcNAcalphaphosphomannosealphamethyl", "label": "CPR:9"}]}
{"sentText": "NAcetylglucosamine1phosphodiester alphaNAcetylglucosaminidase EC 31445 phosphodiester alphaGlcNAcase catalyzes the second step in the synthesis of the mannose 6phosphate determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome", "relationMentions": [{"em1Text": "NAcetylglucosamine1phosphodiester alphaNAcetylglucosaminidase", "em2Text": "mannose 6phosphate", "label": "CPR:9"}, {"em1Text": "EC 31445", "em2Text": "mannose 6phosphate", "label": "CPR:9"}, {"em1Text": "phosphodiester alphaGlcNAcase", "em2Text": "mannose 6phosphate", "label": "CPR:9"}]}
{"sentText": "In the in vitro assay kinsenoside 20 and 50\u03bcgmL markedly inhibited changes in various biochemical substances nitric oxide NO lactic dehydrogenase LDH superoxide dismutase SOD and catalase CAT in human umbilical vein endothelial cells HUVECs damaged by high glucose 35mM and restored vascular endothelial structure by balancing the matrix metalloproteinasesthe tissue inhibitors of matrix metalloproteinases MMPTIMP system", "relationMentions": [{"em1Text": "kinsenoside", "em2Text": "lactic dehydrogenase", "label": "CPR:4"}, {"em1Text": "kinsenoside", "em2Text": "LDH", "label": "CPR:4"}, {"em1Text": "kinsenoside", "em2Text": "superoxide dismutase", "label": "CPR:4"}, {"em1Text": "kinsenoside", "em2Text": "SOD", "label": "CPR:4"}, {"em1Text": "kinsenoside", "em2Text": "catalase", "label": "CPR:4"}, {"em1Text": "kinsenoside", "em2Text": "CAT", "label": "CPR:4"}]}
{"sentText": "The vascular protective effects of kinsenoside were speculated to be attributed to oxidative stress inhibition and the reduction of nuclear factor kappa B NF\u03baB mRNA expression levels in high glucose conditions", "relationMentions": [{"em1Text": "kinsenoside", "em2Text": "nuclear factor kappa B", "label": "CPR:4"}, {"em1Text": "kinsenoside", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "8pCPT2OMecAMPAM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2APB 25 \u03bcM and enhanced by the PKC inhibitor bisindolylmaleimide I 1 \u03bcM", "relationMentions": [{"em1Text": "insulin", "em2Text": "bisindolylmaleimide I", "label": "CPR:3"}, {"em1Text": "8pCPT2OMecAMPAM", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "insulin", "em2Text": "tolbutamide", "label": "CPR:3"}, {"em1Text": "PKC", "em2Text": "bisindolylmaleimide I", "label": "CPR:4"}, {"em1Text": "insulin", "em2Text": "2APB", "label": "CPR:4"}]}
{"sentText": "Our data demonstrate that the actions of both tolbutamide and gliclazide are strongly potentiated by 8pCPT2OMecAMPAM that gliclazide can stimulate phospholipase C activity via a partially pertussis toxinsensitive mechanism and that 8pCPT2OMecAMPAM potentiation of tolbutamide action may involve activation of a 2APBsensitive Ca2 influx", "relationMentions": [{"em1Text": "gliclazide", "em2Text": "phospholipase C", "label": "CPR:3"}]}
{"sentText": "Tolbutamide and gliclazide block the KATP channel Kir62 Sur1 causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells", "relationMentions": [{"em1Text": "Tolbutamide", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "Tolbutamide", "em2Text": "KATP channel", "label": "CPR:4"}, {"em1Text": "Tolbutamide", "em2Text": "Kir62", "label": "CPR:4"}, {"em1Text": "Tolbutamide", "em2Text": "Sur1", "label": "CPR:4"}]}
{"sentText": "Insulin secretion stimulated by both 200 \u03bcM tolbutamide and 20 \u03bcM gliclazide concentrations that had equivalent effects on membrane potential was inhibited by thapsigargin 1 \u03bcM or the Ltype Ca2 channel blocker nicardipine 2 \u03bcM and was potentiated by 8pCPT2OMecAMPAM at concentrations \u22652 \u03bcM in INS1 cells", "relationMentions": [{"em1Text": "Insulin", "em2Text": "tolbutamide", "label": "CPR:3"}, {"em1Text": "Insulin", "em2Text": "gliclazide", "label": "CPR:3"}, {"em1Text": "Insulin", "em2Text": "8pCPT2OMecAMPAM", "label": "CPR:3"}, {"em1Text": "Insulin", "em2Text": "thapsigargin", "label": "CPR:4"}, {"em1Text": "Insulin", "em2Text": "nicardipine", "label": "CPR:4"}, {"em1Text": "Ltype Ca2 channel", "em2Text": "nicardipine", "label": "CPR:4"}]}
{"sentText": "Both tolbutamide and gliclazide stimulated phospholipase C activity however only gliclazide did so independently of its activity at KATP channels and this activity was partially inhibited by pertussis toxin", "relationMentions": [{"em1Text": "tolbutamide", "em2Text": "phospholipase C", "label": "CPR:3"}, {"em1Text": "gliclazide", "em2Text": "phospholipase C", "label": "CPR:3"}, {"em1Text": "gliclazide", "em2Text": "KATP channels", "label": "CPR:3"}]}
{"sentText": "Phosphorylation of AMPK at Thr172 increased by 14fold within 5 min and remained elevated throughout a 30min time course in response to 2deoxyglucose", "relationMentions": [{"em1Text": "AMPK", "em2Text": "2deoxyglucose", "label": "CPR:3"}]}
{"sentText": "Phosphorylation of ERstress marker eIF2\u03b1 was also increased but only at 30 min of 2deoxyglucose exposure", "relationMentions": [{"em1Text": "eIF2\u03b1", "em2Text": "2deoxyglucose", "label": "CPR:3"}]}
{"sentText": "2Deoxyglucose increased phosphorylation of tuberous sclerosis complex 2 TSC2 on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2", "relationMentions": [{"em1Text": "2Deoxyglucose", "em2Text": "TSC2", "label": "CPR:3"}, {"em1Text": "2Deoxyglucose", "em2Text": "tuberous sclerosis complex 2", "label": "CPR:3"}, {"em1Text": "2Deoxyglucose", "em2Text": "TSC2", "label": "CPR:3"}, {"em1Text": "2Deoxyglucose", "em2Text": "AMPK", "label": "CPR:3"}]}
{"sentText": "Conivaptan is a nonpeptide dual V1aV2 AVP receptor antagonist", "relationMentions": [{"em1Text": "Conivaptan", "em2Text": "V1aV2 AVP receptor", "label": "CPR:6"}]}
{"sentText": "Conivaptan a dual vasopressin receptor v1av2 antagonist corrected", "relationMentions": [{"em1Text": "Conivaptan", "em2Text": "vasopressin receptor v1av2", "label": "CPR:6"}]}
{"sentText": "H1receptor antagonists have been utilized following their initial chemical synthesis in 1933 both in the treatment of conditions in which histamine is considered to be of pathogenic importance and conversely to help elucidate the role of histamine in disease through an evaluation of their influence on disease expression", "relationMentions": [{"em1Text": "H1receptor", "em2Text": "histamine", "label": "CPR:5"}, {"em1Text": "H1receptor", "em2Text": "histamine", "label": "CPR:5"}]}
{"sentText": "While there is considerable indirect evidence to implicate histamine in the pathogenesis of asthma a critical evaluation of H1receptor antagonism in this condition has until recently proved difficult as many of the early H1receptor antagonists possessed additional actions such as anticholinergic local anaesthetic alphaadrenoceptor antagonistic and antiserotonin activity", "relationMentions": [{"em1Text": "histamine", "em2Text": "H1receptor", "label": "CPR:5"}, {"em1Text": "histamine", "em2Text": "H1receptor", "label": "CPR:5"}]}
{"sentText": "The recent development of H1receptor antagonists devoid of clinical sedative effects has enabled the administration of doses of H1antihistamines which achieve a greater degree of H1receptor blockade within the airways thus permitting a better appraisal of the role of histamine in this condition", "relationMentions": [{"em1Text": "H1receptor", "em2Text": "histamine", "label": "CPR:5"}, {"em1Text": "H1receptor", "em2Text": "histamine", "label": "CPR:5"}]}
{"sentText": "Cholesterol esterase CE induced surface erosion of polyethylene carbonate PEC and drug release from PEC under mild physiological environment was investigated", "relationMentions": [{"em1Text": "Cholesterol esterase", "em2Text": "PEC", "label": "CPR:9"}, {"em1Text": "CE", "em2Text": "PEC", "label": "CPR:9"}, {"em1Text": "Cholesterol esterase", "em2Text": "polyethylene carbonate", "label": "CPR:9"}, {"em1Text": "CE", "em2Text": "polyethylene carbonate", "label": "CPR:9"}]}
{"sentText": "Intravenous arginine significantly increased the acute glucagon response 129 12 vs 36 6 ngl in controls p 001 notably without affecting plasma glucose", "relationMentions": [{"em1Text": "arginine", "em2Text": "glucagon", "label": "CPR:3"}]}
{"sentText": "Isolated islets displayed improved glucose stimulated insulin secretion after GRA treatment 0061 0007 vs 0030 0004 pmol islet1 h1 at 167 mmoll glucose p 0001 without affecting islet glucose oxidation", "relationMentions": [{"em1Text": "glucose", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "PIP5K1B encodes phosphatidylinositol 4phosphate 5kinase \u03b2 type I pip5k1\u03b2 an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4phosphate PI4P to generate phosphatidylinositol45bisphosphate PI45P2", "relationMentions": [{"em1Text": "PIP5K1B", "em2Text": "phosphatidylinositol45bisphosphate", "label": "CPR:9"}, {"em1Text": "phosphatidylinositol 4phosphate 5kinase \u03b2 type I", "em2Text": "phosphatidylinositol45bisphosphate", "label": "CPR:9"}, {"em1Text": "pip5k1\u03b2", "em2Text": "phosphatidylinositol45bisphosphate", "label": "CPR:9"}, {"em1Text": "PIP5K1B", "em2Text": "PI45P2", "label": "CPR:9"}, {"em1Text": "phosphatidylinositol 4phosphate 5kinase \u03b2 type I", "em2Text": "PI45P2", "label": "CPR:9"}, {"em1Text": "pip5k1\u03b2", "em2Text": "PI45P2", "label": "CPR:9"}, {"em1Text": "PIP5K1B", "em2Text": "phosphatidylinositol 4phosphate", "label": "CPR:9"}, {"em1Text": "phosphatidylinositol 4phosphate", "em2Text": "phosphatidylinositol 4phosphate 5kinase \u03b2 type I", "label": "CPR:9"}, {"em1Text": "phosphatidylinositol 4phosphate", "em2Text": "pip5k1\u03b2", "label": "CPR:9"}, {"em1Text": "PIP5K1B", "em2Text": "PI4P", "label": "CPR:9"}, {"em1Text": "phosphatidylinositol 4phosphate 5kinase \u03b2 type I", "em2Text": "PI4P", "label": "CPR:9"}, {"em1Text": "pip5k1\u03b2", "em2Text": "PI4P", "label": "CPR:9"}]}
{"sentText": "Accordingly loss of pip5k1\u03b2 function in FRDA cells was accompanied by decreased PI45P2 levels and was shown instrumental for destabilization of the actin network and delayed cell spreading", "relationMentions": [{"em1Text": "pip5k1\u03b2", "em2Text": "PI45P2", "label": "CPR:9"}]}
{"sentText": "The expression of regucalcin is stimulated through the action of insulin in liver cells in vitro and in vivo and it is decreased in the liver of rats with type I diabetes induced by streptozotocin administration in vivo", "relationMentions": [{"em1Text": "regucalcin", "em2Text": "streptozotocin", "label": "CPR:4"}]}
{"sentText": "AMPK activators metformin and AICAR partly prevented the cell cycle block oxidative stress and apoptosis induced by compound C The small interfering RNA siRNA targeting of human AMPK mimicked compound Cinduced G2M cell cycle arrest but failed to induce oxidative stress and apoptosis in U251 glioma cells", "relationMentions": [{"em1Text": "AMPK", "em2Text": "metformin", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "AICAR", "label": "CPR:3"}]}
{"sentText": "Indomethacin treatment led to an increase in lipid peroxidation glutathione peroxidase and glucose6phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa", "relationMentions": [{"em1Text": "Indomethacin", "em2Text": "glutathione peroxidase", "label": "CPR:3"}, {"em1Text": "Indomethacin", "em2Text": "glucose6phosphate dehydrogenase", "label": "CPR:3"}, {"em1Text": "Indomethacin", "em2Text": "catalase", "label": "CPR:4"}]}
{"sentText": "Diclofenac\u03b2dglucuronide clopidogrel\u03b2dglucuronide ibuprofen\u03b2dglucuronide Rnaproxen\u03b2dglucuronide and Snaproxen\u03b2dglucuronide selectively inhibited hCES1 with Ki values of 432 \u00b1 047 248 \u00b1 42 355 \u00b1 38 468 \u00b1 21 707 \u00b1 64 \u00b5M respectively but did not significantly inhibit hCES2", "relationMentions": [{"em1Text": "clopidogrel\u03b2dglucuronide", "em2Text": "hCES1", "label": "CPR:4"}, {"em1Text": "ibuprofen\u03b2dglucuronide", "em2Text": "hCES1", "label": "CPR:4"}, {"em1Text": "Rnaproxen\u03b2dglucuronide", "em2Text": "hCES1", "label": "CPR:4"}, {"em1Text": "Snaproxen\u03b2dglucuronide", "em2Text": "hCES1", "label": "CPR:4"}, {"em1Text": "Diclofenac\u03b2dglucuronide", "em2Text": "hCES1", "label": "CPR:4"}]}
{"sentText": "Conclusion Drugdrug interaction studies may be warranted for drugs that metabolize to acyl glucuronides due to the potential inhibition of hCESs", "relationMentions": [{"em1Text": "acyl glucuronides", "em2Text": "hCESs", "label": "CPR:4"}]}
{"sentText": "Objective This study explores the ability of acyl glucuronides to act as substrates or inhibitors of human carboxylesterases 1 hCES1 and 2 hCES2", "relationMentions": [{"em1Text": "acyl glucuronides", "em2Text": "human carboxylesterases 1", "label": "CPR:4"}, {"em1Text": "acyl glucuronides", "em2Text": "hCES1", "label": "CPR:4"}, {"em1Text": "acyl glucuronides", "em2Text": "hCES2", "label": "CPR:4"}, {"em1Text": "acyl glucuronides", "em2Text": "human carboxylesterases 1", "label": "CPR:9"}, {"em1Text": "acyl glucuronides", "em2Text": "hCES1", "label": "CPR:9"}, {"em1Text": "acyl glucuronides", "em2Text": "hCES2", "label": "CPR:9"}]}
{"sentText": "Reversible inhibition of human carboxylesterases by acyl glucuronides", "relationMentions": [{"em1Text": "human carboxylesterases", "em2Text": "acyl glucuronides", "label": "CPR:4"}]}
{"sentText": "Carboxylesterases hydrolyze esters amides and thioesters to produce carboxylic acids and resulting alcohols amines and thiols respectively", "relationMentions": [{"em1Text": "Carboxylesterases", "em2Text": "alcohols", "label": "CPR:9"}, {"em1Text": "Carboxylesterases", "em2Text": "esters", "label": "CPR:9"}, {"em1Text": "Carboxylesterases", "em2Text": "amides", "label": "CPR:9"}, {"em1Text": "Carboxylesterases", "em2Text": "thioesters", "label": "CPR:9"}, {"em1Text": "Carboxylesterases", "em2Text": "carboxylic acids", "label": "CPR:9"}, {"em1Text": "Carboxylesterases", "em2Text": "amines", "label": "CPR:9"}, {"em1Text": "Carboxylesterases", "em2Text": "thiols", "label": "CPR:9"}]}
{"sentText": "Uridine 5diphosphate glucuronosyltransferases are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to acyl glucuronides but it is currently unknown if acyl glucuronides being esters also interact with carboxylesterases", "relationMentions": [{"em1Text": "Uridine 5diphosphate glucuronosyltransferases", "em2Text": "carboxylic acids", "label": "CPR:9"}, {"em1Text": "carboxylesterases", "em2Text": "carboxylic acids", "label": "CPR:9"}, {"em1Text": "Uridine 5diphosphate glucuronosyltransferases", "em2Text": "acyl glucuronides", "label": "CPR:9"}, {"em1Text": "carboxylesterases", "em2Text": "acyl glucuronides", "label": "CPR:9"}, {"em1Text": "Uridine 5diphosphate glucuronosyltransferases", "em2Text": "acyl glucuronides", "label": "CPR:9"}]}
{"sentText": "Methods The stability of six acyl glucuronides in the presence of hCES1 hCES2 and buffer alone 100 mM potassium phosphate pH 74 37\u00b0C were investigated", "relationMentions": [{"em1Text": "acyl glucuronides", "em2Text": "hCES1", "label": "CPR:9"}, {"em1Text": "acyl glucuronides", "em2Text": "hCES2", "label": "CPR:9"}]}
{"sentText": "Furthermore DOX treated WT and p65 MEFs differed in their expression of various apoptosisassociated molecules when the former demonstrated a decrease in the percentage of p65 positive and a more prominent decrease in the percentage of p53positive cells while a decreased percentage of I\u03baB\u03b1positive and a more prominent decrease in the percentage of bcl2positive cells was detected among the latter", "relationMentions": [{"em1Text": "DOX", "em2Text": "p65", "label": "CPR:4"}]}
{"sentText": "Crocin 25 and 50mgkg or vitamin E improved histopathological damages decreased MDA and CKMB increased GSH content and attenuated the increase of Bax Bcl2 ratio activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN", "relationMentions": [{"em1Text": "Crocin", "em2Text": "caspase 3", "label": "CPR:3"}, {"em1Text": "vitamin E", "em2Text": "caspase 3", "label": "CPR:3"}, {"em1Text": "Bax", "em2Text": "DZN", "label": "CPR:3"}, {"em1Text": "caspase 3", "em2Text": "DZN", "label": "CPR:3"}, {"em1Text": "cytochrome c", "em2Text": "DZN", "label": "CPR:3"}, {"em1Text": "Crocin", "em2Text": "CKMB", "label": "CPR:4"}, {"em1Text": "Crocin", "em2Text": "Bax", "label": "CPR:4"}, {"em1Text": "Crocin", "em2Text": "Bcl2", "label": "CPR:4"}, {"em1Text": "Crocin", "em2Text": "cytochrome c", "label": "CPR:4"}, {"em1Text": "vitamin E", "em2Text": "CKMB", "label": "CPR:4"}, {"em1Text": "vitamin E", "em2Text": "Bax", "label": "CPR:4"}, {"em1Text": "vitamin E", "em2Text": "Bcl2", "label": "CPR:4"}, {"em1Text": "Bcl2", "em2Text": "DZN", "label": "CPR:4"}]}
{"sentText": "RESULTS DZN induced histophatological damages and elevated the level of cardiac marker CKMB", "relationMentions": [{"em1Text": "DZN", "em2Text": "CKMB", "label": "CPR:3"}]}
{"sentText": "In the present study we investigated the effect of fenoterol induced constitutive beta2adrenoceptor activity on muscarinic receptor agonist and histamineinduced bovine tracheal smooth muscle contractions", "relationMentions": [{"em1Text": "fenoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:3"}]}
{"sentText": "Effect of fenoterol induced constitutive beta2adrenoceptor activity on contractile receptor function in airway smooth muscle", "relationMentions": [{"em1Text": "fenoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:3"}]}
{"sentText": "In conclusion fenoterol induced constitutive beta2adrenoceptor activity reduces muscarinic receptor agonist and histamineinduced contractions of bovine tracheal smooth muscle which can be reversed by the inverse agonist timolol", "relationMentions": [{"em1Text": "fenoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:3"}, {"em1Text": "beta2adrenoceptor", "em2Text": "timolol", "label": "CPR:5"}]}
{"sentText": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time 5 30 min 18 h at 37 degrees C After extensive washout 3 h 37 degrees C isometric contractions were measured to the full muscarinic receptor agonist methacholine the partial muscarinic receptor agonist 4mchlorophenylcarbamoyloxy2butynyltrimethylammonium McNA343 and histamine", "relationMentions": [{"em1Text": "muscarinic receptor", "em2Text": "4mchlorophenylcarbamoyloxy2butynyltrimethylammonium", "label": "CPR:5"}, {"em1Text": "muscarinic receptor", "em2Text": "histamine", "label": "CPR:5"}, {"em1Text": "muscarinic receptor", "em2Text": "methacholine", "label": "CPR:5"}]}
{"sentText": "Betaglucogallin reduces the expression of lipopolysaccharideinduced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues", "relationMentions": [{"em1Text": "Betaglucogallin", "em2Text": "aldose reductase", "label": "CPR:4"}]}
{"sentText": "Betaglucogallin BGG a recently described AR inhibitor was purified from extracts of the Indian gooseberry Emblica officinalis", "relationMentions": [{"em1Text": "Betaglucogallin", "em2Text": "AR", "label": "CPR:4"}, {"em1Text": "BGG", "em2Text": "AR", "label": "CPR:4"}]}
{"sentText": "In this study we found that BGG showed low cytotoxicity in Raw2647 murine macrophages and effectively inhibited AR activity as measured by a decrease in sorbitol accumulation", "relationMentions": [{"em1Text": "BGG", "em2Text": "AR", "label": "CPR:4"}]}
{"sentText": "In addition BGG mediated inhibition of AR prevented LPSinduced activation of JNK and p38 and lowered ROS levels which could inhibit LPSinduced apoptosis", "relationMentions": [{"em1Text": "BGG", "em2Text": "AR", "label": "CPR:4"}, {"em1Text": "BGG", "em2Text": "JNK", "label": "CPR:4"}, {"em1Text": "BGG", "em2Text": "p38", "label": "CPR:4"}]}
{"sentText": "Aldose reductase AR catalyzes the reduction of toxic lipid aldehydes to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide LPS", "relationMentions": [{"em1Text": "Aldose reductase", "em2Text": "aldehydes", "label": "CPR:9"}, {"em1Text": "AR", "em2Text": "aldehydes", "label": "CPR:9"}, {"em1Text": "Aldose reductase", "em2Text": "alcohol", "label": "CPR:9"}, {"em1Text": "AR", "em2Text": "alcohol", "label": "CPR:9"}]}
{"sentText": "Treatment of Rat2 fibroblast cells with C2ceramide caused the stimulation of cfos SRE dependent reporter gene activity in a dose and timedependent manner by transient transfection analysis", "relationMentions": [{"em1Text": "C2ceramide", "em2Text": "cfos SRE", "label": "CPR:3"}]}
{"sentText": "Next we examined the role of Rho family GTPases in the ceramide induced signalling to SRE activation", "relationMentions": [{"em1Text": "ceramide", "em2Text": "SRE", "label": "CPR:3"}]}
{"sentText": "By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of Cdc42 Rac1 or RhoA C2ceramide induced SRE activation was shown to be selectively repressed by pEXVRacN17 encoding a dominant negative mutant of Rac1 suggesting that Rac activity is essential for the signalling cascade of ceramide to the nucleus", "relationMentions": [{"em1Text": "C2ceramide", "em2Text": "SRE", "label": "CPR:3"}]}
{"sentText": "Exogenous C2ceramide activates cfos serum response element via Racdependent signalling pathway", "relationMentions": [{"em1Text": "C2ceramide", "em2Text": "cfos serum response element", "label": "CPR:3"}]}
{"sentText": "In a further study to analyse the downstream mediator of Rac in the ceramidesignalling pathway we observed that either pretreatment with mepacrine a potent and specific inhibitor of phospholipase A2 or cotransfection with antisense cytosolic phospholipase A2 cPLA2 oligonucleotide repressed the C2ceramide induced SRE activation selectively implying a critical role of cPLA2 in C2ceramideinduced signalling to nucleus", "relationMentions": [{"em1Text": "C2ceramide", "em2Text": "SRE", "label": "CPR:3"}]}
{"sentText": "Together our findings suggest the critical role of Rac and subsequent activation of phospholipase A2 in ceramide signalling to nucleus", "relationMentions": [{"em1Text": "phospholipase A2", "em2Text": "ceramide", "label": "CPR:3"}]}
{"sentText": "Consistent with these results the translocation of cPLA2 protein as well as the release of arachidonic acid a principal product of phospholipase A2 was rapidly induced by the addition of C2ceramide in a Racdependent manner", "relationMentions": [{"em1Text": "arachidonic acid", "em2Text": "phospholipase A2", "label": "CPR:9"}]}
{"sentText": "Effect of SN21678tetrahydro2Hindeno54bfuran8ylethylpropionamide ramelteon TAK375 a selective MT1MT2 receptor agonist on motor coordination was studied using rotarod performance in mice", "relationMentions": [{"em1Text": "ramelteon", "em2Text": "MT1MT2 receptor", "label": "CPR:5"}, {"em1Text": "TAK375", "em2Text": "MT1MT2 receptor", "label": "CPR:5"}, {"em1Text": "SN21678tetrahydro2Hindeno54bfuran8ylethylpropionamide", "em2Text": "MT1MT2 receptor", "label": "CPR:5"}]}
{"sentText": "Effect of ramelteon TAK375 a selective MT1MT2 receptor agonist on motor performance in mice", "relationMentions": [{"em1Text": "ramelteon", "em2Text": "MT1MT2 receptor", "label": "CPR:5"}, {"em1Text": "TAK375", "em2Text": "MT1MT2 receptor", "label": "CPR:5"}]}
{"sentText": "Our previous work built on the early pioneering multikinase inhibitor LY294002 resulted in the only PI3K vasculartargeted PI3K inhibitor prodrug SF1126 which has now completed Phase I clinical trials", "relationMentions": [{"em1Text": "LY294002", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "LY294002", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "PI3K", "em2Text": "SF1126", "label": "CPR:4"}, {"em1Text": "PI3K", "em2Text": "SF1126", "label": "CPR:4"}]}
{"sentText": "This work resulted in the discovery of the 5morpholino7Hthieno32bpyran7one system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward PI3K", "relationMentions": [{"em1Text": "5morpholino7Hthieno32bpyran7one", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "5morpholino7Hthieno32bpyran7one", "em2Text": "PI3K", "label": "CPR:4"}]}
{"sentText": "Synthesis and cancer stem cellbased activity of substituted 5morpholino7Hthieno32bpyran7ones designed as next generation PI3K inhibitors", "relationMentions": [{"em1Text": "5morpholino7Hthieno32bpyran7ones", "em2Text": "PI3K", "label": "CPR:4"}]}
{"sentText": "CP690550 a JAK3 inhibitor is currently in phase II clinical trialsFK778 is a synthetic malononitrilamide that targets the critical enzyme of the de novo pyrimidine synthesis dihydroorotic acid dehydrogenase and receptorassociated tyrosine kinases has completed phase II trials", "relationMentions": [{"em1Text": "CP690550", "em2Text": "JAK3", "label": "CPR:4"}]}
{"sentText": "Firstly the Vmax of GAD was increased when ApoCaM was present whereas the affinity for the substrate glutamate was not affected", "relationMentions": [{"em1Text": "GAD", "em2Text": "glutamate", "label": "CPR:9"}]}
{"sentText": "To determine whether H2S itself provoked inflammation in acinar cells the cells were treated with H2S donor drug sodium hydrosulphide NaHS 10 50 and 100 muM that resulted in a significant increase in SP concentration and expression of PPTA and NK1R in acinar cells", "relationMentions": [{"em1Text": "sodium hydrosulphide", "em2Text": "SP", "label": "CPR:3"}, {"em1Text": "sodium hydrosulphide", "em2Text": "PPTA", "label": "CPR:3"}, {"em1Text": "sodium hydrosulphide", "em2Text": "NK1R", "label": "CPR:3"}, {"em1Text": "NaHS", "em2Text": "SP", "label": "CPR:3"}, {"em1Text": "NaHS", "em2Text": "PPTA", "label": "CPR:3"}, {"em1Text": "NaHS", "em2Text": "NK1R", "label": "CPR:3"}]}
{"sentText": "Caerulein increased the levels of H2S and CSE mRNA expression while CBS mRNA expression was decreased", "relationMentions": [{"em1Text": "Caerulein", "em2Text": "CSE", "label": "CPR:3"}, {"em1Text": "Caerulein", "em2Text": "CBS", "label": "CPR:4"}]}
{"sentText": "Furthermore substance P SP concentration in the acini and expression of SP gene preprotachykininA PPTA and neurokinin1 receptor NK1R the primary receptor for SP are increased in secretagogue caerulein treated acinar cells", "relationMentions": [{"em1Text": "substance P", "em2Text": "caerulein", "label": "CPR:3"}, {"em1Text": "SP", "em2Text": "caerulein", "label": "CPR:3"}, {"em1Text": "SP", "em2Text": "caerulein", "label": "CPR:3"}, {"em1Text": "preprotachykininA", "em2Text": "caerulein", "label": "CPR:3"}, {"em1Text": "PPTA", "em2Text": "caerulein", "label": "CPR:3"}, {"em1Text": "neurokinin1 receptor", "em2Text": "caerulein", "label": "CPR:3"}, {"em1Text": "NK1R", "em2Text": "caerulein", "label": "CPR:3"}]}
{"sentText": "In addition cells pretreated with DLpropargylglycine PAG 3 mM a CSE inhibitor reduced the formation of H2S in caerulein treated cells suggesting that CSE may be the main enzyme involved in H2S formation in mouse acinar cells", "relationMentions": [{"em1Text": "DLpropargylglycine", "em2Text": "CSE", "label": "CPR:4"}, {"em1Text": "PAG", "em2Text": "CSE", "label": "CPR:4"}, {"em1Text": "CSE", "em2Text": "H2S", "label": "CPR:9"}]}
{"sentText": "Inhibition of endogenous production of H2S by PAG significantly suppressed SP concentration PPTA expression and NK1R expression in the acini", "relationMentions": [{"em1Text": "H2S", "em2Text": "SP", "label": "CPR:4"}, {"em1Text": "H2S", "em2Text": "PPTA", "label": "CPR:4"}, {"em1Text": "H2S", "em2Text": "NK1R", "label": "CPR:4"}]}
{"sentText": "These results suggest that the proinflammatory effect of H2S may be mediated by SP NK1R related pathway in mouse pancreatic acinar cells", "relationMentions": [{"em1Text": "H2S", "em2Text": "SP", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "NK1R", "label": "CPR:9"}]}
{"sentText": "Hydrogen sulphide H2S is synthesized from Lcysteine via the action of cystathioninegammalyase CSE and cystathioninebetasynthase CBS", "relationMentions": [{"em1Text": "H2S", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "cystathioninebetasynthase", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "CBS", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "cystathioninegammalyase", "label": "CPR:9"}, {"em1Text": "Lcysteine", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "Lcysteine", "em2Text": "cystathioninebetasynthase", "label": "CPR:9"}, {"em1Text": "Lcysteine", "em2Text": "CBS", "label": "CPR:9"}, {"em1Text": "Lcysteine", "em2Text": "cystathioninegammalyase", "label": "CPR:9"}, {"em1Text": "Hydrogen sulphide", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "Hydrogen sulphide", "em2Text": "cystathioninebetasynthase", "label": "CPR:9"}, {"em1Text": "Hydrogen sulphide", "em2Text": "CBS", "label": "CPR:9"}, {"em1Text": "Hydrogen sulphide", "em2Text": "cystathioninegammalyase", "label": "CPR:9"}]}
{"sentText": "In this study we investigated the presence of H2S and the expression of H2S synthesizing enzymes CSE and CBS in isolated mouse pancreatic acini", "relationMentions": [{"em1Text": "H2S", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "CBS", "label": "CPR:9"}]}
{"sentText": "The results showed that administration of AlCl3 resulted in a significant elevation in the levels of AchE activity CRP NF\u03baB and MCP1 accompanied with a significant depletion in the Ach level", "relationMentions": [{"em1Text": "AlCl3", "em2Text": "AchE", "label": "CPR:3"}, {"em1Text": "AlCl3", "em2Text": "CRP", "label": "CPR:3"}, {"em1Text": "AlCl3", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "AlCl3", "em2Text": "MCP1", "label": "CPR:3"}]}
{"sentText": "6DHSG was metabolised by GSH to form a GSH conjugate GS 6DHSG in RAW 2647 cells via a potential mechanism involving the catalytic activity of glutathioneStransferase GST", "relationMentions": [{"em1Text": "6DHSG", "em2Text": "glutathioneStransferase", "label": "CPR:9"}, {"em1Text": "6DHSG", "em2Text": "GST", "label": "CPR:9"}]}
{"sentText": "The concentration response to levcromakalim LEVC a KATP channel opener was significantly shifted to the left in the inflamed smoothmuscle cells", "relationMentions": [{"em1Text": "levcromakalim", "em2Text": "KATP channel", "label": "CPR:3"}, {"em1Text": "LEVC", "em2Text": "KATP channel", "label": "CPR:3"}]}
{"sentText": "Sulfhydration of sulfonylurea receptor 2B SUR2B was induced by NaHS and colonic inflammation", "relationMentions": [{"em1Text": "sulfonylurea receptor 2B", "em2Text": "NaHS", "label": "CPR:3"}, {"em1Text": "SUR2B", "em2Text": "NaHS", "label": "CPR:3"}]}
{"sentText": "Pharmacological treatment has been studied and it could be demonstrated that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as eg sotalol or ibutilide in patients with a mutation in the IKr coding gene KCNH2 HERG", "relationMentions": [{"em1Text": "sotalol", "em2Text": "IKr", "label": "CPR:4"}, {"em1Text": "sotalol", "em2Text": "KCNH2", "label": "CPR:4"}, {"em1Text": "sotalol", "em2Text": "HERG", "label": "CPR:4"}, {"em1Text": "ibutilide", "em2Text": "IKr", "label": "CPR:4"}, {"em1Text": "ibutilide", "em2Text": "KCNH2", "label": "CPR:4"}, {"em1Text": "ibutilide", "em2Text": "HERG", "label": "CPR:4"}]}
{"sentText": "Although inhibition of LH release can be achieved by estrogen and progestins an optimal inhibitory effect on the prostate is obtained by the combined administration of the antiandrogen with an LHRH agonist that causes a specific blockage of testicular androgen biosynthesis as well as an inhibition of the LH responsiveness to LHRH", "relationMentions": [{"em1Text": "LH", "em2Text": "estrogen", "label": "CPR:4"}, {"em1Text": "LH", "em2Text": "progestins", "label": "CPR:4"}]}
{"sentText": "Glycylsarcosine coadministration could inhibit the uptake of cefadroxil in PEPT2 mice p 001 but not PEPT2 mice", "relationMentions": [{"em1Text": "cefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}, {"em1Text": "cefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}]}
{"sentText": "Although a protonstimulated uptake of cefadroxil was demonstrated in PEPT2 mice pH 65 versus pH 74 p 001 no pH dependence was observed in PEPT2 mice", "relationMentions": [{"em1Text": "cefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}, {"em1Text": "cefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}]}
{"sentText": "Mechanisms of cefadroxil uptake in the choroid plexus studies in wildtype and PEPT2 knockout mice", "relationMentions": [{"em1Text": "cefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}]}
{"sentText": "These findings demonstrate that PEPT2 is the primary transporter responsible for cefadroxil uptake in the choroid plexus", "relationMentions": [{"em1Text": "PEPT2", "em2Text": "cefadroxil", "label": "CPR:9"}]}
{"sentText": "At normal pH 74 and temperature 37 degrees C the uptake of 1 microM cefadroxil was reduced by 83 in PEPT2 mice as compared with PEPT2 mice p 0001", "relationMentions": [{"em1Text": "cefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}, {"em1Text": "cefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}]}
{"sentText": "The choroid plexus uptake of 3Hcefadroxil was studied in peptide transporter 2 PEPT2 wildtype and null mice as a function of temperature transport inhibitors pH and saturability", "relationMentions": [{"em1Text": "3Hcefadroxil", "em2Text": "peptide transporter 2", "label": "CPR:9"}, {"em1Text": "3Hcefadroxil", "em2Text": "PEPT2", "label": "CPR:9"}]}
{"sentText": "In the IBMECA group \u03b1amylase activity was decreased with statistically high significance compared to group I", "relationMentions": [{"em1Text": "IBMECA", "em2Text": "\u03b1amylase", "label": "CPR:4"}]}
{"sentText": "The experiments were performed on 80 male Wistar rats 58 of which survived subdivided into 3 groups Ccontrol rats IEAP group and IIEAP group treated with the adenosine A3 receptor agonist IBMECA 1deoxy163iodophenyl methylamino9Hpurin9ylNmethylBDribofuronamide at a dose of 075 mgkg bw", "relationMentions": [{"em1Text": "adenosine A3 receptor", "em2Text": "IBMECA", "label": "CPR:5"}, {"em1Text": "adenosine A3 receptor", "em2Text": "1deoxy163iodophenyl methylamino9Hpurin9ylNmethylBDribofuronamide", "label": "CPR:5"}]}
{"sentText": "The effects of the adenosine A3 receptor agonist IBMECA on sodium taurocholateinduced experimental acute pancreatitis", "relationMentions": [{"em1Text": "adenosine A3 receptor", "em2Text": "IBMECA", "label": "CPR:5"}]}
{"sentText": "The use of A3 receptor agonist IBMECA attenuates EAP", "relationMentions": [{"em1Text": "A3 receptor", "em2Text": "IBMECA", "label": "CPR:5"}]}
{"sentText": "We describe the discovery of several pyrrolopyrazines as potent and selective Syk inhibitors and the efforts that eventually led to the desired improvements in physicochemical properties and human whole blood potencies", "relationMentions": [{"em1Text": "pyrrolopyrazines", "em2Text": "Syk", "label": "CPR:4"}]}
{"sentText": "Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors", "relationMentions": [{"em1Text": "Pyrrolopyrazines", "em2Text": "Spleen Tyrosine Kinase", "label": "CPR:4"}]}
{"sentText": "Ozone plus PM25 exposure however induced CRP IL6 CK LDH and MDA increase SOD and HRV decrease significantly in a doseresponse way", "relationMentions": [{"em1Text": "Ozone", "em2Text": "CRP", "label": "CPR:3"}, {"em1Text": "Ozone", "em2Text": "IL6", "label": "CPR:3"}, {"em1Text": "Ozone", "em2Text": "CK", "label": "CPR:3"}, {"em1Text": "Ozone", "em2Text": "LDH", "label": "CPR:3"}, {"em1Text": "Ozone", "em2Text": "SOD", "label": "CPR:4"}]}
{"sentText": "Flavopiridol a cyclindependent kinase inhibitor arrests cell division and causes apoptosis in nonsmall lung cancer cells 283660", "relationMentions": [{"em1Text": "Flavopiridol", "em2Text": "cyclindependent kinase", "label": "CPR:4"}]}
{"sentText": "In ex vivo experiments with tumor cells from refractory chronic lymphoblastic leukemia dosedependent CDK2 inhibition associated with apoptotic changes was seen at concentrations greater than 100 nM of flavopiridol", "relationMentions": [{"em1Text": "CDK2", "em2Text": "flavopiridol", "label": "CPR:4"}]}
{"sentText": "Flavopiridol inhibits CDK with an IC50 value of 04 mM 285707", "relationMentions": [{"em1Text": "Flavopiridol", "em2Text": "CDK", "label": "CPR:4"}]}
{"sentText": "Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes CA I and CA II of the same order of magnitude as the clinically used drugs acetazolamide and methazolamide", "relationMentions": [{"em1Text": "human CA", "em2Text": "methazolamide", "label": "CPR:4"}, {"em1Text": "CA I", "em2Text": "methazolamide", "label": "CPR:4"}, {"em1Text": "CA II", "em2Text": "methazolamide", "label": "CPR:4"}, {"em1Text": "human CA", "em2Text": "acetazolamide", "label": "CPR:4"}, {"em1Text": "CA I", "em2Text": "acetazolamide", "label": "CPR:4"}, {"em1Text": "CA II", "em2Text": "acetazolamide", "label": "CPR:4"}]}
{"sentText": "Carbonic anhydrase inhibitors aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity", "relationMentions": [{"em1Text": "Carbonic anhydrase", "em2Text": "aromatic and heterocyclic sulfonamides", "label": "CPR:4"}, {"em1Text": "Carbonic anhydrase", "em2Text": "adamantyl", "label": "CPR:4"}]}
{"sentText": "BACKGROUND AND AIMS Glutamic acid decarboxylase GAD EC 41115 catalyses the conversion of glutamate to gammaaminobutyric acid GABA", "relationMentions": [{"em1Text": "Glutamic acid decarboxylase", "em2Text": "glutamate", "label": "CPR:9"}, {"em1Text": "GAD", "em2Text": "glutamate", "label": "CPR:9"}, {"em1Text": "EC 41115", "em2Text": "glutamate", "label": "CPR:9"}, {"em1Text": "Glutamic acid decarboxylase", "em2Text": "gammaaminobutyric acid", "label": "CPR:9"}, {"em1Text": "GAD", "em2Text": "gammaaminobutyric acid", "label": "CPR:9"}, {"em1Text": "EC 41115", "em2Text": "gammaaminobutyric acid", "label": "CPR:9"}, {"em1Text": "Glutamic acid decarboxylase", "em2Text": "GABA", "label": "CPR:9"}, {"em1Text": "GAD", "em2Text": "GABA", "label": "CPR:9"}, {"em1Text": "EC 41115", "em2Text": "GABA", "label": "CPR:9"}]}
{"sentText": "FCEO significantly inhibited nitric oxide NO and prostaglandin E2 PGE2 by suppressing the protein expression of inducible nitric oxide synthase iNOS and cyclooxygenase COX2 respectively", "relationMentions": [{"em1Text": "nitric oxide", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "nitric oxide", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "prostaglandin E2", "em2Text": "cyclooxygenase COX2", "label": "CPR:4"}, {"em1Text": "PGE2", "em2Text": "cyclooxygenase COX2", "label": "CPR:4"}]}
{"sentText": "The selective PDE 4 inhibitors and to a certain extent the PDE3 inhibitors amrinone and milrinone reduced the GMCSF release in a concentration dependent manner", "relationMentions": [{"em1Text": "PDE 4", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "PDE3", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "milrinone", "em2Text": "GMCSF", "label": "CPR:4"}, {"em1Text": "PDE 4", "em2Text": "amrinone", "label": "CPR:4"}, {"em1Text": "PDE3", "em2Text": "amrinone", "label": "CPR:4"}, {"em1Text": "amrinone", "em2Text": "GMCSF", "label": "CPR:4"}]}
{"sentText": "Amrinone and milrinone selective PDE3 inhibitors suppressed TNF secretion to a lesser extent", "relationMentions": [{"em1Text": "Amrinone", "em2Text": "PDE3", "label": "CPR:4"}, {"em1Text": "Amrinone", "em2Text": "TNF", "label": "CPR:4"}, {"em1Text": "milrinone", "em2Text": "PDE3", "label": "CPR:4"}, {"em1Text": "milrinone", "em2Text": "TNF", "label": "CPR:4"}]}
{"sentText": "The effects of theophylline unspecific PDE inhibitor vinpocetine PDE1 inhibitor EHNA PDE2 inhibitor and the PDE5 inhibitors zaprinast and E 4021 were weak", "relationMentions": [{"em1Text": "theophylline", "em2Text": "PDE", "label": "CPR:4"}, {"em1Text": "vinpocetine", "em2Text": "PDE1", "label": "CPR:4"}, {"em1Text": "PDE5", "em2Text": "zaprinast", "label": "CPR:4"}, {"em1Text": "PDE5", "em2Text": "E 4021", "label": "CPR:4"}]}
{"sentText": "In human blood the tested glucocorticoids beclomethasone dexamethasone and fluticasone inhibited the LPS induced TNF release potently in a concentration dependent manner whereas in dispersed human nasal polyp cells the effect of the glucocorticoids on allergically induced TNF release with the exception of dexamethasone was much less pronounced", "relationMentions": [{"em1Text": "beclomethasone", "em2Text": "TNF", "label": "CPR:4"}, {"em1Text": "beclomethasone", "em2Text": "TNF", "label": "CPR:4"}, {"em1Text": "dexamethasone", "em2Text": "TNF", "label": "CPR:4"}, {"em1Text": "dexamethasone", "em2Text": "TNF", "label": "CPR:4"}, {"em1Text": "fluticasone", "em2Text": "TNF", "label": "CPR:4"}, {"em1Text": "fluticasone", "em2Text": "TNF", "label": "CPR:4"}]}
{"sentText": "Taken together our results suggested that Rg1 protected against A\u03b22535 induced apoptosis at least in part by two complementary GRdependent ERK phosphorylation pathways 1 downregulating HIF1\u03b1 initiated protein nitrotyrosination and 2 inhibiting mitochondrial apoptotic cascades", "relationMentions": [{"em1Text": "Rg1", "em2Text": "ERK", "label": "CPR:3"}, {"em1Text": "Rg1", "em2Text": "A\u03b22535", "label": "CPR:4"}, {"em1Text": "Rg1", "em2Text": "HIF1\u03b1", "label": "CPR:4"}]}
{"sentText": "Activating glucocorticoid receptor ERK signaling pathway contributes to ginsenoside Rg1 protection against \u03b2amyloid peptide induced human endothelial cells apoptosis", "relationMentions": [{"em1Text": "glucocorticoid receptor", "em2Text": "ginsenoside Rg1", "label": "CPR:3"}, {"em1Text": "ERK", "em2Text": "ginsenoside Rg1", "label": "CPR:3"}, {"em1Text": "ginsenoside Rg1", "em2Text": "\u03b2amyloid peptide", "label": "CPR:4"}]}
{"sentText": "These data provided a novel insight to the mechanisms of Rg1 protective effects on A\u03b22535 induced endothelial cells apoptosis suggesting that GRERK signaling pathway might play an important role in it", "relationMentions": [{"em1Text": "Rg1", "em2Text": "A\u03b22535", "label": "CPR:4"}]}
{"sentText": "Rg1 attenuated the A\u03b22535 associated mitochondrial apoptotic events accompanied by inhibiting HIF1\u03b1 expression followed by intracellular reactive nitrogen species generation and protein nitrotyrosination", "relationMentions": [{"em1Text": "Rg1", "em2Text": "A\u03b22535", "label": "CPR:4"}, {"em1Text": "Rg1", "em2Text": "HIF1\u03b1", "label": "CPR:4"}]}
{"sentText": "These protective effects were abolished by glucocorticoid receptor GR antagonist RU486 or pERK inhibitor U0126 rather than estrogen receptor \u03b1 antagonist ICI 82780", "relationMentions": [{"em1Text": "pERK", "em2Text": "U0126", "label": "CPR:4"}, {"em1Text": "estrogen receptor \u03b1", "em2Text": "ICI 82780", "label": "CPR:6"}, {"em1Text": "glucocorticoid receptor", "em2Text": "RU486", "label": "CPR:6"}, {"em1Text": "GR", "em2Text": "RU486", "label": "CPR:6"}]}
{"sentText": "On study day 1 candoxatril acutely increased plasma ANP levels suppressed aldosterone and decreased right atrial and pulmonary capillary wedge pressures", "relationMentions": [{"em1Text": "candoxatril", "em2Text": "ANP", "label": "CPR:3"}]}
{"sentText": "On study day 10 the acute effects of candoxatril were similar to those on day 1 ie ANP was further increased aldosterone was suppressed and right and left ventricular filling pressures were decreased", "relationMentions": [{"em1Text": "candoxatril", "em2Text": "ANP", "label": "CPR:3"}]}
{"sentText": "Candoxatril is a novel orally active inhibitor of neutral endopeptidase EC 342411 the enzyme that degrades atrial natriuretic peptide ANP", "relationMentions": [{"em1Text": "Candoxatril", "em2Text": "neutral endopeptidase", "label": "CPR:4"}, {"em1Text": "Candoxatril", "em2Text": "EC 342411", "label": "CPR:4"}]}
{"sentText": "Effectiveness of endopeptidase inhibition candoxatril in congestive heart failure", "relationMentions": [{"em1Text": "endopeptidase", "em2Text": "candoxatril", "label": "CPR:4"}]}
{"sentText": "Type 2 11\u03b2hydroxysteroid dehydrogenase encoded by the HSD11B2 gene converts cortisol to inactive cortisone and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids", "relationMentions": [{"em1Text": "Type 2 11\u03b2hydroxysteroid dehydrogenase", "em2Text": "cortisol", "label": "CPR:9"}, {"em1Text": "HSD11B2", "em2Text": "cortisol", "label": "CPR:9"}, {"em1Text": "Type 2 11\u03b2hydroxysteroid dehydrogenase", "em2Text": "cortisone", "label": "CPR:9"}, {"em1Text": "HSD11B2", "em2Text": "cortisone", "label": "CPR:9"}]}
{"sentText": "The alpha1adrenoceptor antagonist tamsulosin is selective for alpha1A and alpha1D over alpha1Badrenoceptors", "relationMentions": [{"em1Text": "alpha1adrenoceptor", "em2Text": "tamsulosin", "label": "CPR:6"}, {"em1Text": "tamsulosin", "em2Text": "alpha1A and alpha1D over alpha1Badrenoceptors", "label": "CPR:6"}]}
{"sentText": "The obtained results showed that pioglitazone improved the renal function structural changes renal malondialdehyde MDA tumor necrosis factor alpha TNF\u03b1 nuclear factor kappa B NF\u03baB genes expression in cisplatin injected rats", "relationMentions": [{"em1Text": "pioglitazone", "em2Text": "tumor necrosis factor alpha", "label": "CPR:3"}, {"em1Text": "pioglitazone", "em2Text": "TNF\u03b1", "label": "CPR:3"}, {"em1Text": "pioglitazone", "em2Text": "nuclear factor kappa B", "label": "CPR:3"}, {"em1Text": "pioglitazone", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "tumor necrosis factor alpha", "em2Text": "cisplatin", "label": "CPR:4"}, {"em1Text": "TNF\u03b1", "em2Text": "cisplatin", "label": "CPR:4"}, {"em1Text": "nuclear factor kappa B", "em2Text": "cisplatin", "label": "CPR:4"}, {"em1Text": "NF\u03baB", "em2Text": "cisplatin", "label": "CPR:4"}]}
{"sentText": "Combining in vivo and in vitro findings we identified nine AhR agonists six of which are marketed therapeutics and have been approved by the US Food and Drug Administration including leflunomide flutamide and nimodipine", "relationMentions": [{"em1Text": "AhR", "em2Text": "leflunomide", "label": "CPR:5"}, {"em1Text": "AhR", "em2Text": "flutamide", "label": "CPR:5"}, {"em1Text": "AhR", "em2Text": "nimodipine", "label": "CPR:5"}]}
{"sentText": "Cotreatment with U0126 and YC1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK12 JNK and betacatenin", "relationMentions": [{"em1Text": "U0126", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "YC1", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "sulindac", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "U0126", "em2Text": "betacatenin", "label": "CPR:4"}, {"em1Text": "YC1", "em2Text": "betacatenin", "label": "CPR:4"}, {"em1Text": "sulindac", "em2Text": "betacatenin", "label": "CPR:4"}]}
{"sentText": "Sulindac metabolites simultaneously a increase cellular cyclic GMP and subsequently activate cyclic GMPdependent protein kinase PKG b activate cjun NH2terminal kinase JNK c inhibit extracellular signalregulated kinase 12 ERK12 and d decrease betacatenin protein expression at times and doses consistent with apoptosis", "relationMentions": [{"em1Text": "Sulindac", "em2Text": "cyclic GMPdependent protein kinase", "label": "CPR:3"}, {"em1Text": "Sulindac", "em2Text": "PKG", "label": "CPR:3"}, {"em1Text": "Sulindac", "em2Text": "cjun NH2terminal kinase", "label": "CPR:4"}, {"em1Text": "Sulindac", "em2Text": "JNK", "label": "CPR:4"}, {"em1Text": "Sulindac", "em2Text": "betacatenin", "label": "CPR:4"}]}
{"sentText": "This work showed that appropriate structural modification of diphenidol can lead to M2 selective muscarinic antagonists of possible interest in the field of Alzheimers disease", "relationMentions": [{"em1Text": "diphenidol", "em2Text": "M2", "label": "CPR:6"}]}
{"sentText": "A series of 2carbonyl analogues of the muscarinic antagonist diphenidol bearing 1substituents of different lipophilic electronic and steric properties was synthesized and their affinity for the M2 and M3 muscarinic receptor subtypes was evaluated by functional tests", "relationMentions": [{"em1Text": "diphenidol", "em2Text": "M2 and M3 muscarinic receptor", "label": "CPR:6"}]}
{"sentText": "Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2carbonyl derivatives of diphenidol", "relationMentions": [{"em1Text": "muscarinic receptor", "em2Text": "diphenidol", "label": "CPR:6"}, {"em1Text": "muscarinic receptor", "em2Text": "2carbonyl", "label": "CPR:6"}]}
{"sentText": "In this study aldosterone ALD induced apoptosis of cardiomyocyte was evaluated based on the previous studies and the roles of calpain signaling were clarified", "relationMentions": [{"em1Text": "ALD", "em2Text": "calpain", "label": "CPR:3"}, {"em1Text": "aldosterone", "em2Text": "calpain", "label": "CPR:3"}]}
{"sentText": "ALD increased calpain expression and caspase3 activity and promoted Bid cleavage", "relationMentions": [{"em1Text": "ALD", "em2Text": "calpain", "label": "CPR:3"}, {"em1Text": "ALD", "em2Text": "caspase3", "label": "CPR:3"}]}
{"sentText": "Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and apoptosisinducing factor in aldosterone induced primary cultured cardiomyocytes", "relationMentions": [{"em1Text": "calpain", "em2Text": "aldosterone", "label": "CPR:3"}, {"em1Text": "apoptosisinducing factor", "em2Text": "aldosterone", "label": "CPR:3"}]}
{"sentText": "The upregulation of calpain tBid and caspase3 activity were further inhibited by treatment with EGTA in the presence of ALD", "relationMentions": [{"em1Text": "calpain", "em2Text": "ALD", "label": "CPR:3"}, {"em1Text": "tBid", "em2Text": "ALD", "label": "CPR:3"}, {"em1Text": "caspase3", "em2Text": "ALD", "label": "CPR:3"}, {"em1Text": "calpain", "em2Text": "EGTA", "label": "CPR:4"}, {"em1Text": "tBid", "em2Text": "EGTA", "label": "CPR:4"}, {"em1Text": "caspase3", "em2Text": "EGTA", "label": "CPR:4"}]}
{"sentText": "Furthermore treatment with spironoclactone not only attenuated the proapoptotic effect of ALD but reversed the ALDinduced increase of calpain and AIF levels", "relationMentions": [{"em1Text": "ALD", "em2Text": "calpain", "label": "CPR:3"}, {"em1Text": "ALD", "em2Text": "AIF", "label": "CPR:3"}, {"em1Text": "spironoclactone", "em2Text": "calpain", "label": "CPR:4"}, {"em1Text": "spironoclactone", "em2Text": "AIF", "label": "CPR:4"}]}
{"sentText": "Additionally AIF levels in the cytosol decreased due to EGTA but not due to calpeptin", "relationMentions": [{"em1Text": "AIF", "em2Text": "EGTA", "label": "CPR:4"}]}
{"sentText": "In all patients loperamide induced a significant fall in plasma ACTH levels", "relationMentions": [{"em1Text": "loperamide", "em2Text": "ACTH", "label": "CPR:4"}]}
{"sentText": "Loperamide is a peripheral opiate agonist able to inhibit ACTH secretion", "relationMentions": [{"em1Text": "Loperamide", "em2Text": "ACTH", "label": "CPR:4"}]}
{"sentText": "CRH caused a rise in plasma ACTH after both loperamide from 30 166 to a peak of 108 31 pmoll and placebo from 985 47 to 211 617 pmoll the interaction between treatments and time was significant and the first phase of CRH induced ACTH secretion was significantly lower after loperamide", "relationMentions": [{"em1Text": "CRH", "em2Text": "loperamide", "label": "CPR:4"}, {"em1Text": "ACTH", "em2Text": "loperamide", "label": "CPR:4"}]}
{"sentText": "CCl4 administration triggered inflammatory response in mice livers by activating nuclear factorkappaB NF\u03baB which coincided with the induction of tumor necrosis factoralpha TNF\u03b1 and cyclooxygenase2 COX2", "relationMentions": [{"em1Text": "CCl4", "em2Text": "nuclear factorkappaB", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "tumor necrosis factoralpha", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "TNF\u03b1", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "cyclooxygenase2", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "COX2", "label": "CPR:3"}]}
{"sentText": "CCl4 intoxication caused hepatic necrosis and increased serum ALT activity", "relationMentions": [{"em1Text": "CCl4", "em2Text": "ALT", "label": "CPR:3"}]}
{"sentText": "Furthermore RA significantly inhibited the CCl4 induced apoptosis which was evident from decreased cleavage of caspase3", "relationMentions": [{"em1Text": "CCl4", "em2Text": "caspase3", "label": "CPR:4"}]}
{"sentText": "These actions are consistent with a prejunctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve as confirmed by independent studies showing that zolmitriptan blocks elevations of calcitoningenerelated peptide in jugular venous blood during electrical stimulation of the trigeminal ganglion", "relationMentions": [{"em1Text": "zolmitriptan", "em2Text": "calcitoningenerelated peptide", "label": "CPR:4"}]}
{"sentText": "Zolmitriptan Zomig formerly 311C90 is a novel 5hydroxytryptamine 5HT1B1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura", "relationMentions": [{"em1Text": "311C90", "em2Text": "5hydroxytryptamine 5HT1B1D", "label": "CPR:5"}, {"em1Text": "Zolmitriptan", "em2Text": "5hydroxytryptamine 5HT1B1D", "label": "CPR:5"}, {"em1Text": "Zomig", "em2Text": "5hydroxytryptamine 5HT1B1D", "label": "CPR:5"}]}
{"sentText": "Preclinical pharmacology of zolmitriptan Zomig formerly 311C90 a centrally and peripherally acting 5HT1B1D agonist for migraine", "relationMentions": [{"em1Text": "zolmitriptan", "em2Text": "5HT1B1D", "label": "CPR:5"}, {"em1Text": "Zomig", "em2Text": "5HT1B1D", "label": "CPR:5"}, {"em1Text": "311C90", "em2Text": "5HT1B1D", "label": "CPR:5"}]}
{"sentText": "It has been reported that oligomeric procyanidins of lotus seedpod LSOPC is effective in the alleviation of Alzheimers disease and diabetes through its antioxidant and insulin potentiating activities", "relationMentions": [{"em1Text": "procyanidins", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "They all expressed ASS but not ornithine transcarbamylase OTC the enzyme that converts ornithine the product of degradation of arginine with rhArg to citrulline which is converted back to arginine via ASS", "relationMentions": [{"em1Text": "ornithine", "em2Text": "ornithine transcarbamylase", "label": "CPR:9"}, {"em1Text": "ornithine", "em2Text": "OTC", "label": "CPR:9"}, {"em1Text": "arginine", "em2Text": "rhArg", "label": "CPR:9"}, {"em1Text": "rhArg", "em2Text": "citrulline", "label": "CPR:9"}, {"em1Text": "ASS", "em2Text": "arginine", "label": "CPR:9"}]}
{"sentText": "This surprising correlation between the lack of OTC expression and sensitivity of ASSpositive HCC cells shows that OTCdeficient HCCs are sensitive to rhArg mediated arginine depletion", "relationMentions": [{"em1Text": "rhArg", "em2Text": "arginine", "label": "CPR:9"}]}
{"sentText": "Therefore pretreatment tumor gene expression profiling of ASS and OTC could aid in predicting tumor response to arginine depletion with argininedepleting enzymes", "relationMentions": [{"em1Text": "arginine", "em2Text": "argininedepleting enzymes", "label": "CPR:9"}]}
{"sentText": "cfos expression was induced in urethaneanaesthetized rats by intracisternal capsaicin administration", "relationMentions": [{"em1Text": "cfos", "em2Text": "capsaicin", "label": "CPR:3"}]}
{"sentText": "Sumatriptan and LY 344864 decreased the number of capsaicin induced cfos like immunoreactive cells within trigeminal nucleus caudalis ID50 = 004 and 06 mg kg1", "relationMentions": [{"em1Text": "capsaicin", "em2Text": "cfos", "label": "CPR:3"}, {"em1Text": "Sumatriptan", "em2Text": "cfos", "label": "CPR:4"}, {"em1Text": "LY 344864", "em2Text": "cfos", "label": "CPR:4"}]}
{"sentText": "To establish the relative importance of these subtypes we compared the effects of sumatriptan with those of a selective 5HT1F receptor agonist LY 344864 on cfos protein expression in the trigeminal nucleus caudalis", "relationMentions": [{"em1Text": "5HT1F", "em2Text": "LY 344864", "label": "CPR:5"}]}
{"sentText": "The effect of sumatriptan but not of LY 344864 was prevented by pretreatment with the antagonist SDZ 21009 which displays high affinity for rat 5HT1B receptors", "relationMentions": [{"em1Text": "SDZ 21009", "em2Text": "rat 5HT1B", "label": "CPR:6"}]}
{"sentText": "In addition to this evidence for the involvement of EP2 receptors evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of NaKATPase beta subunit gene transcription includes the stimulatory effect of 17phenyl trinor PGE2 as well as the inhibitory effects of SC51089", "relationMentions": [{"em1Text": "PGE1", "em2Text": "NaKATPase beta", "label": "CPR:3"}, {"em1Text": "NaKATPase beta", "em2Text": "17phenyl trinor PGE2", "label": "CPR:3"}, {"em1Text": "NaKATPase beta", "em2Text": "SC51089", "label": "CPR:4"}]}
{"sentText": "Also consistent with the involvement of Gq coupled EP1 receptors the PGE1 stimulation is inhibited by the PKCI vector encoding the PKC inhibitory domain the PKC inhibitor Go 6976 thapsigargin as well as the calmodulin antagonists W7 and W13", "relationMentions": [{"em1Text": "PKC", "em2Text": "thapsigargin", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "Go 6976", "label": "CPR:4"}, {"em1Text": "calmodulin", "em2Text": "W7", "label": "CPR:6"}, {"em1Text": "calmodulin", "em2Text": "W13", "label": "CPR:6"}]}
{"sentText": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17phenyl trinor PGE2 and the EP2 selective agonist butaprost which stimulate as well as by studies with the antagonists SC51089 EP1 specific and AH 6809 EP1 and EP2 specific", "relationMentions": [{"em1Text": "EP1", "em2Text": "17phenyl trinor PGE2", "label": "CPR:5"}, {"em1Text": "EP1", "em2Text": "17phenyl trinor PGE2", "label": "CPR:5"}, {"em1Text": "EP2 receptors", "em2Text": "butaprost", "label": "CPR:5"}, {"em1Text": "EP2", "em2Text": "butaprost", "label": "CPR:5"}, {"em1Text": "EP1", "em2Text": "SC51089", "label": "CPR:5"}, {"em1Text": "EP1", "em2Text": "SC51089", "label": "CPR:5"}, {"em1Text": "EP1", "em2Text": "SC51089", "label": "CPR:5"}, {"em1Text": "EP1", "em2Text": "AH 6809", "label": "CPR:5"}, {"em1Text": "EP2 receptors", "em2Text": "AH 6809", "label": "CPR:5"}, {"em1Text": "EP1", "em2Text": "AH 6809", "label": "CPR:5"}, {"em1Text": "EP2", "em2Text": "AH 6809", "label": "CPR:5"}, {"em1Text": "EP1", "em2Text": "AH 6809", "label": "CPR:6"}, {"em1Text": "EP2", "em2Text": "AH 6809", "label": "CPR:6"}]}
{"sentText": "Spiro heterocycles as potential inhibitors of SIRT1 PdCmediated synthesis of novel Nindolylmethyl spiroindoline32quinazolines", "relationMentions": [{"em1Text": "SIRT1", "em2Text": "Nindolylmethyl spiroindoline32quinazolines", "label": "CPR:4"}]}
{"sentText": "Novel Nindolylmethyl substituted spiroindoline32quinazolines were designed as potential inhibitiors of SIRT1", "relationMentions": [{"em1Text": "Nindolylmethyl substituted spiroindoline32quinazolines", "em2Text": "SIRT1", "label": "CPR:4"}]}
{"sentText": "Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors prostaglandins E2 and D2", "relationMentions": [{"em1Text": "Cyclopentenone prostaglandins", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "iNOS", "em2Text": "prostaglandins E2 and D2", "label": "CPR:4"}]}
{"sentText": "In activated microglia 15dPGJ2 suppressed iNOS promoter activity iNOS mRNA and protein levels", "relationMentions": [{"em1Text": "15dPGJ2", "em2Text": "iNOS promoter", "label": "CPR:4"}, {"em1Text": "15dPGJ2", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "Cyclopentenone prostaglandins suppress activation of microglia downregulation of inducible nitricoxide synthase by 15deoxyDelta1214prostaglandin J2", "relationMentions": [{"em1Text": "Cyclopentenone prostaglandins", "em2Text": "inducible nitricoxide synthase", "label": "CPR:4"}, {"em1Text": "inducible nitricoxide synthase", "em2Text": "15deoxyDelta1214prostaglandin J2", "label": "CPR:4"}]}
{"sentText": "15dPGJ2 did not block nuclear translocation or DNAbinding activity of the transcription factor NFkappaB but it did inhibit the activity of an NFkappaB reporter construct suggesting that the mechanism of suppression of microglial iNOS by 15dPGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus", "relationMentions": [{"em1Text": "15dPGJ2", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "15dPGJ2", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "The activation may be accelerated by an acute inflammatory process provoked by oleate which is supported by such clinical manifestations as mild fever retrosternal pain leukocytosis and an increase in plasma fibrinogen level which was observed in all during the period", "relationMentions": [{"em1Text": "oleate", "em2Text": "fibrinogen", "label": "CPR:3"}]}
{"sentText": "In vitro studies however revealed that EO inhibits fibrin clot formation because of the Ca2chelating ability of its constituent ethanolamine although oleate or benzyl alcohol exhibited procoagulant activity in FPA formation in vitro", "relationMentions": [{"em1Text": "EO", "em2Text": "fibrin", "label": "CPR:4"}]}
{"sentText": "OBJECTIVE Celecoxib and rofecoxib are two relatively new nonsteroidal antiinflammatory drugs NSAIDs that selectively inhibit the cyclooxygenase2 COX2 isoenzyme at therapeutic concentrations", "relationMentions": [{"em1Text": "rofecoxib", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "rofecoxib", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "Celecoxib", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "Celecoxib", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "This study was conducted in order to understand the association between acute renal failure and the two COX2 inhibitors celecoxib and rofecoxib", "relationMentions": [{"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}]}
{"sentText": "Tamsulosin tamsulosin SL 890591 Rec 152739 SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenalinemediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned human alpha 1D adrenoceptors", "relationMentions": [{"em1Text": "Tamsulosin", "em2Text": "human alpha 1D adrenoceptors", "label": "CPR:6"}, {"em1Text": "tamsulosin", "em2Text": "human alpha 1D adrenoceptors", "label": "CPR:6"}, {"em1Text": "SL 890591", "em2Text": "human alpha 1D adrenoceptors", "label": "CPR:6"}, {"em1Text": "Rec 152739", "em2Text": "human alpha 1D adrenoceptors", "label": "CPR:6"}, {"em1Text": "SNAP 1069", "em2Text": "human alpha 1D adrenoceptors", "label": "CPR:6"}, {"em1Text": "RS 17053", "em2Text": "human alpha 1D adrenoceptors", "label": "CPR:6"}]}
{"sentText": "The potency of the antipsychotic drug risperidone to antagonize alpha 1Aadrenoceptor mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney and alpha 1Badrenoceptor mediated contractions in spleen from guineapig and mouse was evaluated and compared to that of alpha 1adrenoceptor subtypediscriminating antagonists", "relationMentions": [{"em1Text": "risperidone", "em2Text": "alpha 1Badrenoceptor", "label": "CPR:6"}, {"em1Text": "risperidone", "em2Text": "alpha 1adrenoceptor", "label": "CPR:6"}, {"em1Text": "risperidone", "em2Text": "alpha 1Aadrenoceptor", "label": "CPR:6"}]}
{"sentText": "In this article the action of dasatinib BMS354825 is contrasted with that of imatinib a kinase inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders", "relationMentions": [{"em1Text": "dasatinib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "The work of Chen and colleagues shows that dasatinib is a particularly potent inhibitor of PDGFR and that the compound also targets Src kinase", "relationMentions": [{"em1Text": "dasatinib", "em2Text": "PDGFR", "label": "CPR:4"}, {"em1Text": "dasatinib", "em2Text": "Src kinase", "label": "CPR:4"}]}
{"sentText": "In another experiment cyanopindolol an antagonist of the serotonin terminal autoreceptor also prolonged the clearance of 5HT from the CA3 region", "relationMentions": [{"em1Text": "cyanopindolol", "em2Text": "serotonin terminal autoreceptor", "label": "CPR:6"}]}
{"sentText": "From these data it is inferred that both the SERT and NET contribute to the active clearance of exogenously applied 5HT in the dentate gyrus", "relationMentions": [{"em1Text": "SERT", "em2Text": "5HT", "label": "CPR:9"}, {"em1Text": "NET", "em2Text": "5HT", "label": "CPR:9"}]}
{"sentText": "These and other data have generated a working hypothesis that activation of the terminal serotonin autoreceptor enhances the kinetics of 5HT uptake through an effect on the serotonin transporter", "relationMentions": [{"em1Text": "5HT", "em2Text": "serotonin transporter", "label": "CPR:9"}, {"em1Text": "serotonin autoreceptor", "em2Text": "5HT", "label": "CPR:9"}]}
{"sentText": "The antiamnesic effect of minaprine on the cycloheximideinduced memory impairment was also antagonized by a serotonin 5HT releaser pchloroamphetamine and by a 5HT precursor 5hydroxytryptophan whereas a 5HT1A selective agonist 8hydroxy2dinpropylaminotetralin was inactive", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "8hydroxy2dinpropylaminotetralin", "label": "CPR:5"}]}
{"sentText": "The memoryimproving effect of minaprine on cycloheximideinduced amnesia was potentiated by a selective 5HT2 antagonist ritanserin", "relationMentions": [{"em1Text": "5HT2", "em2Text": "ritanserin", "label": "CPR:6"}]}
{"sentText": "Even though the activities of MAT and GNMT were elevated the concentration of liver Sadenosylmethionine was decreased 24 p0001 and Sadenosylhomocysteine increased 113 p0001 in the dwarf mice", "relationMentions": [{"em1Text": "MAT", "em2Text": "Sadenosylmethionine", "label": "CPR:9"}, {"em1Text": "GNMT", "em2Text": "Sadenosylmethionine", "label": "CPR:9"}, {"em1Text": "MAT", "em2Text": "Sadenosylhomocysteine", "label": "CPR:9"}, {"em1Text": "GNMT", "em2Text": "Sadenosylhomocysteine", "label": "CPR:9"}]}
{"sentText": "Activation of alpha 2Badrenoceptors mediates the cardiovascular effects of etomidate", "relationMentions": [{"em1Text": "alpha 2Badrenoceptors", "em2Text": "etomidate", "label": "CPR:3"}]}
{"sentText": "In alpha2Breceptorexpressing HEK293 cells etomidate rapidly increased phosphorylation of the extracellular signalrelated kinases ERK12", "relationMentions": [{"em1Text": "etomidate", "em2Text": "extracellular signalrelated kinases", "label": "CPR:3"}, {"em1Text": "etomidate", "em2Text": "ERK12", "label": "CPR:3"}]}
{"sentText": "METHODS Sedative and cardiovascular responses to etomidate and the alpha2agonist dexmedetomidine were determined in mice deficient in alpha2receptor subtypes", "relationMentions": [{"em1Text": "dexmedetomidine", "em2Text": "alpha2receptor", "label": "CPR:5"}]}
{"sentText": "BACKGROUND The intravenous anesthetic etomidate exhibits structural similarities to specific alpha2adrenoceptor agonists of the type such as dexmedetomidine", "relationMentions": [{"em1Text": "alpha2adrenoceptor", "em2Text": "dexmedetomidine", "label": "CPR:5"}]}
{"sentText": "CONCLUSIONS These results indicate that etomidate acts as an agonist at alpha2adrenoceptors which appears in vivo primarily as an alpha2Breceptormediated increase in blood pressure", "relationMentions": [{"em1Text": "etomidate", "em2Text": "alpha2adrenoceptors", "label": "CPR:5"}]}
{"sentText": "Inhibition of binding of the alpha2receptor antagonist 3HRX821002 to recombinant alpha2receptors by etomidate was tested in human embryonic kidney HEK293 cells in vitro", "relationMentions": [{"em1Text": "alpha2receptor", "em2Text": "3HRX821002", "label": "CPR:6"}, {"em1Text": "3HRX821002", "em2Text": "alpha2receptors", "label": "CPR:6"}]}
{"sentText": "In membranes from HEK293 cells transfected with alpha2receptors etomidate inhibited binding of the alpha2antagonist 3HRX821002 with higher potency from alpha2B and alpha2Creceptors than from alpha2Areceptors Ki alpha2A 208 microm alpha2B 26 microm alpha2C 56 microm", "relationMentions": [{"em1Text": "alpha2receptors", "em2Text": "3HRX821002", "label": "CPR:6"}, {"em1Text": "3HRX821002", "em2Text": "alpha2Areceptors", "label": "CPR:6"}]}
{"sentText": "Quantitative realtime polymerase chain reaction analysis showed that following the exposure of cells to SiO2 NPs the messenger RNA level of apoptotic genes caspase3 and caspase9 were upregulated in a dosedependent manner", "relationMentions": [{"em1Text": "SiO2", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "SiO2", "em2Text": "caspase9", "label": "CPR:3"}]}
{"sentText": "Moreover activities of caspase3 and caspase9 enzymes were also significantly higher in both kinds of cells exposed to SiO2 NPs", "relationMentions": [{"em1Text": "caspase3", "em2Text": "SiO2", "label": "CPR:3"}, {"em1Text": "caspase9", "em2Text": "SiO2", "label": "CPR:3"}]}
{"sentText": "ThioTEPA CYP2B6 inhibitor 25 \u03bcM and the monoclonal antibody against CYP2B6 but not troleandomycin CYP3A4 inhibitor 25 \u03bcM or the monoclonal antibody against CYP3A4 inhibited ketamine Ndemethylation at clinically relevant concentrations", "relationMentions": [{"em1Text": "ThioTEPA", "em2Text": "CYP2B6", "label": "CPR:4"}, {"em1Text": "troleandomycin", "em2Text": "CYP3A4", "label": "CPR:4"}]}
{"sentText": "The intrinsic clearance for both ketamine enantiomers by the high affinity enzyme in HLMs with CYP2B61 1 genotype were at least 2fold and 6fold higher respectively than those for CYP2B616 genotype and CYP2B666 genotype", "relationMentions": [{"em1Text": "ketamine", "em2Text": "CYP2B61", "label": "CPR:9"}]}
{"sentText": "The CYP2B66 Allele Significantly Alters the Ndemethylation of Ketamine Enantiomers In Vitro", "relationMentions": [{"em1Text": "CYP2B66", "em2Text": "Ketamine", "label": "CPR:9"}]}
{"sentText": "Ketamine is primarily metabolized to norketamine by hepatic cytochrome P450 CYP 2B6 and CYP3A4 mediated Ndemethylation", "relationMentions": [{"em1Text": "Ketamine", "em2Text": "cytochrome P450 CYP 2B6", "label": "CPR:9"}, {"em1Text": "Ketamine", "em2Text": "CYP3A4", "label": "CPR:9"}]}
{"sentText": "These results indicate a major role of CYP2B6 in ketamine Ndemethylation in vitro and a significant impact of the CYP2B66 allele on enzyme ketamine binding and catalytic activity", "relationMentions": [{"em1Text": "CYP2B6", "em2Text": "ketamine", "label": "CPR:9"}, {"em1Text": "ketamine", "em2Text": "CYP2B66", "label": "CPR:9"}]}
{"sentText": "The CYP2B66 allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in ketamine metabolism", "relationMentions": [{"em1Text": "CYP2B66", "em2Text": "ketamine", "label": "CPR:9"}]}
{"sentText": "We examined the Ndemethylation of individual ketamine enantiomers using human liver microsomes HLMs genotyped for the CYP2B66 allele insect cell expressed recombinant CYP2B6 and CYP3A4 enzymes and COS1 cell expressed recombinant CYP2B61 and CYP2B66 protein variant", "relationMentions": [{"em1Text": "ketamine", "em2Text": "CYP2B66", "label": "CPR:9"}]}
{"sentText": "PURPOSE Testosteronetoestradiol ratio levels in infertile men improve during treatment with the aromatase inhibitor testolactone and resulting changes in semen parameters", "relationMentions": [{"em1Text": "aromatase", "em2Text": "testolactone", "label": "CPR:4"}]}
{"sentText": "We evaluated the effect of anastrozole a more selective aromatase inhibitor on the hormonal and semen profiles of infertile men with abnormal baseline testosteronetoestradiol ratios", "relationMentions": [{"em1Text": "anastrozole", "em2Text": "aromatase", "label": "CPR:4"}]}
{"sentText": "The results show that CYP2E1 inhibits CYP2B4 mediated metabolism of benzphetamine BNZ with a Ki of 004 \u00b5M", "relationMentions": [{"em1Text": "CYP2B4", "em2Text": "benzphetamine", "label": "CPR:9"}, {"em1Text": "CYP2B4", "em2Text": "BNZ", "label": "CPR:9"}]}
{"sentText": "However CYP2B4 is not an inhibitor of CYP2E1 mediated pnitrophenol hydroxylation", "relationMentions": [{"em1Text": "CYP2E1", "em2Text": "pnitrophenol", "label": "CPR:9"}]}
{"sentText": "To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of PSMA a series of phenylalkylphosphonamidate derivatives of glutamic acid were synthesized and evaluated for their inhibitory potencies against PSMA", "relationMentions": [{"em1Text": "PSMA", "em2Text": "phenylalkylphosphonamidate", "label": "CPR:4"}, {"em1Text": "PSMA", "em2Text": "glutamic acid", "label": "CPR:4"}]}
{"sentText": "In PFC DEX caused activation of AKT augmentation of prosurvival Bcl2 protein and enhanced Bcl2 Bax protein ratio as well Bcl2 translocation to mitochondria", "relationMentions": [{"em1Text": "DEX", "em2Text": "AKT", "label": "CPR:3"}, {"em1Text": "DEX", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "DEX", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "DEX", "em2Text": "Bax", "label": "CPR:3"}]}
{"sentText": "Results of RTPCR analysis showed decrease of p53 mRNA level and no significant difference in Bcl2 and Bax mRNA expressions in DEX treated rats", "relationMentions": [{"em1Text": "p53", "em2Text": "DEX", "label": "CPR:4"}]}
{"sentText": "Antitumor activity of sorafenib in FLT3 driven leukemic cells", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "The demonstration that sorafenib exhibits potent target inhibition and efficacy in FLT3driven models suggests that this compound may have a therapeutic benefit for patients with FLT3 driven leukemias", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "We show that sorafenib BAY 439006 Nexavar potently inhibits FLT3 enzymatic and signaling activities", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "FLT3", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "In HEK293 cells stably transfected with FLT3 WT or FLT3 ITD sorafenib blocked basal and ligand dependent FLT3 mediated tyrosine autophosphorylation as well as extracellular signalregulated kinase12 and Stat5 phosphorylation", "relationMentions": [{"em1Text": "FLT3", "em2Text": "sorafenib", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "extracellular signalregulated kinase12", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "Stat5", "label": "CPR:4"}]}
{"sentText": "In leukemia cell lines MV411 and EOL1 sorafenib treatment resulted in decreased cell proliferation and inhibition of FLT3 signaling", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "The growth of the FLT3 independent RS411 cell line was only weakly inhibited by sorafenib", "relationMentions": [{"em1Text": "FLT3", "em2Text": "sorafenib", "label": "CPR:4"}]}
{"sentText": "DBDCT upregulated the expression of Bax downregulated the expression of Bcl2 and significantly increased the ratio of BaxBcl2", "relationMentions": [{"em1Text": "DBDCT", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "DBDCT", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "DBDCT", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "DBDCT", "em2Text": "Bcl2", "label": "CPR:4"}]}
{"sentText": "DBDCT also caused the phosphorylation of JNK and p38 MAPK", "relationMentions": [{"em1Text": "DBDCT", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "DBDCT", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "DBDCT", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "Aliskiren represents the first in a novel class of renin inhibitors with the potential for treatment of hypertension and related cardiovascular diseases", "relationMentions": [{"em1Text": "Aliskiren", "em2Text": "renin", "label": "CPR:4"}]}
{"sentText": "This led to the discovery of aliskiren a highly potent and selective inhibitor of human renin in vitro and in vivo oncedaily oral doses of aliskiren inhibit renin and lower blood pressure in sodiumdepleted marmosets and hypertensive human patients", "relationMentions": [{"em1Text": "aliskiren", "em2Text": "human renin", "label": "CPR:4"}, {"em1Text": "aliskiren", "em2Text": "renin", "label": "CPR:4"}]}
{"sentText": "Structurebased design of aliskiren a novel orally effective renin inhibitor", "relationMentions": [{"em1Text": "aliskiren", "em2Text": "renin", "label": "CPR:4"}]}
{"sentText": "A phase III randomized placebocontrolled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib andor sorafenib", "relationMentions": [{"em1Text": "VEGFR", "em2Text": "sorafenib", "label": "CPR:4"}, {"em1Text": "tyrosine kinase", "em2Text": "sorafenib", "label": "CPR:4"}, {"em1Text": "VEGFR", "em2Text": "sunitinib", "label": "CPR:4"}, {"em1Text": "tyrosine kinase", "em2Text": "sunitinib", "label": "CPR:4"}]}
{"sentText": "Everolimus RAD001 AfinitorR Novartis is the first oral inhibitor of mTOR mammalian target of rapamycin to reach the oncology clinic", "relationMentions": [{"em1Text": "Everolimus", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "Everolimus", "em2Text": "mammalian target of rapamycin", "label": "CPR:4"}, {"em1Text": "RAD001", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "RAD001", "em2Text": "mammalian target of rapamycin", "label": "CPR:4"}, {"em1Text": "AfinitorR Novartis", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "AfinitorR Novartis", "em2Text": "mammalian target of rapamycin", "label": "CPR:4"}]}
{"sentText": "Synthesis and structureactivity relationship of pyripyropene A derivatives as potent and selective acylCoAcholesterol acyltransferase 2 ACAT2 inhibitors Part 2", "relationMentions": [{"em1Text": "pyripyropene A", "em2Text": "acylCoAcholesterol acyltransferase 2", "label": "CPR:4"}, {"em1Text": "pyripyropene A", "em2Text": "ACAT2", "label": "CPR:4"}]}
{"sentText": "These Gproteins are likely to be involved in the adrenalineinduced inhibition of dihydropyridinesensitive Ca2 currents and in other signal transduction pathways contributing to the adrenaline induced inhibition of insulin secretion", "relationMentions": [{"em1Text": "adrenaline", "em2Text": "insulin", "label": "CPR:4"}]}
{"sentText": "Somatostatin which also inhibits insulin secretion was less efficient inhibition by 20", "relationMentions": [{"em1Text": "Somatostatin", "em2Text": "insulin", "label": "CPR:4"}]}
{"sentText": "Adrenaline inhibits insulin secretion via pertussis toxinsensitive mechanisms", "relationMentions": [{"em1Text": "Adrenaline", "em2Text": "insulin", "label": "CPR:4"}]}
{"sentText": "In contrast to adrenaline and somatostatin galanin another inhibitor of insulin secretion reduced Ca2 currents by about 40 in a pertussis toxininsensitive manner", "relationMentions": [{"em1Text": "adrenaline", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "somatostatin", "em2Text": "insulin", "label": "CPR:4"}]}
{"sentText": "Synthesis and in Vitro Characterisation of Ifenprodil Based Fluorescein Conjugates as GluN1 GluN2B NMethylDaspartate Receptor Antagonists", "relationMentions": [{"em1Text": "Ifenprodil", "em2Text": "GluN1", "label": "CPR:6"}, {"em1Text": "Ifenprodil", "em2Text": "GluN2B", "label": "CPR:6"}, {"em1Text": "Ifenprodil", "em2Text": "NMethylDaspartate Receptor", "label": "CPR:6"}, {"em1Text": "Fluorescein", "em2Text": "GluN1", "label": "CPR:6"}, {"em1Text": "Fluorescein", "em2Text": "GluN2B", "label": "CPR:6"}, {"em1Text": "Fluorescein", "em2Text": "NMethylDaspartate Receptor", "label": "CPR:6"}]}
{"sentText": "Ifenprodil known as the GluNR2B antagonist of reference was chosen as the template for the elaboration of probes", "relationMentions": [{"em1Text": "Ifenprodil", "em2Text": "GluNR2B", "label": "CPR:6"}]}
{"sentText": "Interestingly a Val349 to Ile mutant was inhibited with equal potency to human COX2 with 26dichloro 26dimethyl or 2chloro6methyl substituted inhibitors and in the case of lumiracoxib actually showed an increase in potency", "relationMentions": [{"em1Text": "Val349 to Ile", "em2Text": "26dichloro", "label": "CPR:4"}, {"em1Text": "human COX2", "em2Text": "26dichloro", "label": "CPR:4"}, {"em1Text": "Val349 to Ile", "em2Text": "26dimethyl", "label": "CPR:4"}, {"em1Text": "human COX2", "em2Text": "26dimethyl", "label": "CPR:4"}, {"em1Text": "Val349 to Ile", "em2Text": "2chloro6methyl", "label": "CPR:4"}, {"em1Text": "human COX2", "em2Text": "2chloro6methyl", "label": "CPR:4"}, {"em1Text": "Val349 to Ile", "em2Text": "lumiracoxib", "label": "CPR:4"}, {"em1Text": "human COX2", "em2Text": "lumiracoxib", "label": "CPR:4"}]}
{"sentText": "Taken together with a recent crystal structure of a lumiracoxibCOX2 complex the kinetic analyses presented herein of the inhibition of mutant COX2s by lumiracoxib allows the definition of the molecular basis of COX2 inhibition", "relationMentions": [{"em1Text": "lumiracoxib", "em2Text": "COX2s", "label": "CPR:4"}]}
{"sentText": "Using standard assays lumiracoxib was found to be a poor inhibitor of purified ovine COX1 and a relatively weak inhibitor of purified human COX2", "relationMentions": [{"em1Text": "lumiracoxib", "em2Text": "ovine COX1", "label": "CPR:4"}, {"em1Text": "lumiracoxib", "em2Text": "human COX2", "label": "CPR:4"}]}
{"sentText": "Kinetic studies with lumiracoxib demonstrated that it was a timedependent and slowly reversible inhibitor of human COX2 that exhibited at least two binding steps during inhibition", "relationMentions": [{"em1Text": "lumiracoxib", "em2Text": "human COX2", "label": "CPR:4"}]}
{"sentText": "Lumiracoxib is the first example of a marketed COX2 inhibitor of the arylacetic acid class and it is reported to be the most selective COXIB in vivo", "relationMentions": [{"em1Text": "COX2", "em2Text": "arylacetic acid", "label": "CPR:4"}, {"em1Text": "Lumiracoxib", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Inhibition studies demonstrated that the methyl group on the phenylacetic acid ring is required for COX2 selectivity", "relationMentions": [{"em1Text": "methyl", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "phenylacetic acid", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Molecular determinants for the selective inhibition of cyclooxygenase2 by lumiracoxib", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "lumiracoxib", "label": "CPR:4"}]}
{"sentText": "The chemical identity and position of the substituents on the lower aniline ring were important in determining the potency and extent of COX inhibition as well as COX2 selectivity", "relationMentions": [{"em1Text": "aniline", "em2Text": "COX", "label": "CPR:4"}]}
{"sentText": "Mutation of Ser530 to Ala or Val349 to Ala or Leu abolished the potent inhibition observed with wildtype human COX2 and key lumiracoxib analogs", "relationMentions": [{"em1Text": "human COX2", "em2Text": "lumiracoxib", "label": "CPR:4"}]}
{"sentText": "Moreover kinetic analysis revealed that inhibition by reserpine a typical VMAT2 inhibitor was uncompetitive decreasing maximum velocity and affinity for dopamine", "relationMentions": [{"em1Text": "reserpine", "em2Text": "VMAT2", "label": "CPR:4"}, {"em1Text": "VMAT2", "em2Text": "dopamine", "label": "CPR:9"}]}
{"sentText": "These results suggest that fluoxetine inhibited the activity of VMAT2 by a mechanism different from that of reserpine and did not directly interact with the active site of VMAT2", "relationMentions": [{"em1Text": "VMAT2", "em2Text": "reserpine", "label": "CPR:4"}, {"em1Text": "fluoxetine", "em2Text": "VMAT2", "label": "CPR:4"}, {"em1Text": "fluoxetine", "em2Text": "VMAT2", "label": "CPR:4"}]}
{"sentText": "The present study examined the effect of antidepressants such as selective serotonin reuptake inhibitors SSRIs on VMAT2 activity by measuring adenosine triphosphatedependent 3Hdopamine uptake into synaptic vesicles prepared from rat striatum", "relationMentions": [{"em1Text": "VMAT2", "em2Text": "3Hdopamine", "label": "CPR:9"}]}
{"sentText": "In this study we examined whether betaxolol and other betaadrenoceptor antagonists interact directly with neurotoxin binding to sites 1 and 2 of the voltagesensitive sodium channel Na channel in rat cerebrocortical synaptosomes", "relationMentions": [{"em1Text": "betaxolol", "em2Text": "betaadrenoceptor", "label": "CPR:6"}]}
{"sentText": "Betaxolol a beta1adrenoceptor antagonist used for the treatment of glaucoma is known to be neuroprotective in paradigms of ischaemiaexcitotoxicity", "relationMentions": [{"em1Text": "Betaxolol", "em2Text": "beta1adrenoceptor", "label": "CPR:6"}]}
{"sentText": "Comparison of all the betaadrenoceptor antagonists tested revealed a potency order of propranolol betaxolol approximately levo betaxolol levobunolol approximately carteolol = timolol atenolol", "relationMentions": [{"em1Text": "betaadrenoceptor", "em2Text": "propranolol", "label": "CPR:6"}, {"em1Text": "betaadrenoceptor", "em2Text": "betaxolol", "label": "CPR:6"}, {"em1Text": "betaadrenoceptor", "em2Text": "levobunolol", "label": "CPR:6"}, {"em1Text": "betaadrenoceptor", "em2Text": "carteolol", "label": "CPR:6"}, {"em1Text": "betaadrenoceptor", "em2Text": "timolol", "label": "CPR:6"}, {"em1Text": "betaadrenoceptor", "em2Text": "atenolol", "label": "CPR:6"}]}
{"sentText": "Betaxolol a beta1adrenoceptor antagonist reduces Na influx into cortical synaptosomes by direct interaction with Na channels comparison with other betaadrenoceptor antagonists", "relationMentions": [{"em1Text": "Betaxolol", "em2Text": "beta1adrenoceptor", "label": "CPR:6"}, {"em1Text": "Betaxolol", "em2Text": "betaadrenoceptor", "label": "CPR:6"}]}
{"sentText": "Leukotriene D4 induces cognitive impairment through enhancement of CysLT\u2081 R mediated amyloid\u03b2 generation in mice", "relationMentions": [{"em1Text": "Leukotriene D4", "em2Text": "CysLT\u2081 R", "label": "CPR:3"}, {"em1Text": "Leukotriene D4", "em2Text": "amyloid\u03b2", "label": "CPR:3"}]}
{"sentText": "Moreover LTD4 induced increases in CysLT1R and NF\u03baB p65 in the brain were also attenuated by pranlukast", "relationMentions": [{"em1Text": "LTD4", "em2Text": "CysLT1R", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "p65", "label": "CPR:3"}, {"em1Text": "CysLT1R", "em2Text": "pranlukast", "label": "CPR:4"}, {"em1Text": "NF\u03baB", "em2Text": "pranlukast", "label": "CPR:4"}, {"em1Text": "p65", "em2Text": "pranlukast", "label": "CPR:4"}]}
{"sentText": "These results suggest that LTD4 increases A\u03b2 peptide burden via activation of CysLT1R which further affects APP levels and activity of \u03b2 and \u03b3secretases via the NF\u03baB pathway", "relationMentions": [{"em1Text": "LTD4", "em2Text": "A\u03b2 peptide", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "CysLT1R", "label": "CPR:3"}]}
{"sentText": "The results demonstrated that intracerebral infusions of LTD4 1 ngmouse produced memory impairment as determined by Morris water maze test and Ymaze test in mice and caused the accumulation of A\u03b2140 and A\u03b2142 in the hippocampus and cortex through increased activity of \u03b2 and \u03b3secretases accompanied with increased expression of amyloid precursor protein APP", "relationMentions": [{"em1Text": "LTD4", "em2Text": "A\u03b2140", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "A\u03b2142", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "amyloid precursor protein", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "APP", "label": "CPR:3"}]}
{"sentText": "LTD4 also induced expression of cysteinyl leukotriene receptor 1 CysLT1R and NF\u03baB p65 in the hippocampus and cortex", "relationMentions": [{"em1Text": "LTD4", "em2Text": "cysteinyl leukotriene receptor 1", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "CysLT1R", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "LTD4", "em2Text": "p65", "label": "CPR:3"}]}
{"sentText": "Pretreatment with pranlukast 15 ngmouse intracerebroventricularly a CysLT1R antagonist blocked LTD4induced amyloidogenesis memory deficits", "relationMentions": [{"em1Text": "pranlukast", "em2Text": "CysLT1R", "label": "CPR:6"}]}
{"sentText": "Statins increase p21 through inhibition of histone deacetylase activity and release of promoterassociated HDAC12", "relationMentions": [{"em1Text": "Statins", "em2Text": "HDAC12", "label": "CPR:3"}, {"em1Text": "Statins", "em2Text": "p21", "label": "CPR:3"}, {"em1Text": "Statins", "em2Text": "histone deacetylase", "label": "CPR:4"}]}
{"sentText": "Statins are 3hydroxy3methylglutarylCoA reductase inhibitors broadly used for the control of hypercholesterolemia", "relationMentions": [{"em1Text": "Statins", "em2Text": "3hydroxy3methylglutarylCoA reductase", "label": "CPR:4"}]}
{"sentText": "In the subsequent enzymatic assay it was shown that lovastatin inhibited HDAC2 activity competitively with a Ki value of 316 micromolL", "relationMentions": [{"em1Text": "lovastatin", "em2Text": "HDAC2", "label": "CPR:4"}]}
{"sentText": "Imatinib was also found to inhibit MCSF induced osteoclast survival as well as MCSF induced osteoclast bone resorbing activity but was without effect on interleukin 1alpha IL1alpha and receptor activator of nuclear factor kappa B ligand RANKLinduced inhibition of osteoclasts apoptosis further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of cFMS", "relationMentions": [{"em1Text": "imatinib", "em2Text": "cFMS", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "MCSF", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "MCSF", "label": "CPR:4"}]}
{"sentText": "Recent studies have reported that imatinib mesylate a kinase inhibitor that targets the intracellular tyrosine kinase BCR ABL and the platelet derived growth factor PDGF receptor is an effective inhibitor of the macrophage colony stimulating factor MCSF receptor cFMS", "relationMentions": [{"em1Text": "imatinib mesylate", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "imatinib mesylate", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "imatinib mesylate", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "imatinib mesylate", "em2Text": "platelet derived growth factor PDGF receptor", "label": "CPR:4"}, {"em1Text": "imatinib mesylate", "em2Text": "macrophage colony stimulating factor MCSF receptor", "label": "CPR:4"}, {"em1Text": "imatinib mesylate", "em2Text": "cFMS", "label": "CPR:4"}, {"em1Text": "imatinib mesylate", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Given that MCSF signalling through cFMS plays an important role in osteoclast biology we speculated that blocking such a pathway with imatinib may modulate osteoclast activity", "relationMentions": [{"em1Text": "MCSF", "em2Text": "imatinib", "label": "CPR:4"}, {"em1Text": "cFMS", "em2Text": "imatinib", "label": "CPR:4"}]}
{"sentText": "We report here that lovastatin a drug clinically used for lowering cholesterol levels inhibits the interaction of human LFA1 with its counterreceptor intercellular adhesion molecule1", "relationMentions": [{"em1Text": "lovastatin", "em2Text": "human LFA1", "label": "CPR:4"}, {"em1Text": "lovastatin", "em2Text": "intercellular adhesion molecule1", "label": "CPR:4"}]}
{"sentText": "Structural basis for LFA1 inhibition upon lovastatin binding to the CD11a Idomain", "relationMentions": [{"em1Text": "LFA1", "em2Text": "lovastatin", "label": "CPR:4"}]}
{"sentText": "Particularly the effects of doxycycline used as a non selective MMP inhibitor in experimental and clinical studies will be discussed", "relationMentions": [{"em1Text": "doxycycline", "em2Text": "MMP", "label": "CPR:4"}]}
{"sentText": "Administration of a single dose of DEXP showed a temporal increase in CYP3A activity in both tissues and the induction ratios reached maximum values at 12 h after DEXP administration", "relationMentions": [{"em1Text": "DEXP", "em2Text": "CYP3A", "label": "CPR:3"}, {"em1Text": "DEXP", "em2Text": "CYP3A", "label": "CPR:3"}]}
{"sentText": "Timedependent changes in hepatic and intestinal induction of cytochrome P450 3A after administration of dexamethasone to rats", "relationMentions": [{"em1Text": "cytochrome P450 3A", "em2Text": "dexamethasone", "label": "CPR:3"}]}
{"sentText": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A CYP3A in rats using dexamethasone 21phosphate DEXP and midazolam MDZ as an inducer and a substrate to CYP3A respectively", "relationMentions": [{"em1Text": "cytochrome P450 3A", "em2Text": "dexamethasone 21phosphate", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "dexamethasone 21phosphate", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "dexamethasone 21phosphate", "label": "CPR:3"}, {"em1Text": "cytochrome P450 3A", "em2Text": "DEXP", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "DEXP", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "DEXP", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "midazolam", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "MDZ", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "dexamethasone 21phosphate", "label": "CPR:9"}, {"em1Text": "CYP3A", "em2Text": "DEXP", "label": "CPR:9"}, {"em1Text": "cytochrome P450 3A", "em2Text": "midazolam", "label": "CPR:9"}, {"em1Text": "CYP3A", "em2Text": "midazolam", "label": "CPR:9"}, {"em1Text": "CYP3A", "em2Text": "midazolam", "label": "CPR:9"}, {"em1Text": "CYP3A", "em2Text": "MDZ", "label": "CPR:9"}, {"em1Text": "CYP3A", "em2Text": "MDZ", "label": "CPR:9"}]}
{"sentText": "CYP3A induction in the liver increased depending on the dose of DEXP whereas that in intestine showed a mild increase but the induction level was almost constant regardless of the dose of DEXP", "relationMentions": [{"em1Text": "CYP3A", "em2Text": "DEXP", "label": "CPR:3"}, {"em1Text": "CYP3A", "em2Text": "DEXP", "label": "CPR:3"}]}
{"sentText": "LDH is responsible for pyruvate conversion to lactate through glycolysis", "relationMentions": [{"em1Text": "LDH", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "LDH", "em2Text": "lactate", "label": "CPR:9"}]}
{"sentText": "PURPOSE Dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR ABL has recently been approved for the treatment of chronic myelogenous leukaemia CML in imatinibacquired resistance and intolerance", "relationMentions": [{"em1Text": "Dasatinib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "SRC", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "SRC", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "ABL", "label": "CPR:4"}]}
{"sentText": "Preclinical pharmacokinetics and in vitro metabolism of dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR ABL", "relationMentions": [{"em1Text": "dasatinib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "dasatinib", "em2Text": "SRC", "label": "CPR:4"}, {"em1Text": "dasatinib", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "dasatinib", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "SRC", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "ABL", "label": "CPR:4"}]}
{"sentText": "The results of this study suggest that noradrenaline predominantly but not exclusively mediates contraction of rat aorta through the activation of an alphalDadrenoceptor", "relationMentions": [{"em1Text": "noradrenaline", "em2Text": "alphalDadrenoceptor", "label": "CPR:3"}]}
{"sentText": "An increase in the ADP ATP ratio opens KATP channels leading to membrane hyperpolarization", "relationMentions": [{"em1Text": "ADP", "em2Text": "KATP channels", "label": "CPR:3"}, {"em1Text": "ATP", "em2Text": "KATP channels", "label": "CPR:3"}]}
{"sentText": "Comparison of the effect of rofecoxib a cyclooxygenase 2 inhibitor ibuprofen and placebo on the gastroduodenal mucosa of patients with osteoarthritis a randomized doubleblind placebocontrolled trial", "relationMentions": [{"em1Text": "rofecoxib", "em2Text": "cyclooxygenase 2", "label": "CPR:4"}]}
{"sentText": "OBJECTIVE This randomized doubleblind study tested the hypothesis that rofecoxib a drug that specifically inhibits cyclooxygenase 2 would cause fewer gastroduodenal ulcers than ibuprofen in a multicenter trial and its side effects would be equivalent to those of placebo in a prespecified analysis combining the results with another trial of identical design", "relationMentions": [{"em1Text": "rofecoxib", "em2Text": "cyclooxygenase 2", "label": "CPR:4"}]}
{"sentText": "Huperzine A Hup A is a naturally occurring potent reversible AChE inhibitor that penetrates the bloodbrain barrier", "relationMentions": [{"em1Text": "Huperzine A", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "Hup A", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "The synthetic stereoisomer Hup A is less toxic due to poor AChE inhibition and is suitable for both prepostexposure treatments of nerve agent toxicity", "relationMentions": [{"em1Text": "Hup A", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "In addition vinblastine induces the DNAbinding activities of the transcription factor NF\u03baB HSF1 AP1 and ATF2 together with the expression of HSP70 and Bax proteins", "relationMentions": [{"em1Text": "vinblastine", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "HSF1", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "AP1", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "ATF2", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "HSP70", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "Bax", "label": "CPR:3"}]}
{"sentText": "Also vinblastine enhances the phosphorylation of Ras homologous protein A the accumulation of reactive oxygen species the release of intracellular Ca2 as well as the activation of apoptosis signalregulating kinase 1 cjunNterminal kinase p38 inhibitor of kappaB\u03b1 I\u03baB\u03b1 kinase and inositol requiring enzyme 1\u03b1", "relationMentions": [{"em1Text": "vinblastine", "em2Text": "Ras homologous protein A", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "apoptosis signalregulating kinase 1", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "cjunNterminal kinase", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "inhibitor of kappaB\u03b1", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "I\u03baB\u03b1", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "kinase", "label": "CPR:3"}, {"em1Text": "vinblastine", "em2Text": "inositol requiring enzyme 1\u03b1", "label": "CPR:3"}]}
{"sentText": "Of the PDE inhibitors tested dipyridamole was most effective with IC50 values of 12 and 045 microM for inhibition of cAMP and cGMP hydrolysis respectively", "relationMentions": [{"em1Text": "PDE", "em2Text": "dipyridamole", "label": "CPR:4"}, {"em1Text": "PDE", "em2Text": "cAMP", "label": "CPR:9"}, {"em1Text": "PDE", "em2Text": "cGMP", "label": "CPR:9"}]}
{"sentText": "Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP PDE10A", "relationMentions": [{"em1Text": "cAMP", "em2Text": "PDE10A", "label": "CPR:9"}, {"em1Text": "human phosphodiesterase", "em2Text": "cAMP", "label": "CPR:9"}, {"em1Text": "cGMP", "em2Text": "PDE10A", "label": "CPR:9"}, {"em1Text": "human phosphodiesterase", "em2Text": "cGMP", "label": "CPR:9"}]}
{"sentText": "Recombinant PDE10A transfected and expressed in COS7 cells hydrolyzed cAMP and cGMP with Km values of 026 and 72 microM respectively and Vmax with cGMP was almost twice that with cAMP", "relationMentions": [{"em1Text": "PDE10A", "em2Text": "cAMP", "label": "CPR:9"}, {"em1Text": "PDE10A", "em2Text": "cGMP", "label": "CPR:9"}, {"em1Text": "PDE10A", "em2Text": "cGMP", "label": "CPR:9"}, {"em1Text": "PDE10A", "em2Text": "cAMP", "label": "CPR:9"}]}
{"sentText": "Weekly subcutaneous decitabine produces cumulative increases in HbF and total hemoglobin through a noncytotoxic mechanism of action", "relationMentions": [{"em1Text": "decitabine", "em2Text": "HbF", "label": "CPR:3"}, {"em1Text": "decitabine", "em2Text": "hemoglobin", "label": "CPR:3"}]}
{"sentText": "We examined if subcutaneous decitabine could increase HbF levels and improve SSD pathophysiology without cytotoxicity", "relationMentions": [{"em1Text": "decitabine", "em2Text": "HbF", "label": "CPR:3"}]}
{"sentText": "The cytosine analog 5aza2deoxycytidine decitabine hypomethylates DNA by inhibiting DNA methyltransferase", "relationMentions": [{"em1Text": "cytosine", "em2Text": "DNA methyltransferase", "label": "CPR:4"}, {"em1Text": "5aza2deoxycytidine", "em2Text": "DNA methyltransferase", "label": "CPR:4"}, {"em1Text": "decitabine", "em2Text": "DNA methyltransferase", "label": "CPR:4"}]}
{"sentText": "Such model of Nox4 activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme ie its potential redox regulation and could also define new therapeutic targets in diseases in which quinones and Nox4 are implicated", "relationMentions": [{"em1Text": "Nox4", "em2Text": "quinones", "label": "CPR:3"}]}
{"sentText": "Nox4 oxidase activity is thought to be constitutive and regulated at the transcriptional level however we challenge this point of view and suggest that specific quinone derivatives could modulate this activity", "relationMentions": [{"em1Text": "Nox4", "em2Text": "quinone", "label": "CPR:3"}, {"em1Text": "oxidase", "em2Text": "quinone", "label": "CPR:3"}]}
{"sentText": "In fact we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives AA861 tBuBHQ tBuBQ and duroquinone observed in 3 different cellular models HEK293E TREx\u2122 and chondrocyte cell lines", "relationMentions": [{"em1Text": "Nox4", "em2Text": "quinone", "label": "CPR:3"}, {"em1Text": "Nox4", "em2Text": "AA861", "label": "CPR:3"}, {"em1Text": "Nox4", "em2Text": "tBuBHQ", "label": "CPR:3"}, {"em1Text": "Nox4", "em2Text": "tBuBQ", "label": "CPR:3"}, {"em1Text": "Nox4", "em2Text": "duroquinone", "label": "CPR:3"}]}
{"sentText": "In a recent study using proteinspecific antiacetyl lysine antibodies and immunological methods we demonstrated the ability of aspirin to acetylate the tumor suppressor protein p53", "relationMentions": [{"em1Text": "aspirin", "em2Text": "tumor suppressor protein p53", "label": "CPR:3"}]}
{"sentText": "Although the inhibition of cyclooxygenases by aspirin which leads to its antiinflammatoryanalgesic properties has been well studied the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet illdefined", "relationMentions": [{"em1Text": "cyclooxygenases", "em2Text": "aspirin", "label": "CPR:4"}]}
{"sentText": "Altogether our findings support a model in which Top2\u03b2 deficiency promotes CPT induced apoptosis in quiescent nonSphase cells possibly due to RNAP LS depletion and p53 accumulation", "relationMentions": [{"em1Text": "CPT", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "CPT", "em2Text": "RNAP LS", "label": "CPR:4"}]}
{"sentText": "To explore the molecular basis for CPT hypersensitivity in Top2\u03b2deficient cells we found that upon CPT exposure the RNA polymerase II large subunit RNAP LS became progressively depleted followed by recovery to nearly the original level in wildtype MEFs whereas RNAP LS remained depleted without recovery in Top2\u03b2deficient cells", "relationMentions": [{"em1Text": "CPT", "em2Text": "RNA polymerase II large subunit", "label": "CPR:4"}, {"em1Text": "CPT", "em2Text": "RNAP LS", "label": "CPR:4"}, {"em1Text": "CPT", "em2Text": "RNAP LS", "label": "CPR:4"}]}
{"sentText": "Second ICRF187 a Top2 catalytic inhibitor known to deplete Top2\u03b2 specifically sensitized MEFs to CPT", "relationMentions": [{"em1Text": "ICRF187", "em2Text": "Top2", "label": "CPR:4"}, {"em1Text": "ICRF187", "em2Text": "Top2\u03b2", "label": "CPR:4"}]}
{"sentText": "Felodipine and the pchloro analogue inhibited the actinactivated Mg2ATPase activity of smooth muscle myosin IC50 = 251 microM", "relationMentions": [{"em1Text": "pchloro", "em2Text": "Mg2ATPase", "label": "CPR:4"}, {"em1Text": "pchloro", "em2Text": "myosin", "label": "CPR:4"}, {"em1Text": "Felodipine", "em2Text": "Mg2ATPase", "label": "CPR:4"}, {"em1Text": "Felodipine", "em2Text": "myosin", "label": "CPR:4"}]}
{"sentText": "Similarly felodipine and the pchloro analogue blocked myosin filament assembly induced by low concentrations of calmodulin whereas the oxidized and tbutyl analogues did not", "relationMentions": [{"em1Text": "felodipine", "em2Text": "myosin", "label": "CPR:4"}, {"em1Text": "pchloro", "em2Text": "myosin", "label": "CPR:4"}]}
{"sentText": "We have examined the effects on the activities of three calmodulindependent enzymes cAMP phosphodiesterase caldesmon kinase and myosin light chain kinase of the dihydropyridine Ca2 channel blocker felodipine and three analogues pchloro oxidized and tbutyl exhibiting different pharmacological potencies", "relationMentions": [{"em1Text": "Ca2 channel", "em2Text": "felodipine", "label": "CPR:4"}]}
{"sentText": "Again inhibition of the actinactivated myosin Mg2ATPase and myosin filament assembly by felodipine and the pchloro analogue could be reversed by raising the calmodulin concentration", "relationMentions": [{"em1Text": "myosin", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "Mg2ATPase", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "myosin", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "myosin", "em2Text": "pchloro", "label": "CPR:4"}, {"em1Text": "Mg2ATPase", "em2Text": "pchloro", "label": "CPR:4"}, {"em1Text": "myosin", "em2Text": "pchloro", "label": "CPR:4"}]}
{"sentText": "These observations suggest that some of the pharmacological actions of felodipine on smooth muscle may involve inhibition of calmodulindependent enzymes which are functionally involved in the regulation of smooth muscle contraction", "relationMentions": [{"em1Text": "felodipine", "em2Text": "calmodulindependent enzymes", "label": "CPR:4"}]}
{"sentText": "The cAMP phosphodiesterase was inhibited completely by felodipine and the pchloro analogue with IC50 values of 37 and 15 microM respectively", "relationMentions": [{"em1Text": "cAMP phosphodiesterase", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "cAMP phosphodiesterase", "em2Text": "pchloro", "label": "CPR:4"}]}
{"sentText": "Felodipine and the pchloro analogue inhibited the basal Ca2calmodulinindependent activity of cAMP phosphodiesterase as well as the calmodulin stimulated activity", "relationMentions": [{"em1Text": "Felodipine", "em2Text": "cAMP phosphodiesterase", "label": "CPR:4"}, {"em1Text": "Felodipine", "em2Text": "calmodulin", "label": "CPR:4"}, {"em1Text": "pchloro", "em2Text": "cAMP phosphodiesterase", "label": "CPR:4"}, {"em1Text": "pchloro", "em2Text": "calmodulin", "label": "CPR:4"}]}
{"sentText": "Calmodulin was relatively ineffective in preventing inhibition of cAMP phosphodiesterase by felodipine and the pchloro analogue", "relationMentions": [{"em1Text": "cAMP phosphodiesterase", "em2Text": "felodipine", "label": "CPR:4"}, {"em1Text": "cAMP phosphodiesterase", "em2Text": "pchloro", "label": "CPR:4"}]}
{"sentText": "Felodipine and the pchloro analogue inhibited Ca2calmodulindependent caldesmon kinase with similar potencies IC50 = 174 microM whereas the oxidized and tbutyl analogues caused no inhibition", "relationMentions": [{"em1Text": "Felodipine", "em2Text": "caldesmon kinase", "label": "CPR:4"}, {"em1Text": "pchloro", "em2Text": "caldesmon kinase", "label": "CPR:4"}]}
{"sentText": "Similarly felodipine and the pchloro analogue inhibited myosin light chain kinase activity whether the isolated 20 kD light chain IC50 = 126 microM or intact myosin IC50 = 110 microM was used as substrate", "relationMentions": [{"em1Text": "felodipine", "em2Text": "myosin light chain kinase", "label": "CPR:4"}, {"em1Text": "pchloro", "em2Text": "myosin light chain kinase", "label": "CPR:4"}]}
{"sentText": "Effects of felodipine a dihydropyridine calcium channel blocker and analogues on calmodulindependent enzymes", "relationMentions": [{"em1Text": "felodipine", "em2Text": "calcium channel", "label": "CPR:4"}, {"em1Text": "dihydropyridine", "em2Text": "calcium channel", "label": "CPR:4"}]}
{"sentText": "Aldosterone induced ENaC and basal NaKATPase trafficking via protein kinase D1phosphatidylinositol 4kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells", "relationMentions": [{"em1Text": "Aldosterone", "em2Text": "ENaC", "label": "CPR:3"}, {"em1Text": "Aldosterone", "em2Text": "NaKATPase", "label": "CPR:3"}]}
{"sentText": "Aldosterone also induces the rapid phosphorylation of Protein Kinase D1 PKD1", "relationMentions": [{"em1Text": "Aldosterone", "em2Text": "Protein Kinase D1", "label": "CPR:3"}, {"em1Text": "Aldosterone", "em2Text": "PKD1", "label": "CPR:3"}]}
{"sentText": "In addition by comparing the combined administration of pindolol with either WAY100635 GR127935 or isamoltane we have determined that pindolol produces much of its acute potentiation of fluoxetineinduced increases in extracellular 5HT via its action at the 5HT1BD receptor in addition to any activity it has at the presynaptic 5HT1A receptor", "relationMentions": [{"em1Text": "pindolol", "em2Text": "5HT1A", "label": "CPR:6"}]}
{"sentText": "This effect has been attributed to the antagonist effects of pindolol at the 5HT1A receptor", "relationMentions": [{"em1Text": "pindolol", "em2Text": "5HT1A", "label": "CPR:6"}]}
{"sentText": "In the present study we compared the pharmacology of pindolol WAY100635 a 5HT1A antagonist GR127935 a 5HT1B1D antagonist and isamoltane a 5HT1B antagonist when given acutely in combination with fluoxetine using in vivo microdialysis in the frontal cortex of the freely moving rat", "relationMentions": [{"em1Text": "pindolol", "em2Text": "5HT1A", "label": "CPR:6"}, {"em1Text": "WAY100635", "em2Text": "5HT1A", "label": "CPR:6"}, {"em1Text": "5HT1B", "em2Text": "isamoltane", "label": "CPR:6"}]}
{"sentText": "In the local presence into the LC of the \u03b12adrenoceptor antagonist RS79948 1 \u03bcM systemic citalopram increased NA in the LC Emax = 157 \u00b1 25 and PFC Emax = 175 \u00b1 24", "relationMentions": [{"em1Text": "\u03b12adrenoceptor", "em2Text": "RS79948", "label": "CPR:6"}]}
{"sentText": "Local LC citalopram effect was abolished by LC presence of the 5HT3 receptor antagonist MDL72222 1 \u03bcM but not the 5HT12 receptor antagonist methiothepin 1 \u03bcM", "relationMentions": [{"em1Text": "5HT3", "em2Text": "MDL72222", "label": "CPR:6"}, {"em1Text": "5HT12", "em2Text": "methiothepin", "label": "CPR:6"}]}
{"sentText": "Noradrenaline and phenylephrine alpha1adrenoceptor agonist each produced a concentrationdependent tonic contraction their pD2 values being 687008 and 610005 respectively", "relationMentions": [{"em1Text": "phenylephrine", "em2Text": "alpha1adrenoceptor", "label": "CPR:5"}, {"em1Text": "Noradrenaline", "em2Text": "alpha1adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Prazosin nonselective alpha1adrenoceptor antagonist silodosin selective alpha1Aadrenoceptor antagonist and BMY7378 8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione dihydrochloride selective alpha1Dadrenoceptor antagonist competitively antagonized the phenylephrine induced contraction pA2 values 860007 944006 and 575007 respectively", "relationMentions": [{"em1Text": "alpha1adrenoceptor", "em2Text": "phenylephrine", "label": "CPR:5"}, {"em1Text": "alpha1Aadrenoceptor", "em2Text": "phenylephrine", "label": "CPR:5"}, {"em1Text": "alpha1Dadrenoceptor", "em2Text": "phenylephrine", "label": "CPR:5"}, {"em1Text": "Prazosin", "em2Text": "alpha1adrenoceptor", "label": "CPR:6"}, {"em1Text": "silodosin", "em2Text": "alpha1Aadrenoceptor", "label": "CPR:6"}, {"em1Text": "BMY7378", "em2Text": "alpha1Dadrenoceptor", "label": "CPR:6"}, {"em1Text": "8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione dihydrochloride", "em2Text": "alpha1Dadrenoceptor", "label": "CPR:6"}]}
{"sentText": "alpha1Adrenoceptor antagonists were tested against the phenylephrine alpha1adrenoceptor agonistinduced contraction in isolated hamster ureteral preparations using a functional experimental approach", "relationMentions": [{"em1Text": "phenylephrine", "em2Text": "alpha1adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Despite the structural similarity between benzothiazepines and BDZs mutation of an amino acid important for diltiazem potency I1150A did not affect diazepam potency", "relationMentions": [{"em1Text": "I1150A", "em2Text": "diazepam", "label": "CPR:4"}]}
{"sentText": "Although LVGCC inhibition by BDZs occurred at concentrations that are possibly too high to be clinically relevant and is not likely to play a role in the upregulation of LVGCCs during longterm treatment pentobarbital and ethanol inhibited LVGCCs at clinically relevant concentrations", "relationMentions": [{"em1Text": "LVGCC", "em2Text": "BDZs", "label": "CPR:4"}, {"em1Text": "LVGCCs", "em2Text": "pentobarbital", "label": "CPR:4"}]}
{"sentText": "BDZs and other positive GABAAR modulators including barbiturates ethanol and neurosteroids can also inhibit Ltype voltagegated calcium channels LVGCCs which could contribute to reduced neuronal excitability", "relationMentions": [{"em1Text": "barbiturates", "em2Text": "Ltype voltagegated calcium channels", "label": "CPR:4"}, {"em1Text": "barbiturates", "em2Text": "LVGCCs", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "Ltype voltagegated calcium channels", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "LVGCCs", "label": "CPR:4"}, {"em1Text": "neurosteroids", "em2Text": "Ltype voltagegated calcium channels", "label": "CPR:4"}, {"em1Text": "neurosteroids", "em2Text": "LVGCCs", "label": "CPR:4"}, {"em1Text": "BDZs", "em2Text": "Ltype voltagegated calcium channels", "label": "CPR:4"}, {"em1Text": "BDZs", "em2Text": "LVGCCs", "label": "CPR:4"}]}
{"sentText": "Cav13 channels were less sensitive to pentobarbital inhibition than Cav12 channels similar to dihydropyridine DHP LVGCC antagonists", "relationMentions": [{"em1Text": "Cav13", "em2Text": "pentobarbital", "label": "CPR:4"}, {"em1Text": "pentobarbital", "em2Text": "Cav12", "label": "CPR:4"}, {"em1Text": "Cav13", "em2Text": "dihydropyridine", "label": "CPR:4"}, {"em1Text": "Cav12", "em2Text": "dihydropyridine", "label": "CPR:4"}, {"em1Text": "Cav13", "em2Text": "DHP", "label": "CPR:4"}, {"em1Text": "Cav12", "em2Text": "DHP", "label": "CPR:4"}, {"em1Text": "dihydropyridine", "em2Text": "LVGCC", "label": "CPR:6"}, {"em1Text": "DHP", "em2Text": "LVGCC", "label": "CPR:6"}]}
{"sentText": "All GABAAR modulators induced a negative shift in the steadystate inactivation curve of Cav13 channels but only BDZs and pentobarbital induced a negative shift in Cav12 channel inactivation", "relationMentions": [{"em1Text": "BDZs", "em2Text": "Cav12", "label": "CPR:4"}, {"em1Text": "pentobarbital", "em2Text": "Cav12", "label": "CPR:4"}]}
{"sentText": "Thus we found that 5HHMF enhances heme oxygenase1 HO1 expression via nuclear factorerythroid 2related factor 2 Nrf2 activation", "relationMentions": [{"em1Text": "5HHMF", "em2Text": "heme oxygenase1", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "nuclear factorerythroid 2related factor 2", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "Nrf2", "label": "CPR:3"}]}
{"sentText": "In addition cobalt protoporphyrin CoPP a specific HO1 inducer predominantly suppressed LPSinduced NO production", "relationMentions": [{"em1Text": "cobalt protoporphyrin", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "CoPP", "em2Text": "HO1", "label": "CPR:3"}]}
{"sentText": "5Hydroxy367834hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharidestimulated BV2 microglia via NF\u03baB suppression and Nrf2 dependent heme oxygenase1 induction", "relationMentions": [{"em1Text": "5Hydroxy367834hexamethoxyflavone", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "5Hydroxy367834hexamethoxyflavone", "em2Text": "heme oxygenase1", "label": "CPR:3"}, {"em1Text": "5Hydroxy367834hexamethoxyflavone", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "Further 5HHMF increased specific DNAbinding activity of Nrf2 and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMFinduced NO inhibition which was followed by suppression of HO1 activity", "relationMentions": [{"em1Text": "5HHMF", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "HO1", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "HO1", "label": "CPR:4"}]}
{"sentText": "Taken together our findings indicate that 5HHMF suppresses NO production through modulation of iNOS consequently suppressing NF\u03baB activity and induction of Nrf2 dependent HO1 activity", "relationMentions": [{"em1Text": "5HHMF", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "5HHMF", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "NO", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "Nrf2", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "HO1", "label": "CPR:4"}, {"em1Text": "5HHMF", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "In addition 5HHMF blocked LPSinduced phosphorylation of I\u03baB resulting in suppression of the nuclear translocation of nuclear factor\u03baB NF\u03baB subunits namely p65 and p50 which are important molecules involved in the regulation of iNOS expression", "relationMentions": [{"em1Text": "5HHMF", "em2Text": "I\u03baB", "label": "CPR:4"}, {"em1Text": "5HHMF", "em2Text": "nuclear factor\u03baB", "label": "CPR:4"}, {"em1Text": "5HHMF", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "5HHMF", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "5HHMF", "em2Text": "p50", "label": "CPR:4"}]}
{"sentText": "In this study we found that 5hydroxy367834hexamethoxyflavone 5HHMF from Hizikia fusiforme considerably inhibits lipopolysaccharide LPSstimulated NO production by suppressing the expression of inducible NO synthase iNOS in BV2 microglia", "relationMentions": [{"em1Text": "5hydroxy367834hexamethoxyflavone", "em2Text": "inducible NO synthase", "label": "CPR:4"}, {"em1Text": "5hydroxy367834hexamethoxyflavone", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "5HHMF", "em2Text": "inducible NO synthase", "label": "CPR:4"}, {"em1Text": "5HHMF", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "Pyrrolidine dithiocarbamate PDTC a specific NF\u03baB inhibitor along with 20S proteasome inhibitor PSI significantly inhibited LPSinduced iNOS expression which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF\u03baB activity", "relationMentions": [{"em1Text": "Pyrrolidine dithiocarbamate", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "Pyrrolidine dithiocarbamate", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "PDTC", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "PDTC", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "iNOS", "em2Text": "5HHMF", "label": "CPR:4"}, {"em1Text": "NF\u03baB", "em2Text": "5HHMF", "label": "CPR:4"}]}
{"sentText": "In contrast zinc protoporphyrin ZnPP a specific HO1 inhibitor showed a partial suppressive effect of 5HHMF on LPSinduced NO production", "relationMentions": [{"em1Text": "zinc protoporphyrin", "em2Text": "HO1", "label": "CPR:4"}, {"em1Text": "ZnPP", "em2Text": "HO1", "label": "CPR:4"}]}
{"sentText": "Synthesis and antitumor activity of 134oxadiazole possessing 14benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors", "relationMentions": [{"em1Text": "134oxadiazole", "em2Text": "methionine aminopeptidase type II", "label": "CPR:4"}, {"em1Text": "14benzodioxan", "em2Text": "methionine aminopeptidase type II", "label": "CPR:4"}]}
{"sentText": "One of the CB2 agonists Ncyclopentyl4ethoxy64methylpiperidin1yl135triazin2amine 19 logEC50=75 Emax=255 was selected for further development", "relationMentions": [{"em1Text": "CB2", "em2Text": "Ncyclopentyl4ethoxy64methylpiperidin1yl135triazin2amine", "label": "CPR:5"}]}
{"sentText": "As far as we are aware the compounds 135triazine scaffold represents a new core structure for CB2 agonists", "relationMentions": [{"em1Text": "135triazine", "em2Text": "CB2", "label": "CPR:5"}]}
{"sentText": "Discovery of novel cannabinoid receptor ligands by a virtual screening approach further development of 246trisubstituted 135triazines as CB2 agonists", "relationMentions": [{"em1Text": "246trisubstituted 135triazines", "em2Text": "CB2", "label": "CPR:5"}]}
{"sentText": "Purified PAOh1 SMO oxidizes both spermine Km=16 microM and N1acetylspermine Km=51 microM but does not oxidize spermidine", "relationMentions": [{"em1Text": "PAOh1", "em2Text": "spermine", "label": "CPR:9"}, {"em1Text": "SMO", "em2Text": "spermine", "label": "CPR:9"}, {"em1Text": "PAOh1", "em2Text": "N1acetylspermine", "label": "CPR:9"}, {"em1Text": "SMO", "em2Text": "N1acetylspermine", "label": "CPR:9"}]}
{"sentText": "The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues however specific oligamine analogues were found to be potent inhibitors of the oxidation of spermine by PAOh1 SMO", "relationMentions": [{"em1Text": "spermine", "em2Text": "PAOh1", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "SMO", "label": "CPR:9"}]}
{"sentText": "The discovery of an inducible oxidase whose apparent substrate preference is spermine indicates that polyamine catabolism is more complex than that originally proposed", "relationMentions": [{"em1Text": "oxidase", "em2Text": "spermine", "label": "CPR:9"}]}
{"sentText": "administration of very low doses of okadaic acid 00011 pgmouse and cantharidin 00011 ngmouse which inhibit PP2A produced a dosedependent antagonism of the antinociception induced by morphine sc", "relationMentions": [{"em1Text": "okadaic acid", "em2Text": "PP2A", "label": "CPR:4"}, {"em1Text": "cantharidin", "em2Text": "PP2A", "label": "CPR:4"}]}
{"sentText": "A series of phenolic acids and phenol natural products such as phydroxybenzoic acid pcoumaric acid caffeic acid ferulic acid gallic acid syringic acid quercetin and ellagic acid were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase CA EC 4211", "relationMentions": [{"em1Text": "phydroxybenzoic acid", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "phydroxybenzoic acid", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "phydroxybenzoic acid", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "phydroxybenzoic acid", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "pcoumaric acid", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "pcoumaric acid", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "pcoumaric acid", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "pcoumaric acid", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "caffeic acid", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "caffeic acid", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "caffeic acid", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "caffeic acid", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "ferulic acid", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "ferulic acid", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "ferulic acid", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "ferulic acid", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "phenolic acids", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "phenolic acids", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "phenolic acids", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "phenolic acids", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "gallic acid", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "gallic acid", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "gallic acid", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "gallic acid", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "syringic acid", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "syringic acid", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "syringic acid", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "syringic acid", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "quercetin", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "quercetin", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "quercetin", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "quercetin", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "ellagic acid", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "ellagic acid", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "ellagic acid", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "ellagic acid", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "phenol", "em2Text": "metalloenzyme", "label": "CPR:4"}, {"em1Text": "phenol", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "phenol", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "phenol", "em2Text": "EC 4211", "label": "CPR:4"}]}
{"sentText": "Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides sulfamates used clinically or the coumarins", "relationMentions": [{"em1Text": "Phenols", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "CA", "em2Text": "sulfonamides", "label": "CPR:4"}, {"em1Text": "CA", "em2Text": "sulfamates", "label": "CPR:4"}, {"em1Text": "CA", "em2Text": "coumarins", "label": "CPR:4"}]}
{"sentText": "Inhibition of mammalian isoforms IXIV with a series of natural product polyphenols and phenolic acids", "relationMentions": [{"em1Text": "mammalian isoforms IXIV", "em2Text": "polyphenols", "label": "CPR:4"}, {"em1Text": "mammalian isoforms IXIV", "em2Text": "phenolic acids", "label": "CPR:4"}]}
{"sentText": "Lserine dehydratase SDH a member of the betafamily of pyridoxal phosphatedependent PLP enzymes catalyzes the deamination of Lserine and Lthreonine to yield pyruvate or 2oxobutyrate", "relationMentions": [{"em1Text": "Lserine", "em2Text": "Lserine dehydratase", "label": "CPR:9"}, {"em1Text": "Lserine", "em2Text": "SDH", "label": "CPR:9"}, {"em1Text": "Lserine dehydratase", "em2Text": "Lthreonine", "label": "CPR:9"}, {"em1Text": "SDH", "em2Text": "Lthreonine", "label": "CPR:9"}, {"em1Text": "Lserine dehydratase", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "SDH", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "Lserine dehydratase", "em2Text": "2oxobutyrate", "label": "CPR:9"}, {"em1Text": "SDH", "em2Text": "2oxobutyrate", "label": "CPR:9"}]}
{"sentText": "A series of carbamoylmethylene linked prodrugs of 1 BMS582949 a clinical p38\u03b1 inhibitor were synthesized and evaluated", "relationMentions": [{"em1Text": "carbamoylmethylene", "em2Text": "p38\u03b1", "label": "CPR:4"}, {"em1Text": "BMS582949", "em2Text": "p38\u03b1", "label": "CPR:4"}]}
{"sentText": "Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS582949 a clinical p38\u03b1 inhibitor", "relationMentions": [{"em1Text": "carbamoylmethylene", "em2Text": "p38\u03b1", "label": "CPR:4"}, {"em1Text": "BMS582949", "em2Text": "p38\u03b1", "label": "CPR:4"}]}
{"sentText": "CONCLUSION A longterm intake of ethanol solution downregulates the phosphorylation of CREB in the nucleus accumbens and those changes can be reversed by naloxone which may be one kind of the molecular mechanisms associated with ethanol dependence", "relationMentions": [{"em1Text": "CREB", "em2Text": "naloxone", "label": "CPR:3"}, {"em1Text": "ethanol", "em2Text": "CREB", "label": "CPR:4"}]}
{"sentText": "The decrement of pCREB protein in the nucleus accumbens remained at 24 h 35 and 72 h 28 of ethanol withdrawal which recovered toward control level after 7 d of ethanol withdrawal", "relationMentions": [{"em1Text": "pCREB", "em2Text": "ethanol", "label": "CPR:4"}, {"em1Text": "pCREB", "em2Text": "ethanol", "label": "CPR:4"}]}
{"sentText": "However when naloxone was administered concurrently with ethanol treatment it antagonized the downregulation of pCREB protein in the nucleus accumbens 142 of rats exposed to ethanol", "relationMentions": [{"em1Text": "ethanol", "em2Text": "pCREB", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "pCREB", "label": "CPR:4"}]}
{"sentText": "RESULTS Ethanol given to rats in drinking water decreased the level of pCREB protein in the nucleus accumbens 75 at the time of exposure to ethanol", "relationMentions": [{"em1Text": "Ethanol", "em2Text": "pCREB", "label": "CPR:4"}]}
{"sentText": "The A2A adenosine receptor agonist CGS21680 C23H29N7O6HClxH2O 000101 \u03bcM did not alter NE oxidation currents", "relationMentions": [{"em1Text": "A2A adenosine receptor", "em2Text": "C23H29N7O6HClxH2O", "label": "CPR:5"}, {"em1Text": "A2A adenosine receptor", "em2Text": "CGS21680", "label": "CPR:5"}]}
{"sentText": "Adenosine and N6cyclopentyladenosine CPA A1R agonist constricted MVs but not MAs", "relationMentions": [{"em1Text": "CPA", "em2Text": "A1R", "label": "CPR:5"}, {"em1Text": "Adenosine", "em2Text": "A1R", "label": "CPR:5"}, {"em1Text": "N6cyclopentyladenosine", "em2Text": "A1R", "label": "CPR:5"}]}
{"sentText": "Pasireotide Signifor \u00ae is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of corticotropin from the pituitary adenoma in patients with Cushings disease", "relationMentions": [{"em1Text": "Pasireotide", "em2Text": "corticotropin", "label": "CPR:4"}, {"em1Text": "Signifor", "em2Text": "corticotropin", "label": "CPR:4"}]}
{"sentText": "Also SB365 showed antiangiogenic activity by decreasing the expression of HIF1\u03b1 and VEGF", "relationMentions": [{"em1Text": "SB365", "em2Text": "HIF1\u03b1", "label": "CPR:4"}, {"em1Text": "SB365", "em2Text": "VEGF", "label": "CPR:4"}]}
{"sentText": "When further examined for its anticancer mechanism SB365 effectively suppressed the AKT mTOR pathway both in vitro and in vivo", "relationMentions": [{"em1Text": "SB365", "em2Text": "AKT", "label": "CPR:4"}, {"em1Text": "SB365", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Taken together our study demonstrated that SB365 inhibits the AKT mTOR pathway leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis", "relationMentions": [{"em1Text": "SB365", "em2Text": "AKT", "label": "CPR:4"}, {"em1Text": "SB365", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "In this study using a model of gentamicin C GMCinduced reduction in SGLT1 activity we examined whether ligands for megalin protect LLCPK1 cells from the GMC induced reduction in SGLT1 activity", "relationMentions": [{"em1Text": "gentamicin C", "em2Text": "SGLT1", "label": "CPR:4"}, {"em1Text": "GMC", "em2Text": "SGLT1", "label": "CPR:4"}, {"em1Text": "GMC", "em2Text": "SGLT1", "label": "CPR:4"}]}
{"sentText": "Apolipoprotein E3 apoE3 safeguards pig proximal tubular LLCPK1 cells against reduction in SGLT1 activity induced by gentamicin C Megalin a family of endocytic receptors related to the lowdensity lipoprotein LDL receptor is a major pathway for proximal tubular aminoglycoside accumulation", "relationMentions": [{"em1Text": "SGLT1", "em2Text": "gentamicin C", "label": "CPR:4"}, {"em1Text": "endocytic receptors", "em2Text": "aminoglycoside", "label": "CPR:9"}, {"em1Text": "lowdensity lipoprotein LDL receptor", "em2Text": "aminoglycoside", "label": "CPR:9"}]}
{"sentText": "We previously reported that aminoglycoside antibiotics reduce SGLT1 dependent glucose transport in pig proximal tubular epithelial LLCPK1 cells in parallel with the order of their nephrotoxicity", "relationMentions": [{"em1Text": "aminoglycoside", "em2Text": "SGLT1", "label": "CPR:4"}]}
{"sentText": "Then the cells were treated with various concentrations of apoE3 lactoferrin and bovine serum albumin with or without 100 microgml of GMC and the SGLT1 dependent methyl alphaDglucopyranoside AMG uptake and levels of SGLT1 expression were determined", "relationMentions": [{"em1Text": "SGLT1", "em2Text": "methyl alphaDglucopyranoside", "label": "CPR:9"}, {"em1Text": "SGLT1", "em2Text": "AMG", "label": "CPR:9"}]}
{"sentText": "Actions of nizatidine a selective histamine H2receptor antagonist on gastric acid secretion in dogs rats and frogs", "relationMentions": [{"em1Text": "nizatidine", "em2Text": "histamine H2receptor", "label": "CPR:6"}]}
{"sentText": "Nizatidine LY139037 a selective histamine H2receptor antagonist is a potent inhibitor of gastric acid secretion", "relationMentions": [{"em1Text": "Nizatidine", "em2Text": "histamine H2receptor", "label": "CPR:6"}, {"em1Text": "LY139037", "em2Text": "histamine H2receptor", "label": "CPR:6"}]}
{"sentText": "Based on these suggestions the rational redesign of furanopyrimidine 24 clog P=741 Aurora A IC50 =43 nM HCT116 IC50 =400 nM led to the identification of quinazoline 67 clog P=528 Aurora A IC50 =25 nM HCT116 IC50 =23 nM", "relationMentions": [{"em1Text": "furanopyrimidine", "em2Text": "Aurora A", "label": "CPR:4"}, {"em1Text": "Aurora A", "em2Text": "quinazoline", "label": "CPR:4"}]}
{"sentText": "Three different 3DQSAR models were built and validated by using a set of 66 pyrazole Model I and furanopyrimidine Model II compounds with IC50 values toward Aurora kinase A ranging from 33 nM to 105 \u03bcM", "relationMentions": [{"em1Text": "pyrazole", "em2Text": "Aurora kinase A", "label": "CPR:4"}, {"em1Text": "furanopyrimidine", "em2Text": "Aurora kinase A", "label": "CPR:4"}]}
{"sentText": "3DQSARassisted drug design identification of a potent quinazoline based Aurora kinase inhibitor", "relationMentions": [{"em1Text": "quinazoline", "em2Text": "Aurora kinase", "label": "CPR:4"}]}
{"sentText": "Chelation of calcium ions by BAPTAAM or blockade of ERK12 activation by UO126 also prevented the NMDA effects", "relationMentions": [{"em1Text": "ERK12", "em2Text": "UO126", "label": "CPR:4"}]}
{"sentText": "Thus prolonged activation of NMDA receptors in hippocampal neurons reduced GABAR \u03b4 subunit expression through Ca2 entry and at least in part by ERK12 activation", "relationMentions": [{"em1Text": "GABAR \u03b4 subunit", "em2Text": "Ca2", "label": "CPR:4"}]}
{"sentText": "Amitriptyline but not any other tricyclic or selective serotonin reuptake inhibitor antidepressants promotes TrkA autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells", "relationMentions": [{"em1Text": "Amitriptyline", "em2Text": "TrkA", "label": "CPR:3"}]}
{"sentText": "Thus amitriptyline acts as a TrkA and TrkB agonist and possesses marked neurotrophic activity", "relationMentions": [{"em1Text": "amitriptyline", "em2Text": "TrkB", "label": "CPR:5"}, {"em1Text": "amitriptyline", "em2Text": "TrkA", "label": "CPR:5"}]}
{"sentText": "Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkATrkB heterodimerization and has potent neurotrophic activity", "relationMentions": [{"em1Text": "Amitriptyline", "em2Text": "TrkA", "label": "CPR:5"}, {"em1Text": "Amitriptyline", "em2Text": "TrkB", "label": "CPR:5"}]}
{"sentText": "Increased phosphorylation of p95ErbB2 and AKT in response to HRG was abrogated to varying degrees by GW572016", "relationMentions": [{"em1Text": "p95ErbB2", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "AKT", "em2Text": "GW572016", "label": "CPR:4"}]}
{"sentText": "GW572016 a reversible small molecule inhibitor of EGFR and ErbB2 tyrosine kinases inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts", "relationMentions": [{"em1Text": "GW572016", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "ErbB2", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "tyrosine kinases", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "p95ErbB2", "label": "CPR:4"}]}
{"sentText": "Inhibition of p95ErbB2 p185ErbB2 and EGFR phosphorylation by GW572016 resulted in the inhibition of downstream phospho Erk12 phospho AKT and cyclin D steadystate protein levels", "relationMentions": [{"em1Text": "p95ErbB2", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "p185ErbB2", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "Erk12", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "AKT", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "cyclin D", "label": "CPR:4"}]}
{"sentText": "Truncated ErbB2 receptor p95ErbB2 is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR ErbB2 kinase inhibitor GW572016", "relationMentions": [{"em1Text": "ErbB2", "em2Text": "GW572016", "label": "CPR:4"}]}
{"sentText": "Sulindac sulfide inhibited PPARdelta protein expression and PPARdelta transcriptional activity", "relationMentions": [{"em1Text": "Sulindac sulfide", "em2Text": "PPARdelta", "label": "CPR:4"}, {"em1Text": "Sulindac sulfide", "em2Text": "PPARdelta", "label": "CPR:4"}]}
{"sentText": "Sulindac sulfide inhibited 1433epsilon proteins in HT29 and DLD1 cells in a time and concentrationdependent manner", "relationMentions": [{"em1Text": "Sulindac sulfide", "em2Text": "1433epsilon proteins", "label": "CPR:4"}]}
{"sentText": "Indomethacin and SC236 a selective cyclooxygenase2 COX2 inhibitor exerted a similar effect as sulindac", "relationMentions": [{"em1Text": "Indomethacin", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "Indomethacin", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "SC236", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "SC236", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Synergistic cytotoxicity was demonstrated and pemetrexed significantly decreased the amount of phosphorylated Akt enhanced apoptosis and increased the expression of dCK in A549 and Calu6 cells as well as the expression of the human nucleoside equilibrative transporter 1 hENT1 in all cell lines", "relationMentions": [{"em1Text": "pemetrexed", "em2Text": "dCK", "label": "CPR:3"}, {"em1Text": "pemetrexed", "em2Text": "human nucleoside equilibrative transporter 1", "label": "CPR:3"}, {"em1Text": "pemetrexed", "em2Text": "hENT1", "label": "CPR:3"}, {"em1Text": "pemetrexed", "em2Text": "phosphorylated Akt", "label": "CPR:4"}]}
{"sentText": "These data demonstrated that 1 gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis 2 the gene expression profile of critical genes may predict for drug chemosensitivity and 3 pemetrexed enhances dCK and hENT1 expression thus suggesting the role of geneexpression modulation for rational development of chemotherapy combinations", "relationMentions": [{"em1Text": "pemetrexed", "em2Text": "dCK", "label": "CPR:3"}, {"em1Text": "pemetrexed", "em2Text": "hENT1", "label": "CPR:3"}, {"em1Text": "gemcitabine", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "pemetrexed", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Kynurenic acid KA is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors", "relationMentions": [{"em1Text": "Kynurenic acid", "em2Text": "glutamate receptor", "label": "CPR:6"}, {"em1Text": "Kynurenic acid", "em2Text": "ionotropic glutamate receptors", "label": "CPR:6"}, {"em1Text": "KA", "em2Text": "glutamate receptor", "label": "CPR:6"}, {"em1Text": "KA", "em2Text": "ionotropic glutamate receptors", "label": "CPR:6"}]}
{"sentText": "One of the enzymes responsible for the production of KA kynurenine aminotransferase I KATI also catalyses the reversible transamination of glutamine to oxoglutaramic acid GTK EC 26115", "relationMentions": [{"em1Text": "KA", "em2Text": "kynurenine aminotransferase I", "label": "CPR:9"}, {"em1Text": "KA", "em2Text": "KATI", "label": "CPR:9"}, {"em1Text": "kynurenine aminotransferase I", "em2Text": "glutamine", "label": "CPR:9"}, {"em1Text": "KATI", "em2Text": "glutamine", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "GTK", "label": "CPR:9"}, {"em1Text": "kynurenine aminotransferase I", "em2Text": "oxoglutaramic acid", "label": "CPR:9"}, {"em1Text": "KATI", "em2Text": "oxoglutaramic acid", "label": "CPR:9"}, {"em1Text": "oxoglutaramic acid", "em2Text": "GTK", "label": "CPR:9"}, {"em1Text": "oxoglutaramic acid", "em2Text": "EC 26115", "label": "CPR:9"}]}
{"sentText": "Combined treatment of Mn and DA further augments cell toxicity ROS production and JNK phosphorylation in LRRK2 deficient cells compared to controls", "relationMentions": [{"em1Text": "Mn", "em2Text": "JNK", "label": "CPR:3"}]}
{"sentText": "Although the treatment with MSG increased IRS1 tyrosine phosphorylation pIRS1 by 96 MSG 1702 \u00b1 06 control 87 \u00b1 02 au", "relationMentions": [{"em1Text": "MSG", "em2Text": "pIRS1", "label": "CPR:3"}, {"em1Text": "MSG", "em2Text": "pIRS1", "label": "CPR:3"}]}
{"sentText": "on the other hand exercise training increased pIR by 76 in MSG mice without affecting control mice MSG 118 \u00b1 03 control 128 \u00b1 02 au", "relationMentions": [{"em1Text": "pIR", "em2Text": "MSG", "label": "CPR:4"}, {"em1Text": "pIR", "em2Text": "MSG", "label": "CPR:4"}]}
{"sentText": "The results showed that IR tyrosine phosphorylation pIR was reduced by 42 in MSGobese mice MSG 67 \u00b1 02 arbitrary units au", "relationMentions": [{"em1Text": "pIR", "em2Text": "MSG", "label": "CPR:4"}, {"em1Text": "pIR", "em2Text": "MSG", "label": "CPR:4"}]}
{"sentText": "With the use of sildenafil it has been clearly clinically demonstrated that the selective inhibition of PDE5 is an appropriate effective safe method for the treatment of ED of all aetiologies and severities", "relationMentions": [{"em1Text": "sildenafil", "em2Text": "PDE5", "label": "CPR:4"}]}
{"sentText": "Many clinical studies both pre and postmarketing have demonstrated the clinical efficacy and safety of sildenafil Viagra Pfizer the first approved selective PDE inhibitor for the treatment of ED", "relationMentions": [{"em1Text": "sildenafil", "em2Text": "PDE", "label": "CPR:4"}, {"em1Text": "Viagra", "em2Text": "PDE", "label": "CPR:4"}]}
{"sentText": "Sildenafil is inhibitory of PDE5 at a rate tenfold higher than for the next PDE PDE6 which produces visual changes through the retinal rods", "relationMentions": [{"em1Text": "Sildenafil", "em2Text": "PDE5", "label": "CPR:4"}, {"em1Text": "Sildenafil", "em2Text": "PDE", "label": "CPR:4"}, {"em1Text": "Sildenafil", "em2Text": "PDE6", "label": "CPR:4"}]}
{"sentText": "The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of PDE5 that breaks down cGMP the key pathway for the production of erectile function in humans", "relationMentions": [{"em1Text": "PDE5", "em2Text": "cGMP", "label": "CPR:9"}]}
{"sentText": "cAspAT activity as well as the incorporation of 14Caspartate into the neutral lipid fraction of 3T3F442A adipocytes was stimulated by the thiazolidinedione TZD rosiglitazone", "relationMentions": [{"em1Text": "cAspAT", "em2Text": "thiazolidinedione", "label": "CPR:3"}, {"em1Text": "cAspAT", "em2Text": "TZD", "label": "CPR:3"}, {"em1Text": "cAspAT", "em2Text": "rosiglitazone", "label": "CPR:3"}]}
{"sentText": "RORalpha ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone and its protein amount in nuclear extracts is 18fold increased by rosiglitazone treatment of adipocytes", "relationMentions": [{"em1Text": "RORalpha", "em2Text": "rosiglitazone", "label": "CPR:3"}, {"em1Text": "cAspAT", "em2Text": "rosiglitazone", "label": "CPR:3"}]}
{"sentText": "Finally the amounts of RORalpha and cAspAT mRNAs were similarly increased by TZD treatment of human adipose tissue explants confirming coordinated regulation", "relationMentions": [{"em1Text": "RORalpha", "em2Text": "TZD", "label": "CPR:3"}, {"em1Text": "cAspAT", "em2Text": "TZD", "label": "CPR:3"}]}
{"sentText": "Our data identify cAspAT as a new member of glyceroneogenesis transcriptionally regulated by TZD via the control of RORalpha expression by PPARgamma in adipocytes", "relationMentions": [{"em1Text": "cAspAT", "em2Text": "TZD", "label": "CPR:3"}]}
{"sentText": "The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax a selective inhibitor of both BCL2 and BCL2like 1 BCLXL which has shown clinical efficacy in some BCL2dependent hematological cancers", "relationMentions": [{"em1Text": "navitoclax", "em2Text": "BCL2", "label": "CPR:4"}, {"em1Text": "navitoclax", "em2Text": "BCL2like 1", "label": "CPR:4"}, {"em1Text": "navitoclax", "em2Text": "BCLXL", "label": "CPR:4"}]}
{"sentText": "Here we report the reengineering of navitoclax to create a highly potent orally bioavailable and BCL2 selective inhibitor ABT199", "relationMentions": [{"em1Text": "navitoclax", "em2Text": "BCL2", "label": "CPR:4"}, {"em1Text": "BCL2", "em2Text": "ABT199", "label": "CPR:4"}]}
{"sentText": "ABT199 a potent and selective BCL2 inhibitor achieves antitumor activity while sparing platelets", "relationMentions": [{"em1Text": "ABT199", "em2Text": "BCL2", "label": "CPR:4"}]}
{"sentText": "Suppression of T\u03b2R1 by the pharmacological inhibitor SB431542 markedly reduced VEGF release by HFL1 in response to CSE and this effect was confirmed by T\u03b2R1 siRNA", "relationMentions": [{"em1Text": "T\u03b2R1", "em2Text": "SB431542", "label": "CPR:4"}, {"em1Text": "SB431542", "em2Text": "VEGF", "label": "CPR:4"}]}
{"sentText": "NCFP binds to the CPPHA site on mGlu5 and potentiates mGlu5 mediated responses in both recombinant and native systems", "relationMentions": [{"em1Text": "NCFP", "em2Text": "mGlu5", "label": "CPR:3"}]}
{"sentText": "Combination treatment with the selective 5HT1A antagonist WAY100635 produced a dosedependent augmentation of venlafaxineinduced 330 mgkg sc extracellular 5HT concentrations but had no further effect on NA above that produced by venlafaxine alone", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "WAY100635", "label": "CPR:6"}]}
{"sentText": "The betaadrenergic 5HT1A receptor antagonist pindolol and the selective 5HT1BD antagonist GR127935 produced no significant augmentation of venlafaxineinduced changes in either 5HT or NA", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "pindolol", "label": "CPR:6"}]}
{"sentText": "However topiramate at low concentrations causes slow inhibition of GluR5 kainate receptormediated synaptic currents in the basolateral amygdala indicating that it may protect against seizures at least in part through suppression of GluR5 kainate receptor responses", "relationMentions": [{"em1Text": "topiramate", "em2Text": "GluR5", "label": "CPR:4"}, {"em1Text": "topiramate", "em2Text": "kainate receptor", "label": "CPR:4"}, {"em1Text": "topiramate", "em2Text": "GluR5", "label": "CPR:4"}, {"em1Text": "topiramate", "em2Text": "kainate receptor", "label": "CPR:4"}]}
{"sentText": "The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the GluR5 kainate receptor antagonist LY293558", "relationMentions": [{"em1Text": "GluR5", "em2Text": "LY293558", "label": "CPR:6"}, {"em1Text": "kainate receptor", "em2Text": "LY293558", "label": "CPR:6"}]}
{"sentText": "The ultimate carcinogenic Phase I BP metabolite antiBP78dihydrodiol910epoxide BPDE can be detoxified by glutathione conjugate formation catalyzed by glutathione Stransferases", "relationMentions": [{"em1Text": "glutathione", "em2Text": "glutathione Stransferases", "label": "CPR:9"}]}
{"sentText": "Multidrug resistanceassociated proteins are involved in the transport of the glutathione conjugates of the ultimate carcinogen of benzoapyrene in human Caco2 cells", "relationMentions": [{"em1Text": "Multidrug resistanceassociated proteins", "em2Text": "glutathione", "label": "CPR:9"}]}
{"sentText": "Inhibition studies revealed that the multidrug resistanceassociated proteins ABCCs are involved in the transport of BPDE glutathione conjugates", "relationMentions": [{"em1Text": "multidrug resistanceassociated proteins", "em2Text": "BPDE glutathione", "label": "CPR:9"}, {"em1Text": "ABCCs", "em2Text": "BPDE glutathione", "label": "CPR:9"}]}
{"sentText": "Stable ABCC1 ABCC2 and ABCC3 knockdown cell lines were generated thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of BPDE glutathione conjugates", "relationMentions": [{"em1Text": "ABCC1", "em2Text": "BPDE glutathione", "label": "CPR:9"}, {"em1Text": "ABCC2", "em2Text": "BPDE glutathione", "label": "CPR:9"}, {"em1Text": "ABCC1", "em2Text": "BPDE glutathione", "label": "CPR:9"}, {"em1Text": "ABCC2", "em2Text": "BPDE glutathione", "label": "CPR:9"}]}
{"sentText": "Pretreatment of human breast carcinoma MCF7 cells for 24 h with the groundnut extract and soybean isoflavone increased gene expression of heme oxygenase1 HO1 a major antioxidative stress enzyme", "relationMentions": [{"em1Text": "isoflavone", "em2Text": "heme oxygenase1", "label": "CPR:3"}, {"em1Text": "isoflavone", "em2Text": "HO1", "label": "CPR:3"}]}
{"sentText": "Comparison of cyclooxygenase inhibitory activity and ocular antiinflammatory effects of ketorolac tromethamine and bromfenac sodium", "relationMentions": [{"em1Text": "cyclooxygenase", "em2Text": "bromfenac sodium", "label": "CPR:4"}, {"em1Text": "cyclooxygenase", "em2Text": "ketorolac tromethamine", "label": "CPR:4"}]}
{"sentText": "RESULTS Ketorolac was six times more active against COX1 IC50 = 002 microM than COX2 IC50 = 012 microM while bromfenac was approximately 32 times more active against COX2 IC50 = 00066 microM than COX1 IC50 = 0210 microM", "relationMentions": [{"em1Text": "Ketorolac", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "Ketorolac", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "bromfenac", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "bromfenac", "label": "CPR:4"}]}
{"sentText": "METHODS Cyclooxygenase activity and selectivity was determined in vitro by measuring prostaglandin E2 PGE2 production following incubation of varying concentrations of NSAID with human recombinant COX1 or COX2 and arachidonic acid", "relationMentions": [{"em1Text": "Cyclooxygenase", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "Cyclooxygenase", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "EP1 and EP3 receptor antagonists ONO8713 and ONOAE3240 but not the EP4 antagonists ONOAE3208 and AH 23848 inhibited tumor cell proliferation indicating the significance of EP1 and EP3 but not EP4 for MB growth", "relationMentions": [{"em1Text": "EP1", "em2Text": "ONO8713", "label": "CPR:6"}, {"em1Text": "EP3 receptor", "em2Text": "ONO8713", "label": "CPR:6"}, {"em1Text": "EP1", "em2Text": "ONOAE3240", "label": "CPR:6"}, {"em1Text": "EP3 receptor", "em2Text": "ONOAE3240", "label": "CPR:6"}, {"em1Text": "EP4", "em2Text": "ONOAE3208", "label": "CPR:6"}, {"em1Text": "EP4", "em2Text": "AH 23848", "label": "CPR:6"}]}
{"sentText": "Tumorgrowthpromoting cyclooxygenase2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "prostaglandin E2", "label": "CPR:9"}]}
{"sentText": "PGE2 is synthesized from arachidonic acid by cyclooxygenases COX and prostaglandin E synthases PGES and mediates its biological activity through binding to the four prostanoid receptors EP1 through EP4", "relationMentions": [{"em1Text": "PGE2", "em2Text": "cyclooxygenases", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "COX", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "prostaglandin E synthases", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "PGES", "label": "CPR:9"}, {"em1Text": "arachidonic acid", "em2Text": "cyclooxygenases", "label": "CPR:9"}, {"em1Text": "arachidonic acid", "em2Text": "COX", "label": "CPR:9"}, {"em1Text": "arachidonic acid", "em2Text": "prostaglandin E synthases", "label": "CPR:9"}, {"em1Text": "arachidonic acid", "em2Text": "PGES", "label": "CPR:9"}]}
{"sentText": "Inhibitors of PDE4 rolipram 0110 microM and PDE3 cilostazol 0110 microM delayed spontaneous eosinophil apoptosis maximally by 25 and 15 respectively", "relationMentions": [{"em1Text": "PDE4", "em2Text": "rolipram", "label": "CPR:4"}, {"em1Text": "PDE3", "em2Text": "cilostazol", "label": "CPR:4"}]}
{"sentText": "Inhibitor of cGMPspecific PDE5 zaprinast 0110 microM did not affect eosinophil apoptosis and only slightly increased spontaneous neutrophil apoptosis", "relationMentions": [{"em1Text": "cGMPspecific PDE5", "em2Text": "zaprinast", "label": "CPR:4"}]}
{"sentText": "GW9662 a PPARgamma antagonist prevented P 001 the luteininduced iNOS mRNA downregulation in HD11 cells", "relationMentions": [{"em1Text": "GW9662", "em2Text": "iNOS", "label": "CPR:3"}, {"em1Text": "GW9662", "em2Text": "PPARgamma", "label": "CPR:6"}]}
{"sentText": "We hypothesized that the HED compounds would be most potent at the norepinephrine transporter NET compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers", "relationMentions": [{"em1Text": "HED", "em2Text": "norepinephrine transporter", "label": "CPR:4"}, {"em1Text": "HED", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "Stereospecific inhibition of monoamine uptake transporters by metahydroxyephedrine isomers", "relationMentions": [{"em1Text": "monoamine uptake transporters", "em2Text": "metahydroxyephedrine", "label": "CPR:4"}]}
{"sentText": "To extend structureactivity analyses of binding sites within monoamine transporters and to determine which stereoisomer displayed the best selectivity for PET imaging applications we tested the HED compounds for their abilities to inhibit 3Hneurotransmitter uptake into platelets transfected cells and chromaffin vesicles", "relationMentions": [{"em1Text": "monoamine transporters", "em2Text": "HED", "label": "CPR:4"}]}
{"sentText": "TCDD inhibition of canonical wnt signaling disrupts prostatic bud formation in mouse urogenital sinus", "relationMentions": [{"em1Text": "TCDD", "em2Text": "wnt", "label": "CPR:4"}]}
{"sentText": "Thus the TCDD induced reduction in canonical Wnt signaling is associated with a decrease in activators Rspo2 and Rspo3 rather than an increase in inhibitors Dkk1 and Dkk2 of the pathway", "relationMentions": [{"em1Text": "TCDD", "em2Text": "Wnt", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "Rspo2", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "Rspo3", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "Dkk1", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "Dkk2", "label": "CPR:4"}]}
{"sentText": "This study focuses on determining whether treatment of TCDDexposed UGS organ cultures with RSPO2 andor RSPO3 is capable of rescuing the inhibitory effects of TCDD on canonical Wnt signaling and prostatic bud formation", "relationMentions": [{"em1Text": "TCDD", "em2Text": "Wnt", "label": "CPR:4"}]}
{"sentText": "We discovered that each RSPO alone or in combination partially rescues TCDD inhibition of both canonical Wnt signaling and prostatic bud formation", "relationMentions": [{"em1Text": "TCDD", "em2Text": "Wnt", "label": "CPR:4"}]}
{"sentText": "Moreover overexpressed CYP2J2 and EETs inhibited Ang II induced macrophage migration in a VSMCmacrophage coculture system", "relationMentions": [{"em1Text": "EETs", "em2Text": "Ang II", "label": "CPR:4"}]}
{"sentText": "In cultured vascular smooth muscle cells VSMCs rAAVmediated CYP2J2 overexpression and EETs markedly suppressed Ang II induced inflammatory cytokine expression", "relationMentions": [{"em1Text": "EETs", "em2Text": "Ang II", "label": "CPR:4"}, {"em1Text": "EETs", "em2Text": "cytokine", "label": "CPR:4"}]}
{"sentText": "Cytochrome P450 epoxygenase 2J2 CYP2J2 metabolizes arachidonic acids to form epoxyeicosatrienoic acids EETs which possess various beneficial effects on the cardiovascular system", "relationMentions": [{"em1Text": "Cytochrome P450 epoxygenase 2J2", "em2Text": "EETs", "label": "CPR:9"}, {"em1Text": "CYP2J2", "em2Text": "EETs", "label": "CPR:9"}, {"em1Text": "Cytochrome P450 epoxygenase 2J2", "em2Text": "arachidonic acids", "label": "CPR:9"}, {"em1Text": "CYP2J2", "em2Text": "arachidonic acids", "label": "CPR:9"}, {"em1Text": "Cytochrome P450 epoxygenase 2J2", "em2Text": "epoxyeicosatrienoic acids", "label": "CPR:9"}, {"em1Text": "CYP2J2", "em2Text": "epoxyeicosatrienoic acids", "label": "CPR:9"}]}
{"sentText": "However whether increasing EETs production by CYP2J2 overexpression in vivo could prevent abdominal aortic aneurysm AAA remains unknown", "relationMentions": [{"em1Text": "EETs", "em2Text": "CYP2J2", "label": "CPR:9"}]}
{"sentText": "A decrease in ADA activity was observed when the slices were exposed to organoselenium at the concentrations of 1 10 and 30 \u00b5M", "relationMentions": [{"em1Text": "ADA", "em2Text": "organoselenium", "label": "CPR:4"}]}
{"sentText": "Cotreatments of 5 10 and 20 \u00b5gmL concentrations of MEP with aflatoxin B1 decreased the frequencies of SCE and the malondialdehyde level and increased amount of superoxide dismutase glutathione and glutathione peroxidase which were decreased by aflatoxin", "relationMentions": [{"em1Text": "aflatoxin B1", "em2Text": "superoxide dismutase", "label": "CPR:3"}, {"em1Text": "aflatoxin", "em2Text": "glutathione peroxidase", "label": "CPR:4"}]}
{"sentText": "Phenobarbital PB a typical CAR activator increased the gene expression of HIFtarget genes in the livers of mice including erythropoietin heme oxygenase1 and vascular endothelial growth factora", "relationMentions": [{"em1Text": "Phenobarbital", "em2Text": "CAR", "label": "CPR:3"}, {"em1Text": "Phenobarbital", "em2Text": "erythropoietin", "label": "CPR:3"}, {"em1Text": "Phenobarbital", "em2Text": "heme oxygenase1", "label": "CPR:3"}, {"em1Text": "Phenobarbital", "em2Text": "vascular endothelial growth factora", "label": "CPR:3"}]}
{"sentText": "Cobalt chloride a typical HIF activator induced the gene expression of CARtarget genes including cyp2b9 and cyp2b10 an accumulation of nuclear CAR and an increase in the PBresponsive enhancer modulemediated transactivation in the mouse liver", "relationMentions": [{"em1Text": "Cobalt chloride", "em2Text": "HIF", "label": "CPR:3"}, {"em1Text": "Cobalt chloride", "em2Text": "cyp2b9", "label": "CPR:3"}, {"em1Text": "Cobalt chloride", "em2Text": "cyp2b10", "label": "CPR:3"}]}
{"sentText": "The beta subunit has been cloned and shown to lower the Km of methionine adenosyltransferase II alpha2 the MAT2A product for methionine and to render the enzyme more susceptible to Sadenosylmethionine inhibition", "relationMentions": [{"em1Text": "methionine adenosyltransferase II alpha2", "em2Text": "Sadenosylmethionine", "label": "CPR:4"}, {"em1Text": "MAT2A", "em2Text": "Sadenosylmethionine", "label": "CPR:4"}, {"em1Text": "methionine", "em2Text": "methionine adenosyltransferase II alpha2", "label": "CPR:9"}, {"em1Text": "methionine", "em2Text": "MAT2A", "label": "CPR:9"}]}
{"sentText": "BACKGROUND AIMS Of the 2 genes MAT1A MAT2A encoding methionine adenosyltransferase the enzyme that synthesizes Sadenosylmethionine MAT1A is expressed in liver whereas MAT2A is expressed in extrahepatic tissues", "relationMentions": [{"em1Text": "MAT1A", "em2Text": "Sadenosylmethionine", "label": "CPR:9"}, {"em1Text": "MAT1A", "em2Text": "Sadenosylmethionine", "label": "CPR:9"}, {"em1Text": "MAT2A", "em2Text": "Sadenosylmethionine", "label": "CPR:9"}, {"em1Text": "methionine adenosyltransferase", "em2Text": "Sadenosylmethionine", "label": "CPR:9"}]}
{"sentText": "Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A", "relationMentions": [{"em1Text": "CB1", "em2Text": "SR 141716A", "label": "CPR:6"}]}
{"sentText": "The channel activators avermectin and moxidectin usually retain their inhibitory potency in the Rdl subunit mutants", "relationMentions": [{"em1Text": "avermectin", "em2Text": "Rdl", "label": "CPR:4"}, {"em1Text": "moxidectin", "em2Text": "Rdl", "label": "CPR:4"}]}
{"sentText": "At 106M in transcription assays none of these compounds showed progestin agonist activity whereas mifepristone and its monodemethylated metabolite manifested slight glucocorticoid agonist activity", "relationMentions": [{"em1Text": "mifepristone", "em2Text": "glucocorticoid", "label": "CPR:5"}]}
{"sentText": "5Fluorouracil 5FU 5fluoro2deoxyuridine FdUrd and 5trifluorothymidine F3dThd are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase TS", "relationMentions": [{"em1Text": "5FU", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "5FU", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "5Fluorouracil", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "5Fluorouracil", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "5fluoro2deoxyuridine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "5fluoro2deoxyuridine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "FdUrd", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "FdUrd", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "5trifluorothymidine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "5trifluorothymidine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "F3dThd", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "F3dThd", "em2Text": "TS", "label": "CPR:4"}]}
{"sentText": "When DLD1FdUrd cells expressing increased TS mRNA were treated with FdUrd and F3dThd for only 4 h the resistance ratios of DLD1FdUrd cells to parental DLD1 cells were markedly different for FdUrd and F3dThd suggesting that the cytotoxicity with shorttime exposure to F3dThd is due to a mechanism other than TS inhibition although the cytotoxicity of F3dThd in the shorttime is low compared to that of longtime exposure", "relationMentions": [{"em1Text": "TS", "em2Text": "F3dThd", "label": "CPR:4"}]}
{"sentText": "In conclusion F3dThd an antimetabolite that inhibits TS activity may be effective against 5FU andor FdUrdresistance in colorectal cancer cells caused by amplification of TS andor deletion of orotate phosphoribosyltransferase", "relationMentions": [{"em1Text": "F3dThd", "em2Text": "TS", "label": "CPR:4"}]}
{"sentText": "The failure of the myometrium to respond to ritodrine desensitization was associated with significant reductions in agonistinduced cyclic adenosine monophosphate production and beta 2adrenergic receptor concentration in myometrial tissue collected from these animals compared with the saline solutiontreated controls", "relationMentions": [{"em1Text": "ritodrine", "em2Text": "beta 2adrenergic receptor", "label": "CPR:4"}]}
{"sentText": "Antiarrhythmic effects of epicatechin3gallate a novel sodium channel agonist in cultured neonatal rat ventricular myocytes", "relationMentions": [{"em1Text": "epicatechin3gallate", "em2Text": "sodium channel", "label": "CPR:5"}]}
{"sentText": "Liver BHMT activity was 13fold higher in rats fed the Met deficient diet containing choline which was reflected in corresponding increases in mRNA content and immunodetectable protein", "relationMentions": [{"em1Text": "BHMT", "em2Text": "choline", "label": "CPR:3"}]}
{"sentText": "Independent of dietary choline supplemental Met increased hepatic BHMT activity approximately 30", "relationMentions": [{"em1Text": "choline", "em2Text": "BHMT", "label": "CPR:3"}, {"em1Text": "Met", "em2Text": "BHMT", "label": "CPR:3"}]}
{"sentText": "Choline dehydrogenase CHDH and betainehomocysteine methyltransferase BHMT are 2 enzymes involved in choline oxidation", "relationMentions": [{"em1Text": "Choline dehydrogenase", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "CHDH", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "betainehomocysteine methyltransferase", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "BHMT", "em2Text": "choline", "label": "CPR:9"}]}
{"sentText": "DNA methyltransferase 3a expression was increased in all BPA males and BPA 05 females and reduced in BPA 200 females", "relationMentions": [{"em1Text": "DNA methyltransferase 3a", "em2Text": "BPA", "label": "CPR:3"}, {"em1Text": "DNA methyltransferase 3a", "em2Text": "BPA", "label": "CPR:3"}, {"em1Text": "DNA methyltransferase 3a", "em2Text": "BPA", "label": "CPR:4"}]}
{"sentText": "The calcium homeostasis proteins sarcoendoplasmic reticulum ATPase 2a SERCA2a sodium calcium exchanger1 phospholamban PLB phosphoPLB and calsequestrin 2 are important for contraction and relaxation", "relationMentions": [{"em1Text": "calcium", "em2Text": "PLB", "label": "CPR:9"}, {"em1Text": "calcium", "em2Text": "phosphoPLB", "label": "CPR:9"}, {"em1Text": "calcium", "em2Text": "calsequestrin 2", "label": "CPR:9"}, {"em1Text": "calcium", "em2Text": "sarcoendoplasmic reticulum ATPase 2a", "label": "CPR:9"}, {"em1Text": "calcium", "em2Text": "SERCA2a", "label": "CPR:9"}, {"em1Text": "calcium", "em2Text": "sodium calcium exchanger1", "label": "CPR:9"}, {"em1Text": "calcium", "em2Text": "phospholamban", "label": "CPR:9"}]}
{"sentText": "The results showed that wogonoside promotes the expression of LC3II and Beclin1", "relationMentions": [{"em1Text": "wogonoside", "em2Text": "LC3II", "label": "CPR:3"}, {"em1Text": "wogonoside", "em2Text": "Beclin1", "label": "CPR:3"}]}
{"sentText": "Wogonoside also suppressed the activation of mammalian target of rapamycin mTOR and p70S6 kinase p70S6K by regulating the expression of the extracellular signalregulated kinase ERK12 and p38 involved mitogenactivated protein kinase MAPK signaling pathway", "relationMentions": [{"em1Text": "Wogonoside", "em2Text": "p70S6 kinase", "label": "CPR:4"}, {"em1Text": "Wogonoside", "em2Text": "p70S6K", "label": "CPR:4"}, {"em1Text": "Wogonoside", "em2Text": "mammalian target of rapamycin", "label": "CPR:4"}, {"em1Text": "Wogonoside", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "The mitochondrial respiratory chain complex IV cytochrome c oxidase is a multisubunit enzyme that transfers electrons from cytochrome c to molecular oxygen yielding water", "relationMentions": [{"em1Text": "mitochondrial respiratory chain complex IV", "em2Text": "oxygen", "label": "CPR:9"}, {"em1Text": "cytochrome c oxidase", "em2Text": "oxygen", "label": "CPR:9"}]}
{"sentText": "Similarly pelargonidin induced the expression of CYP1A1 mRNA up to 5fold in HepG2 and LS174T cells relative to the induction by 5 nM 2378tetrachlorodibenzodioxin TCDD the most potent activator of AhR", "relationMentions": [{"em1Text": "pelargonidin", "em2Text": "CYP1A1", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "2378tetrachlorodibenzodioxin", "label": "CPR:3"}, {"em1Text": "2378tetrachlorodibenzodioxin", "em2Text": "AhR", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "AhR", "label": "CPR:3"}]}
{"sentText": "CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures approximately 5 of TCDD potency and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme", "relationMentions": [{"em1Text": "CYP1A1", "em2Text": "pelargonidin", "label": "CPR:3"}, {"em1Text": "CYP1A2", "em2Text": "pelargonidin", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "pelargonidin", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "pelargonidin", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "CYP1A2", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "TCDD", "label": "CPR:3"}]}
{"sentText": "Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T", "relationMentions": [{"em1Text": "Pelargonidin", "em2Text": "AhR", "label": "CPR:3"}]}
{"sentText": "Overall although most anthocyanidins had no effects on AhRCYP1A1 signaling pelargonidin can bind to and activate the AhR and AhRdependent gene expression and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity", "relationMentions": [{"em1Text": "AhR", "em2Text": "pelargonidin", "label": "CPR:3"}, {"em1Text": "CYP1A1", "em2Text": "pelargonidin", "label": "CPR:4"}, {"em1Text": "CYP1A1", "em2Text": "delphinidin", "label": "CPR:4"}]}
{"sentText": "AhR dependent reporter gene expression in transfected HepG2 cells was increased by pelargonidin in a concentrationdependent manner at 24h", "relationMentions": [{"em1Text": "AhR", "em2Text": "pelargonidin", "label": "CPR:3"}]}
{"sentText": "Enzyme kinetic analyses using human liver microsomes revealed inhibition of CYP1A1 activity by delphinidin IC50 78 \u03bcM and pelargonidin IC50 33 \u03bcM", "relationMentions": [{"em1Text": "CYP1A1", "em2Text": "delphinidin", "label": "CPR:4"}, {"em1Text": "CYP1A1", "em2Text": "pelargonidin", "label": "CPR:4"}]}
{"sentText": "In HEK293 cells stably transfected with this receptor serotonin elicits a potent stimulation of adenylyl cyclase activity which is blocked by antipsychotic and antidepressant drugs", "relationMentions": [{"em1Text": "serotonin", "em2Text": "adenylyl cyclase", "label": "CPR:3"}]}
{"sentText": "A headtohead comparison between insulin detemir and NPH insulin in women with type 1 diabetes showed that while foetal outcomes did not differ fasting plasma glucose improved with insulin detemir without an increased incidence of hypoglycaemia", "relationMentions": [{"em1Text": "insulin", "em2Text": "glucose", "label": "CPR:3"}]}
{"sentText": "OBJECTIVE The aim was to test whether the common deletion T in the promoter of FADS2 affects the PUFA biosynthetic pathway and consequently modifies the effect of alphalinolenic acid ALA on myocardial infarction MI", "relationMentions": [{"em1Text": "FADS2", "em2Text": "alphalinolenic acid", "label": "CPR:9"}, {"em1Text": "FADS2", "em2Text": "ALA", "label": "CPR:9"}, {"em1Text": "FADS2", "em2Text": "PUFA", "label": "CPR:9"}]}
{"sentText": "We evaluated the effects of angiotensin II and an angiotensinconverting enzyme inhibitor cilazapril on nerve blood flow NBF and electrophysiology in control and diabetic rats", "relationMentions": [{"em1Text": "angiotensin II", "em2Text": "cilazapril", "label": "CPR:4"}, {"em1Text": "angiotensinconverting enzyme", "em2Text": "cilazapril", "label": "CPR:4"}]}
{"sentText": "We topically applied the nitric oxide synthase NOS inhibitor NGnitroLarginine on sciatic nerve and observed reduced inhibition of NBF in EDN which was correctable with a cilazapril diet", "relationMentions": [{"em1Text": "NOS", "em2Text": "NGnitroLarginine", "label": "CPR:4"}, {"em1Text": "nitric oxide synthase", "em2Text": "NGnitroLarginine", "label": "CPR:4"}]}
{"sentText": "Cadmium activates NADPH oxidase", "relationMentions": [{"em1Text": "Cadmium", "em2Text": "NADPH oxidase", "label": "CPR:3"}]}
{"sentText": "However after 12h CdCl2 treatment cell viability diminished in 50 accompanied by a drastic decrease of metallothioneinII production and an increase in p53 activation and the proapoptotic protein Bax", "relationMentions": [{"em1Text": "CdCl2", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "CdCl2", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "CdCl2", "em2Text": "metallothioneinII", "label": "CPR:4"}]}
{"sentText": "Thus it can be suggested that the inhibitory action of ginseng saponins against the immobilization stressinduced increase of plasma IL6 level would be in periphery at least in part mediated by blocking norepinephrine andor epinephrine induced increase of IL6 level in macrophage rather than in the brain", "relationMentions": [{"em1Text": "IL6", "em2Text": "epinephrine", "label": "CPR:3"}, {"em1Text": "IL6", "em2Text": "norepinephrine", "label": "CPR:3"}, {"em1Text": "ginseng saponins", "em2Text": "IL6", "label": "CPR:4"}, {"em1Text": "ginseng saponins", "em2Text": "IL6", "label": "CPR:4"}]}
{"sentText": "Ginsenosides Rb2 Rd and Rg1 significantly decreased nor epinephrine andor epinephrine induced increase of IL6 level in macrophage cell line RAW 2647", "relationMentions": [{"em1Text": "epinephrine", "em2Text": "IL6", "label": "CPR:3"}, {"em1Text": "Ginsenosides Rb2 Rd and Rg1", "em2Text": "IL6", "label": "CPR:4"}]}
{"sentText": "The inhibitory effect of ginseng saponins on the stressinduced plasma interleukin6 level in mice", "relationMentions": [{"em1Text": "ginseng saponins", "em2Text": "interleukin6", "label": "CPR:4"}]}
{"sentText": "Ginseng total saponins ginsenosides Rb2 Rg1 and Rd administered intraperitoneally attenuated the immobilization stressinduced increase in plasma IL6 level", "relationMentions": [{"em1Text": "saponins", "em2Text": "IL6", "label": "CPR:4"}, {"em1Text": "ginsenosides Rb2 Rg1 and Rd", "em2Text": "IL6", "label": "CPR:4"}]}
{"sentText": "Improvements from baseline in mean glycosylated haemoglobin HbA1c were significantly greater with sitagliptin monotherapy than with placebo in patients with type 2 diabetes", "relationMentions": [{"em1Text": "glycosylated haemoglobin", "em2Text": "sitagliptin", "label": "CPR:3"}, {"em1Text": "HbA1c", "em2Text": "sitagliptin", "label": "CPR:3"}]}
{"sentText": "As addon therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment sitagliptin improved HbA1c to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to metformin", "relationMentions": [{"em1Text": "sitagliptin", "em2Text": "HbA1c", "label": "CPR:3"}, {"em1Text": "HbA1c", "em2Text": "metformin", "label": "CPR:3"}, {"em1Text": "HbA1c", "em2Text": "pioglitazone", "label": "CPR:3"}, {"em1Text": "HbA1c", "em2Text": "metformin", "label": "CPR:4"}]}
{"sentText": "Sitagliptin an oral dipeptidyl peptidase4 DPP4 inhibitor improves glycaemic control by inhibiting DPP4 inactivation of the incretin hormones glucagonlike peptide1 and glucosedependent insulinotropic polypeptide", "relationMentions": [{"em1Text": "Sitagliptin", "em2Text": "incretin hormones", "label": "CPR:3"}, {"em1Text": "Sitagliptin", "em2Text": "glucagonlike peptide1", "label": "CPR:3"}, {"em1Text": "Sitagliptin", "em2Text": "glucosedependent insulinotropic polypeptide", "label": "CPR:3"}, {"em1Text": "Sitagliptin", "em2Text": "DPP4", "label": "CPR:4"}, {"em1Text": "Sitagliptin", "em2Text": "dipeptidyl peptidase4", "label": "CPR:4"}, {"em1Text": "Sitagliptin", "em2Text": "DPP4", "label": "CPR:4"}]}
{"sentText": "In addition pretreatment with ZValAlaAspfluoromethylketone ZVADfmk a broad spectrum of caspase inhibitor could not rescue apoptotic cells from ClpP toxicity", "relationMentions": [{"em1Text": "ZValAlaAspfluoromethylketone", "em2Text": "caspase", "label": "CPR:4"}, {"em1Text": "ZVADfmk", "em2Text": "caspase", "label": "CPR:4"}]}
{"sentText": "In the long term orlistat has been shown to be more effective than placebo in reducing body weight and serum total and lowdensity lipoprotein cholesterol levels", "relationMentions": [{"em1Text": "orlistat", "em2Text": "lowdensity lipoprotein", "label": "CPR:4"}]}
{"sentText": "Orlistat is a new inhibitor of pancreatic lipase enzyme", "relationMentions": [{"em1Text": "Orlistat", "em2Text": "pancreatic lipase", "label": "CPR:4"}]}
{"sentText": "Genistin decreased myosin light chain kinase MLCK protein contents and MLCK mRNA expression in IJS and inhibited both phosphorylation and Mg2 ATPase activity of purified myosin implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin induced inhibitory effects", "relationMentions": [{"em1Text": "Genistin", "em2Text": "myosin light chain kinase", "label": "CPR:4"}, {"em1Text": "Genistin", "em2Text": "MLCK", "label": "CPR:4"}, {"em1Text": "Genistin", "em2Text": "MLCK", "label": "CPR:4"}, {"em1Text": "Genistin", "em2Text": "ATPase", "label": "CPR:4"}, {"em1Text": "MLCK", "em2Text": "genistin", "label": "CPR:4"}, {"em1Text": "MLCK", "em2Text": "genistin", "label": "CPR:4"}]}
{"sentText": "Moreover curcumin alleviated Sim2 expression and reversely raised Drebrin expression in neurons treated with hyperglycaemia", "relationMentions": [{"em1Text": "curcumin", "em2Text": "Sim2", "label": "CPR:3"}, {"em1Text": "curcumin", "em2Text": "Drebrin", "label": "CPR:3"}]}
{"sentText": "It was found that expression of Sim2 protein in cortical neurons was increased in streptozotocin induced diabetes mellitus rat model", "relationMentions": [{"em1Text": "Sim2", "em2Text": "streptozotocin", "label": "CPR:3"}]}
{"sentText": "Polymorphisms in dopamine transporter SLC6A3 are associated with stimulant effects of Damphetamine an exploratory pharmacogenetic study using healthy volunteers", "relationMentions": [{"em1Text": "SLC6A3", "em2Text": "Damphetamine", "label": "CPR:3"}, {"em1Text": "dopamine transporter", "em2Text": "Damphetamine", "label": "CPR:3"}]}
{"sentText": "Endotheliumdependent relaxations nitric oxide NO and endothelium derived hyperpolarizing factor EDHFtype were studied in rabbit iliac artery and aortic rings using the G proteincoupled receptor agonist acetylcholine ACh and by cyclopiazonic acid CPA which promotes storeoperated Ca2 entry by inhibiting the endothelial SERCA pump", "relationMentions": [{"em1Text": "cyclopiazonic acid", "em2Text": "SERCA", "label": "CPR:4"}, {"em1Text": "CPA", "em2Text": "SERCA", "label": "CPR:4"}, {"em1Text": "G proteincoupled receptor", "em2Text": "acetylcholine", "label": "CPR:5"}, {"em1Text": "G proteincoupled receptor", "em2Text": "ACh", "label": "CPR:5"}]}
{"sentText": "Potentiation was prevented by catalase the catalasesuperoxide dismutase mimetic manganese porphyrin and the NADPH oxidase inhibitor apocynin", "relationMentions": [{"em1Text": "NADPH oxidase", "em2Text": "apocynin", "label": "CPR:4"}]}
{"sentText": "Our results suggest that arsenite can potentiate EDHFtype relaxations via a mechanism that is dependent on hydrogen peroxide thus demonstrating that dismutation of the superoxide anion generated by NADPH oxidase can potentially offset loss of NO bioavailability under conditions of reduced eNOS activity", "relationMentions": [{"em1Text": "superoxide", "em2Text": "NADPH oxidase", "label": "CPR:9"}]}
{"sentText": "We isolated partial cDNAs that codified for enzymes implicated in the anthocyanin biosynthesis such as lphenylalanine ammonialyase PAL and chalcone synthase CHS and an antioxidant enzyme such as ascorbate peroxidase APX", "relationMentions": [{"em1Text": "anthocyanin", "em2Text": "lphenylalanine ammonialyase", "label": "CPR:9"}, {"em1Text": "anthocyanin", "em2Text": "PAL", "label": "CPR:9"}, {"em1Text": "anthocyanin", "em2Text": "chalcone synthase", "label": "CPR:9"}, {"em1Text": "anthocyanin", "em2Text": "CHS", "label": "CPR:9"}, {"em1Text": "anthocyanin", "em2Text": "ascorbate peroxidase", "label": "CPR:9"}, {"em1Text": "anthocyanin", "em2Text": "APX", "label": "CPR:9"}]}
{"sentText": "In vitro acetaminophen elicited a 44fold selectivity toward COX2 inhibition IC50=1137 micromolL for COX1 IC50=258 micromolL for COX2", "relationMentions": [{"em1Text": "acetaminophen", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "acetaminophen", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "acetaminophen", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Acetaminophen plasma concentrations remained above the in vitro IC50 for COX2 for at least 5 h postadministration", "relationMentions": [{"em1Text": "Acetaminophen", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Acetaminophen paracetamol is a selective cyclooxygenase2 inhibitor in man", "relationMentions": [{"em1Text": "Acetaminophen", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "paracetamol", "em2Text": "cyclooxygenase2", "label": "CPR:4"}]}
{"sentText": "Ex vivo IC50 values COX1 1052 micromolL COX2 263 micromolL of acetaminophen compared favorably with its in vitro IC50 values", "relationMentions": [{"em1Text": "COX1", "em2Text": "acetaminophen", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "acetaminophen", "label": "CPR:4"}]}
{"sentText": "In contrast to previous concepts acetaminophen inhibited COX2 by more than 80 ie to a degree comparable to nonsteroidal antiinflammatory drugs NSAIDs and selective COX2 inhibitors", "relationMentions": [{"em1Text": "acetaminophen", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "In view of its substantial COX2 inhibition recently defined cardiovascular warnings for use of COX2 inhibitors should also be considered for acetaminophen", "relationMentions": [{"em1Text": "COX2", "em2Text": "acetaminophen", "label": "CPR:4"}]}
{"sentText": "The fact that acetaminophen acts functionally as a selective COX2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX2 blockade", "relationMentions": [{"em1Text": "acetaminophen", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Ex vivo COX inhibition and pharmacokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally", "relationMentions": [{"em1Text": "COX", "em2Text": "acetaminophen", "label": "CPR:4"}]}
{"sentText": "Coagulationinduced thromboxane B2 and lipopolysaccharideinduced prostaglandin E2 were measured ex vivo and in vitro in human whole blood as indices of COX1 and COX2 activity", "relationMentions": [{"em1Text": "thromboxane B2", "em2Text": "COX1", "label": "CPR:9"}, {"em1Text": "prostaglandin E2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "In the interaction of GAL and CAR AChE inhibition was stronger but without any statistical significance", "relationMentions": [{"em1Text": "GAL", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "OBJECTIVES The alkaloid galantamine GAL which exhibits a combined anticholinesterase and direct parasympathomimetic mechanism of action is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases", "relationMentions": [{"em1Text": "galantamine", "em2Text": "anticholinesterase", "label": "CPR:4"}, {"em1Text": "GAL", "em2Text": "anticholinesterase", "label": "CPR:4"}]}
{"sentText": "NaAsO2 increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of tau and tubulin in a dosedependent manner no significant effect was found in the mRNA levels of the heavy subunit of neurofilament microtubuleassociated protein 2 or actin", "relationMentions": [{"em1Text": "NaAsO2", "em2Text": "light and medium subunits of neurofilament", "label": "CPR:3"}, {"em1Text": "NaAsO2", "em2Text": "tau", "label": "CPR:4"}, {"em1Text": "NaAsO2", "em2Text": "tubulin", "label": "CPR:4"}]}
{"sentText": "A naloxonesteroid hybrid azine with selective and longacting opioid antagonism at delta receptors in vitro", "relationMentions": [{"em1Text": "naloxonesteroid hybrid azine", "em2Text": "delta receptors", "label": "CPR:6"}]}
{"sentText": "In this report we show that the hypolipidemic agent atorvastatin is a competitive inhibitor of porcine DPPIV in vitro with Ki=57823 microM", "relationMentions": [{"em1Text": "atorvastatin", "em2Text": "porcine DPPIV", "label": "CPR:4"}]}
{"sentText": "These results may have implications in the development of novel DPPIV inhibitors based on the use of atorvastatin as a lead compound for the treatment of type 2 diabetes", "relationMentions": [{"em1Text": "DPPIV", "em2Text": "atorvastatin", "label": "CPR:4"}]}
{"sentText": "Inhibition of dipeptidyl peptidaseIV DPPIV by atorvastatin", "relationMentions": [{"em1Text": "dipeptidyl peptidaseIV", "em2Text": "atorvastatin", "label": "CPR:4"}, {"em1Text": "DPPIV", "em2Text": "atorvastatin", "label": "CPR:4"}]}
{"sentText": "In addition we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor\u03b1 TNF\u03b1 interleukin1\u03b2 IL1\u03b2 interleukin6 IL6 and prostaglandin E2 PGE2 in activated BV2 cells", "relationMentions": [{"em1Text": "neoechinulin A", "em2Text": "tumour necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "TNF\u03b1", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "interleukin1\u03b2", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "IL1\u03b2", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "interleukin6", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "IL6", "label": "CPR:4"}]}
{"sentText": "Neoechinulin A suppresses amyloid\u03b2 oligomerinduced microglia activation and thereby protects PC12 cells from inflammationmediated toxicity", "relationMentions": [{"em1Text": "Neoechinulin A", "em2Text": "amyloid\u03b2", "label": "CPR:4"}]}
{"sentText": "The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogenactivated protein kinase MAPK molecule p38 apoptosis signalregulating kinase 1 ASK1 and nuclear translocation of nuclear factor\u03baB NF\u03baB p65 and p50 subunits", "relationMentions": [{"em1Text": "neoechinulin A", "em2Text": "mitogenactivated protein kinase", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "MAPK", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "apoptosis signalregulating kinase 1", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "ASK1", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "nuclear factor\u03baB", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "p50", "label": "CPR:4"}]}
{"sentText": "In this study focus was given to evaluate the ability of neoechinulin A an indole alkaloid isolated from marinederived Microsporum sp to attenuate microglial activation by oligomeric amyloid\u03b2 142 A\u03b242", "relationMentions": [{"em1Text": "neoechinulin A", "em2Text": "amyloid\u03b2 142", "label": "CPR:4"}, {"em1Text": "neoechinulin A", "em2Text": "A\u03b242", "label": "CPR:4"}, {"em1Text": "indole", "em2Text": "amyloid\u03b2 142", "label": "CPR:4"}, {"em1Text": "indole", "em2Text": "A\u03b242", "label": "CPR:4"}]}
{"sentText": "Neoechinulin A treatment significantly inhibited the generation of reactive oxygen and nitrogen species in A\u03b242 activated BV2 microglia cells", "relationMentions": [{"em1Text": "Neoechinulin A", "em2Text": "A\u03b242", "label": "CPR:4"}]}
{"sentText": "Epi increased the activity of the human WNT6 promoter through Cav1dependent binding of \u03b2catenin to the proximal WNT6 promoter", "relationMentions": [{"em1Text": "Epi", "em2Text": "human WNT6 promoter", "label": "CPR:3"}, {"em1Text": "Epi", "em2Text": "WNT6 promoter", "label": "CPR:3"}]}
{"sentText": "Epi increased both WNT6 Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC CEA424SV40 TAg", "relationMentions": [{"em1Text": "Epi", "em2Text": "WNT6", "label": "CPR:3"}, {"em1Text": "Epi", "em2Text": "Wnt6", "label": "CPR:3"}, {"em1Text": "Epi", "em2Text": "Cav1", "label": "CPR:3"}]}
{"sentText": "These results showed that WNT6 and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to anthracycline drugs", "relationMentions": [{"em1Text": "WNT6", "em2Text": "anthracycline", "label": "CPR:3"}, {"em1Text": "Cav1", "em2Text": "anthracycline", "label": "CPR:3"}]}
{"sentText": "In this study using reverse transcriptase PCR RTPCR and ELISA we showed that TCDD upregulated the expression and secretion of tumor necrosis factoralpha TNF\u03b1 in a timedependent manner in cultured HAPI microglial cells", "relationMentions": [{"em1Text": "TCDD", "em2Text": "tumor necrosis factoralpha", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "TNF\u03b1", "label": "CPR:3"}]}
{"sentText": "TCDD also caused a fast within 30min as judged by the increase in its mRNA level activation of cytosolic phospholipase A2 cPLA2", "relationMentions": [{"em1Text": "TCDD", "em2Text": "cytosolic phospholipase A2", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "cPLA2", "label": "CPR:3"}]}
{"sentText": "This initial action was accompanied by upregulation of cyclooxygenase2 COX2 an important inflammation marker within 1h after TCDD treatment", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "COX2", "em2Text": "TCDD", "label": "CPR:3"}]}
{"sentText": "Further TCDD exposure could induce phosphorylation and ubiquitinationdependent degradation of I\u043aB\u03b1 and the translocation of NF\u03baB p65 from the cytosol to the nucleus in this microglial cell line", "relationMentions": [{"em1Text": "TCDD", "em2Text": "I\u043aB\u03b1", "label": "CPR:3"}]}
{"sentText": "Thus the NF\u03baB signaling pathway can be activated after TCDD treatment", "relationMentions": [{"em1Text": "NF\u03baB", "em2Text": "TCDD", "label": "CPR:3"}]}
{"sentText": "However Ca2 blockers also obviously attenuated NF\u03baB activation and transnuclear transport induced by TCDD", "relationMentions": [{"em1Text": "NF\u03baB", "em2Text": "TCDD", "label": "CPR:3"}]}
{"sentText": "In concert with these results we highlighted that the secretion of proinflammatory cytokine and NF\u03baB activation induced by TCDD can be mediated by elevation of Ca2i in HAPI microglial cells", "relationMentions": [{"em1Text": "cytokine", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "NF\u03baB", "em2Text": "TCDD", "label": "CPR:3"}]}
{"sentText": "The ARB eprosartan is a nonbiphenyl nontetrazole angiotensin II type 1 receptor AT1 antagonist which acts to decrease total peripheral resistance", "relationMentions": [{"em1Text": "eprosartan", "em2Text": "angiotensin II type 1 receptor", "label": "CPR:6"}, {"em1Text": "eprosartan", "em2Text": "AT1", "label": "CPR:6"}]}
{"sentText": "The potency of the selective alpha 1Dadrenoceptor antagonist BMY 7378 against noradrenaline pA2 = 616 013 and of the selective alpha 1Aadrenoceptor antagonist RS17053 against noradrenaline pKB = 835 010 and against the selective alpha 1Aadrenoceptor agonist A61603 pKB = 840 009 were too low to account for alpha 1D and alpha 1Aadrenoceptor involvement", "relationMentions": [{"em1Text": "alpha 1Aadrenoceptor", "em2Text": "A61603", "label": "CPR:5"}, {"em1Text": "alpha 1Dadrenoceptor", "em2Text": "BMY 7378", "label": "CPR:6"}, {"em1Text": "alpha 1Aadrenoceptor", "em2Text": "RS17053", "label": "CPR:6"}]}
{"sentText": "The putative alpha 1Ladrenoceptor antagonist JTH601 but not the alpha 1Badrenoceptor antagonist chloroethylclonidine 10 microM antagonized noradrenalineinduced contractions of SMA", "relationMentions": [{"em1Text": "alpha 1Ladrenoceptor", "em2Text": "JTH601", "label": "CPR:6"}, {"em1Text": "alpha 1Badrenoceptor", "em2Text": "chloroethylclonidine", "label": "CPR:6"}]}
{"sentText": "Doses of dimethocaine 17 mgkg and cocaine 03 mgkg which produced full 80 substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 trans677a8913bhexahydro3chloro2hydroxyNmethyl5H benzo dnaphtho21bazepine and the dopamine D2 receptor antagonist raclopride both at 0003003 mgkg", "relationMentions": [{"em1Text": "dopamine D1 receptor", "em2Text": "SCH 39166", "label": "CPR:6"}, {"em1Text": "dopamine D1 receptor", "em2Text": "trans677a8913bhexahydro3chloro2hydroxyNmethyl5H benzo dnaphtho21bazepine", "label": "CPR:6"}, {"em1Text": "dopamine D2 receptor", "em2Text": "raclopride", "label": "CPR:6"}]}
{"sentText": "Carvedilol reduced the risk of death or heart failure in patients with abovemedian levels of NBNP or adrenomedullin or both to rates not significantly different from those observed in patients with levels below the median value", "relationMentions": [{"em1Text": "Carvedilol", "em2Text": "NBNP", "label": "CPR:4"}, {"em1Text": "Carvedilol", "em2Text": "adrenomedullin", "label": "CPR:4"}]}
{"sentText": "Carvedilol reduced mortality and heart failure in patients with higher pretreatment plasma NBNP and adrenomedullin", "relationMentions": [{"em1Text": "Carvedilol", "em2Text": "NBNP", "label": "CPR:4"}, {"em1Text": "Carvedilol", "em2Text": "adrenomedullin", "label": "CPR:4"}]}
{"sentText": "Taken together the data provide evidence that the synergistic antiproliferative effect of resveratrol and clofarabine is linked to the inhibition of Akt and Sp1 activities and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma", "relationMentions": [{"em1Text": "resveratrol", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "resveratrol", "em2Text": "Sp1", "label": "CPR:4"}, {"em1Text": "clofarabine", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "clofarabine", "em2Text": "Sp1", "label": "CPR:4"}]}
{"sentText": "In combination with clofarabine the ability of resveratrol to reduce the contents of Sp1 and its target gene products was also evident in a time and dosedependent experiment", "relationMentions": [{"em1Text": "clofarabine", "em2Text": "Sp1", "label": "CPR:4"}, {"em1Text": "resveratrol", "em2Text": "Sp1", "label": "CPR:4"}]}
{"sentText": "The inhibition of phosphoinositide 3kinase using Ly294002 augmented a decrease in the p21 level induced by their combination but it showed no significant effects on expression of Sp1 and cyclin D1", "relationMentions": [{"em1Text": "phosphoinositide 3kinase", "em2Text": "Ly294002", "label": "CPR:4"}, {"em1Text": "Ly294002", "em2Text": "p21", "label": "CPR:4"}]}
{"sentText": "Finally we found that liver kinase B1 LKB1 phosphorylation is required for the phillyrin enhanced activation of AMPK in HepG2 hepatocytes", "relationMentions": [{"em1Text": "phillyrin", "em2Text": "AMPK", "label": "CPR:3"}]}
{"sentText": "These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP1c and FAS through LKB1 AMPK activation suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity", "relationMentions": [{"em1Text": "phillyrin", "em2Text": "LKB1", "label": "CPR:3"}, {"em1Text": "phillyrin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "phillyrin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "phillyrin", "em2Text": "SREBP1c", "label": "CPR:4"}, {"em1Text": "phillyrin", "em2Text": "FAS", "label": "CPR:4"}]}
{"sentText": "Phillyrin attenuates high glucoseinduced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1 AMPactivated protein kinase dependent signalling", "relationMentions": [{"em1Text": "Phillyrin", "em2Text": "LKB1", "label": "CPR:3"}, {"em1Text": "Phillyrin", "em2Text": "AMPactivated protein kinase", "label": "CPR:3"}]}
{"sentText": "Phillyrin strongly inhibited high glucose induced fatty acid synthase FAS expression by modulating sterol regulatory elementbinding protein1c SREBP1c activation", "relationMentions": [{"em1Text": "glucose", "em2Text": "fatty acid synthase", "label": "CPR:3"}, {"em1Text": "glucose", "em2Text": "FAS", "label": "CPR:3"}, {"em1Text": "Phillyrin", "em2Text": "fatty acid synthase", "label": "CPR:4"}, {"em1Text": "Phillyrin", "em2Text": "FAS", "label": "CPR:4"}]}
{"sentText": "Moreover use of the pharmacological AMPactivated protein kinase AMPK inhibitor compound C revealed that AMPK is essential for suppressing SREBP1c expression in phillyrintreated cells", "relationMentions": [{"em1Text": "AMPactivated protein kinase", "em2Text": "compound C", "label": "CPR:4"}, {"em1Text": "AMPK", "em2Text": "compound C", "label": "CPR:4"}, {"em1Text": "AMPK", "em2Text": "compound C", "label": "CPR:4"}]}
{"sentText": "A series of benzenesulfonamides incorporating cyanoacrylamide moieties tyrphostine analogs were assayed as inhibitors of the \u03b2carbonic anhydrase CA EC 4211 from Saccharomyces cerevisiae ScCA", "relationMentions": [{"em1Text": "benzenesulfonamides", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "benzenesulfonamides", "em2Text": "ScCA", "label": "CPR:4"}, {"em1Text": "benzenesulfonamides", "em2Text": "\u03b2carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "benzenesulfonamides", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "cyanoacrylamide", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "cyanoacrylamide", "em2Text": "ScCA", "label": "CPR:4"}, {"em1Text": "cyanoacrylamide", "em2Text": "\u03b2carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "cyanoacrylamide", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "tyrphostine", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "tyrphostine", "em2Text": "ScCA", "label": "CPR:4"}, {"em1Text": "tyrphostine", "em2Text": "\u03b2carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "tyrphostine", "em2Text": "CA", "label": "CPR:4"}]}
{"sentText": "Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae \u03b2carbonic anhydrase", "relationMentions": [{"em1Text": "Benzenesulfonamides", "em2Text": "Saccharomyces cerevisiae \u03b2carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "cyanoacrylamide", "em2Text": "Saccharomyces cerevisiae \u03b2carbonic anhydrase", "label": "CPR:4"}]}
{"sentText": "The mRNA levels of microphthalmiaassociated transcription factor MITF and its downstream genes tyrosinase tyrosinaserelated protein TRP1 and TRP2 were reduced by artemisinic acid treatment", "relationMentions": [{"em1Text": "microphthalmiaassociated transcription factor", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "MITF", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "tyrosinase", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "tyrosinaserelated protein TRP1", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "TRP2", "em2Text": "artemisinic acid", "label": "CPR:4"}]}
{"sentText": "Additionally the mRNA levels of melanogenesisrelated genes cKIT stem cell factor SCF and macrophage migration inhibitory factor MIF were downregulated by artemisinic acid", "relationMentions": [{"em1Text": "cKIT", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "stem cell factor", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "SCF", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "macrophage migration inhibitory factor", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "MIF", "em2Text": "artemisinic acid", "label": "CPR:4"}]}
{"sentText": "Furthermore cAMP production and protein kinase A PKA activity were suppressed by artemisinic acid", "relationMentions": [{"em1Text": "protein kinase A", "em2Text": "artemisinic acid", "label": "CPR:4"}, {"em1Text": "PKA", "em2Text": "artemisinic acid", "label": "CPR:4"}]}
{"sentText": "Moreover attempts to elucidate a possible mechanism underlying the artemisinic acidmediated effects revealed that artemisinic acid regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA HMG CoA reductase gene which was mediated through reduced expression of the CCAATenhancerbinding protein CEBP \u03b1 gene", "relationMentions": [{"em1Text": "artemisinic acid", "em2Text": "hydroxymethylglutaryl CoA HMG CoA reductase", "label": "CPR:4"}, {"em1Text": "artemisinic acid", "em2Text": "CCAATenhancerbinding protein CEBP \u03b1", "label": "CPR:4"}]}
{"sentText": "Artemisinic acid inhibits melanogenesis through downregulation of CEBP \u03b1 dependent expression of HMGCoA reductase gene", "relationMentions": [{"em1Text": "Artemisinic acid", "em2Text": "CEBP \u03b1", "label": "CPR:4"}, {"em1Text": "Artemisinic acid", "em2Text": "HMGCoA reductase", "label": "CPR:4"}]}
{"sentText": "Taken together these findings indicate that the inhibition of melanogenesis by artemisinic acid occurs through reduced expression of the HMG CoA reductase gene which is mediated by CEBP \u03b1 inhibition and suggest that artemisinic acid may be useful as a hyperpigmentation inhibitor", "relationMentions": [{"em1Text": "artemisinic acid", "em2Text": "HMG CoA reductase", "label": "CPR:4"}, {"em1Text": "artemisinic acid", "em2Text": "CEBP \u03b1", "label": "CPR:4"}]}
{"sentText": "Both 5 alphaNET and 3 beta5 alphaNET blocked the PR downregulation induced by P4 as assessed by Western and Northern blot methods", "relationMentions": [{"em1Text": "5 alphaNET", "em2Text": "PR", "label": "CPR:3"}, {"em1Text": "3 beta5 alphaNET", "em2Text": "PR", "label": "CPR:3"}]}
{"sentText": "The inhibition of UG synthesis and PR downregulation by 5 alphaNET and 3 beta5 alphaNET indicates that these NET metabolites possess antiprogestational properties", "relationMentions": [{"em1Text": "PR", "em2Text": "5 alphaNET", "label": "CPR:3"}, {"em1Text": "UG", "em2Text": "5 alphaNET", "label": "CPR:4"}, {"em1Text": "UG", "em2Text": "3 beta5 alphaNET", "label": "CPR:4"}, {"em1Text": "PR", "em2Text": "3 beta5 alphaNET", "label": "CPR:4"}, {"em1Text": "UG", "em2Text": "NET", "label": "CPR:4"}, {"em1Text": "PR", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "As determined by Western and Northern blot analyses 5 alphaNET inhibited the P4induced UG gene expression in a dosedependent manner", "relationMentions": [{"em1Text": "5 alphaNET", "em2Text": "UG", "label": "CPR:4"}]}
{"sentText": "The estrogenic agent 3 beta5 alphaNET and estradiol at a dose of 10 mg also inhibited the UG gene expression induced by P4", "relationMentions": [{"em1Text": "3 beta5 alphaNET", "em2Text": "UG", "label": "CPR:4"}, {"em1Text": "estradiol", "em2Text": "UG", "label": "CPR:4"}]}
{"sentText": "Treatment of A549 and H1299 cells with dioscin caused a dosedependent increase in ERK12 and JNK12 activity accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR", "relationMentions": [{"em1Text": "dioscin", "em2Text": "JNK12", "label": "CPR:3"}, {"em1Text": "dioscin", "em2Text": "ERK12", "label": "CPR:3"}, {"em1Text": "dioscin", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "dioscin", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "dioscin", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Meanwhile autophagy was detected as early as 12 h after an exposure to lowdose dioscin as indicated by an upregulated expression of LC3II and beclin1 proteins", "relationMentions": [{"em1Text": "dioscin", "em2Text": "LC3II", "label": "CPR:3"}, {"em1Text": "dioscin", "em2Text": "beclin1", "label": "CPR:3"}]}
{"sentText": "Taken together our study for the first time suggests that 2hydroxy3methylanthraquinone is able to enhance apoptosis of U937 cells at least in part through activation of pp38MAPK and downregulation of pERK12", "relationMentions": [{"em1Text": "2hydroxy3methylanthraquinone", "em2Text": "pp38MAPK", "label": "CPR:3"}]}
{"sentText": "Our results showed that 2hydroxy3methylanthraquinone decreased phosphorylationERK12 pERK12 and increased pp38MAPK but did not affect expressions of pJNK12 in U937 cells", "relationMentions": [{"em1Text": "2hydroxy3methylanthraquinone", "em2Text": "pp38MAPK", "label": "CPR:3"}]}
{"sentText": "Moreover treatment of U937 cells with 2hydroxy3methylanthraquinone resulted in activation of caspase3", "relationMentions": [{"em1Text": "2hydroxy3methylanthraquinone", "em2Text": "caspase3", "label": "CPR:3"}]}
{"sentText": "Furthermore PD98059 ERK12 inhibitor significantly enhanced 2hydroxy3methylanthraquinoneinduced apoptosis in U937 cells whereas caspase3 inhibitor or SB203580 pp38MAPK inhibitor decreased apoptosis in U937 cells", "relationMentions": [{"em1Text": "SB203580", "em2Text": "pp38MAPK", "label": "CPR:4"}]}
{"sentText": "Ribonucleotide reductase activity was found to be strongly increased in the gemcitabine selected line and purine nucleoside phosphorylase was increased in the 2chlorodeoxyadenosine selected line", "relationMentions": [{"em1Text": "Ribonucleotide reductase", "em2Text": "gemcitabine", "label": "CPR:3"}, {"em1Text": "purine nucleoside phosphorylase", "em2Text": "2chlorodeoxyadenosine", "label": "CPR:3"}]}
{"sentText": "Structureactivity relationship studies indicated that 5ptoluenesulfonylaminophthalimide moiety is a favorable scaffold to exert the \u03b1glucosidase inhibitory activity and substituents at the N2 position have considerable influence on the efficacy of the inhibition activities", "relationMentions": [{"em1Text": "5ptoluenesulfonylaminophthalimide", "em2Text": "\u03b1glucosidase", "label": "CPR:4"}]}
{"sentText": "Several members of a new family of nonsugartype \u03b1glycosidase inhibitors bearing a 5ptoluenesulfonylaminophthalimide moiety and various substituent at the N2 position were synthesized and their activities were investigated", "relationMentions": [{"em1Text": "\u03b1glycosidase", "em2Text": "5ptoluenesulfonylaminophthalimide", "label": "CPR:4"}]}
{"sentText": "A new series of N2substituted5ptoluenesulfonylaminophthalimide analogues as \u03b1glucosidase inhibitors", "relationMentions": [{"em1Text": "N2substituted5ptoluenesulfonylaminophthalimide", "em2Text": "\u03b1glucosidase", "label": "CPR:4"}]}
{"sentText": "The lysosomal inhibitor chloroquine significantly increased RCAN1 accumulation in cells consistent with the hypothesis that higher lysosomal pH impairs RCAN1 degradation leading to a higher RCAN1NFATc1 ratio and consequently NFATc1 inhibition", "relationMentions": [{"em1Text": "chloroquine", "em2Text": "RCAN1", "label": "CPR:3"}]}
{"sentText": "Here we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligandtreated human primary hepatocytes", "relationMentions": [{"em1Text": "p38", "em2Text": "anisomycin", "label": "CPR:3"}, {"em1Text": "MAPK", "em2Text": "anisomycin", "label": "CPR:3"}, {"em1Text": "anisomycin", "em2Text": "CYP2B6", "label": "CPR:3"}]}
{"sentText": "siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA", "relationMentions": [{"em1Text": "anisomycin", "em2Text": "CYP2B6", "label": "CPR:3"}]}
{"sentText": "In addition to CYP2B6 anisomycin cotreatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDPglucuronosyltransferase 1A1 mRNAs", "relationMentions": [{"em1Text": "CYP2B6", "em2Text": "anisomycin", "label": "CPR:3"}, {"em1Text": "anisomycin", "em2Text": "CYP2A7", "label": "CPR:3"}, {"em1Text": "anisomycin", "em2Text": "CYP2C9", "label": "CPR:3"}]}
{"sentText": "No effects were observed when fenclozic acid was assessed for P450dependent and P450independent cytotoxicity to THLE cell lines timedependent inhibition of five major human cytochrome P450 enzymes inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells", "relationMentions": [{"em1Text": "fenclozic acid", "em2Text": "human cytochrome P450", "label": "CPR:4"}, {"em1Text": "fenclozic acid", "em2Text": "efflux transporters", "label": "CPR:4"}, {"em1Text": "fenclozic acid", "em2Text": "BSEP", "label": "CPR:4"}, {"em1Text": "fenclozic acid", "em2Text": "MRP2", "label": "CPR:4"}]}
{"sentText": "Furthermore auranofin inhibited NFkappaB activation induced by MyD88dependent downstream signaling components of TLR4 MyD88 IKKbeta and p65", "relationMentions": [{"em1Text": "auranofin", "em2Text": "NFkappaB", "label": "CPR:4"}]}
{"sentText": "Auranofin as an antirheumatic gold compound suppresses LPSinduced homodimerization of TLR4", "relationMentions": [{"em1Text": "Auranofin", "em2Text": "TLR4", "label": "CPR:4"}]}
{"sentText": "IRF3 activation induced by MyD88independent signaling components TRIF and TBK1 was also downregulated by auranofin", "relationMentions": [{"em1Text": "IRF3", "em2Text": "auranofin", "label": "CPR:4"}, {"em1Text": "TRIF", "em2Text": "auranofin", "label": "CPR:4"}, {"em1Text": "TBK1", "em2Text": "auranofin", "label": "CPR:4"}]}
{"sentText": "Our results first demonstrate that auranofin suppresses the multiple steps in TLR4 signaling especially the homodimerization of TLR4", "relationMentions": [{"em1Text": "auranofin", "em2Text": "TLR4", "label": "CPR:4"}, {"em1Text": "auranofin", "em2Text": "TLR4", "label": "CPR:4"}]}
{"sentText": "The results suggest that the suppression of TLR4 activity by auranofin may be the molecular mechanism through which auranofin exerts antirheumatic activity", "relationMentions": [{"em1Text": "TLR4", "em2Text": "auranofin", "label": "CPR:4"}, {"em1Text": "TLR4", "em2Text": "auranofin", "label": "CPR:4"}]}
{"sentText": "Our results demonstrated that auranofin suppressed TLR4 mediated activation of transcription factors NFkappaB and IRF3 and expression of COX2 a proinflammatory enzyme", "relationMentions": [{"em1Text": "auranofin", "em2Text": "TLR4", "label": "CPR:4"}, {"em1Text": "auranofin", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "auranofin", "em2Text": "IRF3", "label": "CPR:4"}, {"em1Text": "auranofin", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "This suppression was well correlated with the inhibitory effect of auranofin on the homodimerization of TLR4 induced by an agonist", "relationMentions": [{"em1Text": "auranofin", "em2Text": "TLR4", "label": "CPR:4"}]}
{"sentText": "Vandetanib Caprelsa \u00ae AstraZeneca is a oncedaily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growthfactor receptor tyrosine kinase RET constitutively activated in roughly 60 of all MTCs vascular endothelial growthfactor receptors 2 and 3 and epidermal growthfactor receptors", "relationMentions": [{"em1Text": "Vandetanib", "em2Text": "epidermal growthfactor receptors", "label": "CPR:4"}, {"em1Text": "Vandetanib", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "Vandetanib", "em2Text": "growthfactor receptor tyrosine kinase", "label": "CPR:4"}, {"em1Text": "Vandetanib", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "Caprelsa", "em2Text": "epidermal growthfactor receptors", "label": "CPR:4"}, {"em1Text": "Caprelsa", "em2Text": "tyrosine kinase", "label": "CPR:4"}]}
{"sentText": "One exception is tranexamic acid TXA which as a lysine mimetic inhibits binding of plasminogen to fibrin", "relationMentions": [{"em1Text": "tranexamic acid", "em2Text": "plasminogen", "label": "CPR:4"}, {"em1Text": "tranexamic acid", "em2Text": "fibrin", "label": "CPR:4"}, {"em1Text": "TXA", "em2Text": "plasminogen", "label": "CPR:4"}, {"em1Text": "TXA", "em2Text": "fibrin", "label": "CPR:4"}, {"em1Text": "lysine", "em2Text": "plasminogen", "label": "CPR:4"}, {"em1Text": "lysine", "em2Text": "fibrin", "label": "CPR:4"}]}
{"sentText": "Coupling this computational technique with a highquality lowthroughput screen identified 54piperidyl3isoxazolol 4PIOL as a potent plasminogen binding inhibitor with the potential for the treatment of various bleeding disorders", "relationMentions": [{"em1Text": "54piperidyl3isoxazolol", "em2Text": "plasminogen", "label": "CPR:4"}, {"em1Text": "4PIOL", "em2Text": "plasminogen", "label": "CPR:4"}]}
{"sentText": "Epididymal tissue from wildtype mice responded in vitro to noradrenaline and isoprenaline with increased glycerol release reduced IL6 release and increased cAMP accumulation", "relationMentions": [{"em1Text": "noradrenaline", "em2Text": "IL6", "label": "CPR:4"}, {"em1Text": "isoprenaline", "em2Text": "IL6", "label": "CPR:4"}]}
{"sentText": "Phospholipase A2 inhibitors pbromophenacyl bromide and arachidonyl trifluoromethyl ketone suppressed interleukin2 IL2 expression in murine primary splenocytes", "relationMentions": [{"em1Text": "Phospholipase A2", "em2Text": "pbromophenacyl bromide", "label": "CPR:3"}, {"em1Text": "pbromophenacyl bromide", "em2Text": "interleukin2", "label": "CPR:4"}, {"em1Text": "pbromophenacyl bromide", "em2Text": "IL2", "label": "CPR:4"}, {"em1Text": "Phospholipase A2", "em2Text": "arachidonyl trifluoromethyl ketone", "label": "CPR:4"}, {"em1Text": "arachidonyl trifluoromethyl ketone", "em2Text": "interleukin2", "label": "CPR:4"}, {"em1Text": "arachidonyl trifluoromethyl ketone", "em2Text": "IL2", "label": "CPR:4"}]}
{"sentText": "Pretreatment of the splenocytes with both BPB and AACOCF3 suppressed phorbol 12myristate 13acetate plus ionomycininduced IL2 secretion in a concentrationdependent manner", "relationMentions": [{"em1Text": "phorbol 12myristate 13acetate", "em2Text": "IL2", "label": "CPR:3"}, {"em1Text": "BPB", "em2Text": "IL2", "label": "CPR:4"}, {"em1Text": "AACOCF3", "em2Text": "IL2", "label": "CPR:4"}]}
{"sentText": "Likewise IL2 steadystate mRNA expression was inhibited by both PLA2 inhibitors in a concentrationdependent fashion with 90 inhibition at 1 microM BPB and 20 microM AACOCF3", "relationMentions": [{"em1Text": "IL2", "em2Text": "BPB", "label": "CPR:4"}, {"em1Text": "PLA2", "em2Text": "BPB", "label": "CPR:4"}, {"em1Text": "IL2", "em2Text": "AACOCF3", "label": "CPR:4"}, {"em1Text": "PLA2", "em2Text": "AACOCF3", "label": "CPR:4"}]}
{"sentText": "Taken together these data demonstrated that PLA2 inhibitors BPB and AACOCF3 are robust inhibitors of IL2 expression at both the mRNA and protein levels in murine splenocytes", "relationMentions": [{"em1Text": "PLA2", "em2Text": "BPB", "label": "CPR:4"}, {"em1Text": "BPB", "em2Text": "IL2", "label": "CPR:4"}, {"em1Text": "PLA2", "em2Text": "AACOCF3", "label": "CPR:4"}, {"em1Text": "AACOCF3", "em2Text": "IL2", "label": "CPR:4"}]}
{"sentText": "Therefore the objective of the present study was to investigate the effects of PLA2 inhibitors pbromophenacyl bromide BPB and arachidonyl trifluoromethyl ketone AACOCF3 on interleukin2 IL2 expression in murine primary splenocytes", "relationMentions": [{"em1Text": "PLA2", "em2Text": "pbromophenacyl bromide", "label": "CPR:4"}, {"em1Text": "PLA2", "em2Text": "BPB", "label": "CPR:4"}, {"em1Text": "PLA2", "em2Text": "arachidonyl trifluoromethyl ketone", "label": "CPR:4"}, {"em1Text": "PLA2", "em2Text": "AACOCF3", "label": "CPR:4"}]}
{"sentText": "Inhibition 90 of IL2 secretion was observed at 1 microM BPB and 10 microM AACOCF3 compared to the respective vehicle control", "relationMentions": [{"em1Text": "IL2", "em2Text": "BPB", "label": "CPR:4"}, {"em1Text": "IL2", "em2Text": "AACOCF3", "label": "CPR:4"}]}
{"sentText": "The two basic mainstays of gastrointestinal stromal tumours GIST treatment are surgery and imatinib a selective tyrosine kinase inhibitor that allows achieving a stable or responding disease in about 80 of patients with unresectablemetastatic GIST", "relationMentions": [{"em1Text": "imatinib", "em2Text": "tyrosine kinase", "label": "CPR:4"}]}
{"sentText": "TZDs also inhibited alkaline phosphatase activity 5875 p0046 and osteocalcin production 5275 p0031", "relationMentions": [{"em1Text": "TZDs", "em2Text": "alkaline phosphatase", "label": "CPR:4"}, {"em1Text": "TZDs", "em2Text": "osteocalcin", "label": "CPR:4"}]}
{"sentText": "TZD effects on osteoblast viability oleic acid uptake alkaline phosphatase and osteocalcin production are independent of their effects on aromatase", "relationMentions": [{"em1Text": "TZD", "em2Text": "aromatase", "label": "CPR:4"}]}
{"sentText": "We have previously reported that TZDs reduce estrogen synthesis by inhibiting aromatase activity in human granulosa cells HGC", "relationMentions": [{"em1Text": "TZDs", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "estrogen", "em2Text": "aromatase", "label": "CPR:9"}]}
{"sentText": "We studied mouse osteoblasts alone or in a coculture with HGC to determine whether TZD inhibition of aromatase plays a role in their effects on bone metabolism", "relationMentions": [{"em1Text": "TZD", "em2Text": "aromatase", "label": "CPR:4"}]}
{"sentText": "The M564G mutated CrAT showed higher activity toward longer chain acylCoAs activity toward myristoylCoA was 1250fold higher than that of the wildtype CrAT and lower activity toward its natural substrate acetylCoA", "relationMentions": [{"em1Text": "M564G", "em2Text": "acetylCoA", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "acetylCoA", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "acetylCoA", "label": "CPR:9"}, {"em1Text": "M564G", "em2Text": "acylCoAs", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "acylCoAs", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "acylCoAs", "label": "CPR:9"}, {"em1Text": "M564G", "em2Text": "myristoylCoA", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "myristoylCoA", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "myristoylCoA", "label": "CPR:9"}]}
{"sentText": "Kinetic constants of the mutant CrAT showed modification in favor of longer acylCoAs as substrates", "relationMentions": [{"em1Text": "CrAT", "em2Text": "acylCoAs", "label": "CPR:9"}]}
{"sentText": "In the reverse case mutation of the orthologous glycine Gly553 to methionine in carnitine octanoyltransferase COT decreased activity toward its natural substrates medium and longchain acylCoAs and increased activity toward shortchain acylCoAs", "relationMentions": [{"em1Text": "carnitine octanoyltransferase", "em2Text": "acylCoAs", "label": "CPR:9"}, {"em1Text": "COT", "em2Text": "acylCoAs", "label": "CPR:9"}, {"em1Text": "carnitine octanoyltransferase", "em2Text": "acylCoAs", "label": "CPR:9"}, {"em1Text": "COT", "em2Text": "acylCoAs", "label": "CPR:9"}]}
{"sentText": "We conclude that Met564 blocks the entry of medium and longchain acylCoAs to the catalytic site of CrAT", "relationMentions": [{"em1Text": "acylCoAs", "em2Text": "CrAT", "label": "CPR:9"}]}
{"sentText": "Carnitine acetyltransferases CrAT catalyze the reversible conversion of acetylCoA and carnitine to acetylcarnitine and free CoA", "relationMentions": [{"em1Text": "Carnitine acetyltransferases", "em2Text": "acetylCoA", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "acetylCoA", "label": "CPR:9"}, {"em1Text": "Carnitine acetyltransferases", "em2Text": "carnitine", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "carnitine", "label": "CPR:9"}, {"em1Text": "Carnitine acetyltransferases", "em2Text": "acetylcarnitine", "label": "CPR:9"}, {"em1Text": "CrAT", "em2Text": "acetylcarnitine", "label": "CPR:9"}]}
{"sentText": "Catecholamines adrenaline noradrenaline and dopamine are potent inhibitors of phenylalanine 4monooxygenase phenylalanine hydroxylase EC 114161", "relationMentions": [{"em1Text": "adrenaline", "em2Text": "phenylalanine hydroxylase", "label": "CPR:4"}, {"em1Text": "adrenaline", "em2Text": "EC 114161", "label": "CPR:4"}, {"em1Text": "adrenaline", "em2Text": "phenylalanine 4monooxygenase", "label": "CPR:4"}, {"em1Text": "noradrenaline", "em2Text": "phenylalanine hydroxylase", "label": "CPR:4"}, {"em1Text": "noradrenaline", "em2Text": "EC 114161", "label": "CPR:4"}, {"em1Text": "noradrenaline", "em2Text": "phenylalanine 4monooxygenase", "label": "CPR:4"}, {"em1Text": "dopamine", "em2Text": "phenylalanine hydroxylase", "label": "CPR:4"}, {"em1Text": "dopamine", "em2Text": "EC 114161", "label": "CPR:4"}, {"em1Text": "dopamine", "em2Text": "phenylalanine 4monooxygenase", "label": "CPR:4"}, {"em1Text": "Catecholamines", "em2Text": "phenylalanine hydroxylase", "label": "CPR:4"}, {"em1Text": "Catecholamines", "em2Text": "EC 114161", "label": "CPR:4"}, {"em1Text": "Catecholamines", "em2Text": "phenylalanine 4monooxygenase", "label": "CPR:4"}]}
{"sentText": "Central and peripheral administration of kisspeptin stimulates the hypothalamicpituitarygonadal HPG axis whilst preadministration of a gonadotrophin releasing hormone GnRH antagonist abolishes this effect", "relationMentions": [{"em1Text": "kisspeptin", "em2Text": "gonadotrophin releasing hormone", "label": "CPR:4"}, {"em1Text": "kisspeptin", "em2Text": "GnRH", "label": "CPR:4"}]}
{"sentText": "The esterified BM however had only partial transactivation agonistic activity in cells transfected with rat GR whereas BM and esterified DEX had full transactivation agonistic activity", "relationMentions": [{"em1Text": "BM", "em2Text": "rat GR", "label": "CPR:5"}, {"em1Text": "rat GR", "em2Text": "DEX", "label": "CPR:5"}, {"em1Text": "BM", "em2Text": "rat GR", "label": "CPR:5"}]}
{"sentText": "Moreover in rat hepatoma H4IIE cells the esterified BM failed to induce tyrosine aminotransferase which is regulated by GR mediated transactivation activity", "relationMentions": [{"em1Text": "BM", "em2Text": "GR", "label": "CPR:5"}]}
{"sentText": "Consistent with the weak transactivation activity of esterified BM mediated by rat GR there were few side effects evaluated by thymus involution and body weight loss in an antigeninduced asthmatic model in rats", "relationMentions": [{"em1Text": "BM", "em2Text": "rat GR", "label": "CPR:5"}]}
{"sentText": "Dexamethasone DEX betamethasone BM and their esterifiedderivatives had full transrepression agonistic activity in a reporter assay using CV1 cells transfected with either human or rat GR", "relationMentions": [{"em1Text": "Dexamethasone", "em2Text": "human or rat GR", "label": "CPR:5"}, {"em1Text": "DEX", "em2Text": "human or rat GR", "label": "CPR:5"}, {"em1Text": "betamethasone", "em2Text": "human or rat GR", "label": "CPR:5"}, {"em1Text": "BM", "em2Text": "human or rat GR", "label": "CPR:5"}]}
{"sentText": "Moreover IGFBPrP2 noticeably increased in response to TGFbeta1 and alltrans retinoic acid atRA in HPEC and PC3 cells and it decreased in response to IGFI in HPEC", "relationMentions": [{"em1Text": "IGFBPrP2", "em2Text": "alltrans retinoic acid", "label": "CPR:3"}, {"em1Text": "IGFBPrP2", "em2Text": "atRA", "label": "CPR:3"}]}
{"sentText": "Although the data collected on IGFBPrP3 in prostate are modest its role as a growth stimulator andor protooncogene is supported by its preferential expression in cancerous cells and its downregulation by atRA", "relationMentions": [{"em1Text": "IGFBPrP3", "em2Text": "atRA", "label": "CPR:4"}]}
{"sentText": "On the basis of FIP1L1PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease and in the FIP1L1PDGFRa positive cases the tyrosine kinase inhibitor imatinib mesylate Glivec would be effective", "relationMentions": [{"em1Text": "tyrosine kinase", "em2Text": "imatinib mesylate", "label": "CPR:4"}]}
{"sentText": "Uptake of the radiolabeled model substrates estradiol 17\u03b2glucuronide estrone 3sulfate and dehydroepiandrosterone sulfate DHEAS was determined in the absence and presence of compounds 16 using Chinese hamster ovary CHO cells stably expressing either OATP1B1 or OATP1B3", "relationMentions": [{"em1Text": "estradiol 17\u03b2glucuronide", "em2Text": "OATP1B1", "label": "CPR:9"}, {"em1Text": "estradiol 17\u03b2glucuronide", "em2Text": "OATP1B3", "label": "CPR:9"}, {"em1Text": "estrone 3sulfate", "em2Text": "OATP1B1", "label": "CPR:9"}, {"em1Text": "estrone 3sulfate", "em2Text": "OATP1B3", "label": "CPR:9"}, {"em1Text": "dehydroepiandrosterone sulfate", "em2Text": "OATP1B1", "label": "CPR:9"}, {"em1Text": "dehydroepiandrosterone sulfate", "em2Text": "OATP1B3", "label": "CPR:9"}, {"em1Text": "DHEAS", "em2Text": "OATP1B1", "label": "CPR:9"}, {"em1Text": "DHEAS", "em2Text": "OATP1B3", "label": "CPR:9"}]}
{"sentText": "Compound 6 stimulated OATP1B3 mediated estradiol 17\u03b2glucuronide uptake by increasing the apparent affinity of OATP1B3 for its substrate", "relationMentions": [{"em1Text": "OATP1B3", "em2Text": "estradiol 17\u03b2glucuronide", "label": "CPR:9"}, {"em1Text": "OATP1B3", "em2Text": "estradiol 17\u03b2glucuronide", "label": "CPR:9"}]}
{"sentText": "Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3Ogallate and several quercetin derivatives", "relationMentions": [{"em1Text": "OATP1B1", "em2Text": "quercetin", "label": "CPR:9"}, {"em1Text": "OATP1B3", "em2Text": "quercetin", "label": "CPR:9"}, {"em1Text": "OATP1B1", "em2Text": "epigallocatechin 3Ogallate", "label": "CPR:9"}, {"em1Text": "OATP1B3", "em2Text": "epigallocatechin 3Ogallate", "label": "CPR:9"}]}
{"sentText": "Cytotoxicity assays demonstrated that epigallocatechin 3Ogallate EGCG and most of compounds 16 killed preferentially OATP expressing CHO cells", "relationMentions": [{"em1Text": "epigallocatechin 3Ogallate", "em2Text": "OATP", "label": "CPR:9"}, {"em1Text": "EGCG", "em2Text": "OATP", "label": "CPR:9"}]}
{"sentText": "EGCG 1 and 3 were the most potent cytotoxic compounds with EGCG and 3 selectively killing OATP1B3 expressing cells", "relationMentions": [{"em1Text": "EGCG", "em2Text": "OATP1B3", "label": "CPR:9"}]}
{"sentText": "Reboxetine a selective norepinephrine reuptake inhibitor exhibits high affinity and selectivity for the human norepinephrine transporter", "relationMentions": [{"em1Text": "Reboxetine", "em2Text": "human norepinephrine transporter", "label": "CPR:4"}]}
{"sentText": "We previously employed a chemical genomic strategy to identify a novel small molecule MAC13243 as a likely inhibitor of the bacterial lipoprotein targeting chaperone LolA", "relationMentions": [{"em1Text": "MAC13243", "em2Text": "bacterial lipoprotein", "label": "CPR:4"}, {"em1Text": "MAC13243", "em2Text": "chaperone", "label": "CPR:4"}, {"em1Text": "MAC13243", "em2Text": "LolA", "label": "CPR:4"}]}
{"sentText": "Our results showed that low dose BPA and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and Nanog proteins while only BPA could downregulate the expression of Ecadherin protein", "relationMentions": [{"em1Text": "BPA", "em2Text": "Oct4", "label": "CPR:3"}, {"em1Text": "BPA", "em2Text": "Nanog", "label": "CPR:3"}, {"em1Text": "BPA", "em2Text": "Ecadherin", "label": "CPR:4"}]}
{"sentText": "Thus in 158N cells the ability of oxysterols to trigger a mode of cell death by apoptosis involving GSK3 and caspase3 activation is independent of the increase in the Ca2 level and of their accumulation in lipid raft microdomains", "relationMentions": [{"em1Text": "oxysterols", "em2Text": "GSK3", "label": "CPR:3"}, {"em1Text": "oxysterols", "em2Text": "caspase3", "label": "CPR:3"}]}
{"sentText": "To this end 158N murine oligodendrocytes were treated with 7KC or 7\u03b2OHC inducing an apoptotic mode of cell death characterized by condensationfragmentation of the nuclei dephosphorylation of Akt and GSK3 mitochondrial depolarization involving Mcl1 and caspase3 activation", "relationMentions": [{"em1Text": "7KC", "em2Text": "Mcl1", "label": "CPR:3"}, {"em1Text": "7KC", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "7\u03b2OHC", "em2Text": "Mcl1", "label": "CPR:3"}, {"em1Text": "7\u03b2OHC", "em2Text": "caspase3", "label": "CPR:3"}]}
{"sentText": "EGF stimulated phosphorylation of ERK and Bad is blocked by pretreatment with U0126 a selective MAP kinase kinase MKK12 inhibitor", "relationMentions": [{"em1Text": "U0126", "em2Text": "MAP kinase kinase MKK12", "label": "CPR:4"}, {"em1Text": "EGF", "em2Text": "U0126", "label": "CPR:4"}, {"em1Text": "ERK", "em2Text": "U0126", "label": "CPR:4"}, {"em1Text": "Bad", "em2Text": "U0126", "label": "CPR:4"}]}
{"sentText": "Similarly pretreatment with sulindac sulfide blocks the ability of EGF to induce ERK12 and Bad phosphorylation but also downregulates total Bad but not ERK12 protein levels", "relationMentions": [{"em1Text": "sulindac sulfide", "em2Text": "EGF", "label": "CPR:4"}, {"em1Text": "sulindac sulfide", "em2Text": "Bad", "label": "CPR:4"}, {"em1Text": "sulindac sulfide", "em2Text": "Bad", "label": "CPR:4"}]}
{"sentText": "The ability of sulindac to block ERK12 signaling by the EGF receptor may account for at least part of its potent growthinhibitory effects against cancer cells", "relationMentions": [{"em1Text": "sulindac", "em2Text": "ERK12", "label": "CPR:4"}, {"em1Text": "sulindac", "em2Text": "EGF receptor", "label": "CPR:4"}]}
{"sentText": "Sulindac and selective cyclooxygenase COX2 inhibitors cause regression of colonic polyps in familial polyposis patients", "relationMentions": [{"em1Text": "Sulindac", "em2Text": "cyclooxygenase COX2", "label": "CPR:4"}]}
{"sentText": "Sulindac metabolites and other nonsteroidal antiinflammatory drugs selectively inhibit ERK12 phosphorylation in human colon cancer cells", "relationMentions": [{"em1Text": "Sulindac", "em2Text": "ERK12", "label": "CPR:4"}]}
{"sentText": "Sulindac sulfide inhibits epidermal growth factor induced phosphorylation of extracellularregulated kinase 12 and Bad in human colon cancer cells", "relationMentions": [{"em1Text": "Sulindac sulfide", "em2Text": "Bad", "label": "CPR:4"}, {"em1Text": "Sulindac sulfide", "em2Text": "epidermal growth factor", "label": "CPR:4"}]}
{"sentText": "After inflammation was established mice were dosed with the H4R antagonist JNJ 7777120 or antiIL13 antibody for comparison", "relationMentions": [{"em1Text": "H4R", "em2Text": "JNJ 7777120", "label": "CPR:6"}]}
{"sentText": "The activity of polymerases containing mutations known to confer resistance to foscarnet V715M T700A and N495K was inhibited by concentrations of foscarnet eight to 14 times higher than those required to inhibit wildtype polymerases", "relationMentions": [{"em1Text": "polymerases", "em2Text": "foscarnet", "label": "CPR:4"}, {"em1Text": "foscarnet", "em2Text": "V715M", "label": "CPR:4"}, {"em1Text": "foscarnet", "em2Text": "T700A", "label": "CPR:4"}, {"em1Text": "foscarnet", "em2Text": "N495K", "label": "CPR:4"}, {"em1Text": "polymerases", "em2Text": "foscarnet", "label": "CPR:4"}]}
{"sentText": "Development and validation of a nonradioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet", "relationMentions": [{"em1Text": "DNA polymerase", "em2Text": "foscarnet", "label": "CPR:4"}]}
{"sentText": "Absorption and secretion of fluoride increase at acid pH levels possibly because of its nonionized state at these pHs andor because of participation of a FH cotransporter or a FOH antiporter", "relationMentions": [{"em1Text": "fluoride", "em2Text": "FOH antiporter", "label": "CPR:9"}, {"em1Text": "fluoride", "em2Text": "FH cotransporter", "label": "CPR:9"}]}
{"sentText": "An investigation is detailed of the structure activity relationships SAR of two sulfone side chains of compound 1a SCH 900229 a potent PS1 selective \u03b3secretase inhibitor and clinical candidate for the treatment of Alzheimers disease", "relationMentions": [{"em1Text": "SCH 900229", "em2Text": "PS1", "label": "CPR:4"}, {"em1Text": "SCH 900229", "em2Text": "\u03b3secretase", "label": "CPR:4"}]}
{"sentText": "Structure activity relationship studies of tricyclic bispyran sulfone \u03b3secretase inhibitors", "relationMentions": [{"em1Text": "tricyclic bispyran sulfone", "em2Text": "\u03b3secretase", "label": "CPR:4"}]}
{"sentText": "Culture of HepG2 cells with griseofulvin has now been shown to induce both the formation of intracellular aggregates containing K18 as well as an increase in the abundance of K18 mRNA", "relationMentions": [{"em1Text": "griseofulvin", "em2Text": "K18", "label": "CPR:3"}, {"em1Text": "griseofulvin", "em2Text": "K18", "label": "CPR:3"}]}
{"sentText": "This observation suggests that MDMA induced reductions in SERT density do not represent neuroadaptive responses to decreased levels of brain serotonin but may occur in response to some other stimulus or to the neurotoxic effects of MDMA", "relationMentions": [{"em1Text": "MDMA", "em2Text": "SERT", "label": "CPR:4"}]}
{"sentText": "Low levels of serotonin may reduce the density of the serotonin transporter SERT by either increasing trafficking or reducing synthesis a neuroadaptive response", "relationMentions": [{"em1Text": "serotonin", "em2Text": "serotonin transporter", "label": "CPR:4"}, {"em1Text": "serotonin", "em2Text": "SERT", "label": "CPR:4"}]}
{"sentText": "To determine whether 34methylenedioxymethamphetamine MDMA induced reductions in SERT density could be related to such a mechanism pchlorophenylalanine or MDMA was administered to rats and brain serotonin and SERT density were measured", "relationMentions": [{"em1Text": "34methylenedioxymethamphetamine", "em2Text": "SERT", "label": "CPR:4"}, {"em1Text": "MDMA", "em2Text": "SERT", "label": "CPR:4"}]}
{"sentText": "However only MDMA reduced SERT density", "relationMentions": [{"em1Text": "MDMA", "em2Text": "SERT", "label": "CPR:4"}]}
{"sentText": "This study explored whether curcumin improves colonic inflammation in a rat colitis model through inhibition of the TLR4 NF\u03baB signaling pathway and IL27 expression", "relationMentions": [{"em1Text": "curcumin", "em2Text": "TLR4", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "IL27", "label": "CPR:4"}]}
{"sentText": "Compared with the untreated colitis group the curcumin treated group showed significant decreases in the disease activity index colonic mucosa damage index histological score myeloperoxidase activity and expressions of NF\u03baB mRNA IL27 mRNA TLR4 protein NF\u03baB p65 protein and IL27 p28 protein p 005", "relationMentions": [{"em1Text": "curcumin", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "IL27", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "TLR4", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "IL27", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "p28", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "myeloperoxidase", "label": "CPR:4"}]}
{"sentText": "Curcumin improves TNBSinduced colitis in rats by inhibiting IL27 expression via the TLR4 NF\u03baB signaling pathway", "relationMentions": [{"em1Text": "Curcumin", "em2Text": "IL27", "label": "CPR:4"}, {"em1Text": "Curcumin", "em2Text": "TLR4", "label": "CPR:4"}, {"em1Text": "Curcumin", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "There was no significant difference in TLR4 NF\u03baB and IL27 mRNA and proteins between curcumin treated and sulfasalazine treated groups", "relationMentions": [{"em1Text": "TLR4", "em2Text": "curcumin", "label": "CPR:4"}, {"em1Text": "NF\u03baB", "em2Text": "curcumin", "label": "CPR:4"}, {"em1Text": "IL27", "em2Text": "curcumin", "label": "CPR:4"}, {"em1Text": "TLR4", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "NF\u03baB", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "IL27", "em2Text": "sulfasalazine", "label": "CPR:4"}]}
{"sentText": "The antiinflammatory actions of curcumin on colitis may involve inhibition of the TLR4 NF\u03baB signaling pathway and of IL27 expression", "relationMentions": [{"em1Text": "curcumin", "em2Text": "TLR4", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "IL27", "label": "CPR:4"}]}
{"sentText": "Under isotonic conditions Nethylmaleimide NEM produced KCC activation and transient cell shrinkage", "relationMentions": [{"em1Text": "Nethylmaleimide", "em2Text": "KCC", "label": "CPR:3"}, {"em1Text": "NEM", "em2Text": "KCC", "label": "CPR:3"}]}
{"sentText": "A KCC inhibitor dihydroindenyloxy alkanoic acid DIOA blocked RVD more in HCEC than RCEC", "relationMentions": [{"em1Text": "KCC", "em2Text": "dihydroindenyloxy alkanoic acid", "label": "CPR:4"}, {"em1Text": "KCC", "em2Text": "DIOA", "label": "CPR:4"}]}
{"sentText": "Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists", "relationMentions": [{"em1Text": "lorglumide", "em2Text": "cholecystokinin", "label": "CPR:6"}]}
{"sentText": "The most potent compound DL434dichlorobenzoylamino5dipentylamino5oxopen tanoic acid lorglumide CR 1409 has a great affinity for the pancreatic CCK receptors and is a competitive specific and potent CCK antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCKinduced amylase secretion of isolated pancreatic acini", "relationMentions": [{"em1Text": "DL434dichlorobenzoylamino5dipentylamino5oxopen tanoic acid", "em2Text": "CCK", "label": "CPR:6"}, {"em1Text": "lorglumide", "em2Text": "CCK", "label": "CPR:6"}, {"em1Text": "CR 1409", "em2Text": "CCK", "label": "CPR:6"}]}
{"sentText": "Derivatives of 5dipentylamino5oxopentanoic acid are a new class of nonpeptide cholecystokinin CCK antagonists", "relationMentions": [{"em1Text": "5dipentylamino5oxopentanoic acid", "em2Text": "CCK", "label": "CPR:6"}, {"em1Text": "5dipentylamino5oxopentanoic acid", "em2Text": "cholecystokinin", "label": "CPR:6"}]}
{"sentText": "The most potent in vitro DASI discovered is an imidazole derivative with IC50 values against aromatase and steroid sulfatase in a JEG3 cell preparation of 02 and 25 nM respectively", "relationMentions": [{"em1Text": "imidazole", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "imidazole", "em2Text": "steroid sulfatase", "label": "CPR:4"}]}
{"sentText": "The parent phenol of this compound inhibits aromatase with an IC50 value of 0028 nM in the same assay", "relationMentions": [{"em1Text": "phenol", "em2Text": "aromatase", "label": "CPR:4"}]}
{"sentText": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate and its orthohalogenated F Cl Br derivatives are firstgeneration dual aromatase and sulfatase inhibitors DASIs", "relationMentions": [{"em1Text": "F", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "F", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "Cl", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "Cl", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "Br", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "Br", "em2Text": "sulfatase", "label": "CPR:4"}]}
{"sentText": "Synthesis and StructureActivity Relationship Studies of Derivatives of the Dual Aromatase Sulfatase Inhibitor 44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate", "relationMentions": [{"em1Text": "Aromatase", "em2Text": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate", "label": "CPR:4"}, {"em1Text": "Sulfatase", "em2Text": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate", "label": "CPR:4"}]}
{"sentText": "These findings demonstrate that cinnamon polyphenols can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its antioxidative capacity as well as attenuating cytotoxicity via inhibition of iNOS NF\u03baB activation", "relationMentions": [{"em1Text": "polyphenols", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "polyphenols", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "As revealed by glucose oxidase GOD and radioimmunoassay RIA both dimethyldiguanide DC 06gkg1d1 and CPS 03 06 12gkg1d1 treatments significantly resulted in downregulation of blood glucose and insulin levels in serum while the levels of oxidative stress markers were markedly lowered through ELISA assay", "relationMentions": [{"em1Text": "dimethyldiguanide", "em2Text": "insulin", "label": "CPR:4"}]}
{"sentText": "These nonadrenoceptor binding sites may explain certain novel platelet aggregatory properties previously ascribed to clonidine and endogenous clonidinedisplacing substances and may serve as markers of imidazoline receptors in humans", "relationMentions": [{"em1Text": "clonidine", "em2Text": "imidazoline receptors", "label": "CPR:3"}]}
{"sentText": "ORF 17583 a histamine H2receptor antagonist inhibited gastric acid secretion in pylorusligated rats ED50 = 49 mgkg intraduodenal 34 mgkg po", "relationMentions": [{"em1Text": "ORF 17583", "em2Text": "histamine H2receptor", "label": "CPR:6"}]}
{"sentText": "Effects of ORF 17583 other histamine H2receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs", "relationMentions": [{"em1Text": "ORF 17583", "em2Text": "histamine H2receptor", "label": "CPR:6"}]}
{"sentText": "Differences in magnitude of Na dependent lalanine uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in ASCT2 protein expression this being more abundant in WKY PTE cells", "relationMentions": [{"em1Text": "Na", "em2Text": "ASCT2", "label": "CPR:3"}, {"em1Text": "lalanine", "em2Text": "ASCT2", "label": "CPR:3"}, {"em1Text": "lalanine", "em2Text": "ASCT2", "label": "CPR:9"}]}
{"sentText": "In conclusion immortalized SHR and WKY PTE cells take up lalanine mainly through a highaffinity Na dependent amino acid transporter with functional features of ASCT2 transport", "relationMentions": [{"em1Text": "Na", "em2Text": "ASCT2", "label": "CPR:3"}, {"em1Text": "amino acid", "em2Text": "ASCT2", "label": "CPR:3"}, {"em1Text": "lalanine", "em2Text": "ASCT2", "label": "CPR:9"}]}
{"sentText": "In the presence of the system L inhibitor BCH Nadependent lalanine uptake in WKY and SHR PTE cells was inhibited by alanine serine and cysteine which is consistent with amino acid transport through ASCT2", "relationMentions": [{"em1Text": "alanine", "em2Text": "ASCT2", "label": "CPR:4"}, {"em1Text": "serine", "em2Text": "ASCT2", "label": "CPR:4"}, {"em1Text": "cysteine", "em2Text": "ASCT2", "label": "CPR:4"}, {"em1Text": "lalanine", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "amino acid", "em2Text": "ASCT2", "label": "CPR:9"}]}
{"sentText": "This study examined the inward transport of l14Calanine an ASCT2 preferential substrate in monolayers of immortalized renal proximal tubular epithelial PTE cells from WistarKyoto WKY and spontaneously hypertensive SHR rats", "relationMentions": [{"em1Text": "l14Calanine", "em2Text": "ASCT2", "label": "CPR:9"}]}
{"sentText": "The antipsychotic drugs sertindole and pimozide block erg3 a human brain K channel", "relationMentions": [{"em1Text": "sertindole", "em2Text": "erg3", "label": "CPR:4"}, {"em1Text": "sertindole", "em2Text": "human brain K channel", "label": "CPR:4"}, {"em1Text": "pimozide", "em2Text": "erg3", "label": "CPR:4"}, {"em1Text": "pimozide", "em2Text": "human brain K channel", "label": "CPR:4"}]}
{"sentText": "Block of erg3 by sertindole also displayed a positive voltagedependence", "relationMentions": [{"em1Text": "erg3", "em2Text": "sertindole", "label": "CPR:4"}]}
{"sentText": "Pimozide blocked erg3 channel currents with an IC50 of 103 nM and significant inhibition was noted at concentrations of 10 nM and higher", "relationMentions": [{"em1Text": "Pimozide", "em2Text": "erg3", "label": "CPR:4"}]}
{"sentText": "We conclude that erg3 can be blocked by certain antipsychotic drugs like sertindole and pimozide", "relationMentions": [{"em1Text": "erg3", "em2Text": "sertindole", "label": "CPR:4"}, {"em1Text": "erg3", "em2Text": "pimozide", "label": "CPR:4"}]}
{"sentText": "The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K channel known as HERG human etheragogorelated gene erg1", "relationMentions": [{"em1Text": "sertindole", "em2Text": "cardiac K channel", "label": "CPR:4"}, {"em1Text": "sertindole", "em2Text": "HERG", "label": "CPR:4"}, {"em1Text": "sertindole", "em2Text": "human etheragogorelated gene", "label": "CPR:4"}, {"em1Text": "sertindole", "em2Text": "erg1", "label": "CPR:4"}, {"em1Text": "pimozide", "em2Text": "cardiac K channel", "label": "CPR:4"}, {"em1Text": "pimozide", "em2Text": "HERG", "label": "CPR:4"}, {"em1Text": "pimozide", "em2Text": "human etheragogorelated gene", "label": "CPR:4"}, {"em1Text": "pimozide", "em2Text": "erg1", "label": "CPR:4"}]}
{"sentText": "An amphiphile with branched polyethylene glycol architecture also activated the lectin pathway but only through Lficolin recognition", "relationMentions": [{"em1Text": "polyethylene glycol", "em2Text": "lectin", "label": "CPR:3"}]}
{"sentText": "Conformational variations of both phosphodiesterase5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil", "relationMentions": [{"em1Text": "phosphodiesterase5", "em2Text": "sildenafil", "label": "CPR:4"}]}
{"sentText": "Subsequent analysis revealed that cucurbitacin I strongly activates RhoA and the Rho effector Rho kinase ROCK in breast cancer cells and induces the formation of stress fibers", "relationMentions": [{"em1Text": "cucurbitacin I", "em2Text": "RhoA", "label": "CPR:3"}, {"em1Text": "cucurbitacin I", "em2Text": "Rho", "label": "CPR:3"}, {"em1Text": "cucurbitacin I", "em2Text": "Rho kinase", "label": "CPR:3"}, {"em1Text": "cucurbitacin I", "em2Text": "ROCK", "label": "CPR:3"}]}
{"sentText": "Lastly we found that RhoA activation by cucurbitacin I is mediated by reactive oxygen species ROS", "relationMentions": [{"em1Text": "RhoA", "em2Text": "cucurbitacin I", "label": "CPR:3"}]}
{"sentText": "The ROS scavenger Nacetyl lcysteine and the mitochondrial antioxidant MitoTEMPO rescued the inhibitory effect of cucurbitacin I on Rac1 activation", "relationMentions": [{"em1Text": "Nacetyl lcysteine", "em2Text": "Rac1", "label": "CPR:3"}, {"em1Text": "cucurbitacin I", "em2Text": "Rac1", "label": "CPR:4"}]}
{"sentText": "Cucurbitacin I inhibits rac1 activation in breast cancer cells by a reactive oxygen speciesmediated mechanism and independently of janus tyrosine kinase 2 and prex1", "relationMentions": [{"em1Text": "Cucurbitacin I", "em2Text": "rac1", "label": "CPR:4"}]}
{"sentText": "Interestingly disruption of the RhoAROCK pathway prevented the inhibitory effect of cucurbitacin I on Rac1 activation by heregulin", "relationMentions": [{"em1Text": "cucurbitacin I", "em2Text": "Rac1", "label": "CPR:4"}]}
{"sentText": "Moreover they established that the inhibitory effect of cucurbitacin I on Rac1 activity involves the alteration of the balance between Rho and Rac", "relationMentions": [{"em1Text": "cucurbitacin I", "em2Text": "Rac1", "label": "CPR:4"}]}
{"sentText": "Here we found that the anticancer agent cucurbitacin I a Jak2 inhibitor reduced the activation of Rac1 and motility in response to the ErbB3 ligand heregulin in breast cancer cells", "relationMentions": [{"em1Text": "cucurbitacin I", "em2Text": "Jak2", "label": "CPR:4"}, {"em1Text": "cucurbitacin I", "em2Text": "Rac1", "label": "CPR:4"}]}
{"sentText": "These findings suggest that the antiallodynia effect of CP101606 is ascribable to blockade of NR2B receptors at the brain but not at the spinal cord", "relationMentions": [{"em1Text": "CP101606", "em2Text": "NR2B", "label": "CPR:4"}]}
{"sentText": "In order to examine the site of action of an NR2B subtypeselective NMDA antagonist CP101606 we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration", "relationMentions": [{"em1Text": "NR2B", "em2Text": "CP101606", "label": "CPR:6"}, {"em1Text": "NMDA", "em2Text": "CP101606", "label": "CPR:6"}]}
{"sentText": "Brain but not spinal NR2B receptor is responsible for the antiallodynic effect of an NR2B subunitselective antagonist CP101606 in a rat chronic constriction injury model", "relationMentions": [{"em1Text": "NR2B", "em2Text": "CP101606", "label": "CPR:6"}, {"em1Text": "NR2B", "em2Text": "CP101606", "label": "CPR:6"}]}
{"sentText": "In contrast intrathecal injection of a nonselective NMDA antagonist memantine significantly inhibited CCIinduced mechanical allodynia at a dose of 300 nmol indicating the difference in the site of action between the nonselective NMDA antagonist and the NR2Bspecific NMDA antagonist", "relationMentions": [{"em1Text": "NMDA", "em2Text": "memantine", "label": "CPR:6"}]}
{"sentText": "Rasagiline does not modify CNS monoamine tissue levels or monoamineinduced behavioural syndromes at doses which selectively inhibit MAOB but not MAOA", "relationMentions": [{"em1Text": "Rasagiline", "em2Text": "MAOB", "label": "CPR:4"}, {"em1Text": "Rasagiline", "em2Text": "MAOA", "label": "CPR:4"}]}
{"sentText": "Rasagiline Npropargyl1Raminoindan TVP1012 is a potent irreversible monoamine oxidase MAO inhibitor with selectivity for type B of the enzyme which is being developed for treatment of Parkinsons disease", "relationMentions": [{"em1Text": "Rasagiline", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "Rasagiline", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "TVP1012", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "TVP1012", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "Npropargyl1Raminoindan", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "Npropargyl1Raminoindan", "em2Text": "MAO", "label": "CPR:4"}]}
{"sentText": "Reserpineinduced ptosis was reversed by rasagiline at doses above 2 mg x kg1 ip which inhibit MAOA as well as MAOB but not at MAOBselective doses", "relationMentions": [{"em1Text": "rasagiline", "em2Text": "MAOA", "label": "CPR:4"}, {"em1Text": "rasagiline", "em2Text": "MAOB", "label": "CPR:4"}]}
{"sentText": "did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAOA and MAOB by tranylcypromine together with the monoamine precursors", "relationMentions": [{"em1Text": "MAOA", "em2Text": "tranylcypromine", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "tranylcypromine", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "monoamine", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "monoamine", "label": "CPR:4"}]}
{"sentText": "Omega class GSTs have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of monomethylarsonate an intermediate in the pathway of arsenic biotransformation", "relationMentions": [{"em1Text": "Omega class GSTs", "em2Text": "monomethylarsonate", "label": "CPR:9"}]}
{"sentText": "The latter reaction catalyzed by aspartoacylase ASPA produces acetyl groups plus aspartate and has been proposed to occur in both soluble and membranous subfractions of white matter", "relationMentions": [{"em1Text": "aspartoacylase", "em2Text": "acetyl", "label": "CPR:9"}, {"em1Text": "ASPA", "em2Text": "acetyl", "label": "CPR:9"}, {"em1Text": "aspartoacylase", "em2Text": "aspartate", "label": "CPR:9"}, {"em1Text": "ASPA", "em2Text": "aspartate", "label": "CPR:9"}]}
{"sentText": "It is not yet clear whether tamoxifen can reduce breast cancer incidence in women with BRCA1 and BRCA2 mutations although preliminary evidence favors benefit for at least those with a BRCA2 mutation", "relationMentions": [{"em1Text": "tamoxifen", "em2Text": "BRCA2", "label": "CPR:4"}, {"em1Text": "tamoxifen", "em2Text": "BRCA2", "label": "CPR:4"}]}
{"sentText": "Troglitazone inhibited the antigeninduced production of LTB4 C4 and E4 and the potency of the inhibition was comparable to that of zileuton a specific inhibitor of 5lipoxygenase 5LOX and a clinically used antiasthmatic drug", "relationMentions": [{"em1Text": "zileuton", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "zileuton", "em2Text": "5LOX", "label": "CPR:4"}]}
{"sentText": "Troglitazone inhibited LTB4 production by the supernatant fraction of RBL2H3 cell lysate with similar potency to zileuton suggesting that troglitazone inhibits LT production by direct inhibition of 5LOX activity", "relationMentions": [{"em1Text": "zileuton", "em2Text": "5LOX", "label": "CPR:4"}, {"em1Text": "troglitazone", "em2Text": "5LOX", "label": "CPR:4"}]}
{"sentText": "These findings suggest that troglitazone inhibits antigeninduced LT production in the IgEsensitized RBL2H3 cells and A23187stimulated rat peritoneal neutrophils by direct inhibition of 5LOX activity", "relationMentions": [{"em1Text": "troglitazone", "em2Text": "5LOX", "label": "CPR:4"}]}
{"sentText": "The positive correlation between vitamin A and immunoglobulin A concentrations might be the result of the vitamin A inductive effect during immunoglobulins A synthesis", "relationMentions": [{"em1Text": "vitamin A", "em2Text": "immunoglobulin A", "label": "CPR:3"}, {"em1Text": "vitamin A", "em2Text": "immunoglobulins A", "label": "CPR:3"}, {"em1Text": "vitamin A", "em2Text": "immunoglobulin A", "label": "CPR:3"}, {"em1Text": "vitamin A", "em2Text": "immunoglobulins A", "label": "CPR:3"}]}
{"sentText": "Experimental as well as clinical reports support the hypothesis that calcium channel blockers such as verapamil may be an appropriate therapeutic approach in LQTS", "relationMentions": [{"em1Text": "calcium channel", "em2Text": "verapamil", "label": "CPR:4"}]}
{"sentText": "METHODS AND RESULTS In 8 Langendorffperfused rabbit hearts veratridine 01 microM an inhibitor of sodium channel inactivation led to a marked increase in QTinterval and simultaneously recorded monophasic ventricular action potentials MAPs p 005 thereby mimicking LQT3", "relationMentions": [{"em1Text": "veratridine", "em2Text": "sodium channel", "label": "CPR:4"}]}
{"sentText": "Unlike mouse RetSat mRetSat zRetSat A had an altered bond specificity saturating either the 1314 or 78 double bonds of alltransretinol to produce either alltrans1314dihydroretinol or alltrans78dihydroretinol respectively", "relationMentions": [{"em1Text": "zRetSat A", "em2Text": "alltransretinol", "label": "CPR:9"}, {"em1Text": "zRetSat A", "em2Text": "alltrans1314dihydroretinol", "label": "CPR:9"}, {"em1Text": "zRetSat A", "em2Text": "alltrans78dihydroretinol", "label": "CPR:9"}]}
{"sentText": "Specifically alltrans1314dihydroretinol is transiently oxidized to alltrans1314dihydroretinoic acid before being oxidized further by Cyp26 enzymes", "relationMentions": [{"em1Text": "alltrans1314dihydroretinol", "em2Text": "Cyp26", "label": "CPR:9"}]}
{"sentText": "Specificity of zebrafish retinol saturase formation of alltrans1314dihydroretinol and alltrans78 dihydroretinol", "relationMentions": [{"em1Text": "zebrafish retinol saturase", "em2Text": "alltrans1314dihydroretinol", "label": "CPR:9"}, {"em1Text": "zebrafish retinol saturase", "em2Text": "alltrans78 dihydroretinol", "label": "CPR:9"}]}
{"sentText": "zRetSat A also saturated the 1314 or 78 double bonds of alltrans34didehydroretinol vitamin A2 a second endogenous form of vitamin A in zebrafish", "relationMentions": [{"em1Text": "zRetSat A", "em2Text": "alltrans34didehydroretinol", "label": "CPR:9"}, {"em1Text": "zRetSat A", "em2Text": "vitamin A2", "label": "CPR:9"}]}
{"sentText": "Rasagiline is a novel potent and irreversible monoamine oxidase type B MAOB inhibitor which has been approved for treatment of PD", "relationMentions": [{"em1Text": "Rasagiline", "em2Text": "monoamine oxidase type B", "label": "CPR:4"}, {"em1Text": "Rasagiline", "em2Text": "MAOB", "label": "CPR:4"}]}
{"sentText": "Rasagiline inhibits MAOB more potently than selegiline and has the advantage of oncedaily dosing", "relationMentions": [{"em1Text": "Rasagiline", "em2Text": "MAOB", "label": "CPR:4"}]}
{"sentText": "Science 9266 1994 17091713 greatly attenuates the lithium induced potentiation of GluR3", "relationMentions": [{"em1Text": "lithium", "em2Text": "GluR3", "label": "CPR:3"}]}
{"sentText": "Neuron 21 1998 907918 further confirms that lithium enhances GluR3 responses by reducing desensitization since lithiums effects are reversed in this mutant", "relationMentions": [{"em1Text": "lithium", "em2Text": "GluR3", "label": "CPR:3"}]}
{"sentText": "Analysis of splice variants and sitedirected mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the GluR3 flop splice variant and suggested that lithium might inhibit rapid desensitization which is characteristic of this receptor Karkanias N and Papke R Subtypespecific effects of lithium on glutamate receptor function", "relationMentions": [{"em1Text": "lithium", "em2Text": "GluR3 flop", "label": "CPR:3"}, {"em1Text": "lithium", "em2Text": "GluR3 flop", "label": "CPR:3"}]}
{"sentText": "Specifically aniracetam which potentiates wildtype AMPA receptors is ineffective on the nondesensitizing GluR3 L507Y mutant but has synergistic effects with lithium on wildtype receptors", "relationMentions": [{"em1Text": "aniracetam", "em2Text": "AMPA receptors", "label": "CPR:3"}, {"em1Text": "GluR3", "em2Text": "lithium", "label": "CPR:3"}, {"em1Text": "L507Y", "em2Text": "lithium", "label": "CPR:3"}]}
{"sentText": "The BH4 treatment was associated with a 2fold increase in eNOS activity as well as a 70 reduction in endothelial O2 production compared with those in fructosefed rats", "relationMentions": [{"em1Text": "BH4", "em2Text": "eNOS", "label": "CPR:3"}]}
{"sentText": "The BH4 treatment also partially improved the insulin sensitivity and blood pressure as well as the serum triglyceride concentration in the fructosefed rats", "relationMentions": [{"em1Text": "BH4", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "Moreover BH4 treatment of the fructose fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redoxsensitive transcription factors nuclear factorkappaB and activating protein1 which were increased in fructosefed rats", "relationMentions": [{"em1Text": "fructose", "em2Text": "nuclear factorkappaB", "label": "CPR:3"}, {"em1Text": "fructose", "em2Text": "activating protein1", "label": "CPR:3"}, {"em1Text": "fructose", "em2Text": "nuclear factorkappaB", "label": "CPR:3"}, {"em1Text": "fructose", "em2Text": "activating protein1", "label": "CPR:3"}, {"em1Text": "BH4", "em2Text": "nuclear factorkappaB", "label": "CPR:4"}, {"em1Text": "BH4", "em2Text": "activating protein1", "label": "CPR:4"}]}
{"sentText": "We confirm the correlation between higher hCTR1 levels and higher Pt drug uptake in tumor cells sensitive to the drug", "relationMentions": [{"em1Text": "hCTR1", "em2Text": "Pt", "label": "CPR:9"}]}
{"sentText": "It has been claimed that hCTR1 the human high affinity copper transporter is the major entry pathway for cDDP and related drugs via a mechanism that mimics copper", "relationMentions": [{"em1Text": "hCTR1", "em2Text": "cDDP", "label": "CPR:9"}, {"em1Text": "human high affinity copper transporter", "em2Text": "cDDP", "label": "CPR:9"}]}
{"sentText": "Compared with aripiprazole which significantly inhibited the firing activity of VTA DA neurons brexpiprazole displayed less efficacy at D2 receptors", "relationMentions": [{"em1Text": "brexpiprazole", "em2Text": "D2 receptors", "label": "CPR:4"}]}
{"sentText": "In the DRN brexpiprazole completely inhibited the firing of 5HT neurons via 5HT1A agonism and was more potent than aripiprazole ED50 = 230 and 700 mugkg respectively", "relationMentions": [{"em1Text": "brexpiprazole", "em2Text": "5HT1A", "label": "CPR:5"}, {"em1Text": "5HT1A", "em2Text": "aripiprazole", "label": "CPR:5"}]}
{"sentText": "In the locus coeruleus brexpiprazole reversed the inhibitory effect of the preferential 5HT2A receptor agonist DOI 25dimethoxy4iodoamphetamine on norepinephrine neuronal firing ED50 = 110 mugkg demonstrating 5HT2A antagonistic action", "relationMentions": [{"em1Text": "5HT2A", "em2Text": "DOI", "label": "CPR:5"}, {"em1Text": "5HT2A", "em2Text": "25dimethoxy4iodoamphetamine", "label": "CPR:5"}]}
{"sentText": "Brexpiprazole reversed the inhibitory effect of the DA agonist apomorphine on VTA DA neurons ED50 = 61 mugkg whereas it was ineffective when administered alone indicating partial agonistic action on D2 receptors", "relationMentions": [{"em1Text": "apomorphine", "em2Text": "D2 receptors", "label": "CPR:5"}]}
{"sentText": "In the hippocampus brexpiprazole acted as a full agonist at 5HT1A receptors on pyramidal neurons", "relationMentions": [{"em1Text": "brexpiprazole", "em2Text": "5HT1A", "label": "CPR:5"}]}
{"sentText": "In the lateral geniculate nucleus brexpiprazole displayed alpha1Badrenoceptor antagonistic action", "relationMentions": [{"em1Text": "brexpiprazole", "em2Text": "alpha1Badrenoceptor", "label": "CPR:6"}]}
{"sentText": "For AII and ET1 MAP was also increased for the fenofibrate group but not in a dosedependent fashion", "relationMentions": [{"em1Text": "AII", "em2Text": "fenofibrate", "label": "CPR:3"}, {"em1Text": "ET1", "em2Text": "fenofibrate", "label": "CPR:3"}]}
{"sentText": "Nanobodyalbumin nanoparticles NANAPs for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells", "relationMentions": [{"em1Text": "multikinase", "em2Text": "17864", "label": "CPR:4"}]}
{"sentText": "Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were loaded with the multikinase inhibitor 17864 Lxa platinumbound sunitinib analoguewhich couples the drug to methionine residues of albumin and is released in a reductive environment", "relationMentions": [{"em1Text": "multikinase", "em2Text": "17864", "label": "CPR:4"}]}
{"sentText": "Endogenously produced asymmetrically methylated arginine residues are competitive inhibitors of all three isoforms of nitric oxide synthase NOS", "relationMentions": [{"em1Text": "arginine", "em2Text": "nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "arginine", "em2Text": "NOS", "label": "CPR:4"}]}
{"sentText": "The enzyme dimethylarginine dimethylaminohydrolase DDAH specifically hydrolyzes these asymmetrically methylated arginine residues to citrulline and methylamines", "relationMentions": [{"em1Text": "dimethylarginine dimethylaminohydrolase", "em2Text": "arginine", "label": "CPR:9"}, {"em1Text": "arginine", "em2Text": "DDAH", "label": "CPR:9"}]}
{"sentText": "Previously we have proposed that regulation of asymmetric methylarginine concentration by DDAH may provide a novel mechanism for the regulation of NOS activity in vivo", "relationMentions": [{"em1Text": "methylarginine", "em2Text": "DDAH", "label": "CPR:9"}]}
{"sentText": "The structureactivity relationship of a series of dihydroisoquinoline BACE1 inhibitors is described", "relationMentions": [{"em1Text": "dihydroisoquinoline", "em2Text": "BACE1", "label": "CPR:4"}]}
{"sentText": "Structurebased design of novel dihydroisoquinoline BACE1 inhibitors that do not engage the catalytic aspartates", "relationMentions": [{"em1Text": "dihydroisoquinoline", "em2Text": "BACE1", "label": "CPR:4"}]}
{"sentText": "Tissuetype plasminogen activator tPA a serine protease well known for generating plasmin has been demonstrated to induce matrix metalloproteinase9 MMP9 gene expression and protein secretion in renal interstitial fibroblasts", "relationMentions": [{"em1Text": "serine", "em2Text": "matrix metalloproteinase9", "label": "CPR:3"}, {"em1Text": "plasmin", "em2Text": "serine", "label": "CPR:3"}]}
{"sentText": "Furthermore tPA induced rapid tyrosine phosphorylation on the beta subunit of LRP1 which was followed by the activation of Mek1 and its downstream Erk1 and 2", "relationMentions": [{"em1Text": "tyrosine", "em2Text": "Mek1", "label": "CPR:3"}, {"em1Text": "tyrosine", "em2Text": "Erk1 and 2", "label": "CPR:3"}]}
{"sentText": "The data show that CPcPh is less potent at inducing CYP1A gene expression in rainbow trout than benzoapyrene BaP a wellknown Ahreceptor agonist", "relationMentions": [{"em1Text": "CPcPh", "em2Text": "CYP1A", "label": "CPR:3"}, {"em1Text": "CYP1A", "em2Text": "benzoapyrene", "label": "CPR:3"}, {"em1Text": "CYP1A", "em2Text": "BaP", "label": "CPR:3"}]}
{"sentText": "Interestingly the CPcPh dependent upregulation of CYP1A mRNA is positively correlated with the incidences of clastogenic changes in rainbow trout erythrocytes", "relationMentions": [{"em1Text": "CPcPh", "em2Text": "CYP1A", "label": "CPR:3"}]}
{"sentText": "CPcPh has comparably to BaP a potential to repress expression of tumor suppressor p53 in the head kidney of rainbow trout", "relationMentions": [{"em1Text": "CPcPh", "em2Text": "tumor suppressor p53", "label": "CPR:4"}, {"em1Text": "BaP", "em2Text": "tumor suppressor p53", "label": "CPR:4"}]}
{"sentText": "Identification of benzofuran central cores for the inhibition of leukotriene A4 hydrolase", "relationMentions": [{"em1Text": "benzofuran", "em2Text": "leukotriene A4 hydrolase", "label": "CPR:4"}]}
{"sentText": "This paper describes the identification and synthesis of substituted benzofurans as LTH4H inhibitors", "relationMentions": [{"em1Text": "benzofurans", "em2Text": "LTH4H", "label": "CPR:4"}]}
{"sentText": "Benzofuran 28 showed dose responsive target engagement and provides a useful tool to explore a LTA4H inhibitor for the treatment of inflammatory diseases such as asthma and inflammatory bowel disease IBD", "relationMentions": [{"em1Text": "Benzofuran", "em2Text": "LTA4H", "label": "CPR:4"}]}
{"sentText": "Leukotriene A4 hydrolase LTA4H is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA4 to LTB4", "relationMentions": [{"em1Text": "LTA4", "em2Text": "LTA4H", "label": "CPR:9"}, {"em1Text": "Leukotriene A4 hydrolase", "em2Text": "LTA4", "label": "CPR:9"}, {"em1Text": "LTA4H", "em2Text": "LTB4", "label": "CPR:9"}, {"em1Text": "Leukotriene A4 hydrolase", "em2Text": "LTB4", "label": "CPR:9"}]}
{"sentText": "Minocycline treatment prevents the formation of activated caspase3 a known effector of apoptosis as well as the appearance of a calpain cleaved substrate a marker of excitotoxicnecrotic cell death", "relationMentions": [{"em1Text": "Minocycline", "em2Text": "caspase3", "label": "CPR:4"}]}
{"sentText": "Pretreatment of rats with the MAO inhibitor tranylcypromine prevented the increase in brain GABA and ALA levels with PLZ but did not block the effect of VIG on GABA", "relationMentions": [{"em1Text": "MAO", "em2Text": "tranylcypromine", "label": "CPR:4"}]}
{"sentText": "The effects of PLZ on both amino acids and their transaminases were blocked by pretreatment with the MAO inhibitor tranylcypromine", "relationMentions": [{"em1Text": "MAO", "em2Text": "tranylcypromine", "label": "CPR:4"}, {"em1Text": "transaminases", "em2Text": "tranylcypromine", "label": "CPR:4"}]}
{"sentText": "PURPOSE To compare phenelzine PLZ an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase MAO but also elevates rat brain levels of the amino acids aminobutyric acid GABA and alanine ALA with vigabatrin VIG an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase GABAT with regard to their actions on brain levels of GABA and ALA and on activities of MAO GABAT and ALA transaminase ALAT", "relationMentions": [{"em1Text": "phenelzine", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "phenelzine", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "vigabatrin", "em2Text": "GABA transaminase", "label": "CPR:4"}, {"em1Text": "vigabatrin", "em2Text": "GABAT", "label": "CPR:4"}, {"em1Text": "VIG", "em2Text": "GABA transaminase", "label": "CPR:4"}, {"em1Text": "VIG", "em2Text": "GABAT", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "MAO", "label": "CPR:4"}]}
{"sentText": "RESULTS Both PLZ and VIG inhibited GABAT and elevated GABA levels", "relationMentions": [{"em1Text": "PLZ", "em2Text": "GABAT", "label": "CPR:4"}, {"em1Text": "VIG", "em2Text": "GABAT", "label": "CPR:4"}]}
{"sentText": "Only PLZ inhibited MAO and ALAT and elevated ALA levels", "relationMentions": [{"em1Text": "PLZ", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "ALAT", "label": "CPR:4"}]}
{"sentText": "Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine A comparison with vigabatrin", "relationMentions": [{"em1Text": "monoamine oxidase", "em2Text": "phenelzine", "label": "CPR:4"}]}
{"sentText": "This pretreament had no effect on the inhibition of GABAT or the elevation of brain GABA levels produced by VIG", "relationMentions": [{"em1Text": "GABAT", "em2Text": "VIG", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS At the doses studied PLZ was as effective as VIG at elevating brain GABA levels but unlike VIG also inhibited MAO and ALAT and increased brain ALA levels", "relationMentions": [{"em1Text": "VIG", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "VIG", "em2Text": "ALAT", "label": "CPR:4"}]}
{"sentText": "Clinical pharmacology of enalkiren a novel dipeptide renin inhibitor", "relationMentions": [{"em1Text": "enalkiren", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "dipeptide", "em2Text": "renin", "label": "CPR:4"}]}
{"sentText": "Enalkiren A64662 a potent dipeptide renin inhibitor mimics the transition state of the human renin substrate angiotensinogen", "relationMentions": [{"em1Text": "Enalkiren", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "Enalkiren", "em2Text": "human renin", "label": "CPR:4"}, {"em1Text": "A64662", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "A64662", "em2Text": "human renin", "label": "CPR:4"}, {"em1Text": "dipeptide", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "dipeptide", "em2Text": "human renin", "label": "CPR:4"}]}
{"sentText": "The results of clinical trials with enalkiren are encouraging and suggest that renin inhibitors may be safe useful therapeutic agents in the management of hypertension", "relationMentions": [{"em1Text": "enalkiren", "em2Text": "renin", "label": "CPR:4"}]}
{"sentText": "Enalkiren has been shown to produce doserelated suppression of plasma renin activity PRA and angiotensin II when administered intravenously", "relationMentions": [{"em1Text": "Enalkiren", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "Enalkiren", "em2Text": "angiotensin II", "label": "CPR:4"}]}
{"sentText": "Also in contrast to effects of multiple METH injections 1 MDMA caused little or no decrease in binding of the DAT ligand WIN35428 and 2 neither prevention of hyperthermia nor prior depletion of DA prevented the MDMAinduced reduction in plasmalemmal DA transport", "relationMentions": [{"em1Text": "METH", "em2Text": "DAT", "label": "CPR:4"}, {"em1Text": "MDMA", "em2Text": "DAT", "label": "CPR:4"}, {"em1Text": "DA", "em2Text": "DAT", "label": "CPR:9"}, {"em1Text": "DA", "em2Text": "DAT", "label": "CPR:9"}]}
{"sentText": "In addition to affecting DAT function MDMA rapidly decreased vesicular DA transport as assessed in striatal vesicles prepared from treated rats", "relationMentions": [{"em1Text": "DA", "em2Text": "DAT", "label": "CPR:9"}]}
{"sentText": "Concentrationdependent inhibitory effects of baicalin on the metabolism of dextromethorphan a dual probe of CYP2D and CYP3A in rats", "relationMentions": [{"em1Text": "baicalin", "em2Text": "CYP2D", "label": "CPR:4"}, {"em1Text": "baicalin", "em2Text": "CYP3A", "label": "CPR:4"}, {"em1Text": "dextromethorphan", "em2Text": "CYP2D", "label": "CPR:9"}, {"em1Text": "dextromethorphan", "em2Text": "CYP3A", "label": "CPR:9"}]}
{"sentText": "The activity of CYP3A in excised liver samples from rats following multiple baicalin treatment was significantly decreased compared to that of the control group P005 whereas multiple doses of baicalin had no obvious effect on the activity of CYP2D", "relationMentions": [{"em1Text": "CYP3A", "em2Text": "baicalin", "label": "CPR:4"}]}
{"sentText": "Taken together these data demonstrate that baicalin inhibits the metabolism of DXM in a concentrationdependent manner in rats possibly through inhibiting hepatic CYP2D and CYP3A activities", "relationMentions": [{"em1Text": "baicalin", "em2Text": "CYP2D", "label": "CPR:4"}, {"em1Text": "baicalin", "em2Text": "CYP3A", "label": "CPR:4"}, {"em1Text": "DXM", "em2Text": "CYP2D", "label": "CPR:9"}, {"em1Text": "DXM", "em2Text": "CYP3A", "label": "CPR:9"}]}
{"sentText": "In the current study we reveal the inhibitory effects of baicalin on the metabolism of dextromethorphan DXM a dual probe substrate of CYP2D and CYP3A in rats", "relationMentions": [{"em1Text": "baicalin", "em2Text": "CYP2D", "label": "CPR:4"}, {"em1Text": "baicalin", "em2Text": "CYP3A", "label": "CPR:4"}, {"em1Text": "dextromethorphan", "em2Text": "CYP2D", "label": "CPR:9"}, {"em1Text": "dextromethorphan", "em2Text": "CYP3A", "label": "CPR:9"}, {"em1Text": "DXM", "em2Text": "CYP2D", "label": "CPR:9"}, {"em1Text": "DXM", "em2Text": "CYP3A", "label": "CPR:9"}]}
{"sentText": "LineweaverBurk plots demonstrated that baicalin inhibited the activities of CYP2D and CYP3A in a noncompetitive manner in rat liver microsomes RLMs", "relationMentions": [{"em1Text": "baicalin", "em2Text": "CYP2D", "label": "CPR:4"}, {"em1Text": "baicalin", "em2Text": "CYP3A", "label": "CPR:4"}]}
{"sentText": "Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an antiobesity profile", "relationMentions": [{"em1Text": "benzimidazole", "em2Text": "NPY Y5 receptor", "label": "CPR:6"}]}
{"sentText": "We evaluated the clinical effectiveness of esmolol an ultrashortacting beta 1adrenergic receptor blocking drug to control the sinus tachycardia and increase in arterial blood pressures induced by electroconvulsive therapy ECT", "relationMentions": [{"em1Text": "esmolol", "em2Text": "beta 1adrenergic receptor", "label": "CPR:4"}]}
{"sentText": "The beta2adrenoceptor beta2AR agonists clenbuterol and fenoterol have similar beneficial effects in animal models of heart failure", "relationMentions": [{"em1Text": "beta2AR", "em2Text": "clenbuterol", "label": "CPR:5"}, {"em1Text": "beta2adrenoceptor", "em2Text": "clenbuterol", "label": "CPR:5"}, {"em1Text": "beta2AR", "em2Text": "fenoterol", "label": "CPR:5"}, {"em1Text": "beta2adrenoceptor", "em2Text": "fenoterol", "label": "CPR:5"}]}
{"sentText": "beta1Adrenoceptor antagonism 10 mg kg1 bisoprolol prevented 92 P 005 of apoptosis induced by all three agonists but clenbuterolinduced apoptosis could also be prevented by 96 P 005 by beta2AR antagonism 10 mg kg1 ICI 118 551", "relationMentions": [{"em1Text": "beta1Adrenoceptor", "em2Text": "bisoprolol", "label": "CPR:6"}]}
{"sentText": "The mouse CYP2J subfamily includes members that have wide tissue distribution and are active in the metabolism of arachidonic acid AA linoleic acid LA and other lipids and xenobiotics", "relationMentions": [{"em1Text": "CYP2J", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "CYP2J", "em2Text": "linoleic acid", "label": "CPR:9"}]}
{"sentText": "CPT I carnitine palmitoyltransferase I catalyses the conversion of palmitoylCoA into palmitoylcarnitine in the presence of Lcarnitine facilitating the entry of fatty acids into mitochondria", "relationMentions": [{"em1Text": "CPT I", "em2Text": "palmitoylcarnitine", "label": "CPR:9"}, {"em1Text": "carnitine palmitoyltransferase I", "em2Text": "palmitoylcarnitine", "label": "CPR:9"}, {"em1Text": "CPT I", "em2Text": "palmitoylCoA", "label": "CPR:9"}, {"em1Text": "carnitine palmitoyltransferase I", "em2Text": "palmitoylCoA", "label": "CPR:9"}]}
{"sentText": "Cholesterol uptake from lipoproteins intracellular vesicle transport and lipid transfer are also modified by oxysterols", "relationMentions": [{"em1Text": "Cholesterol", "em2Text": "lipoproteins", "label": "CPR:9"}]}
{"sentText": "In addition the new compound perviridicin B 2 three known rocaglate derivatives 9 11 12 and a known sesquiterpene 2oxaisodauc5en12al 17 showed significant NF\u03baB p65 inhibitory activity in an ELISA assay", "relationMentions": [{"em1Text": "perviridicin B", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "perviridicin B", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "rocaglate", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "rocaglate", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "sesquiterpene", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "sesquiterpene", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "2oxaisodauc5en12al", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "2oxaisodauc5en12al", "em2Text": "p65", "label": "CPR:4"}]}
{"sentText": "In further evaluation the representative compound NNdiethylN2Nmethyltetradecanamidoethylprop2en1aminium bromide 3b exhibited potent proapoptotic activity through RhoB activation in HeLa cells", "relationMentions": [{"em1Text": "NNdiethylN2Nmethyltetradecanamidoethylprop2en1aminium bromide", "em2Text": "RhoB", "label": "CPR:3"}]}
{"sentText": "These results suggest that epinastine although identified as a 5HT antagonist acts as a 5HT1 agonist and that it inhibits the noncholinergic contraction in guineapig airways through stimulation of a prejunctional 5HT1like receptor located to sensory nerves", "relationMentions": [{"em1Text": "epinastine", "em2Text": "5HT1like receptor", "label": "CPR:3"}, {"em1Text": "epinastine", "em2Text": "5HT1", "label": "CPR:5"}]}
{"sentText": "Pretreatment of the tissues with combined 5HT1 5HT2 antagonists methysergide 1 microM or methiothepin 01 microM significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction", "relationMentions": [{"em1Text": "5HT1", "em2Text": "epinastine", "label": "CPR:5"}, {"em1Text": "5HT2", "em2Text": "epinastine", "label": "CPR:5"}, {"em1Text": "5HT1", "em2Text": "methysergide", "label": "CPR:6"}, {"em1Text": "5HT2", "em2Text": "methysergide", "label": "CPR:6"}, {"em1Text": "5HT1", "em2Text": "methiothepin", "label": "CPR:6"}, {"em1Text": "5HT2", "em2Text": "methiothepin", "label": "CPR:6"}]}
{"sentText": "Pretreatment with tropisetron 1 microM a 5HT3 antagonist ketanserin 10 microM a 5HT2 antagonist thioperamide 10 microM a histamine H3 antagonist or phentolamine 10 microM an alphaadrenergic antagonist however had no effect", "relationMentions": [{"em1Text": "tropisetron", "em2Text": "5HT3", "label": "CPR:6"}, {"em1Text": "ketanserin", "em2Text": "5HT2", "label": "CPR:6"}, {"em1Text": "thioperamide", "em2Text": "histamine H3", "label": "CPR:6"}]}
{"sentText": "Chlorpheniramine 10 microM another histamine H1 receptor antagonist without significant 5HT receptor binding affinity did not produce any inhibition of the eNANC contraction", "relationMentions": [{"em1Text": "Chlorpheniramine", "em2Text": "histamine H1 receptor", "label": "CPR:6"}]}
{"sentText": "We observed a significant reduction in CSE induced luciferase expression NF\u03baB DNA binding I\u03baB\u03b5 degradation and cRel nuclear translocation in cells pretreated with vitamin C To further validate the result we examined subcellular distribution of cRel in lungs of CSexposed guinea pigs treated or untreated with vitamin C Result showed that vitamin C treatment resulted in markedly reduced cRel nuclear translocation", "relationMentions": [{"em1Text": "cRel", "em2Text": "vitamin C", "label": "CPR:4"}, {"em1Text": "I\u03baB\u03b5", "em2Text": "vitamin C", "label": "CPR:4"}]}
{"sentText": "All these results demonstrate that vitamin C prevents CSEinduced NF\u03baB activation and thus it could be used for the prevention of CSinduced inflammatory diseases", "relationMentions": [{"em1Text": "vitamin C", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "It is possible that vitamin C an antioxidant may prevent cigarette smoke CSinduced NF\u03baB activation that involves degradation of I\u03baB\u03b5 and nuclear translocation of cRelp50 in alveolar epithelial cells", "relationMentions": [{"em1Text": "vitamin C", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "vitamin C", "em2Text": "I\u03baB\u03b5", "label": "CPR:4"}]}
{"sentText": "Vitamin C forestalls cigarette smoke induced NF\u03baB activation in alveolar epithelial cells", "relationMentions": [{"em1Text": "Vitamin C", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "Catalpol also suppressed AGEinduced phosphorylation of mitogen activated protein MAP kinases degradation of I\u03baB\u03b1 and the nuclear localization of NF\u03baB", "relationMentions": [{"em1Text": "Catalpol", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "mitogen activated protein MAP kinases", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "I\u03baB\u03b1", "label": "CPR:4"}]}
{"sentText": "Moreover the production of intracellular reactive oxygen species ROS elicited by AGE was also suppressed by catalpol treatment through dual action of reducing ROS itself and inhibiting NADPH oxidase activity", "relationMentions": [{"em1Text": "catalpol", "em2Text": "NADPH oxidase", "label": "CPR:4"}]}
{"sentText": "Our findings indicate that catalpol suppresses AGEmediated inflammation by inhibiting ROS production and NF\u03baB activity", "relationMentions": [{"em1Text": "catalpol", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "Catalpol reduced the expression of proinflammatory mediates such as monocyte chemotactic protein1 MCP1 tumor necrosis factor\u03b1 TNF\u03b1 inducible NO synthase iNOS and receptor for AGE RAGE", "relationMentions": [{"em1Text": "Catalpol", "em2Text": "monocyte chemotactic protein1", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "MCP1", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "TNF\u03b1", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "inducible NO synthase", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "receptor for AGE", "label": "CPR:4"}, {"em1Text": "Catalpol", "em2Text": "RAGE", "label": "CPR:4"}]}
{"sentText": "Promoter and electromobility shift assays showed that transcriptional activation of NF\u03baB was significantly reduced by catalpol treatment while AP1 was not", "relationMentions": [{"em1Text": "NF\u03baB", "em2Text": "catalpol", "label": "CPR:4"}]}
{"sentText": "Apoptosis studies DAPI staining and caspase 3 activity showed a marked increase in the presence of MXF and VP16 compared to VP16 alone", "relationMentions": [{"em1Text": "caspase 3", "em2Text": "MXF", "label": "CPR:3"}, {"em1Text": "caspase 3", "em2Text": "VP16", "label": "CPR:3"}, {"em1Text": "caspase 3", "em2Text": "VP16", "label": "CPR:3"}]}
{"sentText": "In conclusion the results suggest that the enhancement in the reduction of topo II activity by the combined MXF VP16 treatments was probably due to the increase in the level of the DNAenzyme cleavable complexes formed by both drugs", "relationMentions": [{"em1Text": "topo II", "em2Text": "MXF", "label": "CPR:4"}, {"em1Text": "topo II", "em2Text": "VP16", "label": "CPR:4"}]}
{"sentText": "Etoposide VP16 is a topoisomeraseII topo II inhibitor chemotherapeutic agent", "relationMentions": [{"em1Text": "Etoposide", "em2Text": "topoisomeraseII", "label": "CPR:4"}, {"em1Text": "Etoposide", "em2Text": "topo II", "label": "CPR:4"}, {"em1Text": "VP16", "em2Text": "topoisomeraseII", "label": "CPR:4"}, {"em1Text": "VP16", "em2Text": "topo II", "label": "CPR:4"}]}
{"sentText": "MXF or VP16 slightly affected cellular topo II activity in nuclear extracts derived from drugtreated cells while the combination enhanced inhibitory activity and the reduction in band depletion of topo II", "relationMentions": [{"em1Text": "MXF", "em2Text": "topo II", "label": "CPR:4"}, {"em1Text": "VP16", "em2Text": "topo II", "label": "CPR:4"}]}
{"sentText": "TAS102 currently undergoing clinical trials has been demonstrated to have at least two mechanisms inhibition of TS and incorporation into DNA", "relationMentions": [{"em1Text": "TAS102", "em2Text": "TS", "label": "CPR:4"}]}
{"sentText": "In the present study we measured the enzyme activity of thymidine kinase TK thymidine phosphorylase TP and thymidilate synthase TS in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of TAS102", "relationMentions": [{"em1Text": "thymidilate synthase", "em2Text": "TAS102", "label": "CPR:4"}, {"em1Text": "TS", "em2Text": "TAS102", "label": "CPR:4"}]}
{"sentText": "Because clinical studies investigating interactions between garlic and human immunodeficiency virus protease inhibitors saquinavir and ritonavir have already been performed we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of firstpass intestinal metabolism changes", "relationMentions": [{"em1Text": "human immunodeficiency virus protease", "em2Text": "saquinavir", "label": "CPR:4"}, {"em1Text": "human immunodeficiency virus protease", "em2Text": "ritonavir", "label": "CPR:4"}]}
{"sentText": "Labetalol or = 3 x 108 M and dilevalol or = 108 M caused surmountable antagonism of the isoprenaline responses of the atria and the pA2 values were 860 and 898 at the beta 1adrenoceptors of the rat left atria and 790 and 831 respectively on the guineapig left atria which has functional beta 1 and beta 2adrenoceptors", "relationMentions": [{"em1Text": "isoprenaline", "em2Text": "beta 1adrenoceptors", "label": "CPR:5"}, {"em1Text": "Labetalol", "em2Text": "beta 1adrenoceptors", "label": "CPR:6"}, {"em1Text": "dilevalol", "em2Text": "beta 1adrenoceptors", "label": "CPR:6"}]}
{"sentText": "The isoprenaline attenuation responses of the portal vein were inhibited by labetalol and dilevalol both at or = 107 M and the pA2 value for the labetalol at beta 2adrenoceptors was 759", "relationMentions": [{"em1Text": "labetalol", "em2Text": "beta 2adrenoceptors", "label": "CPR:6"}]}
{"sentText": "It is concluded that labetalol and dilevalol are beta 1adrenoceptor selective antagonists", "relationMentions": [{"em1Text": "labetalol", "em2Text": "beta 1adrenoceptor", "label": "CPR:6"}, {"em1Text": "dilevalol", "em2Text": "beta 1adrenoceptor", "label": "CPR:6"}]}
{"sentText": "PR mRNA abundance in both myometruim and leiomyomata center and marginal area was significantly decreased in 4 patients continuing mifepristone treatment before the operation but not in the other 2 patients stopping RU486 1 month before operation", "relationMentions": [{"em1Text": "PR mRNA", "em2Text": "mifepristone", "label": "CPR:4"}]}
{"sentText": "One of the mechanism of mifepristone action on decreasing leiomyomata volume may be related to suppression on expression of PR gene", "relationMentions": [{"em1Text": "mifepristone", "em2Text": "PR gene", "label": "CPR:4"}]}
{"sentText": "Experimental cystathioninuria was induced in rats by administration of the cystathionine gammalyase inhibitor DLpropargylglycine", "relationMentions": [{"em1Text": "cystathionine gammalyase", "em2Text": "DLpropargylglycine", "label": "CPR:4"}]}
{"sentText": "The nonselective adenosine receptor antagonist caffeine and the selective adenosine A1 receptor antagonist DPCPX injected 15 min before the application of pentetrazole and flumazenil were able to intensify BDZ withdrawal signs in mice", "relationMentions": [{"em1Text": "adenosine receptor", "em2Text": "caffeine", "label": "CPR:6"}, {"em1Text": "adenosine A1 receptor", "em2Text": "DPCPX", "label": "CPR:6"}]}
{"sentText": "The concomitant application of subconvulsive dose of pentetrazole 550 mgkg with low dose of flumazenil 50 mgkg a BDZ receptor antagonist immediately induced BDZ withdrawal signs in these animals", "relationMentions": [{"em1Text": "flumazenil", "em2Text": "BDZ receptor", "label": "CPR:6"}]}
{"sentText": "Here we show that one BLT 12methoxyphenyl3naphthalen2ylurea BLT4 blocked ABCA1 mediated cholesterol efflux to lipidpoor apoAI at a potency similar to that for its inhibition of SRBI IC50 approximately 5560 microM", "relationMentions": [{"em1Text": "BLT4", "em2Text": "ABCA1", "label": "CPR:4"}, {"em1Text": "BLT4", "em2Text": "SRBI", "label": "CPR:4"}, {"em1Text": "BLT", "em2Text": "ABCA1", "label": "CPR:4"}, {"em1Text": "BLT", "em2Text": "SRBI", "label": "CPR:4"}, {"em1Text": "12methoxyphenyl3naphthalen2ylurea", "em2Text": "ABCA1", "label": "CPR:4"}, {"em1Text": "12methoxyphenyl3naphthalen2ylurea", "em2Text": "SRBI", "label": "CPR:4"}, {"em1Text": "ABCA1", "em2Text": "cholesterol", "label": "CPR:9"}]}
{"sentText": "Reciprocally glyburide blocked SRBI mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of ABCA1 IC50 approximately 275300 microM", "relationMentions": [{"em1Text": "glyburide", "em2Text": "ABCA1", "label": "CPR:4"}, {"em1Text": "glyburide", "em2Text": "SRBI", "label": "CPR:4"}]}
{"sentText": "Crossinhibition of SRBI and ABCA1 mediated cholesterol transport by the small molecules BLT4 and glyburide", "relationMentions": [{"em1Text": "SRBI", "em2Text": "glyburide", "label": "CPR:4"}, {"em1Text": "ABCA1", "em2Text": "glyburide", "label": "CPR:4"}, {"em1Text": "SRBI", "em2Text": "cholesterol", "label": "CPR:9"}, {"em1Text": "ABCA1", "em2Text": "cholesterol", "label": "CPR:9"}]}
{"sentText": "The reciprocal inhibition of SRBI and ABCA1 by BLT4 and glyburide raises the possibility that these proteins may share similar or common steps in their mechanisms of lipid transport", "relationMentions": [{"em1Text": "SRBI", "em2Text": "glyburide", "label": "CPR:4"}, {"em1Text": "ABCA1", "em2Text": "glyburide", "label": "CPR:4"}]}
{"sentText": "The activities of ABCA1 and other ATP binding cassette superfamily members are inhibited by the drug glyburide and SRBImediated lipid transport is blocked by small molecule inhibitors called BLTs", "relationMentions": [{"em1Text": "ABCA1", "em2Text": "glyburide", "label": "CPR:4"}, {"em1Text": "ATP binding cassette superfamily", "em2Text": "glyburide", "label": "CPR:4"}]}
{"sentText": "SRBI is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of cholesteryl esters from lipidrich HDL to cells and the efflux of unesterified cholesterol from cells to HDL", "relationMentions": [{"em1Text": "SRBI", "em2Text": "cholesteryl esters", "label": "CPR:9"}, {"em1Text": "SRBI", "em2Text": "cholesterol", "label": "CPR:9"}]}
{"sentText": "ABCA1 mediates the efflux of unesterified cholesterol and phospholipids from cells to lipidpoor apolipoprotein AI apoAI", "relationMentions": [{"em1Text": "ABCA1", "em2Text": "cholesterol", "label": "CPR:9"}]}
{"sentText": "The treatment of mice with FeNTA alone enhances ornithine decarboxylase activity to 46 folds protein carbonyl formation increased up to 29 folds and DNA synthesis expressed in terms of 3H thymidine incorporation increased to 32 folds and antioxidants and antioxidant enzymes decreased to 1825 folds compared with the corresponding salinetreated controls", "relationMentions": [{"em1Text": "FeNTA", "em2Text": "ornithine decarboxylase", "label": "CPR:3"}]}
{"sentText": "Exposure to PAHs their metabolites and ROS further increase AKRs isoform expression that may amplify oxidative damage", "relationMentions": [{"em1Text": "PAHs", "em2Text": "AKRs", "label": "CPR:3"}]}
{"sentText": "Aldoketo reductases AKRs metabolize a wide range of substrates including polycyclic aromatic hydrocarbons PAHs generating metabolites oquinones and reactive oxygen species ROS which are capable of initiating and promoting carcinogenesis", "relationMentions": [{"em1Text": "Aldoketo reductases", "em2Text": "polycyclic aromatic hydrocarbons", "label": "CPR:9"}, {"em1Text": "AKRs", "em2Text": "polycyclic aromatic hydrocarbons", "label": "CPR:9"}, {"em1Text": "Aldoketo reductases", "em2Text": "PAHs", "label": "CPR:9"}, {"em1Text": "AKRs", "em2Text": "PAHs", "label": "CPR:9"}, {"em1Text": "Aldoketo reductases", "em2Text": "oquinones", "label": "CPR:9"}, {"em1Text": "AKRs", "em2Text": "oquinones", "label": "CPR:9"}, {"em1Text": "Aldoketo reductases", "em2Text": "oxygen", "label": "CPR:9"}, {"em1Text": "AKRs", "em2Text": "oxygen", "label": "CPR:9"}]}
{"sentText": "Despite the importance of AKRs in PAHs metabolism there are no studies that evaluate in general human populations the effect of PAHs on AKRs expression in peripheral blood lymphocytes PBLs", "relationMentions": [{"em1Text": "AKRs", "em2Text": "PAHs", "label": "CPR:9"}]}
{"sentText": "The pretreatment with 20 mg L1 LaIII could alleviate the effects of UVB radiation on the activities of nitrate reductase glutamine synthetase glutamate synthase and glutamate dehydrogenase promoting amino acid conversion and protein synthesis in soybean seedlings", "relationMentions": [{"em1Text": "LaIII", "em2Text": "nitrate reductase", "label": "CPR:4"}, {"em1Text": "LaIII", "em2Text": "glutamine synthetase", "label": "CPR:4"}, {"em1Text": "LaIII", "em2Text": "glutamate synthase", "label": "CPR:4"}, {"em1Text": "LaIII", "em2Text": "glutamate dehydrogenase", "label": "CPR:4"}]}
{"sentText": "Based on recent reports that the small molecules isatin and phthalimide are suitable scaffolds for the design of high potency monoamine oxidase MAO inhibitors the present study examines the MAO inhibitory properties of a series of phthalide 2benzofuran13Hone analogues", "relationMentions": [{"em1Text": "isatin", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "isatin", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "phthalimide", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "phthalimide", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "MAO", "em2Text": "phthalide", "label": "CPR:4"}, {"em1Text": "MAO", "em2Text": "2benzofuran13Hone", "label": "CPR:4"}]}
{"sentText": "In most instances C6substituted phthalides exhibit MAOB specific inhibition", "relationMentions": [{"em1Text": "phthalides", "em2Text": "MAOB", "label": "CPR:4"}]}
{"sentText": "Among a series of 6benzyloxyphthalides bearing substituents on the para position of the phenyl ring the general order of potency was CF3 I Br Cl F CH3 H The results also show that the binding modes of representative phthalides are reversible and competitive at both MAO isoforms", "relationMentions": [{"em1Text": "phthalides", "em2Text": "MAO", "label": "CPR:4"}]}
{"sentText": "Inhibition of monoamine oxidase by phthalide analogues", "relationMentions": [{"em1Text": "monoamine oxidase", "em2Text": "phthalide", "label": "CPR:4"}]}
{"sentText": "Binding of the agonist angiotensin II AngII and inverse agonist losartan in wildtype AT1R changed the accessibility of reporter cysteines and the pattern was consistent with ligandspecific lid conformations of ECL2", "relationMentions": [{"em1Text": "losartan", "em2Text": "AT1R", "label": "CPR:5"}]}
{"sentText": "TAS102 is a novel drug containing trifluorothymidine which is phosphorylated by TK1 to its active monophosphated form that in turn can inhibit TS", "relationMentions": [{"em1Text": "TAS102", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "TAS102", "em2Text": "TK1", "label": "CPR:9"}, {"em1Text": "trifluorothymidine", "em2Text": "TK1", "label": "CPR:9"}]}
{"sentText": "Thymidine kinase1 TK1 and thymidylate synthase TS are key enzymes for salvage and de novo pyrimidine synthesis respectively", "relationMentions": [{"em1Text": "Thymidine kinase1", "em2Text": "pyrimidine", "label": "CPR:9"}, {"em1Text": "TK1", "em2Text": "pyrimidine", "label": "CPR:9"}, {"em1Text": "thymidylate synthase", "em2Text": "pyrimidine", "label": "CPR:9"}, {"em1Text": "TS", "em2Text": "pyrimidine", "label": "CPR:9"}]}
{"sentText": "Immunohistochemical characterization of pyrimidine synthetic enzymes thymidine kinase1 and thymidylate synthase in various types of cancer", "relationMentions": [{"em1Text": "pyrimidine", "em2Text": "thymidine kinase1", "label": "CPR:9"}, {"em1Text": "pyrimidine", "em2Text": "thymidylate synthase", "label": "CPR:9"}]}
{"sentText": "Gastrointestinal adenocarcinomas and squamous cell uterine carcinomas were often accompanied by high TS expression indicating activation of pyrimidine synthesis through both the salvage and de novo pathways", "relationMentions": [{"em1Text": "TS", "em2Text": "pyrimidine", "label": "CPR:9"}]}
{"sentText": "The contractions to 5HT were inhibited by ketanserin and alosetron indicating involvement of 5HT2A and 5HT3 receptors respectively", "relationMentions": [{"em1Text": "ketanserin", "em2Text": "5HT2A", "label": "CPR:4"}, {"em1Text": "alosetron", "em2Text": "5HT3", "label": "CPR:4"}]}
{"sentText": "Regarding urease inhibition nbutanol was the most potent fraction IC50 97 \u00b5gmL", "relationMentions": [{"em1Text": "urease", "em2Text": "nbutanol", "label": "CPR:4"}]}
{"sentText": "The current US military and civilian oxime countermeasure 2hydroxyiminomethyl1methylpyridin1ium chloride 2PAM is under consideration for replacement with a more effective acetylcholinesterase reactivator 11methylenebis4hydroxyiminomethylpyridinium dimethanesulfonate MMB4", "relationMentions": [{"em1Text": "acetylcholinesterase", "em2Text": "11methylenebis4hydroxyiminomethylpyridinium dimethanesulfonate", "label": "CPR:3"}, {"em1Text": "acetylcholinesterase", "em2Text": "MMB4", "label": "CPR:3"}]}
{"sentText": "Methylationspecific PCR and bisulfite sequencing identified methylation of this CpG mCpG island of the glut3 gene frequency of methylation increasing 25fold with a 16fold increase in DNA methyl transferase 3a concentrations noted with advancing postnatal age PN14 vs PN3", "relationMentions": [{"em1Text": "CpG", "em2Text": "DNA methyl transferase 3a", "label": "CPR:3"}, {"em1Text": "mCpG", "em2Text": "DNA methyl transferase 3a", "label": "CPR:3"}]}
{"sentText": "5flanking region of glut3luciferase reporter transient transfection in HT22 hippocampal neurons demonstrated that mCpGs inhibit glut3 transcription", "relationMentions": [{"em1Text": "glut3", "em2Text": "mCpGs", "label": "CPR:4"}]}
{"sentText": "Separate 5aza2deoxycytidine pretreatment or in combination with trichostatin A reduced mCpG and specific small interference RNAs targeting Mecp2 and Creb1 separately or together depleting Mecp2 andor Creb1 binding of glut3mCpGs reduced glut3 expression in HT22 cells", "relationMentions": [{"em1Text": "5aza2deoxycytidine", "em2Text": "Mecp2", "label": "CPR:4"}, {"em1Text": "5aza2deoxycytidine", "em2Text": "Creb1", "label": "CPR:4"}, {"em1Text": "trichostatin A", "em2Text": "Mecp2", "label": "CPR:4"}, {"em1Text": "trichostatin A", "em2Text": "Creb1", "label": "CPR:4"}]}
{"sentText": "A pronounced NET knockoutinduced shortening of the immobility time in the TST by ca 50 compared to WT mice was not reduced any further by NET inhibiting ADs such as reboxetine desipramine and imipramine", "relationMentions": [{"em1Text": "NET", "em2Text": "reboxetine", "label": "CPR:4"}, {"em1Text": "NET", "em2Text": "desipramine", "label": "CPR:4"}, {"em1Text": "NET", "em2Text": "imipramine", "label": "CPR:4"}]}
{"sentText": "In conclusion of the seven NSAIDs investigated niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4MUG in a competitive manner", "relationMentions": [{"em1Text": "niflumic acid", "em2Text": "UGT1A9", "label": "CPR:4"}]}
{"sentText": "In vitro inhibitory effects of nonsteroidal antiinflammatory drugs on 4methylumbelliferone glucuronidation in recombinant human UDPglucuronosyltransferase 1A9 potent inhibition by niflumic acid", "relationMentions": [{"em1Text": "human UDPglucuronosyltransferase 1A9", "em2Text": "niflumic acid", "label": "CPR:4"}]}
{"sentText": "MNU induced lesions presented markers indicative of an aggressive phenotype lack of basal cells rupture of the smooth muscle cell layer loss of Ecadherin and high MGMT staining", "relationMentions": [{"em1Text": "MNU", "em2Text": "MGMT", "label": "CPR:3"}, {"em1Text": "MNU", "em2Text": "Ecadherin", "label": "CPR:4"}]}
{"sentText": "The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters alanine aminotransferase aspartate aminotransferase alkaline phosphatase total protein albumin bilirubin cholesterol urea and creatinine", "relationMentions": [{"em1Text": "arsenic", "em2Text": "alanine aminotransferase", "label": "CPR:3"}, {"em1Text": "arsenic", "em2Text": "aspartate aminotransferase", "label": "CPR:3"}, {"em1Text": "arsenic", "em2Text": "alkaline phosphatase", "label": "CPR:3"}, {"em1Text": "arsenic", "em2Text": "albumin", "label": "CPR:3"}]}
{"sentText": "However recent clinical studies have shown that a single lowdose injection of ketamine an Nmethyl daspartate receptor NMDAR antagonist has rapid antidepressant effects that are observed within hours and are long lasting", "relationMentions": [{"em1Text": "ketamine", "em2Text": "Nmethyl daspartate receptor", "label": "CPR:6"}, {"em1Text": "ketamine", "em2Text": "NMDAR", "label": "CPR:6"}]}
{"sentText": "The slower CL was due to the reduction of hepatic biliary excretion 670 decrease and hepatic CYP3A subfamilymediated metabolism 219 decrease of doxorubicin", "relationMentions": [{"em1Text": "CYP3A", "em2Text": "doxorubicin", "label": "CPR:9"}]}
{"sentText": "Doxorubicin is mainly excreted into the bile via Pglycoprotein Pgp and multidrug resistanceassociated protein 2 Mrp2 in hepatobiliary route and metabolized via cytochrome P450 CYP 3A subfamily", "relationMentions": [{"em1Text": "Doxorubicin", "em2Text": "Pglycoprotein", "label": "CPR:9"}, {"em1Text": "Doxorubicin", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "Doxorubicin", "em2Text": "multidrug resistanceassociated protein 2", "label": "CPR:9"}, {"em1Text": "Doxorubicin", "em2Text": "Mrp2", "label": "CPR:9"}, {"em1Text": "Doxorubicin", "em2Text": "cytochrome P450 CYP 3A", "label": "CPR:9"}]}
{"sentText": "Interestingly ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3\u03b2 at inactive form serine 9 whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells", "relationMentions": [{"em1Text": "ursolic acid", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "ursolic acid", "em2Text": "coenzyme A carboxylase", "label": "CPR:3"}, {"em1Text": "ursolic acid", "em2Text": "GSK3\u03b2", "label": "CPR:3"}, {"em1Text": "ursolic acid", "em2Text": "AKT", "label": "CPR:4"}, {"em1Text": "ursolic acid", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Activation of AMPactivated Protein Kinase and Phosphorylation of Glycogen Synthase Kinase3 \u03b2 Mediate Ursolic Acid Induced Apoptosis in HepG2 Liver Cancer Cells", "relationMentions": [{"em1Text": "AMPactivated Protein Kinase", "em2Text": "Ursolic Acid", "label": "CPR:3"}, {"em1Text": "Glycogen Synthase Kinase3 \u03b2", "em2Text": "Ursolic Acid", "label": "CPR:3"}]}
{"sentText": "Conversely AMPK inhibitor compound C or GSK3\u03b2 inhibitor SB216763 blocked the cleavages of PARP and caspase 3 induced by ursolic acid in HepG2 cells", "relationMentions": [{"em1Text": "PARP", "em2Text": "ursolic acid", "label": "CPR:3"}, {"em1Text": "caspase 3", "em2Text": "ursolic acid", "label": "CPR:3"}, {"em1Text": "compound C", "em2Text": "caspase 3", "label": "CPR:4"}, {"em1Text": "AMPK", "em2Text": "compound C", "label": "CPR:4"}, {"em1Text": "GSK3\u03b2", "em2Text": "SB216763", "label": "CPR:4"}, {"em1Text": "SB216763", "em2Text": "caspase 3", "label": "CPR:4"}]}
{"sentText": "Furthermore proteosomal inhibitor MG132 suppressed AMPK activation GSK3\u03b2 phosphorylation cleaved PARP and deceased AEG1 induced by ursolic acid in HepG2 cells", "relationMentions": [{"em1Text": "MG132", "em2Text": "AEG1", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "ursolic acid", "label": "CPR:3"}, {"em1Text": "GSK3\u03b2", "em2Text": "ursolic acid", "label": "CPR:3"}, {"em1Text": "AEG1", "em2Text": "ursolic acid", "label": "CPR:3"}, {"em1Text": "MG132", "em2Text": "AMPK", "label": "CPR:4"}, {"em1Text": "MG132", "em2Text": "GSK3\u03b2", "label": "CPR:4"}, {"em1Text": "AEG1", "em2Text": "ursolic acid", "label": "CPR:4"}]}
{"sentText": "Overall our findings suggest that ursolic acid induced apoptosis in HepG2 cells via AMPK activation and GSK3\u03b2 phosphorylation as a potent chemopreventive agent", "relationMentions": [{"em1Text": "ursolic acid", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "ursolic acid", "em2Text": "GSK3\u03b2", "label": "CPR:3"}]}
{"sentText": "Based on these studies the frequency of spontaneous tail contractions at 26 hpf a developmental stage with minimal AChE expression and activity was significantly higher following exposure to paraoxon concentrations as low as 312 nM", "relationMentions": [{"em1Text": "AChE", "em2Text": "paraoxon", "label": "CPR:3"}]}
{"sentText": "We then showed that static exposure of embryos to paraoxon 312500 nM from 5 to 96 hpf resulted in significant stage and concentrationdependent AChE inhibition albeit these effects were fully reversible within 48 h following transfer to clean water", "relationMentions": [{"em1Text": "paraoxon", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "Using paraoxon as a reference acetylcholinesterase AChE inhibitor the objective of this study was to develop an adverse outcome pathway AOP that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis", "relationMentions": [{"em1Text": "paraoxon", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "paraoxon", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "Conversely opioid antagonists such as naloxone and naltrexone which bind to nonselectively opioid receptors have been shown to decrease alcohol consumption under various experimental conditions", "relationMentions": [{"em1Text": "naltrexone", "em2Text": "opioid receptors", "label": "CPR:3"}, {"em1Text": "naloxone", "em2Text": "opioid receptors", "label": "CPR:6"}]}
{"sentText": "Esmolol a unique cardioselective beta 1adrenergic receptor blocker with a halflife of 9 minutes can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early betablocking therapy", "relationMentions": [{"em1Text": "Esmolol", "em2Text": "beta 1adrenergic receptor", "label": "CPR:4"}]}
{"sentText": "In catalytic properties mouse CA V is closest to CA I however in inhibition by acetazolamide ethoxzolamide and cyanate CA V is very similar to CA II", "relationMentions": [{"em1Text": "CA V", "em2Text": "acetazolamide", "label": "CPR:4"}, {"em1Text": "acetazolamide", "em2Text": "CA II", "label": "CPR:4"}, {"em1Text": "CA V", "em2Text": "ethoxzolamide", "label": "CPR:4"}, {"em1Text": "ethoxzolamide", "em2Text": "CA II", "label": "CPR:4"}, {"em1Text": "CA V", "em2Text": "cyanate", "label": "CPR:4"}, {"em1Text": "cyanate", "em2Text": "CA II", "label": "CPR:4"}]}
{"sentText": "Phosphate a product of the reaction was found to be a potent inhibitor of MjAdSS showing biphasic inhibition of enzyme activity", "relationMentions": [{"em1Text": "Phosphate", "em2Text": "MjAdSS", "label": "CPR:4"}]}
{"sentText": "Adenylosuccinate synthetase AdSS catalyzes the Mg2 dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate in a reaction driven by the hydrolysis of GTP to GDP", "relationMentions": [{"em1Text": "AdSS", "em2Text": "Mg2", "label": "CPR:9"}, {"em1Text": "Adenylosuccinate synthetase", "em2Text": "adenylosuccinate", "label": "CPR:9"}, {"em1Text": "AdSS", "em2Text": "adenylosuccinate", "label": "CPR:9"}]}
{"sentText": "The antiinflammatory drugs sodium salicylate and aspirin inhibited the activation of NFkappa B which further explains the mechanism of action of these drugs", "relationMentions": [{"em1Text": "sodium salicylate", "em2Text": "NFkappa B", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "NFkappa B", "label": "CPR:4"}]}
{"sentText": "Sodium salicylate and aspirin also inhibited NFkappa B dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus HIV long terminal repeat LTR in transfected T cells", "relationMentions": [{"em1Text": "Sodium salicylate", "em2Text": "NFkappa B", "label": "CPR:4"}, {"em1Text": "Sodium salicylate", "em2Text": "Ig kappa", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "NFkappa B", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "Ig kappa", "label": "CPR:4"}]}
{"sentText": "Galanin attenuates cyclic AMP regulatory elementbinding protein CREB phosphorylation induced by chronic morphine and naloxone challenge in Catha cells and primary striatal cultures", "relationMentions": [{"em1Text": "cyclic AMP regulatory elementbinding protein", "em2Text": "morphine", "label": "CPR:3"}, {"em1Text": "CREB", "em2Text": "morphine", "label": "CPR:3"}, {"em1Text": "cyclic AMP regulatory elementbinding protein", "em2Text": "naloxone", "label": "CPR:3"}, {"em1Text": "CREB", "em2Text": "naloxone", "label": "CPR:3"}]}
{"sentText": "Existing ion channel blockers such as amiodarone dronedarone bepridil aprindine and cibenzoline have been found to have an NCX inhibitory action", "relationMentions": [{"em1Text": "ion channel", "em2Text": "cibenzoline", "label": "CPR:4"}, {"em1Text": "cibenzoline", "em2Text": "NCX", "label": "CPR:4"}, {"em1Text": "ion channel", "em2Text": "amiodarone", "label": "CPR:4"}, {"em1Text": "amiodarone", "em2Text": "NCX", "label": "CPR:4"}, {"em1Text": "ion channel", "em2Text": "dronedarone", "label": "CPR:4"}, {"em1Text": "dronedarone", "em2Text": "NCX", "label": "CPR:4"}, {"em1Text": "ion channel", "em2Text": "bepridil", "label": "CPR:4"}, {"em1Text": "bepridil", "em2Text": "NCX", "label": "CPR:4"}, {"em1Text": "ion channel", "em2Text": "aprindine", "label": "CPR:4"}, {"em1Text": "aprindine", "em2Text": "NCX", "label": "CPR:4"}]}
{"sentText": "The pharmacology of NCX inhibitors has been studied extensively since the development of KBR7943 a prototype benzyloxyphenyl NCX inhibitor in 1996", "relationMentions": [{"em1Text": "NCX", "em2Text": "KBR7943", "label": "CPR:4"}, {"em1Text": "NCX", "em2Text": "benzyloxyphenyl", "label": "CPR:4"}]}
{"sentText": "Intriguingly the inhibitory potency of benzyloxyphenyl NCX inhibitors is directly coupled to the rate of Naidependent inactivation", "relationMentions": [{"em1Text": "benzyloxyphenyl", "em2Text": "NCX", "label": "CPR:4"}]}
{"sentText": "The NaCa2 exchanger NCX is a bidirectional transporter that normally extrudes Ca2 from the cell forward mode but also brings Ca2 into the cell reverse mode under special conditions such as intracellular Na Nai accumulation or membrane depolarization", "relationMentions": [{"em1Text": "NaCa2 exchanger", "em2Text": "Ca2", "label": "CPR:9"}, {"em1Text": "NaCa2 exchanger", "em2Text": "Ca2", "label": "CPR:9"}]}
{"sentText": "AIM To assess the efficacy and safety of a 24week treatment with sitagliptin a highly selective oncedaily oral dipeptidyl peptidase4 DPP4 inhibitor in patients with type 2 diabetes who had inadequate glycaemic control glycosylated haemoglobin HbA1c or=75 and or=105 while on glimepiride alone or in combination with metformin", "relationMentions": [{"em1Text": "sitagliptin", "em2Text": "dipeptidyl peptidase4", "label": "CPR:4"}, {"em1Text": "sitagliptin", "em2Text": "DPP4", "label": "CPR:4"}]}
{"sentText": "Efficacy and safety of the dipeptidyl peptidase4 inhibitor sitagliptin in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin", "relationMentions": [{"em1Text": "dipeptidyl peptidase4", "em2Text": "sitagliptin", "label": "CPR:4"}]}
{"sentText": "HSYA suppressed the expression of TLR4 Myd88 ICAM1 TNF\u03b1 IL1\u03b2 and IL6 at the mRNA and protein level and inhibited the adhesion of leukocytes to A549 cells", "relationMentions": [{"em1Text": "HSYA", "em2Text": "Myd88", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "ICAM1", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "TNF\u03b1", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "IL1\u03b2", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "IL6", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "TLR4", "label": "CPR:4"}]}
{"sentText": "HSYA treatment also decreased NF\u03baB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogenactivated protein kinase p38 MAPK", "relationMentions": [{"em1Text": "HSYA", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "mitogenactivated protein kinase", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "HSYA", "em2Text": "MAPK", "label": "CPR:4"}]}
{"sentText": "A series of phosphorylated flavonoids were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase CEase and acetylcholinesterase AChE", "relationMentions": [{"em1Text": "phosphorylated flavonoids", "em2Text": "cholesterol esterase", "label": "CPR:4"}, {"em1Text": "phosphorylated flavonoids", "em2Text": "CEase", "label": "CPR:4"}, {"em1Text": "phosphorylated flavonoids", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "phosphorylated flavonoids", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "The results showed that most of the synthesized compounds exhibited nanomolar potency against CEase much better than the parent flavonoids", "relationMentions": [{"em1Text": "CEase", "em2Text": "flavonoids", "label": "CPR:4"}]}
{"sentText": "Furthermore these phosphorylated flavonoids demonstrated good to high selectivity for CEase over AChE which only showed micromolar potency inhibition of AChE", "relationMentions": [{"em1Text": "phosphorylated flavonoids", "em2Text": "CEase", "label": "CPR:4"}, {"em1Text": "phosphorylated flavonoids", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "phosphorylated flavonoids", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "The structureactivity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of CEase", "relationMentions": [{"em1Text": "hydroxyl", "em2Text": "CEase", "label": "CPR:4"}, {"em1Text": "phosphate", "em2Text": "CEase", "label": "CPR:4"}, {"em1Text": "phosphorylated flavonoids", "em2Text": "CEase", "label": "CPR:4"}]}
{"sentText": "Synthesis and biological evaluation of phosphorylated flavonoids as potent and selective inhibitors of cholesterol esterase", "relationMentions": [{"em1Text": "phosphorylated flavonoids", "em2Text": "cholesterol esterase", "label": "CPR:4"}]}
{"sentText": "In healthy rats ATB429 dose dependently 25 50 or 100 mgkg attenuated CRDinduced hypersensitivity and significantly inhibited CRDinduced overexpression of spinal cFOS mRNA whereas mesalamine had no effect", "relationMentions": [{"em1Text": "ATB429", "em2Text": "cFOS", "label": "CPR:4"}]}
{"sentText": "ATB429induced antinociception was reversed by glibenclamide a ATPsensitive K KATP channel inhibitor", "relationMentions": [{"em1Text": "glibenclamide", "em2Text": "ATPsensitive K KATP channel", "label": "CPR:4"}]}
{"sentText": "Colonic cyclooxygenase2 and interkeukin1beta mRNA and spinal cFOS mRNA expression were significantly downregulated by ATB429 but not by mesalamine", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "ATB429", "label": "CPR:4"}, {"em1Text": "interkeukin1beta", "em2Text": "ATB429", "label": "CPR:4"}, {"em1Text": "cFOS", "em2Text": "ATB429", "label": "CPR:4"}]}
{"sentText": "In this study we have synthesized novel alphahydroxyphenylamide analogues of diphenylhydantoin and examined their ability to inhibit human NaV15 sodium channels expressed in Chinese Hamster Ovary CHOK1 cells", "relationMentions": [{"em1Text": "alphahydroxyphenylamide", "em2Text": "human NaV15", "label": "CPR:4"}, {"em1Text": "alphahydroxyphenylamide", "em2Text": "sodium channels", "label": "CPR:4"}, {"em1Text": "diphenylhydantoin", "em2Text": "human NaV15", "label": "CPR:4"}, {"em1Text": "diphenylhydantoin", "em2Text": "sodium channels", "label": "CPR:4"}, {"em1Text": "human NaV15", "em2Text": "sodium", "label": "CPR:9"}, {"em1Text": "sodium", "em2Text": "channels", "label": "CPR:9"}]}
{"sentText": "In comparison to diphenylhydantoin the novel chloro substituted alphahydroxyphenylamide compounds produced as much as a 20fold greater tonic and frequencydependent blockade of NaV15 channels with an IC50 value of 145 microM", "relationMentions": [{"em1Text": "diphenylhydantoin", "em2Text": "NaV15", "label": "CPR:4"}, {"em1Text": "chloro", "em2Text": "NaV15", "label": "CPR:4"}, {"em1Text": "alphahydroxyphenylamide", "em2Text": "NaV15", "label": "CPR:4"}]}
{"sentText": "Phenytoin diphenylhydantoin DPH is an established sodium channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic and has been effectively used in the treatment of neuropathic pain", "relationMentions": [{"em1Text": "Phenytoin", "em2Text": "sodium channel", "label": "CPR:4"}, {"em1Text": "diphenylhydantoin", "em2Text": "sodium channel", "label": "CPR:4"}, {"em1Text": "DPH", "em2Text": "sodium channel", "label": "CPR:4"}, {"em1Text": "sodium", "em2Text": "channel", "label": "CPR:9"}]}
{"sentText": "Block of human NaV15 sodium channels by novel alphahydroxyphenylamide analogues of phenytoin", "relationMentions": [{"em1Text": "sodium channels", "em2Text": "alphahydroxyphenylamide", "label": "CPR:4"}, {"em1Text": "human NaV15", "em2Text": "alphahydroxyphenylamide", "label": "CPR:4"}, {"em1Text": "sodium channels", "em2Text": "phenytoin", "label": "CPR:4"}, {"em1Text": "human NaV15", "em2Text": "phenytoin", "label": "CPR:4"}, {"em1Text": "sodium", "em2Text": "channels", "label": "CPR:9"}, {"em1Text": "human NaV15", "em2Text": "sodium", "label": "CPR:9"}]}
{"sentText": "This information may be useful in the development of more potent sodium channel blockers", "relationMentions": [{"em1Text": "sodium", "em2Text": "channel", "label": "CPR:9"}]}
{"sentText": "METHODS Part A compared the effects of placebo to four doses of a 5HT4 receptor antagonist SB207266 on the cisapride mediated increase in plasma aldosterone a 5HT4 mediated response and orocaecal transit in 18 subjects", "relationMentions": [{"em1Text": "5HT4", "em2Text": "cisapride", "label": "CPR:5"}, {"em1Text": "5HT4", "em2Text": "SB207266", "label": "CPR:6"}, {"em1Text": "5HT4", "em2Text": "SB207266", "label": "CPR:6"}]}
{"sentText": "Effects of a serotonin 5HT4 receptor antagonist SB207266 on gastrointestinal motor and sensory function in humans", "relationMentions": [{"em1Text": "serotonin 5HT4 receptor", "em2Text": "SB207266", "label": "CPR:6"}]}
{"sentText": "These unexpected and intriguing complexities seem likely to have some as yet undefined role in regulating SSAT activity or stability as a part of polyamine homeostasis", "relationMentions": [{"em1Text": "SSAT", "em2Text": "polyamine", "label": "CPR:9"}]}
{"sentText": "Spermidinespermine N1acetyltransferase SSAT is a key enzyme in the control of polyamine levels in human cells as acetylation of spermidine and spermine triggers export or degradation", "relationMentions": [{"em1Text": "Spermidinespermine N1acetyltransferase", "em2Text": "polyamine", "label": "CPR:9"}, {"em1Text": "Spermidinespermine N1acetyltransferase", "em2Text": "spermidine", "label": "CPR:9"}, {"em1Text": "Spermidinespermine N1acetyltransferase", "em2Text": "spermine", "label": "CPR:9"}]}
{"sentText": "To confirm this novel mechanism of bleomycin induced fibrogenesis we attempted to upregulate Nrf2 and related antioxidant proteins in bleomycin treated fibroblasts using a putative Nrf2 activator caffeic acid phenethyl ester and the results showed that bleomycin induced fibroblast proliferation and collagen content were attenuated through improved redox balance", "relationMentions": [{"em1Text": "Nrf2", "em2Text": "caffeic acid phenethyl ester", "label": "CPR:3"}, {"em1Text": "bleomycin", "em2Text": "Nrf2", "label": "CPR:3"}]}
{"sentText": "In a cellbased model bleomycin suppressed Nrf2 activation via extracellular signalrelated kinase phosphorylation enhancing intracellular reactive oxygen species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion", "relationMentions": [{"em1Text": "bleomycin", "em2Text": "extracellular signalrelated kinase", "label": "CPR:3"}, {"em1Text": "bleomycin", "em2Text": "Nrf2", "label": "CPR:4"}]}
{"sentText": "Treatment of C57 BL6 mice with bleomycin increased fibroblast viability and collagen production and significantly downregulated Nrf2", "relationMentions": [{"em1Text": "bleomycin", "em2Text": "Nrf2", "label": "CPR:4"}]}
{"sentText": "The IC50 values for Gli1 mRNA inhibition in the tumor and skin by TAK441 were estimated to be 00457 and 0113 \u03bcgml respectively", "relationMentions": [{"em1Text": "Gli1", "em2Text": "TAK441", "label": "CPR:4"}]}
{"sentText": "6EthylN1hydroxyacetylpiperidin4yl1methyl4oxo52oxo2phenylethyl3222trifluoroethoxy45dihydro1Hpyrrolo32cpyridine2carboxamide TAK441 is a potent selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer", "relationMentions": [{"em1Text": "TAK441", "em2Text": "hedgehog", "label": "CPR:4"}]}
{"sentText": "Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice", "relationMentions": [{"em1Text": "hedgehog", "em2Text": "TAK441", "label": "CPR:4"}, {"em1Text": "TAK441", "em2Text": "Gli1", "label": "CPR:4"}]}
{"sentText": "In this report we evaluated the growthinhibitory effects of sulindac sulfide a COX1 and COX2 inhibitor exisulind sulindac sulfone a novel proapoptotic agent that does not inhibit COX enzymes and nordihydroguaiaretic acid NDGA a lipoxygenase inhibitor on human lung cancer cell lines", "relationMentions": [{"em1Text": "sulindac sulfide", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "sulindac sulfide", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "nordihydroguaiaretic acid", "em2Text": "lipoxygenase", "label": "CPR:4"}, {"em1Text": "NDGA", "em2Text": "lipoxygenase", "label": "CPR:4"}]}
{"sentText": "Assays examining the ability of TFP to block S100A4mediated disassembly of myosinIIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization", "relationMentions": [{"em1Text": "TFP", "em2Text": "S100A4", "label": "CPR:3"}, {"em1Text": "TFP", "em2Text": "S100A4", "label": "CPR:4"}, {"em1Text": "TFP", "em2Text": "myosinIIA", "label": "CPR:4"}, {"em1Text": "TFP", "em2Text": "S100A4", "label": "CPR:4"}]}
{"sentText": "Using a unique biosensorbased assay trifluoperazine TFP was identified as an inhibitor that disrupts the S100A4 myosinIIA interaction", "relationMentions": [{"em1Text": "trifluoperazine", "em2Text": "S100A4", "label": "CPR:4"}, {"em1Text": "trifluoperazine", "em2Text": "myosinIIA", "label": "CPR:4"}, {"em1Text": "TFP", "em2Text": "S100A4", "label": "CPR:4"}, {"em1Text": "TFP", "em2Text": "myosinIIA", "label": "CPR:4"}]}
{"sentText": "Phenothiazines inhibit S100A4 function by inducing protein oligomerization", "relationMentions": [{"em1Text": "Phenothiazines", "em2Text": "S100A4", "label": "CPR:4"}]}
{"sentText": "Together these studies support a unique mode of inhibition in which phenothiazines disrupt the S100A4 myosinIIA interaction by sequestering S100A4 via small moleculeinduced oligomerization", "relationMentions": [{"em1Text": "phenothiazines", "em2Text": "S100A4", "label": "CPR:4"}, {"em1Text": "phenothiazines", "em2Text": "myosinIIA", "label": "CPR:4"}]}
{"sentText": "Both BRL and SAL produced a significant increase in postural finger tremor in keeping with beta 2adrenoceptor stimulation and this response was totally abolished by pretreatment with N20", "relationMentions": [{"em1Text": "BRL", "em2Text": "beta 2adrenoceptor", "label": "CPR:3"}, {"em1Text": "SAL", "em2Text": "beta 2adrenoceptor", "label": "CPR:3"}]}
{"sentText": "Cardiac effects of the beta 3adrenoceptor agonist BRL35135 in man", "relationMentions": [{"em1Text": "beta 3adrenoceptor", "em2Text": "BRL35135", "label": "CPR:5"}]}
{"sentText": "The aim of the present study was to evaluate the cardiac effects of the beta 3adrenoceptor agonist BRL35135 and determine whether beta 3receptors are involved in mediating chronotropic or inotropic responses in man", "relationMentions": [{"em1Text": "beta 3adrenoceptor", "em2Text": "BRL35135", "label": "CPR:5"}]}
{"sentText": "Eight normal males received single oral doses of BRL35135 8 mg BRL or the selective beta 2adrenoceptor agonist salbutamol 8 mg SAL after pretreatment with either placebo PL bisoprolol 5 mg B5 as a selective beta 1adrenoceptor antagonist or nadolol 20 mg N20 to block beta 1 and beta 2 but not beta 3receptors", "relationMentions": [{"em1Text": "beta 2adrenoceptor", "em2Text": "salbutamol", "label": "CPR:5"}, {"em1Text": "beta 2adrenoceptor", "em2Text": "SAL", "label": "CPR:5"}, {"em1Text": "bisoprolol", "em2Text": "beta 1adrenoceptor", "label": "CPR:6"}]}
{"sentText": "Although both intracellular and membrane Cx43 pools were markedly reduced in cells released from contact inhibition by TCDD siRNAmediated Cx43 knockdown was not sufficient to stimulate proliferation in contactinhibited cells", "relationMentions": [{"em1Text": "Cx43", "em2Text": "TCDD", "label": "CPR:4"}, {"em1Text": "Cx43", "em2Text": "TCDD", "label": "CPR:4"}]}
{"sentText": "Disruption of contact inhibition which was induced by toxic AhR ligands 2378tetrachlorodibenzopdioxin TCDD or polycyclic aromatic hydrocarbons in epithelial WBF344 cells reduced Cx43 protein levels possibly via enhanced proteasomal degradation significantly decreased the amount of gap junction plaques and downregulated GJIC in an AhRdependent manner", "relationMentions": [{"em1Text": "2378tetrachlorodibenzopdioxin", "em2Text": "Cx43", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "Cx43", "label": "CPR:4"}, {"em1Text": "polycyclic aromatic hydrocarbons", "em2Text": "Cx43", "label": "CPR:4"}]}
{"sentText": "Histamine content HDC activity and HDC mRNA expression in nasal mucosa were also significantly increased after TDI provocation", "relationMentions": [{"em1Text": "HDC", "em2Text": "TDI", "label": "CPR:3"}, {"em1Text": "HDC", "em2Text": "TDI", "label": "CPR:3"}]}
{"sentText": "Pretreatment with dexamethasone significantly suppressed nasal allergylike behaviors upregulation of histamine content HDC activity and HDC mRNA induced by TDI in TDIsensitized rats", "relationMentions": [{"em1Text": "HDC", "em2Text": "TDI", "label": "CPR:3"}, {"em1Text": "HDC", "em2Text": "TDI", "label": "CPR:3"}, {"em1Text": "HDC", "em2Text": "TDI", "label": "CPR:3"}, {"em1Text": "dexamethasone", "em2Text": "HDC", "label": "CPR:4"}, {"em1Text": "dexamethasone", "em2Text": "HDC", "label": "CPR:4"}]}
{"sentText": "Repression of HDC gene expression and HDC activity by dexamethasone may underlie its therapeutic effect in the treatment of allergy", "relationMentions": [{"em1Text": "HDC", "em2Text": "dexamethasone", "label": "CPR:4"}, {"em1Text": "HDC", "em2Text": "dexamethasone", "label": "CPR:4"}]}
{"sentText": "Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats", "relationMentions": [{"em1Text": "Dexamethasone", "em2Text": "HDC", "label": "CPR:4"}]}
{"sentText": "However the regulatory mechanism of histamine synthesis by HDC remains to be elucidated", "relationMentions": [{"em1Text": "histamine", "em2Text": "HDC", "label": "CPR:9"}]}
{"sentText": "BACKGROUND Histamine synthesized by histidine decarboxylase HDC from Lhistidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity", "relationMentions": [{"em1Text": "histidine decarboxylase", "em2Text": "Lhistidine", "label": "CPR:9"}, {"em1Text": "HDC", "em2Text": "Lhistidine", "label": "CPR:9"}, {"em1Text": "Histamine", "em2Text": "histidine decarboxylase", "label": "CPR:9"}, {"em1Text": "Histamine", "em2Text": "HDC", "label": "CPR:9"}]}
{"sentText": "CONCLUSIONS These findings indicate that increased synthesis of histamine through upregulation of HDC gene expression and HDC activity in nasal mucosa plays an important role in the development of nasal hypersensitivity", "relationMentions": [{"em1Text": "histamine", "em2Text": "HDC", "label": "CPR:9"}, {"em1Text": "histamine", "em2Text": "HDC", "label": "CPR:9"}]}
{"sentText": "CONCLUSIONS A diet that partially replaces carbohydrate with unsaturated fat may improve insulin sensitivity in a population at risk for cardiovascular disease", "relationMentions": [{"em1Text": "carbohydrate", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "In this study we assessed the effects of clopidogrel and clarithromycin known CYP2B6 and CYP3A inhibitors respectively on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans", "relationMentions": [{"em1Text": "clopidogrel", "em2Text": "CYP2B6", "label": "CPR:4"}, {"em1Text": "clopidogrel", "em2Text": "CYP2B6", "label": "CPR:4"}, {"em1Text": "clopidogrel", "em2Text": "CYP3A", "label": "CPR:4"}, {"em1Text": "clarithromycin", "em2Text": "CYP2B6", "label": "CPR:4"}, {"em1Text": "clarithromycin", "em2Text": "CYP3A", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS CysLTs produced after antigen provocation sequentially induced IL5 production from some immune component cells via CysLT1 receptor activation", "relationMentions": [{"em1Text": "CysLTs", "em2Text": "CysLT1", "label": "CPR:3"}]}
{"sentText": "Increased IL5 activity in the serum was inhibited by both pranlukast and MCI826 by over 90", "relationMentions": [{"em1Text": "IL5", "em2Text": "pranlukast", "label": "CPR:4"}, {"em1Text": "IL5", "em2Text": "MCI826", "label": "CPR:4"}]}
{"sentText": "Extracellular application of meclofenamate EC50 = 25 microM and diclofenac EC50 = 26 microM resulted in the activation of KCNQ2Q3 K currents heterologously expressed in Chinese hamster ovary cells", "relationMentions": [{"em1Text": "diclofenac", "em2Text": "KCNQ2Q3", "label": "CPR:3"}, {"em1Text": "meclofenamate", "em2Text": "KCNQ2Q3", "label": "CPR:3"}]}
{"sentText": "The selective norepinephrine NE transporter inhibitor atomoxetine formerly called tomoxetine or LY139603 has been shown to alleviate symptoms in Attention DeficitHyperactivity Disorder ADHD", "relationMentions": [{"em1Text": "norepinephrine NE transporter", "em2Text": "atomoxetine", "label": "CPR:4"}, {"em1Text": "norepinephrine NE transporter", "em2Text": "tomoxetine", "label": "CPR:4"}, {"em1Text": "norepinephrine NE transporter", "em2Text": "LY139603", "label": "CPR:4"}]}
{"sentText": "Local PGE2 administration prevented the increase of airway IL13 and osteopontin and kept lung plasmacytoid dendritic cell counts close to baseline", "relationMentions": [{"em1Text": "PGE2", "em2Text": "IL13", "label": "CPR:4"}, {"em1Text": "PGE2", "em2Text": "osteopontin", "label": "CPR:4"}]}
{"sentText": "Lung inflammation IL4 production and airway mast cell activity were also prevented under this early shortterm treatment with PGE2", "relationMentions": [{"em1Text": "IL4", "em2Text": "PGE2", "label": "CPR:4"}]}
{"sentText": "The reactivation of brain AChE inhibited with tabun demonstrated better activity of new compound BT074M TMB4 and obidoxime from symmetric oximes and BT05 and BT03 possessing asymmetric structure", "relationMentions": [{"em1Text": "AChE", "em2Text": "BT074M", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "TMB4", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "obidoxime", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "oximes", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "BT05", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "BT03", "label": "CPR:3"}]}
{"sentText": "AChE was easier reactivated after paraoxon treatment", "relationMentions": [{"em1Text": "AChE", "em2Text": "paraoxon", "label": "CPR:3"}]}
{"sentText": "All compounds showed low activity toward inhibition of AChE caused by dichlorvos", "relationMentions": [{"em1Text": "AChE", "em2Text": "dichlorvos", "label": "CPR:4"}]}
{"sentText": "Reactivators showed different activity in the reactivation of rat brain AChE after dichlorvos paraoxon and tabun inhibition", "relationMentions": [{"em1Text": "rat brain AChE", "em2Text": "dichlorvos", "label": "CPR:4"}, {"em1Text": "rat brain AChE", "em2Text": "paraoxon", "label": "CPR:4"}, {"em1Text": "rat brain AChE", "em2Text": "tabun", "label": "CPR:4"}]}
{"sentText": "Using wholecell voltage clamp we examined mibefradil block of four Na channel isoforms expressed in human embryonic kidney cells Nav15 cardiac Nav14 skeletal muscle Nav12 brain and Nav17 peripheral nerve", "relationMentions": [{"em1Text": "mibefradil", "em2Text": "Na channel", "label": "CPR:4"}, {"em1Text": "mibefradil", "em2Text": "Nav15", "label": "CPR:4"}, {"em1Text": "mibefradil", "em2Text": "Nav14", "label": "CPR:4"}, {"em1Text": "mibefradil", "em2Text": "Nav12", "label": "CPR:4"}, {"em1Text": "mibefradil", "em2Text": "Nav17", "label": "CPR:4"}]}
{"sentText": "Mibefradil blocked Nav15 in a usefrequencydependent manner indicating preferential binding to states visited during depolarization", "relationMentions": [{"em1Text": "Mibefradil", "em2Text": "Nav15", "label": "CPR:4"}]}
{"sentText": "Mibefradil blocked currents of all Na channel isoforms with similar affinity and a dependence on holding potential and drug offrate was slowed at depolarized potentials koff was 0024s at 130 mV and 0007s at 100 mV for Nav15", "relationMentions": [{"em1Text": "Mibefradil", "em2Text": "Na channel", "label": "CPR:4"}, {"em1Text": "Mibefradil", "em2Text": "Nav15", "label": "CPR:4"}]}
{"sentText": "Statedependent mibefradil block of Na channels", "relationMentions": [{"em1Text": "mibefradil", "em2Text": "Na channels", "label": "CPR:4"}]}
{"sentText": "In addition inhibiting the binding of the fast inactivation lid Nav15 ICM MTSET did not alter mibefradil block confirming that the drug does not preferentially interact with the fastinactivated state", "relationMentions": [{"em1Text": "Nav15", "em2Text": "mibefradil", "label": "CPR:4"}]}
{"sentText": "When selectively applied to channels after inducing slow inactivation with a 60s pulse to 10 mV mibefradil 1 microM produced 45 fractional block in Nav15 and greater block 88 in an isoform Nav14 that slowinactivates more completely", "relationMentions": [{"em1Text": "mibefradil", "em2Text": "Nav15", "label": "CPR:4"}, {"em1Text": "mibefradil", "em2Text": "Nav14", "label": "CPR:4"}]}
{"sentText": "Our results suggest that mibefradil blocks Na channels in a statedependent manner that does not depend on fast inactivation but probably involves interaction with one or more slowinactivated states", "relationMentions": [{"em1Text": "mibefradil", "em2Text": "Na channels", "label": "CPR:4"}]}
{"sentText": "Mibefradil is a Ttype Ca2 channel antagonist with reported crossreactivity with other classes of ion channels including K Cl and Na channels", "relationMentions": [{"em1Text": "Mibefradil", "em2Text": "Ttype Ca2 channel", "label": "CPR:6"}]}
{"sentText": "Docetaxel is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of bcl2 inactivation which induce apoptosis", "relationMentions": [{"em1Text": "Docetaxel", "em2Text": "bcl2", "label": "CPR:4"}, {"em1Text": "taxane", "em2Text": "bcl2", "label": "CPR:4"}]}
{"sentText": "Both risperidone and 9hydroxyrisperidone are substrates of Pglycoprotein Pgp a transport protein involved in drug absorption distribution and elimination", "relationMentions": [{"em1Text": "risperidone", "em2Text": "Pglycoprotein", "label": "CPR:9"}, {"em1Text": "risperidone", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "9hydroxyrisperidone", "em2Text": "Pglycoprotein", "label": "CPR:9"}, {"em1Text": "9hydroxyrisperidone", "em2Text": "Pgp", "label": "CPR:9"}]}
{"sentText": "Risperidone is metabolized to its active metabolite 9hydroxyrisperidone mainly by the cytochrome P450 enzymes CYP2D6 and 3A4", "relationMentions": [{"em1Text": "9hydroxyrisperidone", "em2Text": "cytochrome P450", "label": "CPR:9"}, {"em1Text": "Risperidone", "em2Text": "cytochrome P450", "label": "CPR:9"}]}
{"sentText": "SL11158 inhibited SSAT activity with a mixed type of inhibition in which the analogue had a 70fold higher affinity for the enzyme than the natural substrate spermine", "relationMentions": [{"em1Text": "SL11158", "em2Text": "SSAT", "label": "CPR:4"}]}
{"sentText": "bisEthyl oligoamine analogues of polyamines such as SL11144 and SL11158 as well as arylamine analogues BW1 a bisphenylbenzyl 373 analogue blocked uptake and interconversion of spermine at micromolar levels and in the case of BW1 acted as substrate for PAO", "relationMentions": [{"em1Text": "BW1", "em2Text": "PAO", "label": "CPR:9"}]}
{"sentText": "A series of pyridoquinazolines have been synthesised characterised and tested for their in vitro EGFR tyrosine kinase inhibitory activity", "relationMentions": [{"em1Text": "pyridoquinazolines", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "pyridoquinazolines", "em2Text": "tyrosine kinase", "label": "CPR:4"}]}
{"sentText": "Synthesis and in vitro evaluation of NAryl pyridoquinazolines derivatives as potent EGFR inhibitors", "relationMentions": [{"em1Text": "NAryl pyridoquinazolines", "em2Text": "EGFR", "label": "CPR:4"}]}
{"sentText": "Exposure to Cu NPs decreased cell viability to 73 p001 and significantly p005 elevated levels of lactate dehydrogenase intracellular reactive oxygen species and interleukin8 that mirrored our findings from subacute in vivo inhalation studies in mice", "relationMentions": [{"em1Text": "Cu", "em2Text": "interleukin8", "label": "CPR:3"}, {"em1Text": "Cu", "em2Text": "lactate dehydrogenase", "label": "CPR:3"}]}
{"sentText": "The TXM peptides were effective in inhibiting AuF induced MAPK JNK and p38 MAPK phosphorylation in correlation with preventing caspase3 cleavage and thereby PARP1 dissociation", "relationMentions": [{"em1Text": "AuF", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "AuF", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "AuF", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "AuF", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "The Trx mimetics peptides TXM protected insulinoma INS 83213 cells from oxidative stress induced by selectively inhibiting TrxR with auranofin AuF", "relationMentions": [{"em1Text": "TrxR", "em2Text": "auranofin", "label": "CPR:4"}, {"em1Text": "TrxR", "em2Text": "AuF", "label": "CPR:4"}]}
{"sentText": "Compared with WT DeltaKPQ INa was more sensitive to flecainide and flecainide preferentially inhibited late INa mean current between 20 and 235 ms after depolarization compared with peak INa", "relationMentions": [{"em1Text": "DeltaKPQ", "em2Text": "flecainide", "label": "CPR:4"}, {"em1Text": "DeltaKPQ", "em2Text": "flecainide", "label": "CPR:4"}]}
{"sentText": "Flecainide block of Na current INa was investigated in wildtype WT or the long QT syndrome 3 LQT3 sodium channel alpha subunit mutation with three amino acids deleted DeltaKPQ stably transfected into human embryonic kidney 293 cells using wholecell patchclamp recordings", "relationMentions": [{"em1Text": "Flecainide", "em2Text": "DeltaKPQ", "label": "CPR:4"}, {"em1Text": "Flecainide", "em2Text": "long QT syndrome 3 LQT3 sodium channel alpha", "label": "CPR:4"}]}
{"sentText": "Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class IC antiarrhythmic flecainide", "relationMentions": [{"em1Text": "LQT3 DeltaKPQ mutant", "em2Text": "flecainide", "label": "CPR:4"}]}
{"sentText": "We conclude that DeltaKPQ interacts differently with flecainide than with WT leading to increased block and slowed recovery especially for late INa", "relationMentions": [{"em1Text": "DeltaKPQ", "em2Text": "flecainide", "label": "CPR:4"}]}
{"sentText": "Both 5AMN and 5MABN had high affinity for \u03bareceptors K i 136 \u00b1 098 and 027 \u00b1 008 respectively and were revealed as potent \u03baantagonists pA2 743 and 818 respectively and \u03bcreceptor antagonists pA2 762 and 785 respectively in the ileum", "relationMentions": [{"em1Text": "5AMN", "em2Text": "\u03bcreceptor", "label": "CPR:6"}, {"em1Text": "5MABN", "em2Text": "\u03bcreceptor", "label": "CPR:6"}]}
{"sentText": "Pololike kinase2 Plk2 is a potential therapeutic target for Parkinsons disease and this Letter describes the SAR of a series of dihydropteridinone based Plk2 inhibitors", "relationMentions": [{"em1Text": "Plk2", "em2Text": "dihydropteridinone", "label": "CPR:4"}]}
{"sentText": "Sphingosine1phosphate promotes the nuclear translocation of \u03b2catenin and thereby induces osteoprotegerin gene expression in osteoblastlike cell lines", "relationMentions": [{"em1Text": "Sphingosine1phosphate", "em2Text": "osteoprotegerin", "label": "CPR:3"}]}
{"sentText": "S1P increased the amount of osteoprotegerin at both mRNA and protein levels and increased the activity of alkaline phosphatase leading to the mineralization", "relationMentions": [{"em1Text": "S1P", "em2Text": "osteoprotegerin", "label": "CPR:3"}]}
{"sentText": "These findings suggest that S1P activates the PI3K Akt signaling pathway leading to the promotion of nuclear translocation of \u03b2catenin in osteoblastlike cells resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase probably relating to the inhibition of osteoclast formation and the mineralization respectively", "relationMentions": [{"em1Text": "S1P", "em2Text": "PI3K", "label": "CPR:3"}, {"em1Text": "S1P", "em2Text": "Akt", "label": "CPR:3"}, {"em1Text": "S1P", "em2Text": "\u03b2catenin", "label": "CPR:3"}, {"em1Text": "S1P", "em2Text": "osteoptotegerin", "label": "CPR:3"}, {"em1Text": "S1P", "em2Text": "alkaline phosphatase", "label": "CPR:3"}]}
{"sentText": "S1P activated phosphatidylinositol 3kinase PI3K Akt signaling leading to the inhibition of glycogen synthase kinase3\u03b2 and the nuclear translocation of \u03b2catenin followed by the increase of the transcriptional activity by \u03b2cateninTcell factor complex formation in both SaOS2 cells and MC3T3E1 cells", "relationMentions": [{"em1Text": "S1P", "em2Text": "phosphatidylinositol 3kinase", "label": "CPR:3"}, {"em1Text": "S1P", "em2Text": "PI3K", "label": "CPR:3"}, {"em1Text": "S1P", "em2Text": "Akt", "label": "CPR:3"}, {"em1Text": "S1P", "em2Text": "glycogen synthase kinase3\u03b2", "label": "CPR:4"}]}
{"sentText": "Plerixafor AMD3100 Genzyme Corporation is a bicyclam molecule that antagonizes the binding of the chemokine stromal cellderived factor1 SDF1 to its cognate receptor CXCR4", "relationMentions": [{"em1Text": "Plerixafor", "em2Text": "stromal cellderived factor1", "label": "CPR:4"}, {"em1Text": "Plerixafor", "em2Text": "SDF1", "label": "CPR:4"}, {"em1Text": "Plerixafor", "em2Text": "CXCR4", "label": "CPR:4"}, {"em1Text": "Plerixafor", "em2Text": "chemokine", "label": "CPR:4"}, {"em1Text": "AMD3100", "em2Text": "stromal cellderived factor1", "label": "CPR:4"}, {"em1Text": "AMD3100", "em2Text": "SDF1", "label": "CPR:4"}, {"em1Text": "AMD3100", "em2Text": "CXCR4", "label": "CPR:4"}, {"em1Text": "AMD3100", "em2Text": "chemokine", "label": "CPR:4"}, {"em1Text": "bicyclam", "em2Text": "stromal cellderived factor1", "label": "CPR:4"}, {"em1Text": "bicyclam", "em2Text": "SDF1", "label": "CPR:4"}, {"em1Text": "bicyclam", "em2Text": "CXCR4", "label": "CPR:4"}, {"em1Text": "bicyclam", "em2Text": "chemokine", "label": "CPR:4"}]}
{"sentText": "Plerixafor a CXCR4 antagonist for the mobilization of hematopoietic stem cells", "relationMentions": [{"em1Text": "Plerixafor", "em2Text": "CXCR4", "label": "CPR:6"}]}
{"sentText": "This stimulation was attenuated by the Pak inhibitor 22dihydroxy11dinaphthyldisulfide IPA3 or dominantnegative Pak1", "relationMentions": [{"em1Text": "Pak", "em2Text": "22dihydroxy11dinaphthyldisulfide", "label": "CPR:4"}, {"em1Text": "Pak", "em2Text": "IPA3", "label": "CPR:4"}]}
{"sentText": "Chronic insulin 24 h activates NHE3 through the classic phosphatidylinositol 3kinase serum and glucocorticoiddependent kinase 1 PI3KSGK1 pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor wortmannin or a dominantnegative SGK1", "relationMentions": [{"em1Text": "phosphatidylinositol 3kinase", "em2Text": "wortmannin", "label": "CPR:4"}, {"em1Text": "PI3K", "em2Text": "wortmannin", "label": "CPR:4"}, {"em1Text": "PI3K", "em2Text": "wortmannin", "label": "CPR:4"}]}
{"sentText": "Results showed that neonatal quinpirole treatment induced D2 priming that was eliminated by olanzapine treatment", "relationMentions": [{"em1Text": "quinpirole", "em2Text": "D2", "label": "CPR:3"}, {"em1Text": "D2", "em2Text": "olanzapine", "label": "CPR:4"}]}
{"sentText": "Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF BDNF and ChAT that was eliminated by olanzapine treatment", "relationMentions": [{"em1Text": "NGF", "em2Text": "olanzapine", "label": "CPR:3"}, {"em1Text": "BDNF", "em2Text": "olanzapine", "label": "CPR:3"}, {"em1Text": "ChAT", "em2Text": "olanzapine", "label": "CPR:3"}, {"em1Text": "quinpirole", "em2Text": "NGF", "label": "CPR:4"}, {"em1Text": "quinpirole", "em2Text": "BDNF", "label": "CPR:4"}, {"em1Text": "quinpirole", "em2Text": "ChAT", "label": "CPR:4"}]}
{"sentText": "Neonatal quinpirole treatment produced a significant decrease in BDNF and ChAT in the frontal cortex that was unaffected by olanzapine treatment", "relationMentions": [{"em1Text": "quinpirole", "em2Text": "BDNF", "label": "CPR:4"}, {"em1Text": "quinpirole", "em2Text": "ChAT", "label": "CPR:4"}]}
{"sentText": "These results show that olanzapine eliminates D2 receptor priming and cognitive impairment and also alleviates decreases in neurotrophins and acetylcholinergic markers produced by D2 priming in the hippocampus", "relationMentions": [{"em1Text": "olanzapine", "em2Text": "D2 receptor", "label": "CPR:4"}]}
{"sentText": "Pinosylvin inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1 cyclin E cyclin A cyclin dependent kinase 2 CDK2 CDK4 cMyc and retinoblastoma protein pRb and the upregulation of p21 WAF1 CIP1 and p53", "relationMentions": [{"em1Text": "Pinosylvin", "em2Text": "p21", "label": "CPR:3"}, {"em1Text": "Pinosylvin", "em2Text": "WAF1", "label": "CPR:3"}, {"em1Text": "Pinosylvin", "em2Text": "CIP1", "label": "CPR:3"}, {"em1Text": "Pinosylvin", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "Pinosylvin", "em2Text": "cyclin D1", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "cyclin E", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "cyclin A", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "cyclin dependent kinase 2", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "CDK2", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "CDK4", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "cMyc", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "retinoblastoma protein", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "pRb", "label": "CPR:4"}]}
{"sentText": "Pinosylvin was also found to attenuate the activation of proteins involved in f ocal adhesion kinase FAK cSrc extracellular signalregulated kinase ERK signaling and phosphoinositide 3kinase PI3K Akt glycogen synthase kinase 3\u03b2 GSK3\u03b2 signaling pathway", "relationMentions": [{"em1Text": "Pinosylvin", "em2Text": "ocal adhesion kinase", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "FAK", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "cSrc", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "extracellular signalregulated kinase", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "phosphoinositide 3kinase", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "glycogen synthase kinase 3\u03b2", "label": "CPR:4"}, {"em1Text": "Pinosylvin", "em2Text": "GSK3\u03b2", "label": "CPR:4"}]}
{"sentText": "Subsequently pinosylvin suppressed the nuclear translocation of \u03b2catenin one of downstream molecules of PI3K Akt GSK3\u03b2 signaling and these events led to the sequential downregulation of \u03b2cateninmediated transcription of target genes including BMP4 ID2 survivin cyclin D1 MMP7 and cMyc", "relationMentions": [{"em1Text": "pinosylvin", "em2Text": "\u03b2catenin", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "GSK3\u03b2", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "\u03b2catenin", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "BMP4", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "ID2", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "survivin", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "cyclin D1", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "MMP7", "label": "CPR:4"}, {"em1Text": "pinosylvin", "em2Text": "cMyc", "label": "CPR:4"}]}
{"sentText": "Suppression of Src ERK and GSK3 \u03b2catenin signaling by pinosylvin inhibits the growth of human colorectal cancer cells", "relationMentions": [{"em1Text": "Src", "em2Text": "pinosylvin", "label": "CPR:4"}, {"em1Text": "ERK", "em2Text": "pinosylvin", "label": "CPR:4"}, {"em1Text": "GSK3", "em2Text": "pinosylvin", "label": "CPR:4"}, {"em1Text": "\u03b2catenin", "em2Text": "pinosylvin", "label": "CPR:4"}]}
{"sentText": "Overall higher alcohol production was reduced by ammonium supplementation and this can be correlated with a general downregulation of genes encoding decarboxylases and dehydrogenases of the Ehrlich pathway", "relationMentions": [{"em1Text": "ammonium", "em2Text": "decarboxylases", "label": "CPR:4"}, {"em1Text": "ammonium", "em2Text": "dehydrogenases", "label": "CPR:4"}]}
{"sentText": "Nitrooxy derivatives showed NOdependent vasorelaxing properties while most of the compounds proved to be very potent and selective COX2 inhibitors in in vitro experimental models", "relationMentions": [{"em1Text": "Nitrooxy", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Novel analgesicantiinflammatory agents 15diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase2 inhibiting nitric oxide donors", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "nitric oxide", "label": "CPR:4"}, {"em1Text": "15diarylpyrrole nitrooxyalkyl ethers", "em2Text": "cyclooxygenase2", "label": "CPR:4"}]}
{"sentText": "New classes of pyrrole derived nitrooxyalkyl inverse esters carbonates and ethers 710 as COX2 selective inhibitors and NO donors were synthesized and are herein reported", "relationMentions": [{"em1Text": "pyrrole", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "nitrooxyalkyl", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "esters", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "carbonates", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "ethers", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "The clinical profile of the angiotensin II receptor blocker eprosartan", "relationMentions": [{"em1Text": "angiotensin II receptor", "em2Text": "eprosartan", "label": "CPR:4"}]}
{"sentText": "In clinical trials eprosartan has proven to be at least as effective as the ACE inhibitor enalapril in reducing BP but with a significantly lower incidence of side effects", "relationMentions": [{"em1Text": "eprosartan", "em2Text": "ACE", "label": "CPR:4"}]}
{"sentText": "In the CCl4 hepatotoxicity model pretreatment with PSM or silymarin resulted in significantly increased activities of ethylmorphineNdemethylase and aniline 4hydroxylase activity and cytochrome P450 compared to the CCl4 only group", "relationMentions": [{"em1Text": "silymarin", "em2Text": "ethylmorphineNdemethylase", "label": "CPR:3"}, {"em1Text": "silymarin", "em2Text": "aniline 4hydroxylase", "label": "CPR:3"}, {"em1Text": "silymarin", "em2Text": "cytochrome P450", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "ethylmorphineNdemethylase", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "aniline 4hydroxylase", "label": "CPR:3"}, {"em1Text": "CCl4", "em2Text": "cytochrome P450", "label": "CPR:3"}]}
{"sentText": "A significant decrease of aspartate aminotransferase alanine aminotransferase lactate dehydrogenase LDH activities and glutathione GSH levels and an increase of malondialdehyde MDA quantity was observed after CCl4 and PC administration alone", "relationMentions": [{"em1Text": "aspartate aminotransferase", "em2Text": "CCl4", "label": "CPR:4"}, {"em1Text": "alanine aminotransferase", "em2Text": "CCl4", "label": "CPR:4"}, {"em1Text": "lactate dehydrogenase", "em2Text": "CCl4", "label": "CPR:4"}, {"em1Text": "LDH", "em2Text": "CCl4", "label": "CPR:4"}]}
{"sentText": "Four prenylflavonoids kurarinone 1 a chalcone of 1 kuraridin 2 kurarinol 3 kushenol H 4 and kushenol K 5 isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase DGAT", "relationMentions": [{"em1Text": "kuraridin", "em2Text": "diacylglycerol acyltransferase", "label": "CPR:4"}, {"em1Text": "kuraridin", "em2Text": "DGAT", "label": "CPR:4"}, {"em1Text": "kurarinol", "em2Text": "diacylglycerol acyltransferase", "label": "CPR:4"}, {"em1Text": "kurarinol", "em2Text": "DGAT", "label": "CPR:4"}, {"em1Text": "kushenol H", "em2Text": "diacylglycerol acyltransferase", "label": "CPR:4"}, {"em1Text": "kushenol H", "em2Text": "DGAT", "label": "CPR:4"}, {"em1Text": "kushenol K", "em2Text": "diacylglycerol acyltransferase", "label": "CPR:4"}, {"em1Text": "kushenol K", "em2Text": "DGAT", "label": "CPR:4"}, {"em1Text": "kurarinone", "em2Text": "diacylglycerol acyltransferase", "label": "CPR:4"}, {"em1Text": "kurarinone", "em2Text": "DGAT", "label": "CPR:4"}, {"em1Text": "chalcone", "em2Text": "diacylglycerol acyltransferase", "label": "CPR:4"}, {"em1Text": "chalcone", "em2Text": "DGAT", "label": "CPR:4"}, {"em1Text": "prenylflavonoids", "em2Text": "diacylglycerol acyltransferase", "label": "CPR:4"}, {"em1Text": "prenylflavonoids", "em2Text": "DGAT", "label": "CPR:4"}]}
{"sentText": "These data suggest that the lavandulyl side chain and the position of the hydroxy group are important for high DGAT inhibitory activity", "relationMentions": [{"em1Text": "lavandulyl", "em2Text": "DGAT", "label": "CPR:4"}, {"em1Text": "hydroxy", "em2Text": "DGAT", "label": "CPR:4"}]}
{"sentText": "In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens", "relationMentions": [{"em1Text": "diacylglycerol acyltransferase", "em2Text": "prenylflavonoids", "label": "CPR:4"}]}
{"sentText": "The flavonoids inhibited DGAT activity in a dosedependent manner with IC50 values of 109 microM 1 98 microM 2 86 microM 3 1420 microM 4 and 250 microM 5", "relationMentions": [{"em1Text": "flavonoids", "em2Text": "DGAT", "label": "CPR:4"}]}
{"sentText": "Dexamethasone DXM decreased the expression of CXCL8 VEGF and iNOS induced by reIL4 while 1400W dihydrochloride 1400W a selective inhibitor of iNOS decreased the expression of Eselectin VEGF and iNOS", "relationMentions": [{"em1Text": "iNOS", "em2Text": "1400W dihydrochloride", "label": "CPR:4"}, {"em1Text": "1400W dihydrochloride", "em2Text": "Eselectin", "label": "CPR:4"}, {"em1Text": "VEGF", "em2Text": "1400W dihydrochloride", "label": "CPR:4"}, {"em1Text": "iNOS", "em2Text": "1400W dihydrochloride", "label": "CPR:4"}, {"em1Text": "iNOS", "em2Text": "1400W", "label": "CPR:4"}, {"em1Text": "1400W", "em2Text": "Eselectin", "label": "CPR:4"}, {"em1Text": "VEGF", "em2Text": "1400W", "label": "CPR:4"}, {"em1Text": "iNOS", "em2Text": "1400W", "label": "CPR:4"}, {"em1Text": "Dexamethasone", "em2Text": "CXCL8", "label": "CPR:4"}, {"em1Text": "Dexamethasone", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "Dexamethasone", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "DXM", "em2Text": "CXCL8", "label": "CPR:4"}, {"em1Text": "DXM", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "DXM", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "DXM and 1400W attenuated the mRNA expression of Eselectin and iNOS induced by the costimulation of reIL4 reTNFalpha and LPS", "relationMentions": [{"em1Text": "DXM", "em2Text": "Eselectin", "label": "CPR:4"}, {"em1Text": "DXM", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "1400W", "em2Text": "Eselectin", "label": "CPR:4"}, {"em1Text": "1400W", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "The beneficial role of 17betaestradiol on blood pressure cardiac hypertrophy vascular osteopontin expression perivascular fibrosis and impaired NOdependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate", "relationMentions": [{"em1Text": "17betaestradiol", "em2Text": "osteopontin", "label": "CPR:3"}, {"em1Text": "osteopontin", "em2Text": "medroxyprogesterone acetate", "label": "CPR:4"}]}
{"sentText": "At a low pH pH 74 but not pH 79 ifenprodil reduces the mean open time of GluN1 GluN2B receptors which may be responsible for its usefulness as a contextdependent inhibitor in conditions like ischemia and stroke when the pH of the extracellular milieu becomes acidic", "relationMentions": [{"em1Text": "ifenprodil", "em2Text": "GluN1", "label": "CPR:4"}, {"em1Text": "ifenprodil", "em2Text": "GluN2B", "label": "CPR:4"}]}
{"sentText": "High glucose HG induces apoptosis of podocytes inhibits AMPK activation inactivates tuberin and activates mTOR", "relationMentions": [{"em1Text": "glucose", "em2Text": "mTOR", "label": "CPR:3"}, {"em1Text": "glucose", "em2Text": "AMPK", "label": "CPR:4"}, {"em1Text": "glucose", "em2Text": "tuberin", "label": "CPR:4"}]}
{"sentText": "Pharmacological doses of the mTOR inhibitor rapamycin reduce albuminura in diabetes", "relationMentions": [{"em1Text": "mTOR", "em2Text": "rapamycin", "label": "CPR:4"}]}
{"sentText": "Inhibition of mTOR by low dose rapamycin decreases HGinduced Nox4 and Nox1 NADPH oxidase activity and podocyte apoptosis", "relationMentions": [{"em1Text": "mTOR", "em2Text": "rapamycin", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "Nox4", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "Nox1", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "NADPH oxidase", "label": "CPR:4"}]}
{"sentText": "Inhibition of mTOR by small dose of rapamycin reduces podocyte apoptosis attenuates glomerular injury and albuminuria", "relationMentions": [{"em1Text": "mTOR", "em2Text": "rapamycin", "label": "CPR:4"}]}
{"sentText": "A dose of 25 microg kg1 day1 of formoterol elicited greater EDL and soleus hypertrophy than salmeterol but resulted in similar betaadrenoceptor downregulation", "relationMentions": [{"em1Text": "formoterol", "em2Text": "betaadrenoceptor", "label": "CPR:4"}, {"em1Text": "salmeterol", "em2Text": "betaadrenoceptor", "label": "CPR:4"}]}
{"sentText": "Two beta2agonists formoterol and salmeterol are approved for treating asthma and have an extended duration of action and increased safety associated with greater beta2adrenoceptor selectivity", "relationMentions": [{"em1Text": "formoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "salmeterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Systemic administration of beta2adrenoceptor agonists formoterol and salmeterol elicit skeletal muscle hypertrophy in rats at micromolar doses", "relationMentions": [{"em1Text": "beta2adrenoceptor", "em2Text": "formoterol", "label": "CPR:5"}, {"em1Text": "beta2adrenoceptor", "em2Text": "salmeterol", "label": "CPR:5"}]}
{"sentText": "Acarbose an alphaglucosidase inhibitor delays the absorption of carbohydrate from the small intestine thereby reducing postprandial hyperglycemia", "relationMentions": [{"em1Text": "Acarbose", "em2Text": "alphaglucosidase", "label": "CPR:4"}]}
{"sentText": "Clinical utility of acarbose an alphaglucosidase inhibitor in cardiometabolic disorders", "relationMentions": [{"em1Text": "acarbose", "em2Text": "alphaglucosidase", "label": "CPR:4"}]}
{"sentText": "The values of mean corpuscular hemoglobin concentration and mean corpuscular hemoglobin increased in the STX group", "relationMentions": [{"em1Text": "hemoglobin", "em2Text": "STX", "label": "CPR:3"}, {"em1Text": "hemoglobin", "em2Text": "STX", "label": "CPR:3"}]}
{"sentText": "First we showed that intracerebroventricular administration of glucose in rats increases DBI expression in hypothalamic gliallike tanycytes", "relationMentions": [{"em1Text": "glucose", "em2Text": "DBI", "label": "CPR:3"}]}
{"sentText": "On phosphorylation of Ser40 by protein kinase A the affinity for H4biopterin increased S05 = 11 2 microM and the negative cooperativity was amplified h = 027 003", "relationMentions": [{"em1Text": "Ser40", "em2Text": "protein kinase A", "label": "CPR:9"}]}
{"sentText": "Valdecoxib is a potent and specific inhibitor of cyclooxygenase2 which is used for the treatment of rheumatoid arthritis osteoarthritis and the dysmenorrhea pain", "relationMentions": [{"em1Text": "Valdecoxib", "em2Text": "cyclooxygenase2", "label": "CPR:4"}]}
{"sentText": "Disposition of a specific cyclooxygenase2 inhibitor valdecoxib in human", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "valdecoxib", "label": "CPR:4"}]}
{"sentText": "In addition Silibinin caused an increase in p53 and p21 protein level as well as mRNA levels", "relationMentions": [{"em1Text": "Silibinin", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "Silibinin", "em2Text": "p21", "label": "CPR:3"}]}
{"sentText": "In mechanistic studies Silibinin decreased the protein level of p34cdc2 which might be the possible molecular mechanism of Silibinin efficacy on the growth inhibition in SGC7901 cells", "relationMentions": [{"em1Text": "Silibinin", "em2Text": "p34cdc2", "label": "CPR:4"}]}
{"sentText": "In summary our data indicates that overexpression of hGSTA4 at levels conferring high GST 4HNE conjugating activity confers a partial growth advantage to HepG2 cells and protects against 4HNE oxidative injury", "relationMentions": [{"em1Text": "GST", "em2Text": "4HNE", "label": "CPR:9"}]}
{"sentText": "4Hydroxynonenal 4HNE is a mutagenic alphabetaunsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione Stransferase GST isoforms", "relationMentions": [{"em1Text": "4HNE", "em2Text": "glutathione Stransferase", "label": "CPR:9"}, {"em1Text": "4HNE", "em2Text": "GST", "label": "CPR:9"}, {"em1Text": "4Hydroxynonenal", "em2Text": "glutathione Stransferase", "label": "CPR:9"}, {"em1Text": "4Hydroxynonenal", "em2Text": "GST", "label": "CPR:9"}, {"em1Text": "alphabetaunsaturated aldehyde", "em2Text": "glutathione Stransferase", "label": "CPR:9"}, {"em1Text": "alphabetaunsaturated aldehyde", "em2Text": "GST", "label": "CPR:9"}]}
{"sentText": "However the loss of proliferative capacity of hGSTA4 cells challenged with levels of 4HNE associated with severe oxidative stress indicates a role of other aldehyde metabolizing enzymes andor GSHelectrophile transporter proteins in providing full cellular protection against 4HNE toxicity", "relationMentions": [{"em1Text": "hGSTA4", "em2Text": "4HNE", "label": "CPR:9"}]}
{"sentText": "The alpha class human GSTA44 enzyme hGSTA44 has a particularly high catalytic efficiency toward 4HNE conjugation", "relationMentions": [{"em1Text": "human GSTA44", "em2Text": "4HNE", "label": "CPR:9"}, {"em1Text": "hGSTA44", "em2Text": "4HNE", "label": "CPR:9"}]}
{"sentText": "HepG2 cells transfected with an hGSTA4 vector construct exhibited high steadystate hGSTA4 mRNA high GST4 4HNE catalytic activities but lower basal glutathione GSH concentrations relative to insertfree vector control cells", "relationMentions": [{"em1Text": "GST4", "em2Text": "4HNE", "label": "CPR:9"}]}
{"sentText": "Specifically hGSTA4 cells had significantly higher GSH concentrations when exposed to 515 microM 4HNE but not at 20 microM 4HNE suggesting extensive GSH utilization at high concentrations of 4HNE", "relationMentions": [{"em1Text": "hGSTA4", "em2Text": "4HNE", "label": "CPR:9"}, {"em1Text": "hGSTA4", "em2Text": "4HNE", "label": "CPR:9"}]}
{"sentText": "dbdb mice treated with DRF 2655 showed 5 and 36fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6phosphatase activity and 651 and 77 increases in the betaoxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase respectively", "relationMentions": [{"em1Text": "DRF 2655", "em2Text": "carnitine palmitoyltransferase", "label": "CPR:3"}, {"em1Text": "DRF 2655", "em2Text": "carnitine acetyltransferase", "label": "CPR:3"}, {"em1Text": "DRF 2655", "em2Text": "phosphoenolpyruvate carboxykinase", "label": "CPR:4"}, {"em1Text": "DRF 2655", "em2Text": "glucose 6phosphatase", "label": "CPR:4"}]}
{"sentText": "OBJECTIVE Preclinical evaluation of DRF 2655 a peroxisome proliferatoractivated receptor alpha PPARalpha and PPARgamma agonist as a bodyweight lowering hypolipidemic and euglycemic agent", "relationMentions": [{"em1Text": "DRF 2655", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "DRF 2655", "em2Text": "peroxisome proliferatoractivated receptor alpha", "label": "CPR:5"}, {"em1Text": "DRF 2655", "em2Text": "PPARalpha", "label": "CPR:5"}]}
{"sentText": "RESULTS DRF 2655 showed concentrationdependent transactivation of PPARalpha and PPARgamma", "relationMentions": [{"em1Text": "DRF 2655", "em2Text": "PPARalpha", "label": "CPR:5"}, {"em1Text": "DRF 2655", "em2Text": "PPARgamma", "label": "CPR:5"}]}
{"sentText": "Indomethacin inhibited both hCOX1 and hCOX2 whereas NS398 and Dup697 selectively inhibited hCOX2", "relationMentions": [{"em1Text": "Indomethacin", "em2Text": "hCOX1", "label": "CPR:4"}, {"em1Text": "Indomethacin", "em2Text": "hCOX2", "label": "CPR:4"}, {"em1Text": "hCOX2", "em2Text": "NS398", "label": "CPR:4"}, {"em1Text": "hCOX2", "em2Text": "Dup697", "label": "CPR:4"}]}
{"sentText": "Both NS398 and Dup697 exhibited timedependent inactivation of hCOX2 as did indomethacin on both enzymes", "relationMentions": [{"em1Text": "NS398", "em2Text": "hCOX2", "label": "CPR:4"}, {"em1Text": "Dup697", "em2Text": "hCOX2", "label": "CPR:4"}, {"em1Text": "hCOX2", "em2Text": "indomethacin", "label": "CPR:4"}]}
{"sentText": "The competitive inhibitor of hCOX1 mefenamic acid also displayed competitive inhibition of hCOX2", "relationMentions": [{"em1Text": "hCOX1", "em2Text": "mefenamic acid", "label": "CPR:4"}, {"em1Text": "mefenamic acid", "em2Text": "hCOX2", "label": "CPR:4"}]}
{"sentText": "The enzyme cyclooxygenase catalyses the oxygenation of arachidonic acid leading to the formation of prostaglandins", "relationMentions": [{"em1Text": "cyclooxygenase", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "cyclooxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "hCOX1 had a specific activity of 188 mumol of O2mg with a Km of 138 microM for arachidonate and Vmax", "relationMentions": [{"em1Text": "hCOX1", "em2Text": "arachidonate", "label": "CPR:9"}]}
{"sentText": "of 1500 nmol of O2nmol of enzyme whereas hCOX2 had a specific activity of 122 mumol of O2mg with a Km of 87 microM for arachidonate and a Vmax", "relationMentions": [{"em1Text": "hCOX2", "em2Text": "arachidonate", "label": "CPR:9"}]}
{"sentText": "Our results have shown that MMP9 messenger ribonucleic acid mRNA expression was inhibited by doxycycline starting at 10 mgkgday P002", "relationMentions": [{"em1Text": "MMP9", "em2Text": "doxycycline", "label": "CPR:4"}]}
{"sentText": "Minocycline showed more potent inhibition on MMP9 mRNA expression starting at 1 P0005 and further at more than 30 P0001 mgkgday", "relationMentions": [{"em1Text": "Minocycline", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "At the enzymatic activity level doxycycline started to suppress MMP9 activity at 5 mgkgday P0001 while minocycline had an effect at a lower dose 1 mgkgday P002", "relationMentions": [{"em1Text": "doxycycline", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "We also assessed the potential relevant signaling pathway in vitro to elucidate the mechanisms underlying the MMP9 inhibition by tetracyclines", "relationMentions": [{"em1Text": "MMP9", "em2Text": "tetracyclines", "label": "CPR:4"}]}
{"sentText": "In vitro minocycline but not doxycycline inhibits MMP9 at least in part via the extracellular signalingrelated kinase 12 ERK12mediated pathway", "relationMentions": [{"em1Text": "minocycline", "em2Text": "MMP9", "label": "CPR:4"}, {"em1Text": "doxycycline", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "This study provided the evidence that the tetracyclines inhibit stimulated cerebral MMP9 at multiple levels and are effective at very low doses offering great potential for therapeutic use", "relationMentions": [{"em1Text": "tetracyclines", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "Doxycycline was shown to decrease cerebral MMP9 activities and angiogenesis induced by vascular endothelial growth factor VEGF", "relationMentions": [{"em1Text": "Doxycycline", "em2Text": "MMP9", "label": "CPR:4"}, {"em1Text": "Doxycycline", "em2Text": "vascular endothelial growth factor", "label": "CPR:4"}, {"em1Text": "Doxycycline", "em2Text": "VEGF", "label": "CPR:4"}]}
{"sentText": "The ratio between the GDC SHMT and C1THF synthase SHMT pathways of Ser synthesis from alpha13CGly and 13Cformate respectively in Arabidopsis shoots was 21 1 in roots 9 1", "relationMentions": [{"em1Text": "SHMT", "em2Text": "Ser", "label": "CPR:9"}, {"em1Text": "SHMT", "em2Text": "Ser", "label": "CPR:9"}, {"em1Text": "GDC", "em2Text": "alpha13CGly", "label": "CPR:9"}, {"em1Text": "C1THF synthase", "em2Text": "13Cformate", "label": "CPR:9"}]}
{"sentText": "On the other hand the accumulation of Ser through the C1THF synthase SHMT pathway in glyD plants was 25fold greater than that in WT plants", "relationMentions": [{"em1Text": "Ser", "em2Text": "SHMT", "label": "CPR:9"}]}
{"sentText": "One major route involves the tetrahydrofolate THFdependent activities of the glycine decarboxylase complex GDC EC 21110 and serine hydroxymethyltransferase SHMT EC 2121 with glycine Gly as onecarbon 1C source", "relationMentions": [{"em1Text": "glycine", "em2Text": "glycine decarboxylase complex", "label": "CPR:9"}, {"em1Text": "glycine", "em2Text": "GDC", "label": "CPR:9"}, {"em1Text": "glycine", "em2Text": "EC 21110", "label": "CPR:9"}, {"em1Text": "glycine", "em2Text": "serine hydroxymethyltransferase", "label": "CPR:9"}, {"em1Text": "glycine", "em2Text": "SHMT", "label": "CPR:9"}, {"em1Text": "glycine", "em2Text": "EC 2121", "label": "CPR:9"}, {"em1Text": "glycine decarboxylase complex", "em2Text": "Gly", "label": "CPR:9"}, {"em1Text": "GDC", "em2Text": "Gly", "label": "CPR:9"}, {"em1Text": "EC 21110", "em2Text": "Gly", "label": "CPR:9"}, {"em1Text": "serine hydroxymethyltransferase", "em2Text": "Gly", "label": "CPR:9"}, {"em1Text": "SHMT", "em2Text": "Gly", "label": "CPR:9"}, {"em1Text": "EC 2121", "em2Text": "Gly", "label": "CPR:9"}]}
{"sentText": "An alternative THFdependent pathway involves the C1THF synthase SHMT activities with formate as 1C source", "relationMentions": [{"em1Text": "C1THF synthase", "em2Text": "formate", "label": "CPR:9"}, {"em1Text": "SHMT", "em2Text": "formate", "label": "CPR:9"}]}
{"sentText": "Firstly transgenic plants overexpressing formate dehydrogenase FDH EC 1212 were used to continue our previous studies on the function of FDH in formate metabolism", "relationMentions": [{"em1Text": "formate", "em2Text": "formate dehydrogenase", "label": "CPR:9"}, {"em1Text": "formate", "em2Text": "FDH", "label": "CPR:9"}, {"em1Text": "formate", "em2Text": "EC 1212", "label": "CPR:9"}, {"em1Text": "formate", "em2Text": "FDH", "label": "CPR:9"}]}
{"sentText": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis the breakdown of formate to CO2 by the FDH reaction is the primary and preferred fate of the organic acid in Arabidopsis", "relationMentions": [{"em1Text": "FDH", "em2Text": "formate", "label": "CPR:9"}, {"em1Text": "FDH", "em2Text": "CO2", "label": "CPR:9"}]}
{"sentText": "BACKGROUND Rivastigmine is a carbamate drug designed to inhibit both acetylcholinesterase and butyrylcholinesterase by reversibly covalently bonding to these enzymes", "relationMentions": [{"em1Text": "Rivastigmine", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "Rivastigmine", "em2Text": "butyrylcholinesterase", "label": "CPR:4"}, {"em1Text": "carbamate", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "carbamate", "em2Text": "butyrylcholinesterase", "label": "CPR:4"}]}
{"sentText": "High p53 protein levels but not genetic or functional p53 status were associated with increased topotecan induced DNAtopoisomerase I complex formation", "relationMentions": [{"em1Text": "p53", "em2Text": "topotecan", "label": "CPR:3"}]}
{"sentText": "Topotecan is a topoisomerase I inhibitor which is currently evaluated as an adjuvant agent for malignant glioma", "relationMentions": [{"em1Text": "Topotecan", "em2Text": "topoisomerase I", "label": "CPR:4"}]}
{"sentText": "Amiloride is a specific inhibitor of uPA but does not inhibit tPA", "relationMentions": [{"em1Text": "Amiloride", "em2Text": "uPA", "label": "CPR:4"}]}
{"sentText": "The inhibitory effect of endothelin1 on the contraction induced by 5HT is abolished by deendothelialization by the endothelin ETB receptor antagonist RES 7011 by indomethacin or by glibenclamide", "relationMentions": [{"em1Text": "endothelin ETB receptor", "em2Text": "RES 7011", "label": "CPR:6"}]}
{"sentText": "The potentiation of the contractile effect induced by 5HT is only somewhat modified by deendothelialization but abolished by the thromboxane A2 receptor antagonists GR32191 and ridogrel", "relationMentions": [{"em1Text": "thromboxane A2 receptor", "em2Text": "GR32191", "label": "CPR:6"}, {"em1Text": "thromboxane A2 receptor", "em2Text": "ridogrel", "label": "CPR:6"}]}
{"sentText": "A novel class of quinoxalines has been discovered as antagonists of the IgG FcRn proteinprotein interaction through optimization of a hit derived from a virtual ligandbased screen", "relationMentions": [{"em1Text": "quinoxalines", "em2Text": "IgG", "label": "CPR:6"}, {"em1Text": "quinoxalines", "em2Text": "FcRn", "label": "CPR:6"}]}
{"sentText": "Agmatine locally synthesized is an endogenous agonist at imidazoline receptors a noncatecholamine ligand at alpha 2adrenergic receptors and may act as a neurotransmitter", "relationMentions": [{"em1Text": "Agmatine", "em2Text": "imidazoline receptors", "label": "CPR:5"}]}
{"sentText": "S3Aminomethyl73hydroxypropoxy1hydroxy13dihydro21benzoxaborole GSK2251052 is a novel boroncontaining antibiotic that inhibits bacterial leucyl tRNA synthetase and that has been in development for the treatment of serious Gramnegative infections", "relationMentions": [{"em1Text": "GSK2251052", "em2Text": "bacterial leucyl tRNA synthetase", "label": "CPR:4"}, {"em1Text": "S3Aminomethyl73hydroxypropoxy1hydroxy13dihydro21benzoxaborole", "em2Text": "bacterial leucyl tRNA synthetase", "label": "CPR:4"}]}
{"sentText": "A combination of in vitro metabolism experiments and a pharmacokinetic study in monkeys with the inhibitor 4methylpyrazole provided strong evidence that alcohol dehydrogenase potentially in association with aldehyde dehydrogenase is the primary enzyme involved in the formation of the M3 metabolite", "relationMentions": [{"em1Text": "4methylpyrazole", "em2Text": "alcohol dehydrogenase", "label": "CPR:4"}]}
{"sentText": "In functional transport assays we found that one of the identified molecules ATM7 increased the reuptake of serotonin possibly by facilitating the interaction of serotonin with transportready conformations of SERT when concentrations of serotonin were low and rate limiting", "relationMentions": [{"em1Text": "serotonin", "em2Text": "SERT", "label": "CPR:9"}, {"em1Text": "serotonin", "em2Text": "SERT", "label": "CPR:9"}, {"em1Text": "serotonin", "em2Text": "SERT", "label": "CPR:9"}]}
{"sentText": "They display sensitivity to TK inhibitors including gefitinib and erlotinib", "relationMentions": [{"em1Text": "TK", "em2Text": "gefitinib", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "erlotinib", "label": "CPR:4"}]}
{"sentText": "Among the FeS cluster biosynthetic proteins are included a pyridoxal phosphatedependent enzyme NifS that is involved in the activation of sulphur from lcysteine and a molecular scaffold protein NifU upon which FeS cluster precursors are formed", "relationMentions": [{"em1Text": "NifS", "em2Text": "lcysteine", "label": "CPR:9"}]}
{"sentText": "In addition the number and area of glutathione Stransferase placental form GSTP positive foci and proliferating cell nuclear antigen PCNA positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mgkg MEG compared with the control animals", "relationMentions": [{"em1Text": "glutathione Stransferase placental form", "em2Text": "MEG", "label": "CPR:3"}, {"em1Text": "GSTP", "em2Text": "MEG", "label": "CPR:3"}, {"em1Text": "proliferating cell nuclear antigen", "em2Text": "MEG", "label": "CPR:3"}, {"em1Text": "PCNA", "em2Text": "MEG", "label": "CPR:3"}]}
{"sentText": "Consumption of alcohol for 8weeks induced severe liver damage with increases in prognostic indicators such as aspartate transaminase alanine transaminase in serum whereas coadministration of CNF suppressed their increases", "relationMentions": [{"em1Text": "alcohol", "em2Text": "aspartate transaminase", "label": "CPR:3"}, {"em1Text": "alcohol", "em2Text": "alanine transaminase", "label": "CPR:3"}]}
{"sentText": "Chronic consumption of alcohol also stimulated abrupt increases in proinflammatory cytokines such as nuclear factor NF\u03baB tumor necrosis factor TNF\u03b1 and interleukin IL1\u03b2 in liver otherwise coadministration of CNF effectively suppressed production of these cytokines dosedependently", "relationMentions": [{"em1Text": "alcohol", "em2Text": "nuclear factor NF\u03baB", "label": "CPR:3"}, {"em1Text": "alcohol", "em2Text": "tumor necrosis factor TNF\u03b1", "label": "CPR:3"}, {"em1Text": "alcohol", "em2Text": "interleukin IL1\u03b2", "label": "CPR:3"}]}
{"sentText": "Dietary EPA DHA treatment restored endogenous biosynthesis of n3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving insulin sensitivity", "relationMentions": [{"em1Text": "EPA", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "DHA", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "Notably 17HDHA treatment reduced adipose tissue expression of inflammatory cytokines increased adiponectin expression and improved glucose tolerance parallel to insulin sensitivity in obese mice", "relationMentions": [{"em1Text": "17HDHA", "em2Text": "adiponectin", "label": "CPR:3"}, {"em1Text": "17HDHA", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "17HDHA", "em2Text": "cytokines", "label": "CPR:4"}]}
{"sentText": "Western blots showed a decrease in nuclear p65 protein expression after exposure to different concentrations of cinobufagin while the phosphorylation of GSK3\u03b2 was simultaneously increased", "relationMentions": [{"em1Text": "cinobufagin", "em2Text": "GSK3\u03b2", "label": "CPR:3"}, {"em1Text": "p65", "em2Text": "cinobufagin", "label": "CPR:4"}]}
{"sentText": "Transduction with constitutively active forms of GSK3\u03b2 could protect against the downregulation of p65 and upregulation of cleaved PARP that are induced by cinobufagin treatment", "relationMentions": [{"em1Text": "PARP", "em2Text": "cinobufagin", "label": "CPR:3"}, {"em1Text": "p65", "em2Text": "cinobufagin", "label": "CPR:4"}]}
{"sentText": "However combined treatment with cinobufagin and SB216367 resulted in a significant reduction in p65 and an increase in cleaved PARP in U2OS cells", "relationMentions": [{"em1Text": "cinobufagin", "em2Text": "PARP", "label": "CPR:3"}, {"em1Text": "SB216367", "em2Text": "PARP", "label": "CPR:3"}, {"em1Text": "cinobufagin", "em2Text": "p65", "label": "CPR:4"}, {"em1Text": "SB216367", "em2Text": "p65", "label": "CPR:4"}]}
{"sentText": "Furthermore we validated the inhibition of GSK3\u03b2 NF\u03baB signaling following cinobufagin treatment", "relationMentions": [{"em1Text": "GSK3\u03b2", "em2Text": "cinobufagin", "label": "CPR:4"}, {"em1Text": "NF\u03baB", "em2Text": "cinobufagin", "label": "CPR:4"}]}
{"sentText": "The major ingredient of ginger 6gingerol could inhibit angiotensin II type 1 receptor activation which partially clarified the mechanism of ginger regulating blood pressure and strengthening heart in the cardiovascular system", "relationMentions": [{"em1Text": "6gingerol", "em2Text": "angiotensin II type 1 receptor", "label": "CPR:4"}]}
{"sentText": "6Gingerol derived from Zingiber officinale Roscoe ginger was identified as a novel angiotensin II type 1 receptor antagonist with an IC50 value of 8173 \u00b5M", "relationMentions": [{"em1Text": "6Gingerol", "em2Text": "angiotensin II type 1 receptor", "label": "CPR:6"}]}
{"sentText": "6gingerol a novel AT\u2081 antagonist for the treatment of cardiovascular disease", "relationMentions": [{"em1Text": "6gingerol", "em2Text": "AT\u2081", "label": "CPR:6"}]}
{"sentText": "N5Substituted H4biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase anddepending on the substituent were competitive inhibitors of phenylalanine hydroxylase N5methyl and N5hydroxymethyl H4biopterin inhibited phenylalanine hydroxylase whereas N5formyl and N5acetyl H4biopterin had no effect", "relationMentions": [{"em1Text": "phenylalanine hydroxylase", "em2Text": "N5methyl", "label": "CPR:4"}, {"em1Text": "phenylalanine hydroxylase", "em2Text": "N5hydroxymethyl H4biopterin", "label": "CPR:4"}, {"em1Text": "N5Substituted H4biopterin", "em2Text": "dihydropteridine reductase", "label": "CPR:9"}]}
{"sentText": "Our data demonstrate differences in the mechanism of stimulation of phenylalanine hydroxylase and nitric oxide synthase by H4biopterin", "relationMentions": [{"em1Text": "phenylalanine hydroxylase", "em2Text": "H4biopterin", "label": "CPR:4"}]}
{"sentText": "Transfection of the brain cDNA into COS1 cells resulted in transporter activity that was blocked by the VMAT inhibitor reserpine and a proton ionophore but not by tetrabenazine which has a high affinity for VMAT2", "relationMentions": [{"em1Text": "VMAT", "em2Text": "reserpine", "label": "CPR:4"}]}
{"sentText": "When HUVECs were stimulated by thrombin without extracellular Larginine NorNOHA dosedependently increased the NOS activity and the NO release with maximal effects at 20 microM", "relationMentions": [{"em1Text": "NorNOHA", "em2Text": "NOS", "label": "CPR:3"}]}
{"sentText": "Extracellular Larginine also dosedependently increased NO release and arginase activity", "relationMentions": [{"em1Text": "Larginine", "em2Text": "arginase", "label": "CPR:3"}]}
{"sentText": "To determine whether arginases modulate the endothelial NO synthesis we investigated the effects of the competitive arginase inhibitor NomegahydroxynorLarginine NorNOHA on the activity of NOS arginases and Larginine transporter and on NO release at surface of human umbilical vein endothelial cells HUVECs", "relationMentions": [{"em1Text": "arginase", "em2Text": "NomegahydroxynorLarginine", "label": "CPR:4"}, {"em1Text": "arginase", "em2Text": "NorNOHA", "label": "CPR:4"}, {"em1Text": "arginases", "em2Text": "NO", "label": "CPR:9"}]}
{"sentText": "In unstimulated cells NorNOHA dosedependently reduced the arginase activity with maximal inhibition at 20 microM", "relationMentions": [{"em1Text": "NorNOHA", "em2Text": "arginase", "label": "CPR:4"}]}
{"sentText": "However despite activation of Larginine uptake the inhibition of arginase activity by NorNOHA was still significant", "relationMentions": [{"em1Text": "arginase", "em2Text": "NorNOHA", "label": "CPR:4"}]}
{"sentText": "These data suggest that endothelial NO synthesis depends on the activity of arginase II in mitochondria and larginine carriers in cell membrane", "relationMentions": [{"em1Text": "NO", "em2Text": "arginase II", "label": "CPR:9"}]}
{"sentText": "Reduced synthesis of nitric oxide NO contributes to the endothelial dysfunction and may be related to limited availability of Larginine the common substrate of constitutive nitricoxide synthase NOS and cytosolic arginase I and mitochondrial arginase II", "relationMentions": [{"em1Text": "nitric oxide", "em2Text": "constitutive nitricoxide synthase", "label": "CPR:9"}, {"em1Text": "nitric oxide", "em2Text": "NOS", "label": "CPR:9"}, {"em1Text": "nitric oxide", "em2Text": "arginase I", "label": "CPR:9"}, {"em1Text": "nitric oxide", "em2Text": "mitochondrial arginase II", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "constitutive nitricoxide synthase", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "NOS", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "arginase I", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "mitochondrial arginase II", "label": "CPR:9"}, {"em1Text": "Larginine", "em2Text": "constitutive nitricoxide synthase", "label": "CPR:9"}, {"em1Text": "Larginine", "em2Text": "NOS", "label": "CPR:9"}, {"em1Text": "Larginine", "em2Text": "arginase I", "label": "CPR:9"}, {"em1Text": "Larginine", "em2Text": "mitochondrial arginase II", "label": "CPR:9"}]}
{"sentText": "Mitochondrial arginase II modulates nitricoxide synthesis through nonfreely exchangeable Larginine pools in human endothelial cells", "relationMentions": [{"em1Text": "Mitochondrial arginase II", "em2Text": "nitricoxide", "label": "CPR:9"}, {"em1Text": "Mitochondrial arginase II", "em2Text": "Larginine", "label": "CPR:9"}]}
{"sentText": "However pretreatment with agents that block late INa like lidocaine mexiletine and RSD1235 a novel mixed ion channel blocker for the rapid pharmacologic conversion of atrial fibrillation significantly attenuates the prolonging effects of Class III agents or those induced by ATXII a specific toxin that delays Na channel inactivation and amplifies late INa greatly mimicking LQT3", "relationMentions": [{"em1Text": "RSD1235", "em2Text": "ion channel", "label": "CPR:4"}]}
{"sentText": "The Na channel block caused by lidocaine and RSD1235 can be through the open or inactivated states of the channel but both equivalently inhibit a late component of Na current INa recorded at 22 degrees C using wholecell patch clamp of Nav 15 expressed in HEK cells", "relationMentions": [{"em1Text": "Na channel", "em2Text": "lidocaine", "label": "CPR:4"}, {"em1Text": "Na channel", "em2Text": "RSD1235", "label": "CPR:4"}]}
{"sentText": "The above results indicate that polyamine depletion delays the onset of apoptosis in IEC6 cells and confers protection against DNA damaging agents suggesting that polyamines might be involved in the caspase activating signal cascade", "relationMentions": [{"em1Text": "polyamines", "em2Text": "caspase", "label": "CPR:3"}]}
{"sentText": "Addition of putrescine restored the induction of apoptosis as indicated by an increase in the number of detached cells and caspase 3 activity", "relationMentions": [{"em1Text": "putrescine", "em2Text": "caspase 3", "label": "CPR:3"}]}
{"sentText": "Depletion of putrescine spermidine and spermine by DLalphadifluoromethylornithine DFMO a specific inhibitor of ornithine decarboxylase ODC that is the first ratelimiting enzyme for polyamine biosynthesis decreased the apoptotic index", "relationMentions": [{"em1Text": "DLalphadifluoromethylornithine", "em2Text": "ornithine decarboxylase", "label": "CPR:4"}, {"em1Text": "DLalphadifluoromethylornithine", "em2Text": "ODC", "label": "CPR:4"}, {"em1Text": "DFMO", "em2Text": "ornithine decarboxylase", "label": "CPR:4"}, {"em1Text": "DFMO", "em2Text": "ODC", "label": "CPR:4"}, {"em1Text": "putrescine", "em2Text": "ornithine decarboxylase", "label": "CPR:9"}, {"em1Text": "putrescine", "em2Text": "ODC", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "ornithine decarboxylase", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "ODC", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "ornithine decarboxylase", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "ODC", "label": "CPR:9"}]}
{"sentText": "Inhibition of Sadenosylmethionine decarboxylase by a specific inhibitor diethylglyoxal bisguanylhydrazone DEGBG led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC", "relationMentions": [{"em1Text": "Sadenosylmethionine decarboxylase", "em2Text": "diethylglyoxal bisguanylhydrazone", "label": "CPR:4"}, {"em1Text": "Sadenosylmethionine decarboxylase", "em2Text": "DEGBG", "label": "CPR:4"}, {"em1Text": "Sadenosylmethionine decarboxylase", "em2Text": "spermidine", "label": "CPR:9"}, {"em1Text": "Sadenosylmethionine decarboxylase", "em2Text": "spermine", "label": "CPR:9"}]}
{"sentText": "On the other hand in patients with a mean serum carvedilol level Cmin of less than 25 nmoll up to 2 weeks after the start ofcarvedilol therapy the degree of reduction in the BNP value after the 3rd month was significantly larger relative to the patient group with Cmin over 25 nmoll", "relationMentions": [{"em1Text": "carvedilol", "em2Text": "BNP", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "BNP", "label": "CPR:4"}]}
{"sentText": "Two mechanisms of action have been identified for A77 1726 inhibition of dihydroorotate dehydrogenase DHODH and inhibition of tyrosine kinases", "relationMentions": [{"em1Text": "A77 1726", "em2Text": "dihydroorotate dehydrogenase", "label": "CPR:4"}, {"em1Text": "A77 1726", "em2Text": "DHODH", "label": "CPR:4"}, {"em1Text": "A77 1726", "em2Text": "tyrosine kinases", "label": "CPR:4"}]}
{"sentText": "DHODH inhibition occurs at lower concentrations of A77 1726 than that of tyrosine kinases and is currently considered the major mode of action", "relationMentions": [{"em1Text": "DHODH", "em2Text": "A77 1726", "label": "CPR:4"}, {"em1Text": "A77 1726", "em2Text": "tyrosine kinases", "label": "CPR:4"}]}
{"sentText": "Interestingly the allele of PRO1 was shown to enhance the activities of gammaglutamyl kinase and gammaglutamyl phosphate reductase both of which catalyze the first two steps of Lproline synthesis from Lglutamate and which together may form a complex in vivo", "relationMentions": [{"em1Text": "gammaglutamyl kinase", "em2Text": "Lproline", "label": "CPR:9"}, {"em1Text": "gammaglutamyl phosphate reductase", "em2Text": "Lproline", "label": "CPR:9"}, {"em1Text": "gammaglutamyl kinase", "em2Text": "Lglutamate", "label": "CPR:9"}, {"em1Text": "gammaglutamyl phosphate reductase", "em2Text": "Lglutamate", "label": "CPR:9"}]}
{"sentText": "Lproline accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding gammaglutamyl kinase", "relationMentions": [{"em1Text": "Lproline", "em2Text": "gammaglutamyl kinase", "label": "CPR:9"}]}
{"sentText": "When cultured in liquid minimal medium yeast cells expressing the mutated gammaglutamyl kinase were found to accumulate intracellular Lproline and showed a prominent increase in cell viability after freezing at 20 degrees C compared to the viability of cells harboring the wildtype PRO1 gene", "relationMentions": [{"em1Text": "gammaglutamyl kinase", "em2Text": "Lproline", "label": "CPR:9"}]}
{"sentText": "These results suggest that the altered gammaglutamyl kinase results in stabilization of the complex or has an indirect effect on gammaglutamyl phosphate reductase activity which leads to an increase in Lproline production in Saccharomyces cerevisiae", "relationMentions": [{"em1Text": "gammaglutamyl kinase", "em2Text": "Lproline", "label": "CPR:9"}, {"em1Text": "gammaglutamyl phosphate reductase", "em2Text": "Lproline", "label": "CPR:9"}]}
{"sentText": "We report here the optimization of human 17\u03b2HSD2 inhibitors in the 25thiophene amide class by varying the size of the linker n equals 0 and 2 between the amide moiety and the phenyl group", "relationMentions": [{"em1Text": "human 17\u03b2HSD2", "em2Text": "25thiophene amide", "label": "CPR:4"}]}
{"sentText": "While none of the phenethylamides n = 2 were active most of the anilides n = 0 turned out to moderately or strongly inhibit 17\u03b2HSD2", "relationMentions": [{"em1Text": "anilides", "em2Text": "17\u03b2HSD2", "label": "CPR:4"}]}
{"sentText": "Structural optimization of 25thiophene amides as highly potent and selective 17\u03b2hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis", "relationMentions": [{"em1Text": "25thiophene amides", "em2Text": "17\u03b2hydroxysteroid dehydrogenase type 2", "label": "CPR:4"}]}
{"sentText": "Theophylline exposure resulted in a sustained increase in mRNA expression for CysS and PDE3A but PDE4D gene expression was unchanged", "relationMentions": [{"em1Text": "Theophylline", "em2Text": "CysS", "label": "CPR:3"}, {"em1Text": "Theophylline", "em2Text": "PDE3A", "label": "CPR:3"}]}
{"sentText": "Multiple exposure to theophylline a phosphodiesterase PDE inhibitor induces acinar hypertrophy in the salivary gland", "relationMentions": [{"em1Text": "theophylline", "em2Text": "PDE", "label": "CPR:4"}, {"em1Text": "theophylline", "em2Text": "phosphodiesterase", "label": "CPR:4"}]}
{"sentText": "Terbutaline Bricanyl and its prodrug Bambuterol Bambec are highly potent beta2adrenoceptor agonists often used in asthma patients", "relationMentions": [{"em1Text": "Bambuterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "Bambec", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "Terbutaline", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "Bricanyl", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1Badrenoceptors by treatment with chlorethylclonidine which is an indication that the tamsulosinsensitive subtype belongs to a class resistant to chlorethylclonidine", "relationMentions": [{"em1Text": "alpha 1Badrenoceptors", "em2Text": "chlorethylclonidine", "label": "CPR:4"}, {"em1Text": "phenylephrine", "em2Text": "alpha 1Badrenoceptors", "label": "CPR:5"}, {"em1Text": "Tamsulosin", "em2Text": "alpha 1Badrenoceptors", "label": "CPR:6"}]}
{"sentText": "These results indicate that the positive inotropic effect mediated via tamsulosin and oxymetazoline sensitive subtype of alpha 1adrenoceptors is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates", "relationMentions": [{"em1Text": "oxymetazoline", "em2Text": "alpha 1adrenoceptors", "label": "CPR:5"}, {"em1Text": "tamsulosin", "em2Text": "alpha 1adrenoceptors", "label": "CPR:6"}]}
{"sentText": "Phenylephrine elicited a concentrationdependent positive inotropic effect via alpha 1adrenoceptors in the presence of either bupranolol or Stimolol", "relationMentions": [{"em1Text": "Phenylephrine", "em2Text": "alpha 1adrenoceptors", "label": "CPR:5"}]}
{"sentText": "The influence of tamsulosin a selective alpha 1Aadrenoceptor antagonist on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1adrenoceptors was studied in comparison with that of another alpha 1Aadrenoceptor ligand oxymetazoline in the rabbit ventricular myocardium", "relationMentions": [{"em1Text": "tamsulosin", "em2Text": "alpha 1Aadrenoceptor", "label": "CPR:6"}]}
{"sentText": "tamsulosin an alpha 1Aadrenoceptor antagonist inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart", "relationMentions": [{"em1Text": "tamsulosin", "em2Text": "alpha 1Aadrenoceptor", "label": "CPR:6"}]}
{"sentText": "Tamsulosin over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1adrenoceptors did not affect the accumulation of 3Hinositol phosphates that was induced by 10 microM phenylephrine", "relationMentions": [{"em1Text": "Tamsulosin", "em2Text": "alpha 1adrenoceptors", "label": "CPR:6"}]}
{"sentText": "PTE also downregulated the expression of STAT3 target genes including the antiapoptotic proteins BclxL and Mcl1 leading to the upregulation of mitochondrial apoptosis pathwayrelated proteins Bax Bak cytosolic Cytochrome c and cleaved Caspase3 and cyclindependent kinase inhibitors such as p21 and p27", "relationMentions": [{"em1Text": "PTE", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "PTE", "em2Text": "Bak", "label": "CPR:3"}, {"em1Text": "PTE", "em2Text": "Cytochrome c", "label": "CPR:3"}, {"em1Text": "PTE", "em2Text": "Caspase3", "label": "CPR:3"}, {"em1Text": "PTE", "em2Text": "p21", "label": "CPR:3"}, {"em1Text": "PTE", "em2Text": "p27", "label": "CPR:3"}, {"em1Text": "PTE", "em2Text": "STAT3", "label": "CPR:4"}, {"em1Text": "PTE", "em2Text": "BclxL", "label": "CPR:4"}, {"em1Text": "PTE", "em2Text": "Mcl1", "label": "CPR:4"}]}
{"sentText": "Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2 STAT3 signaling pathway", "relationMentions": [{"em1Text": "Pterostilbene", "em2Text": "JAK2", "label": "CPR:4"}, {"em1Text": "Pterostilbene", "em2Text": "STAT3", "label": "CPR:4"}]}
{"sentText": "Furthermore PTE treatment directly inhibited the phosphorylation of JAK2 at Tyr 1007 and the downstream activation of STAT3", "relationMentions": [{"em1Text": "PTE", "em2Text": "JAK2", "label": "CPR:4"}, {"em1Text": "PTE", "em2Text": "STAT3", "label": "CPR:4"}]}
{"sentText": "PTE used in combination with a known JAK2 STAT3 inhibitor AG490 further decreased the viability of osteosarcoma cells", "relationMentions": [{"em1Text": "JAK2", "em2Text": "AG490", "label": "CPR:4"}, {"em1Text": "STAT3", "em2Text": "AG490", "label": "CPR:4"}]}
{"sentText": "Taken together PTE is a potent inhibitor of osteosarcoma cell growth that targets the JAK2 STAT3 signaling pathway", "relationMentions": [{"em1Text": "PTE", "em2Text": "JAK2", "label": "CPR:4"}, {"em1Text": "PTE", "em2Text": "STAT3", "label": "CPR:4"}]}
{"sentText": "These data suggest that inhibition of JAK2 STAT3 signaling is a novel mechanism of action for PTE during therapeutic intervention in osteosarcoma cancers", "relationMentions": [{"em1Text": "JAK2", "em2Text": "PTE", "label": "CPR:4"}, {"em1Text": "STAT3", "em2Text": "PTE", "label": "CPR:4"}]}
{"sentText": "Furthermore sinapic acid reduced hepatic hydroxyproline content which correlated with a reduction in the expression of type I collagen mRNA and histological analysis of collagen in liver tissue", "relationMentions": [{"em1Text": "sinapic acid", "em2Text": "type I collagen", "label": "CPR:4"}]}
{"sentText": "Additionally the expression of hepatic fibrosisrelated factors such as \u03b1smooth muscle actin and transforming growth factor\u03b21 TGF\u03b21 were reduced in rats treated with sinapic acid", "relationMentions": [{"em1Text": "\u03b1smooth muscle actin", "em2Text": "sinapic acid", "label": "CPR:4"}, {"em1Text": "transforming growth factor\u03b21", "em2Text": "sinapic acid", "label": "CPR:4"}, {"em1Text": "TGF\u03b21", "em2Text": "sinapic acid", "label": "CPR:4"}]}
{"sentText": "In conclusion we find that sinapic acid exhibits hepatoprotective and antifibrotic effects against DMNinduced liver injury most likely due to its antioxidant activities of scavenging radicals its capacity to suppress TGF\u03b21 and its ability to attenuate activation of hepatic stellate cells", "relationMentions": [{"em1Text": "sinapic acid", "em2Text": "TGF\u03b21", "label": "CPR:4"}]}
{"sentText": "Thalidomide reduced COX2 expression accompanied by a decrease of bcl2 protein TNFalpha VEGF GSH and an increased cytochrome c but had no effect on that of COX1 in MCF7 and HL60", "relationMentions": [{"em1Text": "Thalidomide", "em2Text": "cytochrome c", "label": "CPR:3"}, {"em1Text": "Thalidomide", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "Thalidomide", "em2Text": "bcl2", "label": "CPR:4"}, {"em1Text": "Thalidomide", "em2Text": "TNFalpha", "label": "CPR:4"}, {"em1Text": "Thalidomide", "em2Text": "VEGF", "label": "CPR:4"}]}
{"sentText": "Thalidomide inhibits growth of tumors through COX2 degradation independent of antiangiogenesis", "relationMentions": [{"em1Text": "Thalidomide", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "These results demonstrated that thalidomide might inhibit growth of tumors through COX2 degradation independent of antiangiogenesis", "relationMentions": [{"em1Text": "thalidomide", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Gene expression profiling GEP of GISTS GISTR cells and two IM resistant GIST patients demonstrated that KIT is downregulated implying a major role in IM resistance", "relationMentions": [{"em1Text": "IM", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "IM", "em2Text": "KIT", "label": "CPR:4"}]}
{"sentText": "Molecular modeling of the kinase domain of mutant cKit V654A and AXL showed no binding to IM but efficient binding to MP470 a novel cKitAXL kinase inhibitor", "relationMentions": [{"em1Text": "cKit", "em2Text": "MP470", "label": "CPR:4"}, {"em1Text": "AXL", "em2Text": "MP470", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "MP470", "label": "CPR:4"}]}
{"sentText": "INTRODUCTION In this study we examined the effects of the alphaglucosidase inhibitors acarbose and voglibose on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus", "relationMentions": [{"em1Text": "alphaglucosidase", "em2Text": "voglibose", "label": "CPR:4"}, {"em1Text": "alphaglucosidase", "em2Text": "acarbose", "label": "CPR:4"}, {"em1Text": "alphaglucosidase", "em2Text": "glucose", "label": "CPR:4"}]}
{"sentText": "Blockade of JAK and ERK pathways with AG490 and U0126 respectively abrogated the myocardial infarct size reduction by NDP\u03b1MSH", "relationMentions": [{"em1Text": "JAK", "em2Text": "AG490", "label": "CPR:4"}, {"em1Text": "ERK", "em2Text": "U0126", "label": "CPR:4"}]}
{"sentText": "They included the COX1 inhibitor indomethacin the COX2 inhibitor NS398 the mixed COX1COX2 inhibitor ibuprofen the nitric oxide NO derivatives of indomethacin ibuprofen and flurbiprofen the 5LOX inhibitor REV 5901 and the 5LOX activating protein FLAP inhibitor MK886", "relationMentions": [{"em1Text": "5LOX", "em2Text": "REV 5901", "label": "CPR:4"}, {"em1Text": "5LOX activating protein", "em2Text": "MK886", "label": "CPR:4"}, {"em1Text": "FLAP", "em2Text": "MK886", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "NS398", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "ibuprofen", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "ibuprofen", "label": "CPR:4"}]}
{"sentText": "The COX pathway generates inflammatory prostaglandins while the 5LOX pathway generates inflammatory leukotrienes", "relationMentions": [{"em1Text": "COX", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "5LOX", "em2Text": "leukotrienes", "label": "CPR:9"}]}
{"sentText": "Additionally MPTP significantly downregulated Bcl2 expression in the mitochondria of dopaminergic cells in the SN followed by an increase in Bax expression cytochrome C translocation to the cytosol andcleaved caspase3 expression whereas these were inhibited by CRE or EB treatment", "relationMentions": [{"em1Text": "MPTP", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "MPTP", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "MPTP", "em2Text": "Bcl2", "label": "CPR:4"}]}
{"sentText": "The hemoglobin A1c HbA1c of all patients improved significantly from 81\u00b112 to 76\u00b111 after 12 weeks of addon therapy with sitagliptin p001 and the insulin dosage was reduced from 273\u00b1158 Uday to 245\u00b1165 Uday p0001", "relationMentions": [{"em1Text": "hemoglobin A1c", "em2Text": "sitagliptin", "label": "CPR:3"}, {"em1Text": "HbA1c", "em2Text": "sitagliptin", "label": "CPR:3"}]}
{"sentText": "Addon therapy with the DPP4 inhibitor sitagliptin improves glycemic control in insulintreated Japanese patients with type 2 diabetes mellitus", "relationMentions": [{"em1Text": "DPP4", "em2Text": "sitagliptin", "label": "CPR:4"}]}
{"sentText": "In the present study we have evaluated possible participation of monocarboxylate transporters MCTs responsible for the bidirectional membrane transport of pyruvate in the cytoprotective property in osteoblasts", "relationMentions": [{"em1Text": "monocarboxylate transporters", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "MCTs", "em2Text": "pyruvate", "label": "CPR:9"}]}
{"sentText": "Mammalian ALDH1B1 another mitochondrial enzyme sharing 72 identity with ALDH2 is also capable of metabolizing acetaldehyde but has a tissue distribution and pattern of activity distinct from that of ALDH2", "relationMentions": [{"em1Text": "Mammalian ALDH1B1", "em2Text": "acetaldehyde", "label": "CPR:9"}, {"em1Text": "ALDH2", "em2Text": "acetaldehyde", "label": "CPR:9"}]}
{"sentText": "However salicylate moiety appears to interfere with aspirin inhibitory action on platelets and vascular COX", "relationMentions": [{"em1Text": "aspirin", "em2Text": "COX", "label": "CPR:4"}]}
{"sentText": "Aspirin ASA and other nonsteroidal antiinflammatory drugs which are cyclooxygenase COX inhibitors precipitate asthmatic attacks in ASAintolerant patients while sodium salicylate hardly active on COX by itself is well tolerated by these patients", "relationMentions": [{"em1Text": "Aspirin", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "Aspirin", "em2Text": "COX", "label": "CPR:4"}, {"em1Text": "ASA", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "ASA", "em2Text": "COX", "label": "CPR:4"}]}
{"sentText": "Although the precise mechanism of the protective action of trilisate is unknown our data support the possibility of interaction between salicylate and ASA on cyclooxygenase locus in the respiratory tract in ASAintolerant patients", "relationMentions": [{"em1Text": "salicylate", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "ASA", "em2Text": "cyclooxygenase", "label": "CPR:4"}]}
{"sentText": "Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice", "relationMentions": [{"em1Text": "Minocycline", "em2Text": "cytochrome c", "label": "CPR:4"}]}
{"sentText": "We find that minocycline inhibits mitochondrial permeabilitytransitionmediated cytochrome c release", "relationMentions": [{"em1Text": "minocycline", "em2Text": "cytochrome c", "label": "CPR:4"}]}
{"sentText": "Minocycline mediated inhibition of cytochrome c release is demonstrated in vivo in cells and in isolated mitochondria", "relationMentions": [{"em1Text": "Minocycline", "em2Text": "cytochrome c", "label": "CPR:4"}]}
{"sentText": "Here we studied the effects of the recently developed monoacylglycerol lipase inhibitor JZL184 on basal and stressinduced corticosterone levels in male CD1 mice and found that this compound dramatically increased basal levels without affecting stress responses", "relationMentions": [{"em1Text": "monoacylglycerol lipase", "em2Text": "JZL184", "label": "CPR:4"}]}
{"sentText": "Among these differentially expressed lncRNAs the greatest change was noted for uc002mbe2 which had more than 300 folds induction upon TSA treatment", "relationMentions": [{"em1Text": "uc002mbe2", "em2Text": "TSA", "label": "CPR:3"}]}
{"sentText": "TSA selectively induced uc002mbe2 in four studied HCC cell lines", "relationMentions": [{"em1Text": "TSA", "em2Text": "uc002mbe2", "label": "CPR:3"}]}
{"sentText": "The TSA induced uc002mbe2 expression was positively correlated with the apoptotic effect of TSA in HCC cells", "relationMentions": [{"em1Text": "TSA", "em2Text": "uc002mbe2", "label": "CPR:3"}]}
{"sentText": "Considerable attention has focused on the antitumor effect of histone deacetylase inhibitor Trichostatin A TSA as well as the coding gene expressioninduced apoptosis of cancer cells", "relationMentions": [{"em1Text": "histone deacetylase", "em2Text": "Trichostatin A", "label": "CPR:4"}, {"em1Text": "histone deacetylase", "em2Text": "TSA", "label": "CPR:4"}]}
{"sentText": "Orlistat treatment also results in modest improvements in total cholesterol lowdensity lipoprotein blood pressure and fasting glucose and insulin concentrations", "relationMentions": [{"em1Text": "Orlistat", "em2Text": "lowdensity lipoprotein", "label": "CPR:3"}, {"em1Text": "Orlistat", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "Orlistat a new lipase inhibitor for the management of obesity", "relationMentions": [{"em1Text": "Orlistat", "em2Text": "lipase", "label": "CPR:4"}]}
{"sentText": "Evidence has accumulated in the last few years that the expression of the microsomalperoxidase antigen MTPOAg in thyroid cells is induced by TSH through pathways which involve intracellular cAMP accumulation and protein synthesis", "relationMentions": [{"em1Text": "microsomalperoxidase antigen", "em2Text": "cAMP", "label": "CPR:3"}, {"em1Text": "MTPOAg", "em2Text": "cAMP", "label": "CPR:3"}]}
{"sentText": "TSH and cAMP also increase the levels of the specific mRNA for TPO in thyroid cells from different species", "relationMentions": [{"em1Text": "cAMP", "em2Text": "TPO", "label": "CPR:3"}]}
{"sentText": "A novel benzodimidazole derivate prevents the development of dextran sulfate sodiuminduced murine experimental colitis via inhibition of NLRP3 inflammasome", "relationMentions": [{"em1Text": "benzodimidazole", "em2Text": "NLRP3", "label": "CPR:4"}]}
{"sentText": "Furthermore a decreased CD11c macrophage infiltration in colons and inactivation of caspase1 in peritoneal macrophages were detected in Fc11a 2treated mice", "relationMentions": [{"em1Text": "caspase1", "em2Text": "Fc11a", "label": "CPR:4"}]}
{"sentText": "The mechanism of action of Fc11a2 was related to the inhibition of the cleavage of procaspase1 proIL1\u03b2 and proIL18 which in turn suppressed the activation of NLRP3 inflammasome", "relationMentions": [{"em1Text": "Fc11a2", "em2Text": "procaspase1", "label": "CPR:4"}, {"em1Text": "Fc11a2", "em2Text": "proIL1\u03b2", "label": "CPR:4"}, {"em1Text": "Fc11a2", "em2Text": "proIL18", "label": "CPR:4"}, {"em1Text": "Fc11a2", "em2Text": "NLRP3", "label": "CPR:4"}]}
{"sentText": "Taken together our results demonstrate the ability of Fc11a2 to inhibit NLRP3 inflammasome activation and its potential use in the treatment of inflammatory bowel diseases", "relationMentions": [{"em1Text": "Fc11a2", "em2Text": "NLRP3", "label": "CPR:4"}]}
{"sentText": "In addition the disease activity index histopathologic scores and myeloperoxidase activity were also significantly reduced by Fc11a2 treatment", "relationMentions": [{"em1Text": "myeloperoxidase", "em2Text": "Fc11a2", "label": "CPR:4"}]}
{"sentText": "Moreover protein and mRNA levels of DSSinduced proinflammatory cytokines in colon including TNF\u03b1 IL1\u03b2 IL18 IL17A and IFN\u03b3 were markedly suppressed by Fc11a2", "relationMentions": [{"em1Text": "cytokines", "em2Text": "Fc11a2", "label": "CPR:4"}, {"em1Text": "TNF\u03b1", "em2Text": "Fc11a2", "label": "CPR:4"}, {"em1Text": "IL1\u03b2", "em2Text": "Fc11a2", "label": "CPR:4"}, {"em1Text": "IL18", "em2Text": "Fc11a2", "label": "CPR:4"}, {"em1Text": "IL17A", "em2Text": "Fc11a2", "label": "CPR:4"}, {"em1Text": "IFN\u03b3", "em2Text": "Fc11a2", "label": "CPR:4"}]}
{"sentText": "At PND35 the medial prefrontal cortex mPFC of rats given MPH showed 55 greater immunoreactivity ir for the catecholamine marker tyrosine hydroxylase TH 60 more Nisslstained cells and 40 less norepinephrine transporter NET ir density", "relationMentions": [{"em1Text": "MPH", "em2Text": "tyrosine hydroxylase", "label": "CPR:3"}, {"em1Text": "MPH", "em2Text": "TH", "label": "CPR:3"}, {"em1Text": "MPH", "em2Text": "norepinephrine transporter", "label": "CPR:4"}, {"em1Text": "MPH", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "In hippocampal dentate gyrus MPH receiving rats showed a 51 decrease in NET ir density and a 61 expanded distribution of the newcell marker PSA NCAM polysialylated form of neural cell adhesion molecule", "relationMentions": [{"em1Text": "MPH", "em2Text": "neural cell adhesion molecule", "label": "CPR:3"}, {"em1Text": "MPH", "em2Text": "NCAM", "label": "CPR:3"}, {"em1Text": "MPH", "em2Text": "NET", "label": "CPR:4"}]}
{"sentText": "In medial striatum TH ir decreased by 21 and in hypothalamus neuropeptide Y ir increased by 10 in MPH exposed rats", "relationMentions": [{"em1Text": "neuropeptide Y", "em2Text": "MPH", "label": "CPR:3"}, {"em1Text": "TH", "em2Text": "MPH", "label": "CPR:4"}]}
